Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

SCHEDULE 13E-3

RULE 13E-3 TRANSACTION STATEMENT UNDER SECTION 13(E)

OF THE SECURITIES ACT OF 1934

 

 

ZUORA, INC.

(Name of the Issuer)

 

 

Zuora, Inc.

Zodiac Purchaser, L.L.C.

Zodiac Acquisition Sub, Inc.

Zodiac Guarantor, L.L.C.

Zodiac Holdco, L.L.C.

Silver Lake Alpine Associates II, L.P.

SLA Zurich Holdings, L.P.

SLA Zurich GP, L.L.C.

SLA Zurich Aggregator, L.P.

SL Alpine II Aggregator GP, L.L.C.

Silver Lake Alpine II, L.P.

SLAA II (GP), L.L.C.

Silver Lake Group, L.L.C.

Tien Tzuo

(Names of Persons Filing Statement)

Class A Common Stock, par value $0.0001 per share

(Title of Class of Securities)

98983V106

(CUSIP Number of Class of Securities)

 

Tien Tzuo

Chief Executive Officer

Zuora, Inc.

c/o Zuora, Inc.

101 Redwood Shores Parkway

Redwood City, CA

94065

Tel: (888) 976-9056

 

Zodiac Purchaser, L.L.C.

Zodiac Acquisition Sub, Inc.

c/o Silver Lake

2775 Sand Hill Road

Menlo Park, CA

94025

Tel: (650) 233-8120

 

Zodiac Guarantor, L.L.C.

Zodiac Holdco, L.L.C.

Silver Lake Alpine Associates II, L.P.

SLA Zurich Holdings, L.P.

SLA Zurich GP, L.L.C.

SLA Zurich Aggregator, L.P.

SL Alpine II Aggregator GP, L.L.C.

Silver Lake Alpine II, L.P.

SLAA II (GP), L.L.C.

Silver Lake Group, L.L.C.

2775 Sand Hill Road

Menlo Park, CA

94025

Tel: (650) 233-8120

(Name, Address, and Telephone Number of Person Authorized to Receive Notices and Communications on Behalf of the Persons Filing Statement)

With copies to

 

Sarah K. Solum

Steven Li

Freshfields US LLP

855 Main Street

Redwood City, CA 94063

(650) 618-9250

 

Elizabeth Cooper

Louis Argentieri

Simpson Thacher & Bartlett LLP

New York, New York 10017

(212) 455-2000

 

Melissa Sawyer

Peter Jones

Sullivan & Cromwell LLP

125 Broad Street

New York, NY 10004-2498

United States

(212) 558-4000

 

 

This statement is filed in connection with (check the appropriate box):

 

a. 

    The filing of solicitation materials or an information statement subject to Regulation 14A, Regulation 14C or Rule 13e-3(c) under the Securities Exchange Act of 1934.

b. 

    The filing of a registration statement under the Securities Act of 1933.

c. 

    A tender offer.

d. 

    None of the above.

Check the following box if the soliciting materials or information statement referred to in checking box (a) are preliminary copies:

Check the following box if the filing is a final amendment reporting the results of the transaction:

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of this transaction, passed upon the merits or fairness of this transaction, or passed upon the adequacy or accuracy of the disclosure in this transaction statement on Schedule 13E-3. Any representation to the contrary is a criminal offense.

 

 

 


Table of Contents

TABLE OF CONTENTS

 

Item 1. Summary Term Sheet

     3  

Item 2. Subject Company Information

     3  

Item 3. Identity and Background of Filing Person

     4  

Item 4. Terms of the Transaction

     4  

Item 5. Past Contacts, Transactions, Negotiations and Agreements

     6  

Item 6. Purposes of the Transaction and Plans or Proposals

     7  

Item 7. Purposes, Alternatives, Reasons and Effects

     9  

Item 8. Fairness of the Transaction

     11  

Item 9. Reports, Opinions, Appraisals and Negotiations

     13  

Item 10. Source and Amounts of Funds or Other Consideration

     14  

Item 11. Interest in Securities of the Subject Company

     14  

Item 12. The Solicitation or Recommendation

     15  

Item 13. Financial Statements

     16  

Item 14. Persons/assets Retained, Employed, Compensated or Used

     16  

Item 15. Additional Information

     17  

Item 16. Exhibits

     17  


Table of Contents

INTRODUCTION

This Transaction Statement on Schedule 13E-3 (this “Transaction Statement”) is being filed with the U.S. Securities and Exchange Commission (the “SEC”) pursuant to Section 13(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), jointly by the following persons (each, a “Filing Person,” and collectively, the “Filing Persons”): (1) Zuora, Inc., a Delaware corporation (“Zuora” or the “Company”) and the issuer of the (a) Class A Common Stock, par value $0.0001 per share (the “Zuora Class A Common Stock”) and (b) Class B Common Stock, par value $0.0001 per share (the “Zuora Class B Common Stock” and together with the Zuora Class A Common Stock, the “Zuora Common Stock”) that is the subject of the Rule 13e-3 transaction; (2) Zodiac Purchaser, L.L.C., a Delaware limited liability company (“Parent”); (3) Zodiac Acquisition Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (“Merger Sub”, and together with Parent, the “Parent Entities”); (4) Zodiac Guarantor, L.L.C. (“Guarantor”); (5) Zodiac Holdco, L.L.C. (“Holdco”); (6) Silver Lake Alpine Associates II, L.P., a Delaware limited partnership (“SLAA”); (7) SLA Zurich Holdings, L.P., a Delaware limited partnership (“SLA Zurich Holdings”); (8) SLA Zurich GP, L.L.C., a Delaware limited liability company (“SLA Zurich GP”); (9) SLA Zurich Aggregator, L.P., a Delaware limited partnership (“SLA Zurich Aggregator”); (10) SL Alpine II Aggregator GP, L.L.C., a Delaware limited liability company (“SLA Aggregator GP”); (11) Silver Lake Alpine II, L.P., a Delaware limited partnership (“SLA II”); (12) SLAA II (GP), L.L.C., a Delaware limited liability company (“SLAA GP”); (13) Silver Lake Group, L.L.C., a Delaware limited liability company (“SLG”, and together with Guarantor, Holdco, SLAA, SLA Zurich Holdings, SLA Zurich GP, SLA Zurich Aggregator, SLA Aggregator GP, SLA II and SLAA GP, the “Silver Lake Filing Parties”); and (14) Tien Tzuo (the “Tzuo Filing Party”).

This Transaction Statement relates to the Agreement and Plan of Merger, dated October 17, 2024 (including all exhibits and documents attached thereto, and as it may be amended, supplemented or modified, from time to time, the “Merger Agreement”), by and among Zuora, Parent and Merger Sub. The Merger Agreement provides that, subject to the terms and conditions set forth in the Merger Agreement, Merger Sub will merge with and into Zuora (the “Merger”), with Zuora surviving the Merger and becoming a wholly owned subsidiary of Parent.

At the effective time of the Merger (the “Effective Time”), (1) each share of Zuora Common Stock outstanding immediately prior to the Effective Time (other than shares held by (a) the Company, the Parent Entities and any of their respective subsidiaries and the shares of Zuora Common Stock rolled over by Tien Tzuo, The Next Left Trust and the 70 Thirty Trust (together, the “CEO Rollover Stockholders”) pursuant to the Support and Rollover Agreement (as defined below) (the “Owned Company Shares”) and (b) stockholders who have neither voted in favor of the adoption of the Merger Agreement nor consented thereto in writing, who are entitled to appraisal and who have properly exercised appraisal rights for such shares in accordance with Section 262 of the General Corporation Law of the State of Delaware (the “DGCL”)) and who do not validly withdraw or otherwise lose their appraisal rights will be cancelled and extinguished and automatically converted into the right to receive cash in an amount equal to $10.00 per share, without interest thereon and subject to any applicable withholding taxes and (2) each Owned Company Share will be cancelled and extinguished without any conversion thereof or consideration paid therefor. Following the Merger, Zuora Class A Common Stock will be delisted from the New York Stock Exchange (“NYSE”), Zuora will be deregistered under the Exchange Act and the Company’s stockholders (other than the Silver Lake Filing Parties and the CEO Rollover Stockholders, indirectly) will cease to have any ownership interest in the Company.

In connection with entering into the Merger Agreement, on October 17, 2024, the CEO Rollover Stockholders entered into a voting, support and rollover agreement (the “Support and Rollover Agreement”) with Parent, Holdco, Zuora and, solely for purposes specified therein, SLA II. Pursuant to the Support and Rollover Agreement, the CEO Rollover Stockholders agreed, among other things, to vote all of their shares of Zuora Common Stock in favor of the adoption of the Merger Agreement, subject to the terms and conditions contained in the Support and Rollover Agreement. In addition, pursuant to the Support and Rollover Agreement, the CEO Rollover Stockholders will elect and thereafter contribute shares of Zuora Common Stock with an aggregate value of $70,000,000 (the “Aggregate Rolled Value”) to a direct or indirect parent company of Parent in exchange for equity interests in such direct or indirect parent company of Parent. As a result of the Merger, the shares of Zuora Common Stock contributed to such direct or indirect parent company of Parent by the CEO Rollover Stockholders will be cancelled and extinguished without any conversion thereof or consideration paid therefor along with the other Owned Company Shares.

Zuora’s Board of Directors (the “Zuora Board”) formed a Special Committee of the Zuora Board comprised solely of independent and disinterested directors (the “Special Committee”) to explore, consider, review, evaluate and, if appropriate, negotiate the terms of, one or more transactions for strategic alternatives to the current stand-alone plan for Zuora, including a potential sale of Zuora (the foregoing, collectively, the “Strategic Alternatives Process”). The Special Committee, as more fully described in the Proxy Statement, with the assistance of its own independent financial and legal advisors, considered, evaluated and negotiated the Merger Agreement. At the conclusion of its review, the Special Committee, among other things, unanimously (1) determined that the Merger Agreement, the Merger and the other transactions contemplated by the Merger Agreement are advisable, fair to and in the best interests of Zuora and the Unaffiliated Company Stockholders (as defined below), (2) recommended that the Zuora Board determine that the Merger Agreement, the Merger and the other transactions contemplated by the Merger Agreement are advisable, fair to and in the best interests of Zuora and its stockholders and adopt and approve the Merger Agreement, the Merger and the other transactions contemplated by the Merger Agreement and (3) recommended that, subject to approval by the Zuora Board, the Zuora Board submit the Merger Agreement to Zuora’s stockholders entitled to vote thereon for adoption thereby and resolve to recommend that such stockholders adopt the Merger Agreement and approve the transactions contemplated by the Merger Agreement, including the Merger. “Unaffiliated Company Stockholders” means the holders of Zuora common stock, excluding (1) any holder who enters into a rollover agreement, including Mr. Tien Tzuo and certain of his affiliates that hold shares of Zuora common stock, (2) the Silver Lake Filing Parties or its affiliates (including Parent and Merger Sub), (3) any person that Zuora has determined to be an “officer” of Zuora within the meaning of Rule 16a-1(f) of the Securities Exchange Act of 1934, as amended and (4) those members of the Zuora Board who are (A) not members of the Special Committee or (B) members designated by an affiliate of the Silver Lake Filing Parties.

 

1

 


Table of Contents

The Zuora Board, acting upon the unanimous recommendation of the Special Committee, unanimously (1) determined that the Merger Agreement, the Merger and the other transactions contemplated by the Merger Agreement are advisable, fair to and in the best interests of Zuora and its stockholders, (2) adopted and approved the Merger Agreement, the Merger and the other transactions contemplated by the Merger Agreement and (3) directed that the Merger Agreement be submitted to Zuora’s stockholders entitled to vote thereon for adoption thereby and resolved to recommend that such stockholders adopt the Merger Agreement and the transactions contemplated thereby, including the Merger.

The Merger cannot be completed without the affirmative vote of (1) the holders of a majority of the voting power of the outstanding shares of capital stock of Zuora entitled to vote thereon, voting as a single class, (2) the holders of a majority of the voting power of the outstanding shares of capital stock of Zuora held by the Unaffiliated Company Stockholders entitled to vote thereon, voting as a single class, and (3) the holders of a majority of the outstanding shares of Zuora Class A Common Stock and Zuora Class B Common Stock entitled to vote thereon, each voting separately as a class.

Concurrently with the filing of this Transaction Statement, the Company is filing a proxy statement (the “Proxy Statement”) under Regulation 14A of the Exchange Act with the SEC, pursuant to which the Company is soliciting proxies from the Company’s stockholders in connection with the Merger. The Proxy Statement is attached hereto as Exhibit (a)(1). A copy of the Merger Agreement is attached to the Proxy Statement as Annex A. As of the date hereof, the Proxy Statement is in preliminary form, and is subject to completion or amendment. Terms used but not defined in this Transaction Statement have the meanings assigned to them in the Proxy Statement.

Pursuant to General Instruction F to Schedule 13E-3, the information in the Proxy Statement, including all annexes thereto, is expressly incorporated by reference herein in its entirety, and responses to each item herein are qualified in their entirety by the information contained in the Proxy Statement. The cross-references below are being supplied pursuant to General Instruction G to Schedule 13E-3 and show the location in the Proxy Statement of the information required to be included in response to the items of Schedule 13E-3.

While each of the Filing Persons acknowledges that the Merger may be deemed to constitute a “going private” transaction for purposes of Rule 13e-3 under the Exchange Act, the filing of this Transaction Statement shall not be construed as an admission by any Filing Person, or by any affiliate of a Filing Person, that the Company is “controlled” by any of the Filing Persons and/or their respective affiliates.

 

2

 


Table of Contents

SCHEDULE 13E-3 ITEMS

Item 1. Summary Term Sheet

The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

“Summary Term Sheet”

“Questions and Answers”

Item 2. Subject Company Information

(a) Name and address. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

“Summary Term Sheet—The Parties to the Merger”

“The Parties to the Merger—Zuora”

“Important Information Regarding Zuora”

“Questions and Answers”

(b) Securities. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

“Summary Term Sheet—The Special Meeting—Record Date; Shares Entitled to Vote; Quorum”

“The Special Meeting—Record Date; Shares Entitled to Vote; Quorum”

“Questions and Answers”

“Important Information Regarding Zuora—Security Ownership of Certain Beneficial Owners and Management”

(c) Trading market and price. The information set forth in the Proxy Statement under the following caption is incorporated herein by reference:

“Important Information Regarding Zuora—Market Price of Zuora Common Stock”

(d) Dividends. The information set forth in the Proxy Statement under the following caption is incorporated herein by reference:

“Important Information Regarding Zuora—Dividends”

(e) Prior public offerings. The information set forth in the Proxy Statement under the following caption is incorporated herein by reference:

“Important Information Regarding Zuora—Prior Public Offerings”

(f) Prior stock purchases. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

“Important Information Regarding Zuora—Prior Public Offerings”

“Important Information Regarding Zuora—Transactions in Zuora Common Stock”

 

3

 


Table of Contents

Item 3. Identity and Background of Filing Person

(a) — (c) Name and address; Business and background of entities; Business and background of natural persons. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

“Summary Term Sheet—The Parties to the Merger”

“The Parties to the Merger”

“Important Information Regarding Zuora”

“Important Information Regarding the Purchaser Filing Parties”

Item 4. Terms of the Transaction

(a)—(1) Material terms. Tender offers. Not applicable

(a)—(2) Material terms. Mergers or similar transactions. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

“Summary Term Sheet”

“Questions and Answers”

“Special Factors—Background of the Merger”

“Special Factors—Reasons for the Merger; Recommendation of the Special Committee and the Zuora Board”

“Special Factors—Purposes and Reasons of the Purchaser Filing Parties”

“Special Factors—Position of the Silver Lake Filing Parties and Parent Entities as to the Fairness of the Merger”

“Special Factors—Position of the CEO Rollover Stockholders as to the Fairness of the Merger”

“Special Factors—Plans for Zuora After the Merger”

“Special Factors—Certain Effects of the Merger”

“Special Factors—Certain Effects on Zuora if the Merger is Not Completed”

“Special Factors—Interests of Zuora’s Directors and Executive Officers in the Merger”

“Special Factors—U.S. Federal Income Tax Considerations of the Merger”

“Special Factors—Accounting Treatment”

“The Special Meeting—Votes Required”

“The Merger Agreement—Exchange and Payment Procedures”

“The Merger Agreement—Merger Consideration”

“The Merger Agreement—Conditions to the Closing of the Merger”

“The Voting, Support and Rollover Agreement”

 

4

 


Table of Contents

Annex A—Agreement and Plan of Merger

Annex C— The Voting, Support and Rollover Agreement

(c) Different terms. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

“Summary Term Sheet”

“Questions and Answers”

“Special Factors—Certain Effects of the Merger”

“Special Factors—Purposes and Reasons of the Purchaser Filing Parties”

“Special Factors—Interests of Zuora’s Directors and Executive Officers in the Merger”

“The Merger Agreement—Merger Consideration”

“The Merger Agreement—Exchange and Payment Procedures”

“The Merger Agreement—Employee Matters”

“The Merger Agreement—Indemnification and Insurance”

“The Voting, Support and Rollover Agreement”

“Proposal 2: The Compensation Proposal”

Annex A—Agreement and Plan of Merger

Annex C—The Voting, Support and Rollover Agreement

(d) Appraisal rights. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

“Summary Term Sheet—Appraisal Rights”

“Questions and Answers”

“The Special Meeting—Appraisal Rights”

“Appraisal Rights”

(e) Provisions for unaffiliated security holders. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

“Questions and Answers”

“Appraisal Rights”

“Provisions for Unaffiliated Company Stockholders”

(f) Eligibility for listing or trading. Not applicable.

 

5

 


Table of Contents

Item 5. Past Contacts, Transactions, Negotiations and Agreements

(a)(1) — (2) Transactions. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

“Summary Term Sheet”

“Special Factors—Background of the Merger”

“Special Factors—Certain Effects of the Merger”

“Special Factors—Interests of Zuora’s Directors and Executive Officers in the Merger”

“Special Factors—Financing of the Merger”

“The Merger Agreement”

“The Voting, Support and Rollover Agreement”

“Important Information Regarding Zuora—Prior Public Offerings”

“Important Information Regarding Zuora—Transactions in Zuora Common Stock”

“Important Information Regarding Zuora—Past Contracts, Transactions, Negotiations and Agreements”

“Important Information Regarding the Purchaser Filing Parties”

“Proposal 2: The Compensation Proposal”

Annex A—Agreement and Plan of Merger

Annex C—The Voting, Support and Rollover Agreement

(b) — (c) Significant corporate events; Negotiations or contacts. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

“Summary Term Sheet”

“Special Factors—Background of the Merger”

“Special Factors—Reasons for the Merger; Recommendation of the Special Committee and the Zuora Board”

“Special Factors—Purposes and Reasons of the Purchaser Filing Parties”

“Special Factors—Position of the Silver Lake Filing Parties and Parent Entities as to the Fairness of the Merger”

“Special Factors—Position of the CEO Rollover Stockholders as to the Fairness of the Merger”

“Special Factors—Interests of Zuora’s Directors and Executive Officers in the Merger”

“The Merger Agreement”

“The Voting, Support and Rollover Agreement”

Annex A—Agreement and Plan of Merger

 

6

 


Table of Contents

Annex C—The Voting, Support and Rollover Agreement

(e) Agreements involving the subject company’s securities. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

“Summary Term Sheet”

“Questions and Answers”

“Special Factors—Background of the Merger”

“Special Factors—Certain Effects of the Merger”

“Special Factors—Intent of Zuora’s Directors and Executive Officers to Vote in Favor of the Merger”

“Special Factors—Intent of Certain Stockholders to Vote in Favor of the Merger”

“Special Factors—Interests of Zuora’s Directors and Executive Officers in the Merger”

“Special Factors—Financing of the Merger”

“The Merger Agreement”

“The Special Meeting—Votes Required”

“The Voting, Support and Rollover Agreement”

“Proposal 2: The Compensation Proposal”

Annex A—Agreement and Plan of Merger

Annex C—The Voting, Support and Rollover Agreement

Item 6. Purposes of the Transaction and Plans or Proposals

(b) Use of securities acquired. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

“Summary Term Sheet”

“Special Factors—Purposes and Reasons of the Purchaser Filing Parties”

“Special Factors—Plans for Zuora After the Merger”

“Special Factors—Certain Effects of the Merger”

“Special Factors—Certain Effects on Zuora if the Merger is Not Completed”

“Special Factors—Interests of Zuora’s Directors and Executive Officers in the Merger”

“Special Factors—Delisting and Deregistration of Zuora Common Stock”

“Special Factors—Financing of the Merger”

“The Merger Agreement—Effect of the Merger”

 

7

 


Table of Contents

“The Merger Agreement—Directors and Officers; Certificate of Incorporation; Bylaws”

“The Merger Agreement—Merger Consideration”

“The Merger Agreement—Exchange and Payment Procedures”

Annex A—Agreement and Plan of Merger

(c)(1) — (8) Plans. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

“Summary Term Sheet”

“Questions and Answers”

“Special Factors—Background of the Merger”

“Special Factors—Reasons for the Merger; Recommendation of the Special Committee and the Zuora Board”

“Special Factors—Purposes and Reasons of the Purchaser Filing Parties”

“Special Factors—Opinion of Qatalyst Partners LP”

“Special Factors—Position of the Silver Lake Filing Parties and Parent Entities as to the Fairness of the Merger”

“Special Factors—Position of the CEO Rollover Stockholders as to the Fairness of the Merger”

“Special Factors—Plans for Zuora After the Merger”

“Special Factors—Certain Effects of the Merger”

“Special Factors—Certain Effects on Zuora if the Merger is Not Completed”

“Special Factors—Intent of Zuora’s Directors and Executive Officers to Vote in Favor of the Merger”

“Special Factors—Intent of Certain Stockholders to Vote in Favor of the Merger”

“Special Factors—Interests of Zuora’s Directors and Executive Officers in the Merger”

“Special Factors—Financing of the Merger”

“The Merger Agreement—Effect of the Merger”

“The Merger Agreement— Directors and Officers; Certificate of Incorporation; Bylaws”

“The Merger Agreement—Merger Consideration”

“The Voting, Support and Rollover Agreement”

“Important Information Regarding Zuora”

Annex A—Agreement and Plan of Merger

Annex B—Opinion of Qatalyst Partners LP

 

8

 


Table of Contents

Item 7. Purposes, Alternatives, Reasons and Effects

(a) Purposes. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

“Summary Term Sheet”

“Questions and Answers”

“Special Factors—Background of the Merger”

“Special Factors—Reasons for the Merger; Recommendation of the Special Committee and the Zuora Board”

“Special Factors—Purposes and Reasons of the Purchaser Filing Parties”

“Special Factors—Opinion of Qatalyst Partners LP”

“Special Factors—Position of the Silver Lake Filing Parties and Parent Entities as to the Fairness of the Merger”

“Special Factors—Position of the CEO Rollover Stockholders as to the Fairness of the Merger”

“Special Factors—Plans for Zuora After the Merger”

“Special Factors—Certain Effects of the Merger”

Annex B—Opinion of Qatalyst Partners LP

(b) Alternatives. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

“Summary Term Sheet”

“Special Factors—Background of the Merger”

“Special Factors—Reasons for the Merger; Recommendation of the Special Committee and the Zuora Board”

“Special Factors—Purposes and Reasons of the Purchaser Filing Parties”

“Special Factors—Position of the Silver Lake Filing Parties and Parent Entities as to the Fairness of the Merger”

“Special Factors—Position of the CEO Rollover Stockholders as to the Fairness of the Merger”

“Special Factors—Plans for Zuora After the Merger”

“Special Factors—Certain Effects on Zuora if the Merger is Not Completed”

(c) Reasons. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

“Summary Term Sheet”

“Special Factors—Background of the Merger”

“Special Factors—Reasons for the Merger; Recommendation of the Special Committee and the Zuora Board”

“Special Factors—Purposes and Reasons of the Purchaser Filing Parties”

“Special Factors—Opinion of Qatalyst Partners LP”

 

9

 


Table of Contents

“Special Factors—Position of the Silver Lake Filing Parties and Parent Entities as to the Fairness of the Merger”

“Special Factors—Position of the CEO Rollover Stockholders as to the Fairness of the Merger”

“Special Factors—Plans for Zuora After the Merger”

“Special Factors—Certain Effects of the Merger”

“Special Factors—Certain Effects on Zuora if the Merger is Not Completed”

“Special Factors—Unaudited Prospective Financial Information”

Annex B—Opinion of Qatalyst Partners LP

(d) Effects. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

“Summary Term Sheet”

“Questions and Answers”

“Special Factors—Background of the Merger”

“Special Factors—Reasons for the Merger; Recommendation of the Special Committee and the Zuora Board”

“Special Factors—Purposes and Reasons of the Purchaser Filing Parties”

“Special Factors—Opinion of Qatalyst Partners LP”

“Special Factors—Position of the Silver Lake Filing Parties and Parent Entities as to the Fairness of the Merger”

“Special Factors—Position of the CEO Rollover Stockholders as to the Fairness of the Merger”

“Special Factors—Plans for Zuora After the Merger”

“Special Factors—Certain Effects of the Merger”

“Special Factors—Certain Effects on Zuora if the Merger is Not Completed”

“Special Factors—Interests of Zuora’s Directors and Executive Officers in the Merger”

“Special Factors—U.S. Federal Income Tax Considerations of the Merger”

“Special Factors—Financing of the Merger”

“Special Factors—Fees and Expenses”

“Special Factors—Delisting and Deregistration of Zuora Common Stock”

“The Merger Agreement—Effect of the Merger”

“The Merger Agreement— Directors and Officers; Certificate of Incorporation; Bylaws”

“The Merger Agreement—Merger Consideration”

“The Merger Agreement—Indemnification and Insurance”

 

10

 


Table of Contents

“The Merger Agreement—Employee Matters”

“Appraisal Rights”

“The Voting, Support and Rollover Agreement”

“Proposal 2: The Compensation Proposal”

Annex A—Agreement and Plan of Merger

Annex B—Opinion of Qatalyst Partners LP

Annex C—The Voting, Support and Rollover Agreement

Equity Commitment Letter, dated October 17, 2024, by and Silver Lake Alpine II, L.P. and Parent, attached hereto as Exhibit 16(b)(i)

Equity Commitment Letter, dated October 17, 2024, by and among Hux Investment Pte. Ltd. and Parent, attached hereto as Exhibit 16(b)(ii)

Amended and Restated Commitment Letter, dated November 13, 2024, by and among Royal Bank of Canada, Banco Santander, S.A., New York Branch, Bank of Montreal, BMO Capital Markeys Corp., Barclays Bank PLC, KKR Capital Markets LLC, KKR CORPORATE LENDING (CA) LLC, SF Credit Partners, LLC, Stifel Nicolaus and Company, Incorporated, Wells Fargo Securities, LLC, Wells Fargo Bank, National Association and Parent, attached hereto as Exhibit 16(b)(iii)

Limited Guarantee, dated as of October 17, 2024, by and among Silver Lake Alpine II, L,P. and Zuora, Inc., attached hereto as Exhibit 16(b)(iv)

Limited Guarantee, dated as of October 17, 2024, by and among Hux Investment Pte. Ltd. and Zuora, Inc., attached hereto as Exhibit 16(b)(v)

Item 8. Fairness of the Transaction

(a) — (b) Fairness; Factors considered in determining fairness. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

“Summary Term Sheet”

“Questions and Answers”

“Special Factors—Background of the Merger”

“Special Factors—Reasons for the Merger; Recommendation of the Special Committee and the Zuora Board”

“Special Factors—Purposes and Reasons of the Purchaser Filing Parties”

“Special Factors—Opinion of Qatalyst Partners LP”

“Special Factors—Position of the Silver Lake Filing Parties and Parent Entities as to the Fairness of the Merger”

“Special Factors—Position of the CEO Rollover Stockholders as to the Fairness of the Merger”

“Special Factors—Certain Effects of the Merger”

“Special Factors—Interests of Zuora’s Directors and Executive Officers in the Merger”

 

11

 


Table of Contents

Annex B—Opinion of Qatalyst Partners LP

The discussion materials dated April 14, 2024, April 17, 2024, April 30, 2024, June 15, 2024, July 2, 2024, July 10, 2024, October 15, 2024 and October 16, 2024, each prepared by Qatalyst Partners LP and reviewed by the Special Committee and/or the Zuora Board, as applicable, are attached hereto as Exhibits 16(c)(ii) though and including 16(c)(ix), and are incorporated by reference herein.

(c) Approval of security holders. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

“Summary Term Sheet”

“Questions and Answers”

“Special Factors—Reasons for the Merger; Recommendation of the Special Committee and the Zuora Board”

“Special Factors—Purposes and Reasons of the Purchaser Filing Parties”

“Special Factors—Position of the Silver Lake Filing Parties and Parent Entities as to the Fairness of the Merger”

“Special Factors—Position of the CEO Rollover Stockholders as to the Fairness of the Merger”

“The Special Meeting—Record Date; Shares Entitled to Vote; Quorum”

“The Special Meeting—Votes Required”

“The Special Meeting—Voting of Proxies”

“The Special Meeting—Revocability of Proxies”

“The Merger Agreement—Conditions to the Closing of the Merger”

“Proposal 1: The Merger Proposal”

Annex A—Agreement and Plan of Merger

(d) Unaffiliated representative. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

“Summary Term Sheet”

“Special Factors—Background of the Merger”

“Special Factors—Reasons for the Merger; Recommendation of the Special Committee and the Zuora Board”

“Special Factors—Purposes and Reasons of the Purchaser Filing Parties”

“Special Factors—Position of the Silver Lake Filing Parties and Parent Entities as to the Fairness of the Merger”

“Special Factors—Position of the CEO Rollover Stockholders as to the Fairness of the Merger”

“Special Factors—Opinion of Qatalyst Partners LP”

Annex B—Opinion of Qatalyst Partners LP

 

12

 


Table of Contents

(e) Approval of directors. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

“Summary Term Sheet”

“Questions and Answers”

“Special Factors—Background of the Merger”

“Special Factors—Reasons for the Merger; Recommendation of the Special Committee and the Zuora Board”

“Special Factors—Purposes and Reasons of the Purchaser Filing Parties”

“Special Factors—Position of the Silver Lake Filing Parties and Parent Entities as to the Fairness of the Merger”

“Special Factors—Position of the CEO Rollover Stockholders as to the Fairness of the Merger”

“Special Factors—Interests of Zuora’s Directors and Executive Officers in the Merger”

“Special Factors—Intent of Zuora’s Directors and Executive Officers to Vote in Favor of the Merger”

(f) Other offers. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

“Special Factors—Background of the Merger”

“Special Factors—Reasons for the Merger; Recommendation of the Special Committee and the Zuora Board”

“Special Factors—Purposes and Reasons of the Purchaser Filing Parties”

Item 9. Reports, Opinions, Appraisals and Negotiations

(a) — (b) Report, opinion or appraisal; Preparer and summary of the report, opinion or appraisal. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

“Summary Term Sheet”

“Questions and Answers”

“Special Factors—Background of the Merger”

“Special Factors—Reasons for the Merger; Recommendation of the Special Committee and the Zuora Board”

“Special Factors—Purposes and Reasons of the Purchaser Filing Parties”

“Special Factors—Opinion of Qatalyst Partners LP”

“Special Factors—Position of the Silver Lake Filing Parties and Parent Entities as to the Fairness of the Merger”

“Special Factors—Position of the CEO Rollover Stockholders as to the Fairness of the Merger”

“Where You Can Find Additional Information”

Annex B—Opinion of Qatalyst Partners LP

 

13

 


Table of Contents

(c) Availability of documents. The information set forth in the Proxy Statement under the following caption is incorporated herein by reference:

“Where You Can Find Additional Information”

The reports, opinions or appraisals referenced in this Item 9 will be made available for inspection and copying at the principal executive offices of the Company during its regular business hours by any interested equity holder of Zuora common stock or by a representative who has been so designated in writing.

Item 10. Source and Amounts of Funds or Other Consideration

(a) — (b), (d) Source of funds; Conditions; Borrowed funds. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

“Summary Term Sheet”

“Special Factors—Financing of the Merger”

“The Merger Agreement—Other Covenants”

“The Merger Agreement—Conditions to the Closing of the Merger”

“The Merger Agreement—Conduct of Business Pending the Merger”

Annex A—Agreement and Plan of Merger

(c) Expenses. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

“Summary Term Sheet”

“Questions and Answers”

“Special Factors—Certain Effects on Zuora if the Merger is Not Completed”

“Special Factors—Fees and Expenses”

“The Special Meeting—Solicitation of Proxies”

“The Merger Agreement—Fees and Expenses”

“The Merger Agreement—Company Termination Fee”

“The Merger Agreement—Parent Termination Fee”

Annex A—Agreement and Plan of Merger

Item 11. Interest in Securities of the Subject Company

(a) Securities ownership. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

“Summary Term Sheet”

“Special Factors—Interests of Zuora’s Directors and Executive Officers in the Merger”

 

14

 


Table of Contents

“Important Information Regarding Zuora—Security Ownership of Certain Beneficial Owners and Management”

“Important Information Regarding the Purchaser Filing Parties”

“The Voting, Support and Rollover Agreement”

Annex C—The Voting, Support and Rollover Agreement

(b) Securities transactions. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

“Special Factors—Background of the Merger”

“Important Information Regarding Zuora—Transactions in Zuora Common Stock”

“Important Information Regarding Zuora—Prior Public Offerings”

“The Merger Agreement”

“The Voting, Support and Rollover Agreement”

Annex A—Agreement and Plan of Merger

Annex C—The Voting, Support and Rollover Agreement

Item 12. The Solicitation or Recommendation

(d) Intent to tender or vote in a going—private transaction. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

“Summary Term Sheet”

“Questions and Answers”

“Special Factors—Background of the Merger”

“Special Factors—Reasons for the Merger; Recommendation of the Special Committee and the Zuora Board”

“Special Factors—Purposes and Reasons of the Purchaser Filing Parties”

“Special Factors—Position of the Silver Lake Filing Parties and Parent Entities as to the Fairness of the Merger”

“Special Factors—Position of the CEO Rollover Stockholders as to the Fairness of the Merger”

“Special Factors—Intent of Zuora’s Directors and Executive Officers to Vote in Favor of the Merger”

“Special Factors—Intent of Certain Stockholders to Vote in Favor of the Merger”

“The Special Meeting—Votes Required”

“The Voting, Support and Rollover Agreement”

Annex C—The Voting, Support and Rollover Agreement

 

15

 


Table of Contents

(e) Recommendation of others. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

“Summary Term Sheet”

“Questions and Answers”

“Special Factors—Background of the Merger”

“Special Factors—Reasons for the Merger; Recommendation of the Special Committee and the Zuora Board”

“Special Factors—Purposes and Reasons of the Purchaser Filing Parties”

“Special Factors—Position of the Silver Lake Filing Parties and Parent Entities as to the Fairness of the Merger”

“Special Factors—Position of the CEO Rollover Stockholders as to the Fairness of the Merger”

“Proposal 1: The Merger Proposal”

Item 13. Financial Information

(a) Financial statements. The audited consolidated financial statements set forth in Item 8 of the Company’s Annual Report on Form 10—K for the fiscal year ended January 31, 2024 and the financial statements set forth in Item 1 of the Company’s Quarterly Report on Form 10—Q for the quarterly period ended July 31, 2024 are incorporated herein by reference.

The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

“Special Factors—Certain Effects of the Merger”

“Special Factors—Unaudited Prospective Financial Information”

“Important Information Regarding Zuora—Selected Historical Consolidated Financial Data”

“Important Information Regarding Zuora—Book Value Per Share”

“Where You Can Find Additional Information”

(b) Pro forma information. Not applicable.

Item 14. Persons/Assets, Retained, Employed, Compensated or Used

(a) — (b) Solicitations or recommendations; Employees and corporate assets. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

“Summary Term Sheet”

“Questions and Answers”

“Special Factors—Background of the Merger”

“Special Factors—Reasons for the Merger; Recommendation of the Special Committee and the Zuora Board”

“Special Factors—Opinion of Qatalyst Partners LP”

“Special Factors—Purposes and Reasons of the Purchaser Filing Parties”

 

16

 


Table of Contents

“Special Factors—Position of the Silver Lake Filing Parties and Parent Entities as to the Fairness of the Merger”

“Special Factors—Position of the CEO Rollover Stockholders as to the Fairness of the Merger”

“Special Factors—Interests of Zuora’s Directors and Executive Officers in the Merger”

“Special Factors—Fees and Expenses”

“The Special Meeting—Solicitation of Proxies”

“The Voting, Support and Rollover Agreement”

Annex B—Opinion of Qatalyst Partners LP

Annex C—The Voting, Support and Rollover Agreement

Item 15. Additional Information

(b) Golden Parachute Compensation. The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

“Summary Term Sheet”

“Special Factors—Interests of Zuora’s Directors and Executive Officers in the Merger”

“The Merger Agreement—Merger Consideration”

“Proposal 2: The Compensation Proposal”

Annex A—Agreement and Plan of Merger

(c) Other material information. The information set forth in the Proxy Statement, including all annexes thereto, is incorporated herein by reference.

Item 16. Exhibits

The following exhibits are filed herewith:

16(a)(2)(i) Preliminary Proxy Statement of Zuora, Inc. (the “Proxy Statement”) (included in the Schedule 14A filed on November 22, 2024 and incorporated herein by reference).

16(a)(2)(ii) Form of Proxy Card (included in the Proxy Statement and incorporated herein by reference).

16(a)(2)(iii) Letter to Stockholders (included in the Proxy Statement and incorporated herein by reference).

16(a)(2)(iv) Notice of Special Meeting of Stockholders (included in the Proxy Statement and incorporated herein by reference).

16(a)(2)(v) Current Report on Form 8-K, dated October 17, 2024 (included in Form 8-K filed on October 17, 2024 and incorporated herein by reference).

16(a)(2)(vi) Email from Tien Tzuo, Chief Executive Officer of the Company, sent to the Company’s employees, dated October 17, 2024 (included in Schedule 14A filed on October 17, 2024 and incorporated herein by reference).

 

17

 


Table of Contents

16(a)(2)(vii) Employee Q&A Document, dated October 17, 2024 (included in Schedule 14A filed on October 17, 2024 and incorporated herein by reference).

16(a)(2)(viii) Customer Letter, dated October  17, 2024 (included in Schedule 14A filed on October  17, 2024 and incorporated herein by reference).

16(a)(2)(ix) Partner Letter, dated October 17, 2024 (included in Schedule 14A filed on October  17, 2024 and incorporated herein by reference).

16(a)(2)(x) Industry Analyst Letter, dated October 17, 2024 (included in Schedule 14A filed on October 17, 2024 and incorporated herein by reference).

16(a)(2)(xi) Social media posts, dated October  17, 2024 (included in Schedule 14A filed on October  17, 2024 and incorporated herein by reference).

16(a)(2)(xii) Current Report on Form 8-K, dated October 18, 2024 (included in Form 8-K filed on October 18, 2024 and incorporated herein by reference).

16(a)(2)(xiii) Employee Newsletter, dated October  22, 2024 (included in Schedule 14A filed on October  22, 2024 and incorporated herein by reference).

16(a)(2)(xiv) Updated Employee Q&A Document, dated October 31, 2024 (included in Schedule 14A filed on October 31, 2024 and incorporated herein by reference).

16(b)(i) Equity Commitment Letter, dated October 17, 2024, executed by Silver Lake Alpine II, L.P. and Parent.

16(b)(ii) Equity Commitment Letter, dated October 17, 2024, executed by Hux Investment Pte., Ltd. and Parent.

16(b)(iii) Amended and Restated Commitment Letter, dated November  13, 2024, by and among Royal Bank of Canada, Banco Santander, S.A., New York Branch, Bank of Montreal, BMO Capital Markeys Corp., Barclays Bank PLC, KKR Capital Markets LLC, KKR CORPORATE LENDING (CA) LLC, SF Credit Partners, LLC, Stifel Nicolaus and Company, Incorporated, Wells Fargo Securities, LLC, Wells Fargo Bank, National Association and Parent.

16(b)(iv) Limited Guarantee, dated as of October  17, 2024, by and among Silver Lake Alpine II, L,P. and Zuora, Inc.

16(b)(v) Limited Guarantee, dated as of October  17, 2024, by and among Hux Investment Pte. Ltd. and Zuora, Inc.

16(c)(i) Opinion of Qatalyst Partners LP to the Board of Directors of Zuora, Inc., dated October  16, 2024 (included as Annex B to the Proxy Statement and incorporated herein by reference).

16(c)(ii)* Discussion materials prepared by Qatalyst Partners LP, dated April  14, 2024, for the Special Committee of the Board of Directors of Zuora, Inc.

16(c)(iii) Discussion materials prepared by Qatalyst Partners LP, dated April  17, 2024, for the Special Committee of the Board of Directors of Zuora, Inc.

16(c)(iv) Discussion materials prepared by Qatalyst Partners LP, dated April  30, 2024, for the Special Committee of the Board of Directors of Zuora, Inc.

16(c)(v)* Discussion materials prepared by Qatalyst Partners LP, dated June 15, 2024, for the Special Committee of the Board of Directors of Zuora, Inc.

 

18

 


Table of Contents

16(c)(vi)* Discussion materials prepared by Qatalyst Partners LP, dated July 2, 2024, for the Special Committee of the Board of Directors of Zuora, Inc.

16(c)(vii)* Discussion materials prepared by Qatalyst Partners LP, dated July  10, 2024, and shared with the Special Committee of the Board of Directors of Zuora, Inc. for reference.

16(c)(viii)* Discussion materials prepared by Qatalyst Partners LP, dated October 15, 2024, for the Special Committee of the Board of Directors of Zuora, Inc.

16(c)(ix)* Discussion materials prepared by Qatalyst Partners LP, dated October  16, 2024, for the Special Committee of the Board of Directors of Zuora, Inc.

16(d)(i) Agreement and Plan of Merger, dated as of October 17, 2024, by and among Zuora, Inc., Parent and Merger Sub (included as Annex A to the Proxy Statement and incorporated herein by reference).

16(d)(ii) Voting, Support and Rollover Agreement, dated as of October 17, 2024, by and among Zodiac Purchaser, L.L.C., Zodiac Holdco, L.L.C., Silver Lake Alpine II, L.P., Zuora, Inc., and the stockholders party thereto (included as Annex C to the Proxy Statement and incorporated herein by reference).

16(f) Section 262 of the Delaware General Corporation Law.

107 Filing Fee Table.

* Certain portions of this exhibit marked with “[***]” have been redacted and provided separately to the Securities and Exchange Commission pursuant to a request for confidential treatment.

 

19

 


Table of Contents

SIGNATURES

After due inquiry and to the best of the undersigned’s knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

Dated: November 22, 2024

ZUORA, INC.

 

By:  

/s/ Andrew M. Cohen

  Name: Andrew M. Cohen
  Title: Chief Legal Officer and Secretary

 

20

 


Table of Contents

After due inquiry and to the best of the undersigned’s knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

Dated: November 22, 2024

 

ZODIAC PURCHASER, L.L.C.
By:   Zodiac Guarantor, L.L.C., its managing member
By:   Zodiac Holdco, L.L.C., its managing member
By:   Silver Lake Alpine Associates II, L.P., its managing member
By:   SLAA II (GP), L.L.C., its general partner
By:   Silver Lake Group, L.L.C., its managing member
By:  

/s/ Andrew J. Schader

  Name: Andrew J. Schader
 

Title: Managing Director and General Counsel

ZODIAC ACQUISITION SUB, INC.
By:  

/s/ Andrew J. Schader

  Name: Andrew J. Schader
  Title: Secretary

 

21

 


Table of Contents

After due inquiry and to the best of the undersigned’s knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

Dated: November 22, 2024

 

SILVER LAKE ALPINE ASSOCIATES II, L.P.
By:   SLAA II (GP), L.L.C., its general partner
By:   Silver Lake Group, L.L.C., its managing member
By:  

/s/ Andrew J. Schader

  Name: Andrew J. Schader
  Title: Managing Director and General Counsel
SLA ZURICH HOLDINGS, L.P.
By:   SLA Zurich GP, L.L.C., its general partner
By:  

/s/ Andrew J. Schader

  Name: Andrew J. Schader
  Title: Managing Director and General Counsel
SLA ZURICH GP, L.L.C.
By:  

/s/ Andrew J. Schader

  Name: Andrew J. Schader
  Title: Managing Director
SLA ZURICH AGGREGATOR, L.P.
By:   SL Alpine II Aggregator GP, L.L.C., its general partner
By:   Silver Lake Alpine Associates II, L.P., its managing member
By:   SLAA II (GP), L.L.C., its general partner
By:   Silver Lake Group, L.L.C., its managing member
By:  

/s/ Andrew J. Schader

  Name: Andrew J. Schader
  Title: Managing Director and General Counsel
SL ALPINE II AGGREGATOR GP, L.L.C.
By:   Silver Lake Alpine II Associates, L.P., its managing member
By:   SLAA II (GP), L.L.C., its general partner
By:   Silver Lake Group, L.L.C., its managing member
By:  

/s/ Andrew J. Schader

  Name: Andrew J. Schader
  Title: Managing Director and General Counsel
SILVER LAKE ALPINE II, L.P.
By:   Silver Lake Alpine Associates II, L.P., its general partner
By:   SLAA II (GP), L.L.C., its general partner
By:   Silver Lake Group, L.L.C., its managing member
By:  

/s/ Andrew J. Schader

  Name: Andrew J. Schader
  Title: Managing Director and General Counsel
SLAA II (GP), L.L.C.
By:   Silver Lake Group, L.L.C., its managing member
By:  

/s/ Andrew J. Schader

  Name: Andrew J. Schader
  Title: Managing Director and General Counsel
SILVER LAKE GROUP, L.L.C.
By:  

/s/ Andrew J. Schader

  Name: Andrew J. Schader
  Title: Managing Director and General Counsel

 

22

 


Table of Contents

After due inquiry and to the best of the undersigned’s knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

Dated: November 22, 2024

 

TIEN TZUO
By:  

/s/ Tien Tzuo

  Name: Tien Tzuo

 

23

 

EXHIBIT 16(b)(i)

CONFIDENTIAL

Execution Version

October 17, 2024

Zodiac Purchaser, L.L.C.

c/o Silver Lake Alpine II, L.P.

2775 Sand Hill Road, Suite 100

Menlo Park, CA 94025

 

Re:

Equity Financing Commitment

Ladies and Gentlemen:

Reference is made to the Agreement and Plan of Merger, dated as of the date hereof (as amended, supplemented or otherwise modified from time to time, the “Merger Agreement”), by and among Zodiac Purchaser, L.L.C., a Delaware limited liability company (“Parent”), Zodiac Acquisition Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (“Merger Sub”) and Zuora, Inc., a Delaware corporation (the “Company”), pursuant to which, upon the terms and subject to the conditions set forth therein, among other things, Merger Sub shall merge with and into the Company (the “Merger”), with the Company surviving the Merger as a wholly owned subsidiary of Parent. Reference is also made to the Other Equity Commitment Letter of even date herewith delivered to Parent by Hux Investment Pte. Ltd. (the “Other Equity Commitment Letter”). Each capitalized term used and not defined herein shall have the meaning ascribed to it in the Merger Agreement, except as otherwise provided herein. Silver Lake Alpine II, L.P. is referred to herein as the “Equity Investor” and Hux Investment Pte. Ltd. is referred to herein as the “Other Equity Investor”. This letter agreement is being delivered by the Equity Investor to Parent in connection with the execution of the Merger Agreement.

1. Commitment. Subject to the conditions set forth herein, including without limitation the Other Equity Investor Ownership Percentage Cap (as defined below), the Equity Investor hereby agrees to purchase at or immediately prior to the Closing equity securities of Parent (collectively, the “Subject Securities”), for an aggregate purchase price, in the form of cash in immediately available U.S. funds to Parent (or a parent entity that directly or indirectly wholly owns Parent), equal to $57,000,000 (such commitment, the “Equity Financing Commitment”), solely for the purpose of permitting Parent to fund, and to the extent necessary to fund (together with the proceeds of the Debt Financing, proceeds of the equity commitment under the Other Equity Commitment Letter, and cash on hand at the Company and its Subsidiaries available for funding in accordance with the Merger Agreement), the Required Amount, and not for any other purpose, it being understood that the Equity Investor (together with its permitted assigns, as applicable) shall not under any circumstances be obligated under this letter agreement to purchase any equity of, or make any other payment or contribution to, or investment in, Parent other than the purchase of the Subject Securities pursuant to the terms hereof for a purchase price equal to the Equity Financing Commitment. The obligation of the Equity Investor (together with its permitted assigns, as applicable) to fund the Equity Financing Commitment (a) is subject solely to (i) the terms of this letter agreement, (ii) the satisfaction or waiver by Parent of all of the conditions to Parent’s and Merger Sub’s obligations to effect the Closing set forth in Sections 7.01


(Conditions to the Obligations of Each Party) and 7.02 (Conditions to the Obligations of Parent and Merger Sub) of the Merger Agreement (other than those conditions that, by their nature, are to be satisfied at the Closing, but subject to such conditions being able to be satisfied), (iii) the prior or substantially concurrent receipt by Parent, Merger Sub or the Company of the proceeds of (A) the Debt Financing and (B) the equity commitment under the Other Equity Commitment Letter (provided, that the failure of the condition in this subclause (B) to be satisfied shall not limit the ability of Parent or, subject to Section 6(b), the Company to seek to enforce the obligations of the Equity Investor hereunder if Parent and/or the Company, as applicable, is also concurrently seeking enforcement of the obligations of the Other Equity Investor pursuant to the Other Equity Commitment Letter), and (iv) the substantially concurrent consummation of the Closing on the terms and subject to the conditions of the Merger Agreement (assuming the funding of the Equity Financing Commitment) and (b) subject to the foregoing clause (a), will occur simultaneously with the issuance to the Equity Investor of the Subject Securities. Subject to the terms of the Merger Agreement and Other Equity Investor Ownership Percentage Cap, the amount to be funded under this letter agreement may be reduced dollar for dollar (any such reduction to be allocated between the Equity Investor hereunder and the Other Equity Investor under the Other Equity Commitment Letter as designated in writing by Parent, subject to the Other Equity Investor Ownership Percentage Cap) in the event that Parent does not require all of the Equity Financing Commitment in order to consummate the transactions contemplated by the Merger Agreement (including payment of the Required Amount), but only to the extent Parent (x) consummates the transactions contemplated by the Merger Agreement at the Closing with the Equity Investor directly or indirectly contributing less than the full amount of the Equity Financing Commitment and (y) makes all payments required to pay the Required Amount to be made by Parent or Merger Sub under the Merger Agreement in connection with the consummation of the transactions contemplated thereby. The amount to be funded under this letter agreement may also be reduced (I) dollar for dollar (any such reduction to be allocated between the Equity Investor hereunder and the Other Equity Investor under the Other Equity Commitment Letter as designated in writing by Parent, subject to the Other Equity Investor Ownership Percentage Cap) by an amount equal to the Merger Consideration that would be payable in respect of shares of Company Common Stock that are beneficially owned by Parent or its Affiliates (including as a result of the contribution of any Rollover Shares (other than the CEO Rollover Shares) pursuant to the Rollover Agreements (other than the CEO Support and Rollover Agreement)), and (II) for the amount of Convertible Notes contributed by the Equity Investor to Parent at or prior to Closing in excess of an amount equal to the difference between the total amount of the Convertible Notes (as calculated based on the “Fundamental Change Repurchase Price” (as such term is defined in the Convertible Notes Indenture)) and the Convertible Notes Closing Cash Payment Cap, but in each case of (I) and (II) only to the extent Parent (x) consummates the transactions contemplated by the Merger Agreement at the Closing with the Equity Investor directly or indirectly contributing less than the full amount of the Equity Financing Commitment and (y) makes or causes to be made (including from the proceeds of the Debt Financing and cash on hand at the Company and its Subsidiaries available for funding in accordance with the Merger Agreement) all payments required to pay the Required Amount to be made by Parent or Merger Sub under the Merger Agreement in connection with the consummation of the transactions contemplated thereby. Notwithstanding the foregoing, the Investor agrees that no such reduction shall be made if reasonably likely to impair, delay or prevent the consummation of the Closing. The Equity Financing Commitment shall be reduced dollar for dollar, subject to the Other Equity Investor Ownership Cap, by an amount equal to 53% of any

 

2


Upsize (as defined in the CEO Support and Rollover Agreement), effective immediately and automatically upon the acceptance of the Investors of such Upsize pursuant to the CEO Support and Rollover Agreement. Notwithstanding anything to the contrary in this letter agreement, to the extent that the amount to be funded under this letter agreement and/or the Other Equity Commitment Letter is reduced in accordance with the terms hereof or thereof, the amount of the “Equity Financing Commitment” (as such term is defined under the Other Equity Commitment Letter) (the “Other Equity Financing Commitment Amount”) shall be reduced to an amount such that the Other Equity Financing Commitment Amount shall not be greater than the dollar amount that, if funded by the Other Investor (or its Affiliate) simultaneous with the funding of the Equity Financing Commitment hereunder would result in the Other Equity Investor and its Affiliates collectively owning, directly or indirectly (as determined for US federal income tax purposes), a number of equity interests of Parent or the Company (or their respective direct or indirect parent entities) (including on a “look-through” basis taking into account any other Person directly or indirectly investing into Parent or the Company (or their respective direct or indirect parent entities)) representing more than 48.7% (by vote or value) of the issued and outstanding equity interests of any such entity (the “Other Equity Investor Ownership Percentage Cap”).

2. Termination. Unless terminated pursuant to this Section 2, this letter agreement may not be revoked and shall remain in full force and effect and shall be binding on the Equity Investor and its successors and permitted assigns. The Equity Investor’s obligation to fund the Equity Financing Commitment will terminate automatically and immediately upon the earliest to occur of (a) the valid termination of the Merger Agreement in accordance with its terms, (b) the commencement, directly or indirectly, by the Company or any of its Affiliates of any Proceeding against the Equity Investor, the Other Equity Investor, Parent or Merger Sub or any other Parent Related Party (as defined below) relating to this letter agreement, the limited guarantee of even date herewith of the Equity Investor (the “Guarantee”), the limited guarantee of even date herewith of the Other Equity Investor (the “Other Guarantee” and, together with the Guarantee, the “Guarantees”), the Merger Agreement or any of the transactions contemplated hereby or thereby (including in respect of any oral representations made or alleged to be made in connection therewith) other than any Proceeding by (i) the Company against Parent or Merger Sub seeking (A) specific performance against Parent and/or Merger Sub pursuant to, and subject to the limitations in, Section 9.09 (Specific Performance) of the Merger Agreement and in accordance with this letter agreement, and/or (B) payment of either the Parent Termination Fee or the Regulatory Termination Fee, Reimbursement Obligations and Enforcement Costs, in each case in accordance with, and solely to the extent permitted under, the Merger Agreement (including Sections 6.17(f) (Financing), 9.04(d) (Parent Termination Fee), 9.04(e) (Regulatory Termination Fee) and 9.04(h) (Fees and Expenses) thereof), (ii) the Company against the Equity Investor or the Other Equity Investor seeking (A) payment of their respective obligations under the Guarantees in accordance with, and solely to the extent permitted under, the respective Guarantees and/or (B) specific performance of the Equity Investor’s obligation to fund its Equity Financing Commitment or of the Other Equity Investor’s obligation to fund its commitment under the Other Equity Commitment, in each case in accordance with, and solely to the extent permitted under, the terms hereof and the terms of the Merger Agreement, and (iii) the Company under the Confidentiality Agreement (the Proceedings set forth in the foregoing clauses (i) through (iii), the “Non-Prohibited Claims”), (c) any final non-appealable judgment of a court of competent jurisdiction against any of Parent, Merger Sub or Guarantor with respect to any Non-Prohibited Claim that includes an award of either the Parent Termination Fee or the Regulatory Termination Fee, the Reimbursement

 

3


Obligations and/or the Enforcement Costs, (d) the Closing and the payment of the Equity Financing Commitment (at which time the obligations hereunder shall be discharged) and (e) the valid termination of the Other Equity Commitment Letter other than (i) following the Other Equity Investor’s funding its Equity Financing Commitment or (ii) in connection with any Equity Assignment. Upon termination of this letter agreement, the Equity Investor shall not have any further obligations or liabilities hereunder. Sections 2 (Termination), 4 (Assignment; Amendments and Waivers; Entire Agreement), 5 (Parties in Interest), 6 (Limited Recourse; Enforcement), 7 (Confidentiality) and 8 (Governing Law; Jurisdiction; Waiver of Jury Trial) of this letter agreement shall survive and remain in full force and effect, notwithstanding any termination of this letter agreement. For the avoidance of doubt, upon the valid termination of this letter agreement, all obligations of the Equity Investor to fund the Equity Financing Commitment shall terminate and no surviving provision shall be deemed to require the Equity Investor to fund any portion of the Equity Financing Commitment.

3. Representations and Warranties. The Equity Investor hereby represents and warrants (and makes no other representations or warranties, express or implied) that:

(a) It is duly organized or incorporated, validly existing and in good standing under the laws of its jurisdiction of organization or incorporation.

(b) The execution, delivery of and performance under this letter agreement by it is within its organizational or corporate powers and has been duly authorized by all necessary organizational, general partner, manager or corporate action, as applicable.

(c) This letter agreement has been duly executed and delivered by it and, assuming the due authorization, execution and delivery by Parent, constitutes its valid and binding agreement, enforceable against it in accordance with its terms, except as such enforceability may be limited by bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or other similar applicable law relating to or affecting creditors’ rights generally by general principles of equity.

(d) The execution and delivery of and performance under, this letter agreement by it do not and will not (i) violate its organizational documents, (ii) violate any provision of Applicable Law or any Order (subject to the making, obtaining and receipt of the consents, approvals, authorizations, permits of, filings with and notifications to any governmental authority described in Section 7.01(c) of the Merger Agreement) or (iii) conflict with any material agreement binding upon it, except in the case of (ii) and (iii) as would not reasonably be expected to, individually or in the aggregate, materially affect its ability to enter into this letter agreement or perform its obligations hereunder.

(e) Subject to the making, obtaining and receipt of the consents, approvals, authorizations, permits of, filings with and notifications to any governmental authority described in Section 7.01(c) of the Merger Agreement, all consents, approvals, authorizations, permits of, filings with and notifications to, any governmental authority necessary for the due execution, delivery and performance of this letter by the Equity Investor have been obtained or made and all conditions thereof have been duly complied with, and no other action by, and no notice to or filing with, any governmental authority is required in connection with the execution, delivery or performance of this letter except as would not reasonably be expected to, individually or in the aggregate, materially affect the Equity Investor’s ability to enter into this letter or perform its obligations hereunder.

 

4


(f) From the date hereof until the termination of this letter agreement in accordance with Section 2 hereof, the Equity Investor has, and until such time will maintain, uncalled capital commitments or unrestricted funds on hand in an amount not less than the Equity Financing Commitment.

(g) The Equity Financing Commitment is no more than the maximum amount the Equity Investor is permitted to invest in any one portfolio investment pursuant to the terms of its organizational or governing documents or otherwise, or no such restriction exists.

4. Assignment; Amendments and Waivers; Entire Agreement.

(a) The rights and obligations under this letter agreement may not be assigned or delegated (whether by operation of law, merger, consolidation or otherwise) by any party hereto without the prior written consent of the other parties and the Company, and any attempted assignment shall be null and void and of no force or effect. Notwithstanding the foregoing, (i) Parent may assign, delegate or otherwise transfer all or a portion of their rights or obligations under this letter agreement to any assignee of Parent’s obligations under the Merger Agreement pursuant to an assignment in accordance with Section 9.05 (Assignment; Benefit) of the Merger Agreement, and (ii) the Equity Investor may assign, delegate or otherwise transfer all or a portion of its obligation to fund the Equity Financing Commitment to one or more of its Affiliated investment vehicles or co-investors or any Person that is, directly or indirectly, wholly owned or otherwise controlled by or Affiliated with such Equity Investor or co-investors, one or more of such Affiliated investment vehicles and/or one or more Subsidiaries that are wholly owned or otherwise controlled by or affiliated with such Equity Investor and/or Affiliated investment funds and/or co-investors; provided that, in each case, no such assignment, delegation or transfer shall relieve the Equity Investor of its obligations hereunder.

(b) This letter agreement may not be amended, and no provision hereof waived or modified, except by an instrument signed by each of the parties hereto and with the prior written consent of the Company, and this letter agreement may not be terminated other than in accordance with Section 2 hereof. The failure of any party to assert any of its rights under this letter agreement or otherwise shall not constitute a waiver of those rights.

(c) This letter agreement, the Other Commitment Letter, the Guarantees and the Merger Agreement constitute the entire agreement among the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and undertakings, both written and oral, among the parties hereto or any of their Affiliates with respect to the subject matter hereof and thereof.

 

5


5. Parties in Interest. This letter agreement shall be binding upon and inure solely to the benefit of each party hereto and their respective successors and permitted assigns, and nothing in this letter agreement, express or implied, is intended to or shall confer upon any other Person any right, benefit or remedy of any nature whatsoever under or by reason of this letter agreement; provided, however that (a) the Parent Related Parties are express, intended third party beneficiaries of Section 6(a) hereto and (b) the Company hereby is made an express, intended third party beneficiary of this letter agreement solely to the extent, and subject to the limitations, set forth in Section 6(b).

6. Limited Recourse; Enforcement.

(a) Notwithstanding anything that may be expressed or implied in this letter agreement, the Other Equity Commitment Letter, the Guarantees, the Merger Agreement or any document or instrument delivered in connection herewith or therewith, Parent, by its acceptance of the benefits of the Equity Financing Commitment provided herein, covenants, agrees and acknowledges that no Person other than the Equity Investor (and its successors and assigns) shall have any obligations hereunder or in connection with the transactions contemplated hereby and that, notwithstanding that the Equity Investor or any of its permitted assigns may be a partnership, limited liability company or other type of entity, no Person has any rights of recovery against, and no recourse hereunder or under any documents or instruments delivered in connection herewith or in respect of any oral representations made or alleged to have been made in connection herewith or therewith shall be had against, any of Parent’s, Merger Sub’s, the Equity Investor’s or any of their or their respective Affiliates’ respective former, current or future directors, officers, employees, direct or indirect holders of any equity, stockholders, controlling persons, Affiliates, attorneys, members, managers, general or limited partners, assignees, agents, representatives or representatives of any of the foregoing (but not including Parent, Merger Sub or the Equity Investor, a “Parent Related Party” and together, the “Parent Related Parties”), whether by or through attempted piercing of the corporate (or limited liability company or limited partnership) veil, by or through a claim (whether at law or equity or in tort, contract or otherwise) by or on behalf of the Equity Investor against any Parent Related Party, by the enforcement of any assessment or by any legal or equitable proceeding, or by virtue of any applicable Law, or otherwise, it being agreed and acknowledged that no personal liability whatsoever shall attach to, be imposed on or otherwise be incurred by any Parent Related Party for any obligations of the Equity Investor or any of its successors or assigns under this letter agreement, under the Merger Agreement, the Guarantee or under any documents or instrument delivered in connection herewith or therewith, in respect of any transaction contemplated hereby or thereby or in respect of any oral representations made or alleged to have been made in connection herewith or therewith or for any claim (whether at law or equity or in tort, contract or otherwise) based on, in respect of, or by reason of such obligations or their creation; provided, however, that notwithstanding anything to the contrary provided herein or any document or instrument delivered in connection herewith, nothing herein shall limit the rights of the Company in respect of any Non-Prohibited Claims.

(b) This letter agreement may only be enforced by Parent, and none of Parent’s creditors nor any other Person that is not a party to this letter agreement shall have any right to enforce this letter agreement or to cause Parent to enforce this letter agreement; provided, however, that the Company is hereby made an express third party beneficiary of the rights granted to Parent under this letter agreement only for the purpose of specifically enforcing (subject to the limitations set forth in the Merger Agreement) the Equity Investor’s obligation to fund, as and when due, the Equity Financing Commitment hereunder if and only if pursuant to Section 9.09(a) (Specific Performance) of the Merger Agreement the Company is entitled to file an action in a court of competent jurisdiction seeking specific performance to cause Parent and Merger Sub to consummate the Closing and cause the funding of the Equity Financing Commitment pursuant to the terms hereof and for no other purpose (including, without limitation, any claim for monetary damages hereunder or under the Merger Agreement).

 

6


(c) Concurrently with the execution and delivery of this letter agreement, the Equity Investor is executing and delivering to the Company the Guarantee and, concurrently with the execution and delivery of the Other Equity Commitment Letter, the Other Equity Investor is executing and delivering to the Company the Other Guarantee, in each case, relating to certain of Parent’s obligations under the Merger Agreement. Except as expressly set forth in Section 6(b) hereof, the Company’s remedies against the Equity Investor and the Other Equity Investor with respect to any Non-Prohibited Claims shall, and are intended to, be the sole and exclusive direct or indirect remedies available to the Company and its Affiliates, and each of their respective former, current and future directors, officers, employees, holder of any equity, stockholders, controlling persons, Affiliates, attorneys, members, managers, general or limited partners, assignees, agents and representatives against the Equity Investor, the Other Equity Investor or any Parent Related Party for any liability, loss, damage or recovery of any kind in connection with, relating to, arising out of or resulting from any breach of this letter agreement or the Merger Agreement, the failure of the Merger to be consummated for any reason or otherwise in connection with the transactions contemplated hereby and thereby or in respect of any representations made or alleged to have been made in connection therewith, whether in equity or at law, in contract, in tort or otherwise (whether or not Parent’s or Merger Sub’s breach is caused by the breach by the Equity Investor of its obligations under this letter agreement) or the Other Equity Investor of its obligations under the Other Equity Commitment Letter, and neither the Equity Investor, the Other Equity Investor nor any Parent Related Party shall have any further liability or obligation (except in respect of the Non-Prohibited Claims) relating to or arising out of such matters.

7. Confidentiality. This letter agreement shall be treated as confidential and is being provided to Parent solely in connection with the Merger Agreement. This letter agreement may not be used, circulated, quoted or otherwise referred to in any document, except with the written consent of the Equity Investor; provided that no such written consent shall be required for disclosures by Parent to the Company or the Other Equity Investor, so long as the Company or the Other Equity Investor, as applicable, agrees to keep such information confidential on terms substantially identical to the terms contained in this Section 7 or who are otherwise subject to confidentiality obligations; provided, further, that any party hereto may disclose the existence of this letter agreement to the extent required by any Applicable Law, the applicable rules of any national securities exchange, in connection with any securities regulatory agency filings relating to the transactions contemplated by the Merger Agreement, or in connection with the enforcement of any such party’s rights hereunder.

8. Governing Law; Jurisdiction; Waiver of Jury Trial.

(a) This letter agreement and all disputes or controversies arising out of or relating to this letter agreement or the transactions contemplated hereby, including the applicable statute of limitations, shall be governed by and construed in accordance with the laws of the State of Delaware, without regard to the conflicts of law rules that would cause the application of law of any jurisdiction other than those of the State of Delaware.

 

7


(b) The parties hereto agree that any Proceeding seeking to enforce any provision of, or based on any matter arising out of or in connection with, this letter agreement or the transactions contemplated by this letter agreement shall be brought and determined exclusively in the Court of Chancery of the State or Delaware or, if that court does not have subject matter jurisdiction, the state or federal courts in the State of Delaware (the “Delaware Courts”). Each party hereto hereby irrevocably submits to the exclusive jurisdiction of the Delaware Courts in respect of any Proceeding arising out of or relating to this letter agreement or the transactions contemplated by this letter agreement, or relating to enforcement of any of the terms of this letter agreement, and hereby waives, and agrees not to assert, as a defense in any such Proceeding, any claim that it is not subject personally to the jurisdiction of such court, that the Proceeding is brought in an inconvenient forum, that the venue of the Proceeding is improper or that this letter agreement or the transactions contemplated by this letter agreement may not be enforced in or by such courts. Each party hereto agrees that notice or the service of process in any Proceeding arising out of or relating to this letter agreement or the transactions contemplated by this letter agreement shall be properly served or delivered if delivered in the manner contemplated by Section 9.01 (Notices) of the Merger Agreement or in any other manner permitted by law.

(c) WAIVER OF JURY TRIAL. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATED TO THIS LETTER AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS LETTER AGREEMENT. EACH OF THE PARTIES HERETO HEREBY (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF THE OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT HAS BEEN INDUCED TO ENTER INTO THIS LETTER AGREEMENT AND THE TRANSACTIONS CONTEMPLATED BY THIS LETTER AGREEMENT, AS APPLICABLE, BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 8(c).

9. Headings. The descriptive headings herein are inserted for convenience of reference only and are not intended to be part of or to affect the meaning or interpretation of this letter agreement.

10. Counterparts. This letter agreement may be executed and delivered (including by means of telecopied signature pages or other means of electronic transmission, such as by electronic mail in “pdf” form or any electronic signature complying with the U.S. Federal ESIGN Act of 2000, e.g., www.docusign.com) in counterparts, and by the different parties hereto in separate counterparts, each of which when executed shall be deemed to be an original but all of which taken together shall constitute one and the same letter agreement. The letter agreement shall become effective when each party hereto shall have received a counterpart hereof signed by all of the other parties hereto. Until and unless each party has received a counterpart hereof signed by each other party hereto, this letter agreement shall have no effect and no party shall have any right or obligation hereunder (whether by virtue of any other oral or written agreement or other communication). The parties irrevocably and unreservedly agree that this letter agreement may be executed by way of electronic signatures and the parties agree that this letter, or any part thereof, shall not be challenged or denied any legal effect, validity and/or enforceability solely on the ground that it is in the form of an electronic record.

[Remainder of this page intentionally left blank.]

 

8


Very truly yours,
Equity Investor:
SILVER LAKE ALPINE II, L.P.
By:   Silver Lake Alpine Associates II, L.P., its general partner
By:   SLAA II (GP), L.L.C., its general partner
By:   Silver Lake Group, L.L.C., its managing member
By:  

/s/ Joseph Osnoss

Name:   Joseph Osnoss
Title:   Managing Director


Accepted and acknowledged:

ZODIAC PURCHASER, L.L.C.

By: Zodiac Guarantor, L.L.C., its managing member

By: Zodiac Holdco, L.L.C., its managing member

By: Silver Lake Alpine Associates II, L.P., its managing member

By: SLAA II (GP), L.L.C., its general partner

By: Silver Lake Group, L.L.C., its managing member

 

By:  

/s/ Joseph Osnoss

Name:   Joseph Osnoss
Title:   Managing Director

EXHIBIT 16(b)(ii)

CONFIDENTIAL

Execution Version

October 17, 2024

Zodiac Purchaser, L.L.C.

c/o Silver Lake Alpine II, L.P.

2775 Sand Hill Road, Suite 100

Menlo Park, CA 94025

 

Re:

Equity Financing Commitment

Ladies and Gentlemen:

Reference is made to the Agreement and Plan of Merger, dated as of the date hereof (as amended, supplemented or otherwise modified from time to time, the “Merger Agreement”), by and among Zodiac Purchaser, L.L.C., a Delaware limited liability company (“Parent”), Zodiac Acquisition Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (“Merger Sub”) and Zuora, Inc., a Delaware corporation (the “Company”), pursuant to which, upon the terms and subject to the conditions set forth therein, among other things, Merger Sub shall merge with and into the Company (the “Merger”), with the Company surviving the Merger as a wholly owned subsidiary of Parent. Reference is also made to the Other Equity Commitment Letter of even date herewith delivered to Parent by Silver Lake Alpine II, L.P. (the “Other Equity Commitment Letter”). Each capitalized term used and not defined herein shall have the meaning ascribed to it in the Merger Agreement, except as otherwise provided herein. Hux Investment Pte. Ltd. is referred to herein as the “Equity Investor” and Silver Lake Alpine II, L.P. is referred to herein as the “Other Equity Investor”. This letter agreement is being delivered by the Equity Investor to Parent in connection with the execution of the Merger Agreement.

1. Commitment. Subject to the conditions set forth herein, including without limitation the Ownership Percentage Cap (as defined below), the Equity Investor hereby agrees to purchase at or immediately prior to the Closing equity securities of Parent (collectively, the “Subject Securities”), for an aggregate purchase price, in the form of cash in immediately available U.S. funds to Parent (or a parent entity that directly or indirectly wholly owns Parent), equal to $410,000,000 (as such amount may be reduced pursuant to Section 4(a) of this letter agreement in connection with an Equity Assignment on the terms and subject to the conditions of Section 6.17(a) of the Merger Agreement (including Section 6.17(a) of the Parent Disclosure Schedule), such commitment, the “Equity Financing Commitment”), solely for the purpose of permitting Parent to fund, and to the extent necessary to fund (together with the proceeds of the Debt Financing, proceeds of the equity commitment under the Other Equity Commitment Letter, and cash on hand at the Company and its Subsidiaries available for funding in accordance with the Merger Agreement), the Required Amount, and not for any other purpose, it being understood that the Equity Investor (together with its permitted assigns, as applicable) shall not under any circumstances be obligated under this letter agreement to purchase any equity of, or make any other payment or contribution to, or investment in, Parent other than the purchase of the Subject Securities pursuant to the terms hereof for a purchase price equal to the Equity Financing Commitment. The obligation of the Equity Investor (together with its permitted assigns, as


applicable) to fund the Equity Financing Commitment (a) is subject solely to (i) the terms of this letter agreement, (ii) the satisfaction or waiver by Parent of all of the conditions to Parent’s and Merger Sub’s obligations to effect the Closing set forth in Sections 7.01 (Conditions to the Obligations of Each Party) and 7.02 (Conditions to the Obligations of Parent and Merger Sub) of the Merger Agreement (other than those conditions that, by their nature, are to be satisfied at the Closing, but subject to such conditions being able to be satisfied), (iii) the prior or substantially concurrent receipt by Parent, Merger Sub or the Company of the proceeds of (A) the Debt Financing and (B) the equity commitment under the Other Equity Commitment Letter (provided, that the failure of the condition in this subclause (B) to be satisfied shall not limit the ability of Parent or, subject to Section 6(b), the Company to seek to enforce the obligations of the Equity Investor hereunder if Parent and/or the Company, as applicable, is also concurrently seeking enforcement of the obligations of the Other Equity Investor pursuant to the Other Equity Commitment Letter), and (iv) the substantially concurrent consummation of the Closing on the terms and subject to the conditions of the Merger Agreement (assuming the funding of the Equity Financing Commitment) and (b) subject to the foregoing clause (a), will occur simultaneously with the issuance to the Equity Investor of the Subject Securities. Subject to the terms of the Merger Agreement and Ownership Percentage Cap, the amount to be funded under this letter agreement may be reduced dollar for dollar (any such reduction to be allocated between the Equity Investor hereunder and the Other Equity Investor under the Other Equity Commitment Letter as designated in writing by Parent, subject to the Ownership Percentage Cap) in the event that Parent does not require all of the Equity Financing Commitment in order to consummate the transactions contemplated by the Merger Agreement (including payment of the Required Amount), but only to the extent Parent (x) consummates the transactions contemplated by the Merger Agreement at the Closing with the Equity Investor directly or indirectly contributing less than the full amount of the Equity Financing Commitment and (y) makes all payments required to pay the Required Amount to be made by Parent or Merger Sub under the Merger Agreement in connection with the consummation of the transactions contemplated thereby. The amount to be funded under this letter agreement may also be reduced (I) dollar for dollar (any such reduction to be allocated between the Equity Investor hereunder and the Other Equity Investor under the Other Equity Commitment Letter as designated in writing by Parent, subject to the Ownership Percentage Cap) by an amount equal to the Merger Consideration that would be payable in respect of shares of Company Common Stock that are beneficially owned by Parent or its Affiliates (including as a result of the contribution of any Rollover Shares (other than the CEO Rollover Shares) pursuant to the Rollover Agreements (other than the CEO Support and Rollover Agreement)), and (II) for the amount of Convertible Notes contributed by the Equity Investor to Parent at or prior to Closing in excess of an amount equal to the difference between the total amount of the Convertible Notes (as calculated based on the “Fundamental Change Repurchase Price” (as such term is defined in the Convertible Notes Indenture)) and the Convertible Notes Closing Cash Payment Cap, but in each case of (I) and (II) only to the extent Parent (x) consummates the transactions contemplated by the Merger Agreement at the Closing with the Equity Investor directly or indirectly contributing less than the full amount of the Equity Financing Commitment and (y) makes or causes to be made (including from the proceeds of the Debt Financing and cash on hand at the Company and its Subsidiaries available for funding in accordance with the Merger Agreement) all payments required to pay the Required Amount to be made by Parent or Merger Sub under the Merger Agreement in connection with the consummation of the transactions contemplated thereby. Notwithstanding the foregoing, the Investor agrees that no such reduction shall be made if reasonably likely to impair, delay or

 

2


prevent the consummation of the Closing. The Equity Financing Commitment shall be reduced dollar-for-dollar (subject to the Ownership Percentage Cap), by an amount equal to 47% of any Upsize (as defined in the CEO Support and Rollover Agreement), effective immediately and automatically upon the acceptance by Parent of such Upsize pursuant to the CEO Support and Rollover Agreement. Notwithstanding anything to the contrary in this letter agreement, to the extent that the amount to be funded under this letter agreement and/or the Other Equity Commitment Letter is reduced in accordance with the terms hereof or thereof, the amount of the Equity Financing Commitment shall be reduced to an amount such that the Equity Financing Commitment shall not be greater than the dollar amount that, if funded by the Investor (or its Affiliate) simultaneous with the funding of the “Equity Financing Commitment” (as such term is defined under the Other Equity Commitment Letter) would result in the Equity Investor and its Affiliates collectively owning, directly or indirectly (as determined for US federal income tax purposes), a number of equity interests of Parent or the Company (or their respective direct or indirect parent entities) (including on a “look-through” basis taking into account any other Person directly or indirectly investing into Parent or the Company (or their respective direct or indirect parent entities)) representing more than 48.7% (by vote or value) of the issued and outstanding equity interests of any such entity (the “Ownership Percentage Cap”). For clarity, if the amounts to be funded or contributed under this letter agreement and the Other Equity Commitment Letter are funded and contributed in accordance with the terms hereof and thereof, the Equity Investor’s and its Affiliates’ collective ownership (in the manner calculated above) in the entities above will be less than the Ownership Percentage Cap.

2. Termination. Unless terminated pursuant to this Section 2, this letter agreement may not be revoked and shall remain in full force and effect and shall be binding on the Equity Investor and its successors and permitted assigns. The Equity Investor’s obligation to fund the Equity Financing Commitment will terminate automatically and immediately upon the earliest to occur of (a) the valid termination of the Merger Agreement in accordance with its terms, (b) the commencement, directly or indirectly, by the Company or any of its Affiliates of any Proceeding against the Equity Investor, the Other Equity Investor, Parent or Merger Sub or any other Parent Related Party (as defined below) relating to this letter agreement, the limited guarantee of even date herewith of the Equity Investor (the “Guarantee”), the limited guarantee of even date herewith of the Other Equity Investor (the “Other Guarantee” and, together with the Guarantee, the “Guarantees”), the Merger Agreement or any of the transactions contemplated hereby or thereby (including in respect of any oral representations made or alleged to be made in connection therewith) other than any Proceeding by (i) the Company against Parent or Merger Sub seeking (A) specific performance against Parent and/or Merger Sub pursuant to, and subject to the limitations in, Section 9.09 (Specific Performance) of the Merger Agreement and in accordance with this letter agreement, and/or (B) payment of either the Parent Termination Fee or the Regulatory Termination Fee, Reimbursement Obligations and Enforcement Costs, in each case in accordance with, and solely to the extent permitted under, the Merger Agreement (including Sections 6.17(f) (Financing), 9.04(d) (Parent Termination Fee), 9.04(e) (Regulatory Termination Fee) and 9.04(h) (Fees and Expenses) thereof), (ii) the Company against the Equity Investor or the Other Equity Investor seeking (A) payment of their respective obligations under the Guarantees in accordance with, and solely to the extent permitted under, the respective Guarantees and/or (B) specific performance of the Equity Investor’s obligation to fund its Equity Financing Commitment or of the Other Equity Investor’s obligation to fund its commitment under the Other Equity Commitment, in each case in accordance with, and solely to the extent permitted under, the terms

 

3


hereof and the terms of the Merger Agreement, and (iii) the Company under the Confidentiality Agreement (the Proceedings set forth in the foregoing clauses (i) through (iii), the “Non-Prohibited Claims”), (c) any final non-appealable judgment of a court of competent jurisdiction against any of Parent, Merger Sub or Guarantor with respect to any Non-Prohibited Claim that includes an award of either the Parent Termination Fee or the Regulatory Termination Fee, the Reimbursement Obligations and/or the Enforcement Costs, (d) the Closing and the payment of the Equity Financing Commitment (at which time the obligations hereunder shall be discharged) and (e) the valid termination of the Other Equity Commitment Letter other than following the Other Equity Investor’s funding its Equity Financing Commitment. Upon termination of this letter agreement, the Equity Investor shall not have any further obligations or liabilities hereunder. Sections 2 (Termination), 4 (Assignment; Amendments and Waivers; Entire Agreement), 5 (Parties in Interest), 6 (Limited Recourse; Enforcement), 7 (Confidentiality) and 8 (Governing Law; Jurisdiction; Waiver of Jury Trial) of this letter agreement shall survive and remain in full force and effect, notwithstanding any termination of this letter agreement. For the avoidance of doubt, upon the valid termination of this letter agreement, all obligations of the Equity Investor to fund the Equity Financing Commitment shall terminate and no surviving provision shall be deemed to require the Equity Investor to fund any portion of the Equity Financing Commitment.

3. Representations and Warranties. The Equity Investor hereby represents and warrants (and makes no other representations or warranties, express or implied) that:

(a) It is duly organized or incorporated, validly existing and in good standing under the laws of its jurisdiction of organization or incorporation.

(b) The execution, delivery of and performance under this letter agreement by it is within its organizational or corporate powers and has been duly authorized by all necessary organizational, general partner, manager or corporate action, as applicable.

(c) This letter agreement has been duly executed and delivered by it and, assuming the due authorization, execution and delivery by Parent, constitutes its valid and binding agreement, enforceable against it in accordance with its terms, except as such enforceability may be limited by bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or other similar applicable law relating to or affecting creditors’ rights generally by general principles of equity.

(d) The execution and delivery of and performance under, this letter agreement by it do not and will not (i) violate its organizational documents, (ii) violate any provision of Applicable Law or any Order (subject to the making, obtaining and receipt of the consents, approvals, authorizations, permits of, filings with and notifications to any governmental authority described in Section 7.01(c) of the Merger Agreement) or (iii) conflict with any material agreement binding upon it, except in the case of (ii) and (iii) as would not reasonably be expected to, individually or in the aggregate, materially affect its ability to enter into this letter agreement or perform its obligations hereunder.

 

4


(e) Subject to the making, obtaining and receipt of the consents, approvals, authorizations, permits of, filings with and notifications to any governmental authority described in Section 7.01(c) of the Merger Agreement, all consents, approvals, authorizations, permits of, filings with and notifications to, any governmental authority necessary for the due execution, delivery and performance of this letter by the Equity Investor have been obtained or made and all conditions thereof have been duly complied with, and no other action by, and no notice to or filing with, any governmental authority is required in connection with the execution, delivery or performance of this letter except as would not reasonably be expected to, individually or in the aggregate, materially affect the Equity Investor’s ability to enter into this letter or perform its obligations hereunder.

(f) The Equity Investor (i) has, and will continue to have for so long as this Equity Commitment Letter is in effect, the financial capacity to pay and perform its obligations under this Equity Commitment Letter, and (ii) will have at such time as the Equity Investor is obligated to fund the Equity Financing Commitment, sufficient cash, available lines of credit or other sources of immediately available funds to fulfill its obligations under this Equity Commitment Letter.

4. Assignment; Amendments and Waivers; Entire Agreement.

(a) The rights and obligations under this letter agreement may not be assigned or delegated (whether by operation of law, merger, consolidation or otherwise) by any party hereto without the prior written consent of the other parties and the Company, and any attempted assignment shall be null and void and of no force or effect. Notwithstanding the foregoing, (i) Parent may assign, delegate or otherwise transfer all or a portion of their rights or obligations under this letter agreement to any assignee of Parent’s obligations under the Merger Agreement pursuant to an assignment in accordance with Section 9.05 (Assignment; Benefit) of the Merger Agreement, (ii) the Equity Investor may assign, delegate or otherwise transfer all or a portion of its obligation to fund the Equity Financing Commitment to one or more of its Affiliated investment vehicles or co-investors or any Person that is, directly or indirectly, wholly owned or otherwise controlled by or Affiliated with such Equity Investor or co-investors, one or more of such Affiliated investment vehicles and/or one or more Subsidiaries that are wholly owned or otherwise controlled by or affiliated with such Equity Investor and/or Affiliated investment funds and/or co-investors; provided that, in each case, no such assignment, delegation or transfer shall relieve the Equity Investor of its obligations hereunder, and (iii) the Equity Investor may assign all or a portion of its obligations to fund the Equity Financing Commitment (the “Assigned Commitment”) to one or more third parties (each, an “Assigned Investor”) in connection with an Equity Assignment on the terms and subject to the conditions of Section 6.17(a) of the Merger Agreement (including Section 6.17(a) of the Parent Disclosure Schedule) and upon such assignment, the Equity Investor shall be released from its obligations hereunder (and the Equity Financing Commitment shall be reduced) dollar for dollar to the extent of the amount of such Assigned Commitment; provided that such Assigned Investor shall enter into a separate equity commitment letter with Parent on terms no less favorable to Parent (and with respect to the Company’s rights as a third-party beneficiary hereunder, the Company) as contained herein with respect to such Assigned Commitment.

(b) This letter agreement may not be amended, and no provision hereof waived or modified, except by an instrument signed by each of the parties hereto and with the prior written consent of the Company, and this letter agreement may not be terminated other than in accordance with Section 2 hereof. The failure of any party to assert any of its rights under this letter agreement or otherwise shall not constitute a waiver of those rights.

 

5


(c) This letter agreement, the Other Commitment Letter, the Guarantees and the Merger Agreement constitute the entire agreement among the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and undertakings, both written and oral, among the parties hereto or any of their Affiliates with respect to the subject matter hereof and thereof.

5. Parties in Interest. This letter agreement shall be binding upon and inure solely to the benefit of each party hereto and their respective successors and permitted assigns, and nothing in this letter agreement, express or implied, is intended to or shall confer upon any other Person any right, benefit or remedy of any nature whatsoever under or by reason of this letter agreement; provided, however that (a) the Parent Related Parties are express, intended third party beneficiaries of Section 6(a) hereto and (b) the Company hereby is made an express, intended third party beneficiary of this letter agreement solely to the extent, and subject to the limitations, set forth in Section 6(b).

6. Limited Recourse; Enforcement.

(a) Notwithstanding anything that may be expressed or implied in this letter agreement, the Other Equity Commitment Letter, the Guarantees, the Merger Agreement or any document or instrument delivered in connection herewith or therewith, Parent, by its acceptance of the benefits of the Equity Financing Commitment provided herein, covenants, agrees and acknowledges that no Person other than the Equity Investor (and its successors and assigns) shall have any obligations hereunder or in connection with the transactions contemplated hereby and that, notwithstanding that the Equity Investor or any of its permitted assigns may be a partnership, limited liability company or other type of entity, no Person has any rights of recovery against, and no recourse hereunder or under any documents or instruments delivered in connection herewith or in respect of any oral representations made or alleged to have been made in connection herewith or therewith shall be had against, any of Parent’s, Merger Sub’s, the Equity Investor’s or any of their or their respective Affiliates’ respective former, current or future directors, officers, employees, direct or indirect holders of any equity, stockholders, controlling persons, Affiliates, attorneys, members, managers, general or limited partners, assignees, agents, representatives or representatives of any of the foregoing (but not including Parent, Merger Sub or the Equity Investor, a “Parent Related Party” and together, the “Parent Related Parties”), whether by or through attempted piercing of the corporate (or limited liability company or limited partnership) veil, by or through a claim (whether at law or equity or in tort, contract or otherwise) by or on behalf of the Equity Investor against any Parent Related Party, by the enforcement of any assessment or by any legal or equitable proceeding, or by virtue of any applicable Law, or otherwise, it being agreed and acknowledged that no personal liability whatsoever shall attach to, be imposed on or otherwise be incurred by any Parent Related Party for any obligations of the Equity Investor or any of its successors or assigns under this letter agreement, under the Merger Agreement, the Guarantee or under any documents or instrument delivered in connection herewith or therewith, in respect of any transaction contemplated hereby or thereby or in respect of any oral representations made or alleged to have been made in connection herewith or therewith or for any claim (whether at law or equity or in tort, contract or otherwise) based on, in respect of, or by reason of such obligations or their creation; provided, however, that notwithstanding anything to the contrary provided herein or any document or instrument delivered in connection herewith, nothing herein shall limit the rights of the Company in respect of any Non-Prohibited Claims.

 

6


(b) This letter agreement may only be enforced by Parent, and none of Parent’s creditors nor any other Person that is not a party to this letter agreement shall have any right to enforce this letter agreement or to cause Parent to enforce this letter agreement; provided, however, that the Company is hereby made an express third party beneficiary of the rights granted to Parent under this letter agreement only for the purpose of specifically enforcing (subject to the limitations set forth in the Merger Agreement) the Equity Investor’s obligation to fund, as and when due, the Equity Financing Commitment hereunder if and only if pursuant to Section 9.09(a) (Specific Performance) of the Merger Agreement the Company is entitled to file an action in a court of competent jurisdiction seeking specific performance to cause Parent and Merger Sub to consummate the Closing and cause the funding of the Equity Financing Commitment pursuant to the terms hereof and for no other purpose (including, without limitation, any claim for monetary damages hereunder or under the Merger Agreement).

(c) Concurrently with the execution and delivery of this letter agreement, the Equity Investor is executing and delivering to the Company the Guarantee and, concurrently with the execution and delivery of the Other Equity Commitment Letter, the Other Equity Investor is executing and delivering to the Company the Other Guarantee, in each case, relating to certain of Parent’s obligations under the Merger Agreement. Except as expressly set forth in Section 6(b) hereof, the Company’s remedies against the Equity Investor and the Other Equity Investor with respect to any Non-Prohibited Claims shall, and are intended to, be the sole and exclusive direct or indirect remedies available to the Company and its Affiliates, and each of their respective former, current and future directors, officers, employees, holder of any equity, stockholders, controlling persons, Affiliates, attorneys, members, managers, general or limited partners, assignees, agents and representatives against the Equity Investor, the Other Equity Investor or any Parent Related Party for any liability, loss, damage or recovery of any kind in connection with, relating to, arising out of or resulting from any breach of this letter agreement or the Merger Agreement, the failure of the Merger to be consummated for any reason or otherwise in connection with the transactions contemplated hereby and thereby or in respect of any representations made or alleged to have been made in connection therewith, whether in equity or at law, in contract, in tort or otherwise (whether or not Parent’s or Merger Sub’s breach is caused by the breach by the Equity Investor of its obligations under this letter agreement) or the Other Equity Investor of its obligations under the Other Equity Commitment Letter, and neither the Equity Investor, the Other Equity Investor nor any Parent Related Party shall have any further liability or obligation (except in respect of the Non-Prohibited Claims) relating to or arising out of such matters.

7. Confidentiality. This letter agreement shall be treated as confidential and is being provided to Parent solely in connection with the Merger Agreement. This letter agreement may not be used, circulated, quoted or otherwise referred to in any document, except with the written consent of the Equity Investor; provided that no such written consent shall be required for disclosures by Parent to the Company or the Other Equity Investor, so long as the Company or the Other Equity Investor, as applicable, agrees to keep such information confidential on terms substantially identical to the terms contained in this Section 7 or who are otherwise subject to confidentiality obligations; provided, further, that any party hereto may disclose the existence of this letter agreement to the extent required by any Applicable Law, the applicable rules of any national securities exchange, in connection with any securities regulatory agency filings relating to the transactions contemplated by the Merger Agreement, or in connection with the enforcement of any such party’s rights hereunder.

 

7


8. Governing Law; Jurisdiction; Waiver of Jury Trial.

(a) This letter agreement and all disputes or controversies arising out of or relating to this letter agreement or the transactions contemplated hereby, including the applicable statute of limitations, shall be governed by and construed in accordance with the laws of the State of Delaware, without regard to the conflicts of law rules that would cause the application of law of any jurisdiction other than those of the State of Delaware.

(b) The parties hereto agree that any Proceeding seeking to enforce any provision of, or based on any matter arising out of or in connection with, this letter agreement or the transactions contemplated by this letter agreement shall be brought and determined exclusively in the Court of Chancery of the State or Delaware or, if that court does not have subject matter jurisdiction, the state or federal courts in the State of Delaware (the “Delaware Courts”). Each party hereto hereby irrevocably submits to the exclusive jurisdiction of the Delaware Courts in respect of any Proceeding arising out of or relating to this letter agreement or the transactions contemplated by this letter agreement, or relating to enforcement of any of the terms of this letter agreement, and hereby waives, and agrees not to assert, as a defense in any such Proceeding, any claim that it is not subject personally to the jurisdiction of such court, that the Proceeding is brought in an inconvenient forum, that the venue of the Proceeding is improper or that this letter agreement or the transactions contemplated by this letter agreement may not be enforced in or by such courts. Each party hereto agrees that notice or the service of process in any Proceeding arising out of or relating to this letter agreement or the transactions contemplated by this letter agreement shall be properly served or delivered if delivered in the manner contemplated by Section 9.01 (Notices) of the Merger Agreement or in any other manner permitted by law.

(c) WAIVER OF JURY TRIAL. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATED TO THIS LETTER AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS LETTER AGREEMENT. EACH OF THE PARTIES HERETO HEREBY (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF THE OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT HAS BEEN INDUCED TO ENTER INTO THIS LETTER AGREEMENT AND THE TRANSACTIONS CONTEMPLATED BY THIS LETTER AGREEMENT, AS APPLICABLE, BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 8(c).

9. Headings. The descriptive headings herein are inserted for convenience of reference only and are not intended to be part of or to affect the meaning or interpretation of this letter agreement.

 

8


10. Counterparts. This letter agreement may be executed and delivered (including by means of telecopied signature pages or other means of electronic transmission, such as by electronic mail in “pdf” form or any electronic signature complying with the U.S. Federal ESIGN Act of 2000, e.g., www.docusign.com) in counterparts, and by the different parties hereto in separate counterparts, each of which when executed shall be deemed to be an original but all of which taken together shall constitute one and the same letter agreement. The letter agreement shall become effective when each party hereto shall have received a counterpart hereof signed by all of the other parties hereto. Until and unless each party has received a counterpart hereof signed by each other party hereto, this letter agreement shall have no effect and no party shall have any right or obligation hereunder (whether by virtue of any other oral or written agreement or other communication). The parties irrevocably and unreservedly agree that this letter agreement may be executed by way of electronic signatures and the parties agree that this letter, or any part thereof, shall not be challenged or denied any legal effect, validity and/or enforceability solely on the ground that it is in the form of an electronic record.

11. Waiver of Sovereign Immunity. To the extent permitted by Applicable Law, if the Equity Investor has or hereafter may acquire any immunity (sovereign or otherwise) from any Proceeding, from jurisdiction of any court of from set-off or any legal process (whether service or notice, attachment prior to judgment, attachment in aid of execution of judgment, execution of judgment or otherwise) with respect to itself or any of its property, the Equity Investor hereby irrevocably waives and agrees not to plead or claim such immunity in respect of its obligations under this letter agreement or the transactions contemplated hereby.

[Remainder of this page intentionally left blank.]

 

9


Very truly yours,
Equity Investor:
HUX INVESTMENT PTE. LTD.
By:  

/s/ Kenan Basha

  Name:   Kenan Basha
  Title:   Authorized Signatory


Accepted and acknowledged:

ZODIAC PURCHASER, L.L.C.

By: Zodiac Guarantor, L.L.C., its managing member

By: Zodiac Holdco, L.L.C., its managing member

By: Silver Lake Alpine Associates II, L.P., its managing member

By: SLAA II (GP), L.L.C., its general partner

By: Silver Lake Group, L.L.C., its managing member

 

By:  

/s/ Andrew J. Schader

Name:   Andrew J. Schader
Title:   Managing Director and General Counsel

EXHIBIT 16(b)(iii)

CONFIDENTIAL

Execution Version

November 13, 2024

Zodiac Purchaser, L.L.C.

c/o Silver Lake Partners

55 Hudson Yards

550 West 34th Street, 40th Floor

New York, NY 10001

Project Zodiac

Amended and Restated Commitment Letter

Ladies and Gentlemen:

Reference is made to the Commitment Letter, dated October 17, 2024 (the “Original Signing Date” and, such letter, the “Original Commitment Letter”) by and between Royal Bank of Canada (“Royal Bank”), RBC Capital Markets1 (“RBCCM” and, together with Royal Bank, “RBC”), Banco Santander, S.A., New York Branch (“Santander”), Bank of Montreal (“Bank of Montreal”), BMO Capital Markets Corp. (“BMOCM” and, together with Bank of Montreal, “BMO”) and Barclays Bank PLC (“Barclays” and, together with RBC, Santander, BMO and any commitment parties added pursuant to the terms hereof, collectively, the “Original Commitment Parties”). The Original Commitment Letter is hereby amended and restated, replaced and superseded in its entirety as follows and such Original Commitment Letter shall be of no further effect.

You have advised the Original Commitment Parties, KKR Capital Markets LLC (“KCM”), KKR CORPORATE LENDING (CA) LLC, (“KCL”), SF Credit Partners, LLC (“SF”), Stifel Nicolaus and Company, Incorporated (“Stifel Nicolaus” and, together with SF, “Stifel”), Wells Fargo Bank, National Association (“Wells Fargo Bank”) and Wells Fargo Securities, LLC (“Wells Fargo Securities” and, together with Wells Fargo Bank, “Wells Fargo”; Wells Fargo, together with Original Commitment Parties, KCM, KCL and Stifel, collectively, “we”, “us” or the “Commitment Parties”) that Zodiac Purchaser, L.L.C., a limited liability company organized under the laws of the State of Delaware (“Buyer” or “you”), formed at the direction of Silver Lake Partners and its affiliates (collectively with the funds, partnerships, co-investment entities and other investment vehicles managed, advised or controlled thereby or by one or more directors thereof or under common control therewith, “Silver Lake”) and Hux Investment Pte. Ltd (collectively with the funds, partnerships, co-investment entities and other investment vehicles managed, advised or controlled thereby or by one or more directors thereof or under common control therewith, “GIC” and, together with Silver Lake, the “Sponsors”), intends to consummate the Transactions described in the Transaction Description attached hereto as Exhibit A (the “Transaction Description”). Capitalized terms used but not defined herein shall have the meanings assigned to them in the Transaction Description, the Summary of Principal Terms and Conditions attached hereto as Exhibit B (the “Term Sheet”) and the Summary of Additional Conditions attached hereto as Exhibit C (together with this commitment letter and the Term Sheet, the “Commitment Letter”).

 

1 

RBC Capital Markets is the brand name for the capital markets businesses of Royal Bank of Canada and its affiliates.


1. Commitments.

In connection with the Transactions, each of Royal Bank, Santander, Bank of Montreal, Barclays, KCL, SF and Wells Fargo Bank is pleased to advise you of its several, but not joint, commitment to provide 20%, 20%, 20%, 20%, 8%, 4% and 8%, respectively, of the aggregate principal amount of each of the Initial Term Loan Facility and the Revolving Facility. Royal Bank, Santander, Bank of Montreal, Barclays, KCL, SF and Wells Fargo Bank are referred to herein as the “Initial Lenders” and each individually as an “Initial Lender.

2. Titles and Roles.

It is agreed that (i) each of RBCCM, Santander, BMO, Barclays, KCM, Stifel Nicolaus and Wells Fargo Securities, will act as a joint lead arranger for each of the Facilities (each in such capacity, a “Lead Arranger” and, collectively, the “Lead Arrangers”), (ii) each of RBCCM, Santander, BMO, Barclays, KCM, Stifel Nicolaus and Wells Fargo Securities will act as a joint bookrunner for each of the Facilities (each in such capacity, a “Joint Bookrunner” and, collectively, the “Joint Bookrunners”) and (iii) Royal Bank will act as administrative agent and collateral agent for the Facilities (in such capacities, the “Administrative Agent”). It is further agreed that (a) RBCCM shall have “left side” designation and shall appear on the top left of any Information Materials (as defined below) and all other marketing materials in respect of each of the Initial Term Loan Facility and the Revolving Facility and (b) the other Lead Arrangers will be listed in alphabetical order to the right of RBCCM in any Information Materials and all other marketing materials in respect of the Initial Term Loan Facility and the Revolving Facility. You agree that no other agents, co-agents, arrangers, co-arrangers, bookrunners, co-bookrunners, managers or co-managers will be appointed, no other titles will be awarded and, with respect to the Facilities, no compensation (other than compensation expressly contemplated by this Commitment Letter and the Fee Letter referred to below) will be paid by you or any of your affiliates to any Lender (as defined below) in order to obtain its commitment to participate in the Facilities unless you and the Majority Lead Arrangers (as defined in the Fee Letter referred to below) shall so agree.

3. Syndication.

The Lead Arrangers reserve the right, prior to and/or after the Closing Date (as defined below), to syndicate all or a portion of the Initial Lenders’ respective commitments hereunder to a group of banks, financial institutions and other institutional lenders and investors identified by the Lead Arrangers in consultation with you and reasonably acceptable to the Lead Arrangers and you, including, without limitation, any relationship lenders designated by you and reasonably acceptable to the Lead Arrangers (such banks, financial institutions and other institutional lenders and investors, together with the Initial Lenders, the “Lenders”). Notwithstanding the foregoing, the Lead Arrangers will not syndicate to those banks, financial institutions and other institutional lenders and investors (i) that have been separately identified in writing by you (x) to us prior to the date of this Commitment Letter, (y) to us after the date of this Commitment Letter and prior to the Closing Date, that are reasonably acceptable to the Lead Arrangers holding a majority of the aggregate amount of outstanding financing commitments in respect of the Facilities (the “Required Lead Arrangers”) and (z) to the Administrative Agent after the Closing Date, that are reasonably acceptable to the Administrative Agent), (ii) those persons who are competitors of you, the Target and your and their respective subsidiaries that are separately identified in writing by you to us from time to time, (iii) in the case of each of clauses (i) and (ii), any of their respective affiliates (other than bona fide debt fund affiliates) that are either (a) identified in writing by you from time to time or (b) clearly identifiable on the basis of such affiliate’s name and (iv) any Excluded Affiliates (as defined in the Precedent Documentation) (clauses (i), (ii), (iii) and (iv) above, collectively “Disqualified Lenders”); provided that designations of Disqualified Lenders may not apply retroactively to disqualify any entity that has previously acquired an assignment or participation in any Facility. In the event that any portion of the Facilities are syndicated to investments funds to whom KKR Credit Advisors (US) LLC serves as an investment manager, neither KCM nor KCL shall directly be assigned that portion of the Facilities and that portion shall be assigned exclusively to other Commitment Parties.

 

2


Notwithstanding the Lead Arrangers’ right to syndicate the Facilities and receive commitments with respect thereto, (i) no Initial Lender shall be relieved, released or novated from its obligations hereunder (including its obligation to fund the Facilities on the date of both the consummation of the Acquisition and the initial funding under the Initial Term Loan Facility (the date of such consummation and funding, the “Closing Date”)) in connection with any syndication, assignment or participation of the Facilities, including its commitments in respect thereof, until after the initial funding of the Facilities on the Closing Date has occurred, (ii) no assignment or novation shall become effective with respect to all or any portion of any Initial Lender’s commitments in respect of the Facilities until after the initial funding of the Facilities and (iii) unless you otherwise agree in writing, each Commitment Party shall retain exclusive control over all rights and obligations with respect to its commitments in respect of the Facilities, including all rights with respect to consents, modifications, supplements, waivers and amendments, until the Closing Date has occurred.

Without limiting your obligations to assist with the syndication efforts as set forth herein, it is understood that the Initial Lenders’ commitments hereunder are not conditioned upon the syndication of, or receipt of commitments in respect of, the Facilities and in no event shall the commencement or successful completion of syndication of the Facilities constitute a condition to the effectiveness of the Facilities Documentation on the Closing Date or the availability or funding of the Facilities on the Closing Date. The Lead Arrangers may commence syndication efforts promptly (taking into account the expected timing of the Acquisition) after your acceptance of this Commitment Letter and as part of their syndication efforts, it is their intent to have Lenders commit to the Facilities prior to the Closing Date (subject to the limitations set forth in the preceding paragraph). Until the earlier of (i) the date upon which a Successful Syndication (as defined in the Fee Letter referred to below) of the applicable Facilities is achieved and (ii) the 30th day following the Closing Date (such earlier date, the “Syndication Date”), you agree actively to assist the Lead Arrangers in completing a timely syndication that is reasonably satisfactory to us and you. Such assistance shall include, without limitation, (a) your using commercially reasonable efforts to ensure that any syndication efforts benefit materially from your existing lending and investment banking relationships and the existing lending and investment banking relationships of the Sponsors and, to the extent practical and appropriate and in all instances subject to the limitations on your rights set forth in the Acquisition Agreement, the Target’s and its subsidiaries’ existing lending and investment banking relationships, (b) direct contact between senior management, certain representatives and certain advisors of you and the Sponsors, on the one hand, and the proposed Lenders, on the other hand (and your using commercially reasonable efforts to arrange, to the extent practical and appropriate and in all instances subject to the limitations on your rights set forth in the Acquisition Agreement, such contact between senior management, certain representatives or certain advisors of the Target and its subsidiaries, on the one hand, and the proposed Lenders, on the other hand), in all such cases at times and locations to be mutually agreed upon, (c) your and the Sponsors’ assistance (including the use of commercially reasonable efforts to cause, to the extent practical and appropriate and in all instances subject to the limitations on your rights set forth in the Acquisition Agreement, the Target and its subsidiaries to assist) in the preparation of the Information Materials (as defined below) and other customary marketing materials to be used in connection with the syndication, (d) using your commercially reasonable efforts to procure, at your expense, prior to the launch of the general syndication of the Facilities, public ratings for the Initial Term Loan Facility from at least two of S&P Global Ratings (“S&P”), Moody’s Investors Service, Inc. (“Moody’s”) and Fitch Ratings Inc. (“Fitch”), and a public corporate credit rating and a public corporate family rating in respect of the Borrower after giving effect to the Transactions from each of S&P and Moody’s, respectively, (e) the hosting, with the Lead Arrangers, of a reasonable number of meetings to be mutually agreed upon of

 

3


prospective Lenders at times and locations to be mutually agreed upon (and your using commercially reasonable efforts to cause, to the extent practical and appropriate and in all instances subject to the limitations on your rights set forth in the Acquisition Agreement, the relevant senior officers of the Target to be available for such meetings) and (f) ensuring there being no competing issues, offerings, placements, arrangements or syndications of debt securities or syndicated commercial bank or other syndicated credit facilities by or on behalf of you or any of your subsidiaries, and after using your commercially reasonable efforts, to the extent practical, appropriate and reasonable and in all instances subject to the limitations on your rights set forth in the Acquisition Agreement, the Target or any of its subsidiaries, being offered, placed or arranged (other than (A) the Facilities and (B) any indebtedness of the Target and its subsidiaries permitted to be incurred or to remain outstanding on the Closing Date under the Acquisition Agreement) without the written consent of the Required Lead Arrangers (such consent not to be unreasonably withheld or delayed), if such issuance, offering, placement or arrangement would materially and adversely impair the primary syndication of the Facilities (it is understood that the Target’s and its subsidiaries’ deferred purchase price obligations, ordinary course working capital facilities and ordinary course capital lease, or purchase money and equipment financings (any such debt, “Ordinary Course Indebtedness”) will not be deemed to materially and adversely impair the primary syndication of the Facilities). Notwithstanding anything to the contrary contained in this Commitment Letter or the Fee Letter or any other letter agreement or undertaking concerning the financing of the Transactions to the contrary, none of the obtaining of the public ratings referenced above or the compliance with any of the other provisions set forth in this paragraph, including in any of clauses (a) through (f) above or the next succeeding paragraph, shall constitute a condition to the commitments hereunder or the funding of the Facilities on the Closing Date.

The Lead Arrangers, in their capacities as such, will manage, in consultation with you, all aspects of any syndication of the Facilities, including decisions as to the selection of institutions reasonably acceptable to you to be approached and when they will be approached, when their commitments will be accepted, which institutions will participate (subject to your consent rights set forth in the third preceding paragraph and your rights of appointment set forth in the fourth preceding paragraph and excluding Disqualified Lenders), the allocation of the commitments among the Lenders and the amount and distribution of fees among the Lenders. To assist the Lead Arrangers in their syndication efforts, you agree to promptly prepare and provide (and to cause the Sponsors to provide and to use commercially reasonable efforts to cause, to the extent practical and appropriate and in all instances subject to the limitations on your rights set forth in the Acquisition Agreement, the Target and its subsidiaries to provide) to the Lead Arrangers customary information with respect to Holdings, the Borrower, the Target and their respective subsidiaries and the Transactions set forth in clause (c) of the immediately preceding paragraph, the historical financial information set forth in paragraph 4 of Exhibit C hereto and customary financial estimates, forecasts and other projections (such estimates, forecasts and other projections delivered to us by you, the “Projections”). For the avoidance of doubt, you will not be required to provide any information to the extent that the provision thereof would violate any law, rule or regulation, or any obligation of confidentiality binding upon (so long as such obligations are not entered into in contemplation of this Commitment Letter), or waive any privilege that may be asserted by, you, the Target or any of your or their respective subsidiaries or affiliates (in which case you agree to use commercially reasonable efforts to have any such confidentiality obligation waived, and otherwise in all instances, to the extent practicable and not prohibited by applicable law, rule or regulation, promptly notify us that information is being withheld pursuant to this sentence). Notwithstanding anything herein to the contrary, the only financial statements that shall be required to be provided to the Commitment Parties in connection with the syndication of the Facilities shall be those required to be delivered pursuant to paragraph 4 of Exhibit C hereto.

You hereby acknowledge that (a) the Lead Arrangers will make available Projections and other customary marketing material and presentations, including a customary confidential information memoranda to be used in connection with the syndication of the Facilities (the “Information Memorandum”) (such Projections, other marketing material and the Information Memorandum,

 

4


collectively, with the Term Sheet, the “Information Materials”) on a confidential basis to the proposed syndicate of Lenders by posting the Information Materials on Intralinks, Debt X, SyndTrak Online or by similar electronic means and (b) certain of the Lenders may be “public side” Lenders (i.e., Lenders that wish to receive only information that (i) is publicly available, (ii) is not material with respect to you, Holdings, the Borrower, the Target or your or their respective subsidiaries or securities for purposes of United States federal and state securities laws or (iii) constitutes information of the type that is included by the Target in any filings with the Securities and Exchange Commission (the “SEC”) or that would be included in such filings if you, Holdings, the Borrower or your or their respective subsidiaries were public reporting companies (as reasonably determined by you) (collectively, the “Public Side Information”; any information that is not Public Side Information, “Private Side Information”)) and who may be engaged in investment and other market related activities with respect to you or the Target or your or the Target’s respective subsidiaries or securities) (each, a “Public Sider” and each Lender that is not a Public Sider, a “Private Sider”). You will be solely responsible for the contents of the Information Materials and each of the Commitment Parties shall be entitled to use and rely upon the information contained therein without responsibility for independent verification thereof.

You agree to assist (and to cause the Sponsors to assist and to use commercially reasonable efforts to cause, to the extent practical and appropriate and in all instances subject to the limitations on your rights set forth in the Acquisition Agreement, the Target to assist) us in preparing an additional version of the Information Materials to be used in connection with the syndication of the Facilities that consists exclusively of Public Side Information with respect to you or the Target or your or the Target’s respective subsidiaries or securities to Public Siders. It is understood that in connection with your assistance described above, customary authorization letters executed and delivered by you or the Target (which shall include a customary negative assurance representation) will be included in any Information Materials that authorize the distribution thereof to prospective Lenders, represent that the additional version of the Information Materials does not include any Private Side Information (other than information about the Transactions or the Facilities) and exculpate you, the Investors (as defined below), the Target, the Borrower and us and our affiliates with respect to any liability related to the use of the contents of the Information Materials or related marketing materials by the recipients thereof. Before distribution of any Information Materials you agree, at our reasonable request, to identify that portion of the Information Materials that may be distributed to the Public Siders as “Public Information”, which, at a minimum, shall mean that the word “PUBLIC” shall appear prominently on the first page thereof. By marking Information Materials as “PUBLIC”, you shall be deemed to have authorized the Commitment Parties and the proposed Lenders to treat such Information Materials as not containing any Private Side Information (it being understood that you shall not be under any obligation to mark the Information Materials “PUBLIC”). We will not make any materials not marked “PUBLIC” available to Public Siders.

You acknowledge and agree that, subject to the confidentiality and other provisions of this Commitment Letter, the following documents, without limitation, may be distributed to both Private Siders and Public Siders, unless you advise the Lead Arrangers in writing (including by email) within a reasonable time prior to their intended distribution that such materials should only be distributed to Private Siders (provided that such materials have been provided to you and your counsel for review a reasonable period of time prior thereto): (a) administrative materials prepared by the Lead Arrangers for prospective Lenders (such as a lender meeting invitation, bank allocation, if any, and funding and closing memoranda), (b) term sheets and notification of changes in the Facilities’ terms and conditions, (c) drafts and final versions of the Facilities Documentation and (d) financial statements of the Borrower and its subsidiaries of a type that would be publicly filed if the Borrower or its subsidiaries were public reporting companies and publicly filed financial statements of the Target and its subsidiaries. If you advise us in writing (including by email), within a reasonable period of time prior to dissemination, that any of the foregoing should be distributed only to Private Siders, then Public Siders will not receive such materials without your prior consent.

 

5


4. Information.

You hereby represent and warrant that (a) all written information and written data (such information and data, other than (i) the Projections and (ii) information of a general economic or industry specific nature, the “Information”) (in the case of Information regarding the Target and its subsidiaries and its and their respective businesses, to the best of your knowledge), that has been or will be made available to the Commitment Parties directly or indirectly by you, the Target or by any of your or its subsidiaries or representatives, in each case, on your behalf in connection with the transactions contemplated hereby, when taken as a whole and together with the reports and other information filed by the Target with the SEC (including the risk factors therein), is or will be, when furnished, correct in all material respects and does not or will not, when furnished and when taken as a whole, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements contained therein not materially misleading in light of the circumstances under which such statements are made (after giving effect to all supplements and updates thereto from time to time) and (b) the Projections that have been or will be made available to the Commitment Parties by you or by any of your subsidiaries or representatives, in each case, on your behalf in connection with the transactions contemplated hereby have been, or will be, prepared in good faith based upon assumptions that are believed by you to be reasonable at the time prepared and at the time the related Projections are so furnished to the Commitment Parties; it being understood that the Projections are as to future events and are not to be viewed as facts, the Projections are subject to significant uncertainties and contingencies, many of which are beyond your control, that no assurance can be given that any particular Projections will be realized and that actual results during the period or periods covered by any such Projections may differ significantly from the projected results and such differences may be material. You agree that, if at any time prior to the later of the Closing Date and the Syndication Date, you become aware that any of the representations and warranties in the preceding sentence would be incorrect in any material respect if the Information and the Projections were being furnished, and such representations and warranties were being made, at such time, then you will (or, with respect to the Information and Projections relating to the Target and its subsidiaries, will use commercially reasonable efforts to) promptly supplement the Information and the Projections such that such representations and warranties are correct in all material respects under those circumstances (or, in the case of the Information relating to the Target and its subsidiaries and its and their respective businesses, to the best of your knowledge, such representations and warranties are correct in all material respects under those circumstances). In arranging and syndicating the Facilities, the Lead Arrangers (i) will be entitled to use and rely primarily on the Information and the Projections without responsibility for independent verification thereof and (ii) assume no responsibility for the accuracy or completeness of the Information or the Projections.

5. Fees.

As consideration for the commitments of the Initial Lenders hereunder and for the agreement of the Lead Arrangers and the Joint Bookrunners to perform the services described herein, you agree to pay (or cause to be paid) the fees set forth in the Term Sheet and in the Amended and Restated Fee Letter dated the date hereof and delivered herewith with respect to the Facilities (the “Fee Letter”), if and to the extent payable. Once paid, such fees shall not be refundable under any circumstances, except as expressly set forth herein or therein or as otherwise separately agreed to in writing by you and us.

6. Conditions.

The commitments of the Initial Lenders hereunder to fund the Facilities on the Closing Date and the agreements of the Lead Arrangers and the Joint Bookrunners to perform the services described herein are subject solely to (a) the applicable conditions expressly set forth in the section entitled “Conditions to Initial Borrowing” in Exhibit B hereto and (b) the applicable conditions expressly set forth in Exhibit C hereto, and upon satisfaction (or waiver by the Commitment Parties) of such conditions, the Administrative Agent, each Lender and each other party thereto will execute and deliver the Facilities Documentation to which it is a party and the initial funding of the Facilities shall occur; it being understood that there are no other conditions (implied or otherwise) to the commitments hereunder, including compliance with the terms of this Commitment Letter, the Fee Letter and the Facilities Documentation.

 

6


Notwithstanding anything to the contrary in this Commitment Letter (including each of the exhibits attached hereto), the Fee Letter, the Facilities Documentation or any other letter agreement or other undertaking concerning the financing of the Transactions to the contrary, (i) the only representations and warranties relating to you, Holdings, the Borrower or the Target or your or their respective subsidiaries or businesses or otherwise, the making and accuracy of which shall be a condition to the availability and funding of the Facilities on the Closing Date shall be (a) such of the representations and warranties (if any) made by, or with respect to, the Target and its subsidiaries in the Acquisition Agreement as are material to the interests of the Lenders, but only to the extent that you (or your affiliate) have the right (taking into account any applicable notice and cure provisions) to terminate your (and/or its) obligations under the Acquisition Agreement or decline to consummate the Acquisition or otherwise results in a failure of a condition precedent in the Acquisition Agreement (in each case, in accordance with the terms thereof) as a result of a breach of such representations and warranties in the Acquisition Agreement (to such extent, the “Specified Acquisition Agreement Representations”) and (b) the Specified Representations (as defined below) in all material respects; provided that any Specified Representations qualified by materiality shall be, as so qualified, accurate in all respects and (ii) the terms of the Facilities Documentation shall be in a form such that they do not impair the availability or funding of the Facilities on the Closing Date if the applicable conditions expressly set forth in the section entitled “Conditions to Initial Borrowing” in Exhibit B hereto and in Exhibit C hereto are satisfied (or waived by the Commitment Parties) (provided that, to the extent any security interest in any Collateral is not or cannot be provided and/or perfected on the Closing Date (other than the pledge and perfection of the security interests (1) in the certificated equity securities, if any, of the Borrower, the Target and any wholly owned U.S. material subsidiaries of the Borrower and the Target (to the extent required by the Term Sheet) and (2) in other assets with respect to which a lien may be perfected by the filing of a financing statement under the Uniform Commercial Code; provided that any such certificated equity securities of the Target and such subsidiaries of the Target will be required to be delivered on the Closing Date only to the extent such certificates are actually received from the Target) after your use of commercially reasonable efforts to do so or without undue burden or expense, then the provision and/or perfection of a security interest in such Collateral shall not constitute a condition precedent to the availability of the Facilities on the Closing Date, but instead shall be required to be delivered after the Closing Date pursuant to arrangements and timing to be mutually agreed by the Administrative Agent and the Borrower acting reasonably but no later than 90 days after the Closing Date (or such longer period as may be agreed by the Administrative Agent and the Borrower acting reasonably)). For purposes hereof, “Specified Representations” means, with respect to the Facilities the applicable representations and warranties of the Borrower and the Guarantors to be set forth in the Facilities Documentation relating to organizational existence of the Borrower and the Guarantors party thereto as of the Closing Date; power and authority, due authorization, execution, delivery and enforceability, in each case, related to, the entering into, borrowing under, guaranteeing under, performance of, and granting of security interests in the Collateral pursuant to, the Facilities Documentation; solvency as of the Closing Date (after giving effect to the Transactions) of the Borrower and its subsidiaries on a consolidated basis (solvency to be defined in a manner consistent with the manner in which solvency is determined in the solvency certificate to be delivered pursuant to Exhibit C); Federal Reserve margin regulations; the use of the proceeds of the Facilities not violating the PATRIOT Act, OFAC or FCPA; the Investment Company Act; the incurrence of the loans to be made under the Facilities, the provision of the Guarantees in respect of the Facilities and the granting of the security interests in the Collateral to secure the Facilities, and the entering into of the Facilities Documentation on the Closing Date, do not conflict with the organizational documents of the Borrower or the Guarantors party thereto; and, subject to the provisos in clause (ii) of the immediately preceding sentence, creation, validity and perfection of security interests in the Collateral. For the avoidance of doubt, the representation set forth in paragraph 1 of Exhibit C shall not be a Specified Representation. This paragraph, and the provisions herein, shall be referred to as the “Limited Conditionality Provisions.

 

7


7. Limitation on Liability; Indemnity; Settlement.

(a) Limitation on Liability.

Notwithstanding any other provision of this Commitment Letter, (i) in no event shall any Commitment Party, any of their respective affiliates or their respective officers, directors, employees, agents, controlling persons, advisors, attorneys or other representatives (each an “Arranger-Related Person”) shall be liable for any damages arising from the use by others of information or other materials obtained through internet, electronic, telecommunications or other information transmission systems, except to the extent that such damages have resulted from the willful misconduct, bad faith or gross negligence of such Arranger-Related Person (as determined by a court of competent jurisdiction in a final and non-appealable decision) and (ii) none of you (or any of your subsidiaries), the Investors (or any of their respective affiliates), the Target (or any of its subsidiaries or affiliates) or any Arranger-Related Person shall be liable for any indirect, special, punitive or consequential damages (including, without limitation, any loss of profits, business or anticipated savings) in connection with this Commitment Letter, the Fee Letter, the Original Commitment Letter, the Original Fee Letter (as defined in the Fee Letter), the Transactions (including the Facilities and the use of proceeds thereunder), or with respect to any activities related to the Facilities, including the preparation of this Commitment Letter, the Fee Letter, the Original Commitment Letter, the Original Fee Letter and the Facilities Documentation; provided that nothing in this paragraph shall limit your indemnity and reimbursement obligations to the extent that such indirect, special, punitive or consequential damages are included in any claim by a third party with respect to which the applicable Indemnified Party is entitled to indemnification under subsection (b) of this Section 7.

(b) Indemnity.

To induce the Commitment Parties to enter into this Commitment Letter and the Fee Letter and to proceed with the Facilities Documentation, you agree (a) to indemnify and hold harmless each Commitment Party, its respective affiliates and the respective officers, directors, employees, agents, controlling persons, advisors, attorneys and other representatives of each of the foregoing and their successors and permitted assigns (other than Lenders that are not Initial Lenders) (each, an “Indemnified Person”), from and against any and all losses, claims, damages and liabilities of any kind or nature and reasonable and documented or invoiced out-of-pocket fees and expenses, joint or several, to which any such Indemnified Person may become subject to the extent arising out of, resulting from, or in connection with any actual or threatened claim, litigation, investigation or proceeding (including any inquiry or investigation) in connection with this Commitment Letter (including the Term Sheet), the Fee Letter, the Original Commitment Letter, the Original Fee Letter, the Transactions or any related transaction contemplated hereby or thereby, the Facilities or any use of the proceeds thereof (any of the foregoing, a “Proceeding”), regardless of whether any such Indemnified Person is a party thereto, whether or not such Proceedings are brought by you, your equity holders, affiliates or creditors or any other third person, and to promptly reimburse after receipt of a written request, each such Indemnified Person for any reasonable and documented or invoiced out-of-pocket legal fees and expenses incurred in connection with investigating or defending any of the foregoing by one firm of counsel for all such Indemnified Persons, taken as a whole and, if necessary, by a single firm of local counsel in each appropriate jurisdiction (which may include a single firm of special counsel acting in multiple jurisdictions) for all such Indemnified Persons, taken as a whole (and, in the case of an actual or perceived conflict of interest where the Indemnified Person affected by such conflict notifies you of the existence of such conflict and thereafter retains its own counsel, by another firm of counsel for such affected Indemnified Person) or other reasonable and documented or invoiced out-of-pocket fees and expenses

 

8


incurred in connection with investigating, responding to, or defending any of the foregoing; provided that the foregoing indemnity will not, as to any Indemnified Person, apply to losses, claims, damages, liabilities or related expenses to the extent that they have resulted from (i) the willful misconduct, bad faith or gross negligence of such Indemnified Person or any Related Indemnified Person (as defined below) (as determined by a court of competent jurisdiction in a final and non-appealable decision), (ii) a material breach of the obligations of such Indemnified Person or any Related Indemnified Person under this Commitment Letter, the Fee Letter, the Original Commitment Letter or the Original Fee Letter (as determined by a court of competent jurisdiction in a final and non-appealable decision) or (iii) any Proceeding solely between or among Indemnified Persons not arising from any act or omission by you or any of your affiliates; provided that the Administrative Agent, the Lead Arrangers and the Joint Bookrunners to the extent fulfilling their respective roles as an agent or arranger under the Facilities and in their capacities as such, shall remain indemnified in such Proceedings to the extent that none of the exceptions set forth in any of clauses (i) or (ii) of the immediately preceding proviso apply to such person at such time and (b) to the extent that the Closing Date occurs, to reimburse each Commitment Party from time to time, upon presentation of a summary statement, for all reasonable and documented or invoiced out-of-pocket expenses (including but not limited to expenses of each Commitment Party’s consultants’ fees (to the extent any such consultant has been retained with your prior written consent (not to be unreasonably withheld or delayed)), syndication expenses, travel expenses and reasonable fees, disbursements and other charges of counsel to the Commitment Parties, the Lead Arrangers, the Joint Bookrunners and the Administrative Agent identified in the Term Sheet (and, in the case of an actual or perceived conflict of interest where the Indemnified Person affected by such conflict informs you of such conflict and thereafter retains its own counsel, of another firm of counsel for such affected Indemnified Person), and, if necessary, of a single firm of local counsel to the Commitment Parties in each appropriate jurisdiction (which may include a single firm of special counsel acting in multiple jurisdictions) and of such other counsel retained with your prior written consent (not to be unreasonably withheld or delayed)), in each case incurred in connection with the Facilities and the preparation, negotiation and enforcement of this Commitment Letter, the Fee Letter, the Original Commitment Letter, the Original Fee Letter, the Facilities Documentation and any security arrangements in connection therewith (collectively, the “Expenses”). You acknowledge that we may receive a future benefit on matters unrelated to this matter, including, without limitation, discount, credit or other accommodation, from any of such counsel based on the fees such counsel may receive on account of their relationship with us, including without limitation fees paid pursuant hereto (it being understood and agreed that, in no event, shall the Expenses include items in respect of any unrelated matter or otherwise be increased as a result of such counsel’s representation of us on another matter or on account of our relationship with such counsel). The foregoing provisions in this paragraph shall be superseded, in each case, to the extent covered thereby by the applicable provisions contained in the Facilities Documentation upon execution and delivery thereof and thereafter shall have no further force and effect.

Related Indemnified Person” of an Indemnified Person means (1) any controlling person or any affiliate of such Indemnified Person, (2) the respective directors, officers, or employees of such Indemnified Person or any of its controlling persons or any of its affiliates and (3) the respective agents, advisors, attorneys and representatives of such Indemnified Person or any of its controlling persons or any of its affiliates, in the case of this clause (3), acting at the instructions of such Indemnified Person, controlling person or such affiliate (it being understood and agreed that any agent, advisor or representative of such Indemnified Person or any of its controlling persons or any of its affiliates engaged to represent or otherwise advise such Indemnified Person, controlling person or affiliate in connection with the Transactions shall be deemed to be acting at the instruction of such person).

 

9


(c) Settlement.

You shall not be liable for any settlement of any Proceeding effected without your written consent (which consent shall not be unreasonably withheld, conditioned or delayed), but if settled with your written consent or if there is a final and non-appealable judgment by a court of competent jurisdiction in any such Proceeding, you agree to indemnify and hold harmless each Indemnified Person from and against any and all losses, claims, damages, liabilities and reasonable and documented legal or other out-of-pocket expenses by reason of such settlement or judgment in accordance with and to the extent provided in the other provisions of this Section 7. It is further agreed that the Commitment Parties shall be severally liable in respect of their commitments to the Facilities, on a several, and not joint basis with any other Lender.

You shall not, without the prior written consent of any Indemnified Person (which consent shall not be unreasonably withheld, conditioned or delayed) (it being understood that the withholding of consent due to non-satisfaction of any of the conditions described in clauses (i), (ii) and (iii) of this sentence shall be deemed reasonable), effect any settlement of any pending or threatened Proceedings in respect of which indemnity could have been sought hereunder by such Indemnified Person unless such settlement (i) includes an unconditional release of such Indemnified Person in form and substance reasonably satisfactory to such Indemnified Person from all liability or claims that are the subject matter of such proceedings, (ii) does not include any statement as to or any admission of fault, culpability, wrong doing or a failure to act by or on behalf of any Indemnified Person and (iii) contains customary confidentiality provisions with respect to the terms of such settlement. Each Indemnified Person shall be severally obligated to refund or return any and all amounts paid by you under this Section 7 to the extent such Indemnified Person is not entitled to payment of such amounts in accordance with the terms hereof (as determined by a court of competent jurisdiction in a final and non-appealable judgment).

8. Sharing of Information, Absence of Fiduciary Relationships, Affiliate Activities.

You acknowledge that the Commitment Parties and their respective affiliates may be providing debt financing, equity capital or other services (including, without limitation, financial advisory services) to other persons in respect of which you, the Investors, the Target and your and their respective subsidiaries and affiliates may have conflicting interests regarding the transactions described herein and otherwise. The Commitment Parties and their respective affiliates will not use confidential information obtained from you, the Target or any of your or their respective subsidiaries or affiliates by virtue of the transactions contemplated by this Commitment Letter or their other relationships with you, the Target or any of your or their respective subsidiaries or affiliates in connection with the performance by them or their affiliates of services for other persons, and the Commitment Parties and their respective affiliates will not furnish any such information to other persons, except to the extent permitted below. You also acknowledge that the Commitment Parties and their respective affiliates do not have any obligation to use in connection with the transactions contemplated by this Commitment Letter, or to furnish to you, the Target or any of your or their respective subsidiaries or affiliates confidential information obtained by them from other persons.

As you know, the Commitment Parties and their respective affiliates may be full-service securities firms engaged, either directly or through their affiliates, in various activities, including securities trading, commodities trading, investment management, financing and brokerage activities and financial planning and benefits counseling for both companies and individuals. In the ordinary course of these activities, the Commitment Parties and their respective affiliates may actively engage in commodities trading or trade the debt and equity securities (or related derivative securities) and financial instruments (including bank loans and other obligations) of you (and your affiliates), the Target (and its affiliates), the Target’s and your respective customers or competitors and other companies which may be the subject of the arrangements contemplated by this Commitment Letter for their own account and for the accounts of their customers and may at any time hold long and short positions in such securities. The Commitment Parties and their respective affiliates may also co-invest with, make direct investments in, and invest or co-invest client monies in or with funds or other investment vehicles managed by other parties, and such funds or other investment vehicles may trade or make investments in securities of you (and your affiliates), the Borrower, the Target (and its affiliates) or other companies which may be the subject of the arrangements contemplated by this Commitment Letter or engage in commodities or other trading with any thereof.

 

10


The Commitment Parties and their respective affiliates may have economic interests that conflict with those of the Target, you and the Borrower and your and their respective subsidiaries and affiliates and are under no obligation to disclose any conflicting interest to you, the Target and the Borrower and your and their respective subsidiaries and affiliates. You agree that each Commitment Party will act under this Commitment Letter as an independent contractor and that nothing in this Commitment Letter or the Fee Letter will be deemed to create an advisory, fiduciary or agency relationship or fiduciary or other implied duty between such Commitment Party and its respective affiliates, on the one hand, and you, the Borrower and the Target, your and their respective equity holders or your and their respective subsidiaries and affiliates, on the other hand. You acknowledge and agree that (i) the transactions contemplated by this Commitment Letter and the Fee Letter are arm’s-length commercial transactions between the Commitment Parties and their respective affiliates, on the one hand, and you, on the other, (ii) in connection therewith and with the process leading to such transaction each Commitment Party and its applicable affiliates (as the case may be) are acting solely as principals and not as agents or fiduciaries of you, the Borrower, the Target, your and their respective management, equity holders, creditors, subsidiaries, affiliates or any other person, (iii) each Commitment Party and its applicable affiliates (as the case may be) have not assumed an advisory or fiduciary responsibility or any other obligation in favor of you, the Target, the Borrower or your or their respective affiliates with respect to the financing transactions contemplated hereby, the exercise of the remedies with respect thereto or the process leading thereto (irrespective of whether such Commitment Party or any of its affiliates has advised or is currently advising you, the Borrower, or the Target or any of your or their respective affiliates on other matters) and no Commitment Party has any obligation to you, the Target, the Borrower or your or their respective affiliates with respect to the transactions contemplated hereby except the obligations expressly set forth in this Commitment Letter and the Fee Letter and (iv) the Commitment Parties and their respective affiliates have not provided any legal, accounting, regulatory or tax advice and you have consulted your own legal and financial advisors to the extent you deemed appropriate.

You further acknowledge and agree that you are responsible for making your own independent judgment with respect to such transactions and the process leading thereto. You agree that you will not claim that the Commitment Parties or their applicable affiliates, as the case may be, have rendered advisory services of any nature or respect, or owe a fiduciary, agency or similar duty to you or your affiliates, in connection with such transactions or the process leading thereto.

Furthermore, without limiting any provision set forth herein, you agree not to assert, to the fullest extent permitted by law, any claims you may have with respect to such transactions or the process leading thereto against us or our affiliates for alleged breach of fiduciary duty and agree that we and our affiliates shall have no liability (whether direct or indirect) to you in respect of such a fiduciary claim or to any person asserting a fiduciary duty claim on behalf of or in right of you, including your equityholders, employees or creditors.

9. Confidentiality.

You agree that you will not disclose, directly or indirectly, the Fee Letter or the contents thereof or, prior to your acceptance hereof, this Commitment Letter, the Term Sheet, the other exhibits and attachments hereto or the contents of each thereof, or the activities of any Commitment Party pursuant hereto or thereto, to any person or entity without the prior written approval of the Lead Arrangers (such approval not to be unreasonably withheld, delayed or conditioned), except (a) to the Investors and to any of your or the Investors’ affiliates and your and their respective officers, directors, employees, agents,

 

11


attorneys, accountants, advisors, controlling persons and equity holders and to actual and potential co-investors who are informed of the confidential nature thereof, on a confidential and need-to-know basis, (b) if the Commitment Parties consent in writing to such proposed disclosure or (c) pursuant to an order of any court or administrative agency or in any pending legal, judicial or administrative proceeding, or otherwise as required by applicable law, rule or regulation or compulsory legal process or to the extent requested or required by governmental and/or regulatory authorities, in each case based on the reasonable advice of your legal counsel (in which case you agree, to the extent practicable and not prohibited by applicable law, rule or regulation, to inform us promptly thereof prior to disclosure); provided that (i) you may disclose this Commitment Letter (but not the Fee Letter or the contents thereof) and the contents hereof to the Target, its subsidiaries and affiliates and its and their respective officers, directors, employees, agents, attorneys, accountants, advisors and controlling persons, on a confidential and need-to-know basis, (ii) you may disclose the Commitment Letter and its contents (including the Term Sheet and other exhibits and attachments hereto) (but not the Fee Letter or the contents thereof) in any syndication or other marketing materials in connection with the Facilities (including the Information Materials) or in connection with any public or regulatory filing requirement relating to the Transactions, (iii) you may disclose the Term Sheet and other exhibits and attachments to the Commitment Letter, and the contents thereof, to potential Lenders and to rating agencies in connection with obtaining public ratings for the Borrower and the Initial Term Loan Facility, (iv) you may disclose the aggregate fee amount contained in the Fee Letter as part of Projections, pro forma information or a generic disclosure of aggregate sources and uses related to fee amounts related to the Transactions to the extent customary or required in marketing materials for the Facilities or in any public or regulatory filing requirement relating to the Transactions (and only to the extent aggregated with all other fees and expenses of the Transactions and not presented as an individual line item unless required by applicable law, rule or regulation) and (v) if the fee amounts payable pursuant to the Fee Letter and the economic terms of the “Market Flex Provisions” in the Fee Letter, and such other portions as mutually agreed, have been redacted in a manner reasonably agreed by us (including the portions thereof addressing fees payable to the Commitment Parties and/or the Lenders), you may disclose the Fee Letter and the contents thereof to the Target, its subsidiaries and affiliates and its and their respective officers, directors, employees, agents, attorneys, accountants, advisors and controlling persons, on a confidential and need-to-know basis. For the avoidance of doubt, nothing in this paragraph prohibits any individual from communicating or disclosing information that is the subject of the confidentiality obligations set forth in this paragraph regarding suspected violations of laws, rules or regulations to a governmental, regulatory, or self-regulatory authority.

Each Commitment Party and its affiliates will use all non-public information provided to any of them or such affiliates by or on behalf of you hereunder or in connection with the Acquisition and the related Transactions solely for the purpose of providing the services which are the subject of this Commitment Letter and negotiating, evaluating and consummating the transactions contemplated hereby and shall treat confidentially all such information and shall not publish, disclose or otherwise divulge, such information; provided that nothing herein shall prevent such Commitment Party and its affiliates from disclosing any such information (a) pursuant to the order of any court or administrative agency or in any pending legal, judicial or administrative proceeding, or otherwise as required by applicable law, rule or regulation or compulsory legal process based on the reasonable advice of counsel (in which case such Commitment Party agrees (except with respect to any audit or examination conducted by bank accountants or any self-regulatory authority or governmental regulatory authority exercising examination or regulatory authority), to the extent practicable and not prohibited by applicable law, rule or regulation, to inform you promptly thereof prior to disclosure), (b) upon the request or demand of any regulatory authority having jurisdiction, or purporting to have jurisdiction, over such Commitment Party or any of its affiliates (in which case such Commitment Party agrees (except with respect to any audit or examination conducted by bank accountants or any self-regulatory authority or governmental regulatory authority exercising examination or regulatory authority), to the extent practicable and not prohibited by applicable law, rule or regulation, to inform you promptly thereof prior to disclosure), (c) to the extent that such information becomes publicly

 

12


available other than by reason of improper disclosure by such Commitment Party or any of its Related Parties (as defined below) in violation of any confidentiality obligations owing to you, the Investors, the Borrower, the Target or any of your or their respective subsidiaries and affiliates, (d) to the extent that such information is or was received by such Commitment Party or any of its Related Parties from a third party that is not, to such Commitment Party’s knowledge, subject to contractual or fiduciary confidentiality obligations owing to you, the Investors, the Target or any of your or their respective subsidiaries and affiliates, (e) to the extent that such information is independently developed by such Commitment Party or any of its Related Parties without the use of any confidential information, (f) to such Commitment Party’s affiliates and to its and their respective employees, officers, directors, legal counsel, independent auditors, rating agencies, professionals and other experts or agents who need to know such information in connection with the Transactions and who are informed of the confidential nature of such information and who are subject to customary confidentiality obligations and who have been advised of their obligation to keep information of this type confidential (with each such Commitment Party, to the extent within its control, responsible for such person’s compliance with this paragraph) (the persons identified in this clause (f), collectively, the “Related Parties”), (g) to potential or prospective Lenders, hedge providers, participants or assignees, (h) to the extent you consent in writing to any specific disclosure or (i) to the extent such information was already in such Commitment Party’s possession prior to any duty or other understanding of confidentiality entered into in connection with the Transactions; provided that for purposes of clause (g) above, (i) the disclosure of any such information to any Lenders, hedge providers, participants or assignees or prospective Lenders, hedge providers, participants or assignees referred to above shall be made subject to the acknowledgment and acceptance by such Lender, hedge provider, participant or assignee or prospective Lender, hedge provider, participant or assignee that such information is being disseminated on a confidential basis (on substantially the terms set forth in this paragraph or as is otherwise reasonably acceptable to you and such Commitment Party, including, without limitation, as agreed in any Information Materials or other marketing materials) in accordance with the standard syndication processes of such Commitment Party or customary market standards for dissemination of such type of information, which shall in any event require “click through” or other affirmative actions on the part of recipient to access such information and (ii) no such disclosure shall be made by such Commitment Party to any person that is at such time a Disqualified Lender. In addition, each Commitment Party may disclose the existence of the Facilities and the information about the Facilities to market data collectors, similar services providers to the lending industry, and service providers to the Commitment Parties in connection with the administration and management of the Facilities. In the event that the Facilities are funded, the Commitment Parties’ and their respective affiliates’, if any, obligations under this paragraph shall terminate automatically and be superseded by the confidentiality provisions in the Facilities Documentation upon the initial funding thereunder to the extent that such provisions are binding on such Commitment Parties.

Subject to the immediately preceding sentence, the confidentiality provisions set forth in this Section 9 shall survive the termination of this Commitment Letter and expire and shall be of no further effect after the second anniversary of the Original Signing Date.

Notwithstanding anything to the contrary contained herein, the confidentiality provisions of the Original Commitment letter shall remain in full force and effect with respect to the Original Commitment Letter and the Original Fee Letter in accordance with the terms of the Original Commitment Letter.

10. Miscellaneous.

This Commitment Letter and the commitments hereunder shall not be assignable by any party hereto (other than (i) any assignment occurring as a matter of law pursuant to, or otherwise substantially simultaneously with, the Acquisition on the Closing Date, in each case to the Target, Merger Sub or the Borrower, (ii) by you to (a) Target, Merger Sub or the Borrower substantially simultaneously with the Acquisition on the Closing Date or (b) a U.S. domestically organized entity, in each case, so long as such

 

13


entity is, or will be, controlled by you or the Investors after giving effect to the Transactions and shall (directly or indirectly through one or more wholly-owned subsidiaries) own the Target and the Borrower and agrees to be bound by the terms hereof and of the Fee Letter or (iii) subject to the second paragraph of Section 3, by the Initial Lenders in connection with the syndication of the Facilities) without the prior written consent of each other party hereto (such consent not to be unreasonably withheld, conditioned or delayed) (and any attempted assignment without such consent shall be null and void). This Commitment Letter and the commitments hereunder are intended to be solely for the benefit of the parties hereto (and Indemnified Persons and Arranger-Related Persons) and do not and are not intended to confer any benefits upon, or create any rights in favor of, any person other than the parties hereto (and Indemnified Persons and Arranger-Related Persons to the extent expressly set forth herein) and, for the avoidance of doubt, no Commitment Party may enter into any other agreements or arrangement to share any economics provided in the Commitment Letter or Fee Letter with any other parties (other than any agreement or arrangement with an affiliate of such Commitment Party as permitted hereunder or under the Fee Letter). Subject to the limitations set forth in Section 3 above, each Commitment Party reserves the right to employ the services of its respective affiliates or branches in providing services contemplated hereby and to allocate, in whole or in part, to their affiliates or branches certain fees payable to such Commitment Party in such manner as such Commitment Party and its respective affiliates or branches may agree in their sole discretion and, to the extent so employed, such affiliates and branches shall be entitled to the benefits and protections afforded to, and subject to the provisions governing the conduct of, such Commitment Party hereunder. This Commitment Letter may not be amended or any provision hereof waived or modified except by an instrument in writing signed by each of the Commitment Parties and you. This Commitment Letter may be executed in any number of counterparts, each of which shall be deemed an original and all of which, when taken together, shall constitute one agreement. Delivery of an executed counterpart of a signature page of this Commitment Letter by facsimile transmission or other electronic transmission (i.e., a “pdf” or “tif”) shall be effective as delivery of a manually executed counterpart hereof. Electronic transmission shall be deemed to include any electronic symbol or process attached to, or associated with, any contract or other record and adopted by a person with the intent to sign, authenticate or accept such contract or record (“Electronic Signatures”), deliveries or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature, physical delivery thereof or the use of a paper-based recordkeeping system, as the case may be, to the extent and as provided for in any applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records Act, or any other similar state laws based on the Uniform Electronic Transactions Act. This Commitment Letter (including the exhibits hereto), together with the Fee Letter and any other letter agreement entered into with any of the Commitment Parties on or prior to the Original Signing Date, (i) are the only agreements that have been entered into among the parties hereto with respect to our commitments with respect to the Facilities and (ii) supersede all prior understandings, whether written or oral, among us with respect to the Facilities and sets forth the entire understanding of the parties hereto with respect thereto. THIS COMMITMENT LETTER, AND ANY CLAIM, CONTROVERSY OR DISPUTE ARISING UNDER, OR RELATED TO, THIS COMMITMENT LETTER (INCLUDING, WITHOUT LIMITATION, ANY CLAIMS SOUNDING IN CONTRACT LAW OR TORT LAW ARISING OUT OF THE SUBJECT MATTER HEREOF) SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK; provided that, notwithstanding the foregoing, it is understood and agreed that (a) the interpretation of the definition of “Company Material Adverse Effect” (as defined in the Acquisition Agreement) (and whether or not a Company Material Adverse Effect has occurred), (b) the determination of the accuracy of any Specified Acquisition Agreement Representation and whether as a result of any inaccuracy thereof you (or your affiliate) have the right (taking into account any applicable cure provisions) to terminate your obligations under the Acquisition Agreement or decline to consummate the Acquisition and (c) the determination of whether the Acquisition has been consummated in accordance with the terms of the Acquisition Agreement, in each case shall be governed by, and construed in accordance with, the laws of the State of Delaware as applied to the Acquisition Agreement, without regard to the principles of conflicts of law that would cause the application of law of any jurisdiction other than those of the State of Delaware.

 

14


Any Joint Bookrunner may, in consultation with you, place customary advertisements in financial and other newspapers and periodicals or on a home page or similar place for dissemination of customary information on the Internet or worldwide web as it may choose, and circulate similar promotional materials, in each case, after the Closing Date, in the form of “tombstone” or otherwise describing the name of the Borrower and the amount, type and closing date of the Transactions, all at the expense of such Joint Bookrunner.

Each of the parties hereto agrees that this Commitment Letter is a binding and enforceable agreement with respect to the subject matter contained herein, including an agreement to negotiate in good faith the Facilities Documentation by the parties hereto in a manner consistent with this Commitment Letter, it being acknowledged and agreed that the commitments provided hereunder are subject solely to conditions precedent described in the first paragraph of Section 6 of this Commitment Letter.

EACH OF THE PARTIES HERETO IRREVOCABLY WAIVES THE RIGHT TO TRIAL BY JURY IN ANY ACTION, PROCEEDING, CLAIM OR COUNTERCLAIM BROUGHT BY OR ON BEHALF OF ANY PARTY RELATED TO OR ARISING OUT OF THIS COMMITMENT LETTER, THE FEE LETTER, THE ORIGINAL COMMITMENT LETTER OR THE ORIGINAL FEE LETTER OR THE PERFORMANCE OF SERVICES HEREUNDER OR THEREUNDER.

Each of the parties hereto hereby irrevocably and unconditionally (a) submits, for itself and its property, to the exclusive jurisdiction of any New York State court or Federal court of the United States of America sitting in New York County in the State of New York, and any appellate court from any thereof, in any action or proceeding arising out of or relating to this Commitment Letter, the Fee Letter, the Original Commitment Letter, the Original Fee Letter or the transactions contemplated hereby or thereby, or for recognition or enforcement of any judgment, and agrees that all claims in respect of any such action or proceeding shall be heard and determined in such New York State court or, to the extent permitted by law, in such Federal court, (b) waives, to the fullest extent it may legally and effectively do so, any objection which it may now or hereafter have to the laying of venue of any suit, action or proceeding arising out of or relating to this Commitment Letter, the Fee Letter, the Original Commitment Letter, the Original Fee Letter or the transactions contemplated hereby or thereby in any New York State or in any such Federal court, (c) waives, to the fullest extent permitted by law, the defense of an inconvenient forum to the maintenance of such action or proceeding in any such court and (d) agrees that a final judgment in any such suit, action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law. Each of the parties hereto agrees that service of process, summons, notice or document by registered mail addressed to you or us at the addresses set forth above shall be effective service of process for any suit, action or proceeding brought in any such court.

We hereby notify you that pursuant to the requirements of the USA PATRIOT Act (Title III of Pub. L. 107-56 (signed into law October 26, 2001)) (the “PATRIOT Act”) and the requirements of 31 C.F.R. § 1010.230 (the “Beneficial Ownership Regulation”), each of us and each of the Lenders may be required to obtain, verify and record information that identifies the Borrower and the Guarantors, which information may include their names, addresses, tax identification numbers and other information that will allow each of us and the Lenders to identify the Borrower, the Target, Holdings and the other Guarantors in accordance with the PATRIOT Act or the Beneficial Ownership Regulation, as applicable. This notice is given in accordance with the requirements of the PATRIOT Act and is effective for each of us and the Lenders. You hereby acknowledge and agree that the Lead Arrangers shall be permitted to share any and all such information with the Lenders.

 

15


The indemnification, compensation (if applicable), reimbursement (if applicable), syndication, jurisdiction, governing law, venue, waiver of jury trial and confidentiality provisions contained herein and in the Fee Letter and the provisions of Section 8 of this Commitment Letter shall remain in full force and effect regardless of whether Facilities Documentation shall be executed and delivered and notwithstanding the termination or expiration of this Commitment Letter or the Initial Lenders’ commitments hereunder; provided that your obligations under this Commitment Letter (except as specifically set forth in the third through seventh paragraphs of Section 3 and the penultimate sentence of Section 4, and other than your obligations with respect to the confidentiality of the Fee Letter and the contents thereof) shall automatically terminate and be superseded by the provisions of the Facilities Documentation (to the extent covered therein) upon the initial funding thereunder, and you shall automatically be released from all liability in connection therewith at such time. You may terminate this Commitment Letter and/or the Initial Lenders’ commitments with respect to any of the Facilities (or any portion thereof) hereunder at any time subject to the provisions of the preceding sentence (any such commitment termination shall reduce the commitments of each Initial Lender on a pro rata basis based on their respective commitments to the relevant Facility as of the date hereof).

Section headings used herein are for convenience of reference only and are not to affect the construction of, or to be taken into consideration in interpreting, this Commitment Letter.

This Commitment Letter and the Fee Letter shall become effective upon execution and delivery by all parties hereto and thereto, respectively. We agree to hold our commitment to provide the Facilities and our other undertakings in connection therewith available for you until the earliest of (i) after execution and delivery of the Acquisition Agreement and prior to the consummation of the Transactions, the termination of the Acquisition Agreement by you in a signed writing in accordance with its terms, (ii) the consummation of the Acquisition without the funding of the Facilities and (iii) 11:59 p.m., New York City time on the date that is five business days after the End Date (as defined in, and as may be extended pursuant to, the Acquisition Agreement as in effect as of the Original Signing Date) (such earliest time, the “Expiration Date”). Upon the occurrence of any of the events referred to in the preceding sentence, this Commitment Letter and the commitments of the Commitment Parties hereunder and the agreement of the Commitment Parties to provide the services described herein shall automatically terminate unless the Commitment Parties shall, in their sole discretion, agree to an extension in writing. The termination of any commitment pursuant to this paragraph will not prejudice your rights and remedies in respect of any breach or repudiation of this Commitment Letter.

[Remainder of this page intentionally left blank]

 

16


We are pleased to have been given the opportunity to assist you in connection with the financing for the Transactions.

 

Very truly yours,
ROYAL BANK OF CANADA
By:  

/s/ John Cokinos

  Name: John Cokinos
  Title: Managing Director


BANCO SANTANDER, S.A., NEW YORK BRANCH
By:  

/s/ Max Walling

Name: Max Wallins
Title: Managing Director
By:  

/s/ Andrew Maletta

Name: D. Andrew Maletta
Title: Executive Director


BANK OF MONTREAL
By:  

/s/ Andrew Berryman

  Name: Andrew Berryman
  Title:Director
BMO CAPITAL MARKETS CORP.
By:  

/s/ Matthew Lynn

  Name: Matthew Lynn
  Title: Managing Director


BARCLAYS BANK PLC
By:  

/s/ Jeremy Hazan

  Name: Jeremy Hazan
  Title: Managing Director


KKR CAPITAL MARKETS LLC
By:  

/s/ John Knox

  Name: John Knox
  Title: Authorized Signatory
KKR CORPORATE LENDING (CA) LLC
By:  

/s/ John Knox

  Name: John Knox
  Title: Authorized Signatory


SF CREDIT PARTNERS, LLC
By:  

/s/ Henry B. Lang

  Name: Henry B. Lang
  Title: Chief Investment Officer
STIFEL NICOLAUS AND COMPANY, INCORPORATED
By:  

/s/ Henry B. Lang

  Name: Henry B. Lang
  Title: Managing Director


WELLS FARGO SECURITIES, LLC
By:  

/s/ Kevin Sanders

  Name: Kevin Sanders
  Title: Managing Director
WELLS FARGO BANK, NATIONAL ASSOCIATION
By:  

/s/ Nicholas Grocholski

  Name: Nicholas Grocholski
  Title: Managing Director


Accepted and agreed to as of
the date first above written:
ZODIAC PURCHASER, L.L.C.
By:   Zodiac Guarantor, L.L.C.,
  its managing member
By:   Zodiac Holdco, L.L.C.,
  its managing member
By:   Silver Lake Alpine Associates II, L.P.,
  its managing member
By:   SLAA II (GP), L.L.C.,
  its general partner
By:   Silver Lake Group, L.L.C.,
  its managing member
By:  

/s/ Joseph Osnoss

  Name: Joseph Osnoss
  Title: Managing Director


EXHIBIT A

Project Zodiac

Transaction Description

Capitalized terms used but not defined in this Exhibit A shall have the meanings set forth in the other Exhibits to the Commitment Letter to which this Exhibit A is attached (the “Commitment Letter”) or in the Commitment Letter. In the case of any such capitalized term that is subject to multiple and differing definitions, the appropriate meaning thereof in this Exhibit A shall be determined by reference to the context in which it is used.

Zodiac Purchaser, L.L.C., a limited liability company organized under the laws of the State of Delaware (“Buyer”), formed at the direction of Silver Lake Partners and its affiliates (collectively with the funds, partnerships, co-investment entities and other investment vehicles managed, advised or controlled thereby or by one or more directors thereof or under common control therewith, “Silver Lake”) and Hux Investment Pte. Ltd (collectively with the funds, partnerships, co-investment entities and other investment vehicles managed, advised or controlled thereby or by one or more directors thereof or under common control therewith, “GIC” and, together with Silver Lake, the “Sponsors”), intends to acquire, directly or indirectly (the “Acquisition”), the equity interests of a company previously identified to us and code-named “Zodiac” (the “Target”), from the equity holders thereof (collectively, the “Sellers”). Buyer intends to consummate the Acquisition pursuant to an Agreement and Plan of Merger, dated as of the Original Signing Date (together with all exhibits, schedules and other disclosure letters thereto, collectively, as amended, the “Acquisition Agreement”), by and among Buyer, Zodiac Acquisition Sub, Inc., a newly formed corporation organized under the laws of the State of Delaware and a wholly owned subsidiary of Buyer (“Merger Sub”), and the Target, pursuant to which (i) Merger Sub will merge with and into the Target (the “Merger”), with the Target being the surviving entity of the Merger and (ii) the Sellers will receive cash (the “Acquisition Consideration”) in exchange for their capital stock, restricted stock units, profits interests and/or options in the Target. Immediately after giving effect to the Merger and the other Transactions, the Target will be a wholly-owned direct or indirect subsidiary of Buyer.

In connection with the foregoing, it is intended that:

 

  a)

A portion of the existing 3.95%/5.50% convertible senior PIK toggle notes due 2029 issued by the Target and held by Silver Lake (the “Existing Target Notes”) (including all remaining interest through maturity thereon) will be repurchased for cash (the “Existing Target Notes Repurchase”) and the remaining Existing Target Notes will be contributed to a parent entity of Buyer in exchange for a combination of Preferred Equity and common stock of such parent entity on or prior to the Closing Date (such common stock, “Silver Lake Rollover Common Equity”; the repurchase, contribution and/or exchange described in this clause (a), the “Existing Target Notes Repurchase/Exchange and Rollover”).

 

  b)

An indirect parent entity of the Borrower (as defined in Exhibit B to the Commitment Letter), will issue to the Sponsors and any other initial purchasers thereof newly issued shares of a class of preferred equity (the “Preferred Equity”) in an aggregate initial stated value of up to $350 million.

 

  c)

GIC and certain other investors (including certain equity holders of the Target who may be given the opportunity to rollover capital stock, restricted stock units, profits interests, options and/or other equity interests into Buyer or one of its affiliates (in such capacity, the “Rollover Investors”) and certain members of the management of the Target and its subsidiaries) arranged by and/or designated by the Sponsors (collectively with the Sponsors, the “Investors”) will directly or indirectly make cash equity contributions to Buyer, the net proceeds of which will


  be further contributed, directly or indirectly, to Merger Sub (provided that any such contribution to Merger Sub in a form other than common equity shall be reasonably satisfactory to the Required Lead Arrangers) (the foregoing cash equity contributions to Merger Sub (which, for the avoidance of doubt, shall include the Preferred Equity issuance), the “Equity Contribution”), in an aggregate amount equal to, when combined with the fair market value of any Silver Lake Rollover Common Equity, capital stock or other equity interests of any of the Rollover Investors rolled over or invested in connection with the Transactions (as defined below) and the proceeds of the Preferred Equity issuance, at least 35% of the sum of (1) the aggregate gross proceeds of the Facilities borrowed on the Closing Date, excluding the aggregate gross proceeds of (A) any Loans (as defined in Exhibit B to the Commitment Letter) to fund original issue discount and/or upfront fees in connection with the exercise of the “Market Flex Provisions” under the Fee Letter and (B) any Revolving Loans (as defined in Exhibit B to the Commitment Letter) to fund any working capital needs on the Closing Date and (2) the equity capitalization of the Borrower and its subsidiaries on the Closing Date after giving effect to all of the Transactions (the “Minimum Equity Contribution”); provided that, if applicable, to the extent any stockholder or other equity holder of the Target has exercised appraisal rights in connection with the Transactions, then on the Closing Date the Investors may elect to issue one or more equity commitment letters and/or arrange for one or more letters of credit to be issued on their behalf in an aggregate amount not less than the amount of consideration that would otherwise be paid under the Acquisition Agreement in respect of the shares or other equity interests subject to such appraisal rights (the “Appraisal Shares”) and, for purposes of this Commitment Letter, an aggregate amount of such equity commitment letters and/or letters of credit up to, but not in excess of, the amount of consideration that would otherwise be paid under the Acquisition Agreement in respect of the Appraisal Shares shall be included in the amount and percentage of the Equity Contribution from and after the Closing Date as if such amount was funded in cash (with it being understood that, on or prior to the date of the final resolution of all such appraisal rights, the lesser of (a) the amount necessary to satisfy such appraisal rights in full and (b) an amount equal to the full amount committed under such equity commitment letters and/or the face value of any such letters of credit shall be funded, directly or indirectly, in cash to the Borrower in the form of common equity, or other equity on terms reasonably acceptable to the Required Lead Arrangers).

 

  d)

The Borrower will (i) obtain up to $850 million under a senior secured term loan facility described in Exhibit B to the Commitment Letter (the “Initial Term Loan Facility”) and (ii) obtain up to $100 million in commitments under a senior secured revolving credit facility described in Exhibit B to the Commitment Letter (the “Revolving Facility” and, together with the Initial Term Loan Facility, the “Facilities”).

 

  e)

All principal, accrued, but unpaid interest, fees and other amounts (other than contingent obligations not then due and payable) outstanding on the Closing Date under the Loan and Security Agreement, dated as of June 14, 2017 (as amended by the First Amendment to Loan and Security Agreement, dated October 11, 2018, the Second Amendment to Loan and Security Agreement, dated January 19, 2021, the Third Amendment to Loan and Security Agreement, dated October 11, 2022 and as further amended, supplemented or modified from time to time prior to the Original Signing Date, the “Existing Credit Agreement”), among Silicon Valley Bank, the Target, Zoura Services, LLC and Leeyo Software, Inc. shall be repaid in full in connection with, and substantially concurrently with the closing of, the Transactions, and all commitments to lend and guarantees and security in connection therewith shall have been terminated and/or released or customary arrangements for such termination and/or release have been agreed upon with the administrative agent (the “Refinancing”).


  f)

The proceeds of the Equity Contribution, the Preferred Equity and the Facilities and/or a portion of the cash on hand at the Target and its subsidiaries on the Closing Date will be applied to pay (i) the Acquisition Consideration, (ii) for the Refinancing, (iii) for the Existing Target Notes Repurchase and (iv) the fees and expenses incurred in connection with the Transactions (such fees and expenses, the “Transaction Costs”, and the amounts set forth in clauses (i) through (iv) above, collectively, the “Acquisition Funds”).

The transactions described above (including the payment of Transaction Costs) are collectively referred to herein as the “Transactions.


EXHIBIT B

Project Zodiac

Credit Facilities

Summary of Principal Terms and Conditions2

 

Borrower:    Zodiac Purchaser, L.L.C., a limited liability company organized under the laws of the State of Delaware (the “Borrower”).
Transactions:    As set forth in Exhibit A to the Commitment Letter.
Administrative Agent and Collateral Agent:    Royal Bank will act as sole administrative agent and sole collateral agent (in such capacities, the “Administrative Agent”) for a syndicate of banks, financial institutions and other institutional lenders and investors reasonably acceptable to the Lead Arrangers and the Borrower, excluding any Disqualified Lender (together with the Initial Lenders, the “Lenders”), and will perform the duties customarily associated with such roles.
Lead Arrangers and Joint Bookrunners:    Each of RBCCM, Santander, BMO, Barclays, KCM, Stifel Nicolaus and Wells Fargo Securities will act as a lead arranger (each in such capacity, a “Lead Arranger” and, together, the “Lead Arrangers”), and each of RBCCM, Santander, BMO, Barclays, KCM, Stifel Nicolaus and Wells Fargo Securities will act as a bookrunner (each in such capacity, a “Joint Bookrunner” and, together, the “Joint Bookrunners”), in each case for the Facilities, and each will perform the duties customarily associated with such roles.
Other Agents:    The Borrower may designate Lead Arrangers or their affiliates to act as syndication agent, documentation agent or co-documentation agent as provided in the Commitment Letter.
Facilities:   

(A) A senior secured term loan facility (the “Initial Term Loan Facility” and, together with any Incremental Term Facility (as defined below), each a “Term Loan Facility” and collectively, the “Term Loan Facilities”) in an aggregate principal amount of up to $850 million plus, at the Borrower’s election, an amount sufficient to fund any original issue discount or upfront fees required to be funded in connection with the “Market Flex Provisions” in the Fee Letter. The loans under the Initial Term Loan Facility are referred to as the “Initial Term Loans” and, together with any Incremental Term Loans (as defined below), the “Term Loans.” The Lenders holding Term Loans are referred to as the “Term Lenders.”

 

(B) A senior secured revolving facility (the “Revolving Facility”, together with the Term Loan Facility, the “Facilities”) in an aggregate principal amount of up to $100 million. The loans under the Revolving Facility are referred to as the “Revolving Loans”, and together with the Term Loans, the “Loans”, and the commitments under the Revolving Facility are referred to as the “Revolving Commitments.” The Lenders with Revolving Commitments are referred to as the “Revolving Lenders.”

 

2 

All capitalized terms used but not defined herein shall have the meaning given them in the Commitment Letter to which this Term Sheet is attached, including Exhibits A and C thereto.

 

B-1


Incremental Facilities:   

The Facilities Documentation will permit the Borrower or any Subsidiary Guarantor (as defined below) to add one or more incremental term loan facilities under the Facilities Documentation or to increase any existing term loan facility (each, an “Incremental Term Facility” and the loans under any Incremental Term Facility, the “Incremental Term Loans”) and/or increase any of the Revolving Commitments (any such increase, an “Incremental Revolving Increase”) and/or add one or more incremental revolving credit facility tranches (each an “Incremental Revolving Facility”; the Incremental Term Facilities, the Incremental Revolving Increases and the Incremental Revolving Facilities (and, in each case, the commitments in respect thereof) are collectively referred to as “Incremental Facilities”) in an aggregate amount not to exceed the sum of (A) (x) the greater of (1) $144 million and (2) 100% of Consolidated EBITDA (to be defined as provided under “Financial Definitions” below) for the last four fiscal quarters of the Borrower for which financial statements are available (such greater amount, the “Incremental Starter Amount”) less (y) the aggregate amount of any Incremental Equivalent Debt (as defined below) incurred in reliance on the equivalent threshold as set forth in this clause (A) plus (B) all voluntary prepayments of the Term Loan Facility and Incremental Equivalent Debt that is secured on an equal priority basis with the Term Loan Facility (including all repayments or purchases made at a discount to par (in an amount equal to the principal amount of such repayment)) and voluntary prepayments of Revolving Loans to the extent accompanied by a permanent reduction of the Revolving Commitments thereunder, in each case, made prior to such date of incurrence and not funded with the proceeds of long-term debt plus (C) an amount equal to the amount of indebtedness that is permitted to be incurred in reliance on the General Debt Basket (as defined below) (this clause (C), the “General Debt Basket Incremental Component”) plus (D) an additional amount such that, after giving effect to the incurrence of any such Incremental Facility pursuant to this clause (D) (which shall assume that all such indebtedness was secured on a first lien basis, whether or not so secured, and which shall be deemed to include the full amount of any Incremental Revolving Increase or Incremental Revolving Facility assuming that the full amount of such increase or Incremental Revolving Facility, as applicable, had been drawn, and after giving effect to any acquisition consummated concurrently therewith and any other acquisition, disposition, debt incurrence, debt retirement and other appropriate pro forma adjustment events, including any debt incurrence (but without giving effect to any amount incurred simultaneously under either (1) clause (A), (B) or (C) above or (2) the Revolving Facility) or retirement subsequent to the end of the applicable test period and on or prior to the date of such incurrence, all to be further defined in the Facilities Documentation), the Borrower would be in compliance, on a pro forma basis (and without netting any cash proceeds of such incurrence), with a First Lien Leverage Ratio (to be defined as provided under “Financial Definitions” below) (recomputed as of the last day of the most recently ended fiscal quarter of the Borrower for which financial statements are available) equal to or less than either (x) 5.50:1.00 or (y) the First Lien Leverage Ratio immediately prior to the incurrence of such Incremental Facility (this clause (D), the “Leverage Based Incremental Amount”); provided that:

 

(i) no event of default (except in connection with permitted acquisitions or other investments, where no payment or bankruptcy event of default will be the standard) under the Facilities Documentation has occurred and is continuing or would exist after giving effect thereto;

 

B-2


  

(ii)  the maturity date of any such Incremental Term Facility shall be no earlier than the maturity date of the Initial Term Loan Facility and the weighted average life of any such Incremental Term Facility shall not be shorter than the then remaining weighted average life of the Initial Term Loan Facility and the maturity date of any such Incremental Revolving Facility shall be no earlier than the maturity date of the Initial Revolving Facility; provided that, at the option of the Borrower, this clause (ii) shall not apply to (A) Incremental Term Facilities in an aggregate outstanding principal amount of up to the greater of (x) $290 million and (y) 200% of Consolidated EBITDA for the last four fiscal quarters of the Borrower for which financial statements are available of Incremental Facilities (the “Incremental Maturity Carveout”), (B) customary bridge facilities or (C) Incremental Term Facilities incurred in connection with an investment or acquisition;

 

(iii)  the currency, pricing, interest rate margins, discounts, premiums, rate floors and fees and (subject to clause (ii) above) maturity and amortization schedule applicable to any Incremental Term Facility or Incremental Revolving Facility shall be determined by the Borrower and the lenders thereunder; provided that only during the period commencing on the Closing Date and ending on the date that is six months after the Closing Date (the “MFN Sunset Date”) and only with respect to any Incremental Term Facilities in the form of broadly syndicated U.S. dollar-denominated term B loans that are incurred pursuant to clause (A) and/or (B) above (other than Incremental Term Loans incurred in reliance on any portion of clause (B) thereof that is attributable to permanent commitment reductions of revolving credit facilities) that are secured by liens on the Collateral ranking equal in priority with the liens on the Collateral securing the Secured Obligations and mature on or prior to the maturity date of the Initial Term Loan Facility, and except (1) with respect to Incremental Term Facilities incurred in connection with an investment or an acquisition and (2) with respect to Incremental Term Facilities incurred pursuant to clause (A) and/or (B) above in an aggregate principal amount of up to the greater of (x) $290 million and (y) 200% of Consolidated EBITDA for the last four fiscal quarters of the Borrower for which financial statements are available, in the event that the interest rate margins for any such Incremental Term Facility are higher than the interest rate margins for the Initial Term Loan Facility by more than 100 basis points (the “MFN Cushion”), then the interest rate margins for the Initial Term Loan Facility shall be increased to the extent necessary so that such interest rate margins are equal to the interest rate margins for such Incremental Term Facility minus 100 basis points; provided, further, that, in determining the interest rate margins applicable to any Incremental Term Facility and the Initial Term Loan Facility (A) OID or upfront fees (which shall be deemed to constitute like amounts of OID) or other fees payable by the Borrower to the Lenders under the Initial Term Loan Facility or any Incremental Term Facility in the initial primary syndication thereof, if any, shall be included (with OID or upfront fees being equated to interest based on assumed four-year life to maturity), (B) arrangement, structuring, ticking, commitment, amendment, unused line or underwriting fees or other similar fees payable in connection with the Initial Term Loan Facility or such Incremental Term Loans, as applicable, consent fees for an amendment (in each case regardless of whether such fees are paid to or shared in whole or in part with any lender) and such other fees not paid to all relevant lenders generally with respect to such indebtedness shall be excluded, (C) the applicable interest rate margins shall be deemed to include any credit spread or similar adjustment applicable to a one-

 

B-3


  

month Term SOFR borrowing and (D) (1) to the extent that Term SOFR for a three-month interest period on the closing date of any such Incremental Term Facility is less than the Term SOFR floor for the Initial Term Loan Facility, the amount of such difference shall be deemed added to the interest margin for the Initial Term Loan Facility, solely for the purpose of determining whether an increase in the interest rate margins for the Initial Term Loan Facility shall be required and (2) with respect to any Incremental Term Facility, to the extent that Term SOFR applicable to the Initial Term Loan Facility for a three-month interest period on the closing date of any such Incremental Term Facility is less than the interest rate floor, if any, applicable to any such Incremental Term Facility, the amount of such difference shall be deemed added to the interest rate margins for the loans under the Incremental Term Facility solely for the purpose of determining whether an increase in the interest rate margins for the Initial Term Loan Facility shall be required (collectively, the “MFN Protection”);

 

(iv) any Incremental Term Facility or any Incremental Revolving Facility shall be on terms and pursuant to documentation to be determined; provided that, to the extent such terms and documentation are not consistent with the Initial Term Loan Facility or Initial Revolving Facility, as the case may be (except to the extent permitted by clause (ii) or (iii) above), they shall be reasonably satisfactory to the Administrative Agent (it being understood that, to the extent that any financial maintenance or other covenant is added for the benefit of any (A) Incremental Term Facility, no consent shall be required from the Administrative Agent or any of the Lenders to the extent that such financial maintenance or other covenant is (1) also added for the benefit of any existing Facility or (2) only applicable after the latest maturity of any existing Facility); or (B) Incremental Revolving Facility, no consent shall be required from the Administrative Agent or any of the Lenders to the extent that such financial maintenance or other covenant is (1) also added for the benefit of the Initial Revolving Facility or (2) only applicable after the latest maturity of any existing Facility); and

 

(v)   (a) any Incremental Facility that is secured shall only be secured by the Collateral and (b) no Incremental Facility shall be guaranteed by entities other than the Guarantors or the Borrower.

 

The Borrower or the applicable Subsidiary Guarantor may (but is not obligated to) seek commitments in respect of the Incremental Facilities from existing Lenders (each of which shall be entitled to agree or decline to participate in its sole discretion) and from additional banks, financial institutions and other institutional lenders or investors who will become Lenders in connection therewith (“Additional Lenders”); provided that (i) the Administrative Agent shall have consent rights (not to be unreasonably withheld) with respect to such Additional Lender, if such consent would be required under the heading “Assignments and Participations” for an assignment of loans or commitments, as applicable, to such Additional Lender, (ii) solely with respect to any Incremental Revolving Increase, the Issuing Banks (as defined in the Precedent Documentation) shall have consent rights (not to be unreasonably withheld) with respect to such Additional Lender, if such consent would be required under the heading “Assignments and Participations” for an assignment of revolving loans or commitments, as applicable, to such Additional Lender and (iii) the restrictions applicable to Affiliated Lenders (to be defined in accordance with the Documentation Considerations) under “Assignments and Participations” shall apply to commitments in respect of Incremental Facilities.

 

B-4


Refinancing Facilities:    The Facilities Documentation will permit the Borrower or any Guarantor to refinance loans or commitments (including by extending the maturity) under the Facilities or loans or commitments under any Incremental Facility on terms and conditions substantially consistent with the Precedent Documentation (as defined below) after giving effect to Documentation Considerations (the “Refinancing Indebtedness”).
Purpose:   

(A)  The proceeds of borrowings under the Initial Term Loan Facility will be used by the Borrower and its subsidiaries, together with the proceeds from borrowings under the Revolving Facility and cash on hand at the Target and its subsidiaries, to pay the Acquisition Funds (including, at the Borrower’s election, to fund original issue discount (“OID”) or upfront fees required pursuant to the “Market Flex Provisions” in the Fee Letter) to the extent otherwise permitted above and may be used after the Closing Date for working capital or other general corporate purposes and any other use not prohibited by the Facilities Documentation.

 

(B)  The letters of credit and proceeds of Revolving Loans (except as set forth below) may be used by the Borrower and its subsidiaries for working capital and other general corporate purposes, including the financing of permitted acquisitions and other permitted investments and permitted dividends and other distributions on account of the capital stock of the Borrower (or any direct or indirect parent company thereof) and any other use not prohibited by the Facilities Documentation, and, subject to the limitations set forth under “Availability” below, to finance a portion of the Acquisition Funds.

  

(C)  The proceeds of any Incremental Facility may be used by the Borrower and its subsidiaries for working capital and other general corporate purposes, including the financing of permitted acquisitions, other permitted investments and dividends and other permitted distributions on account of the capital stock of the Borrower (or any direct or indirect parent company thereof) and any other use not prohibited by the Facilities Documentation.

Availability:   

The Initial Term Loan Facility will be available in a single drawing on the Closing Date. Amounts borrowed under the Initial Term Loan Facility that are repaid or prepaid may not be reborrowed.

 

The Revolving Facility will be available on (subject to the limitations set forth in the next two succeeding sentences) and after the Closing Date and at any time prior to the final maturity of the Revolving Facility. The Revolving Facility (exclusive of letter of credit usage) will be made available on the Closing Date in an amount sufficient to fund (i) any OID or upfront fees required to be funded on the Closing Date pursuant to the “Market Flex Provisions” in the Fee Letter, plus (ii) ordinary course working capital requirements of the Borrower and its subsidiaries on the Closing Date, plus (iii) refinance any amount under the revolving facility under the Existing Credit Agreement, plus (iv) Acquisition Funds in an aggregate amount, in the case of this clause (iv), not to exceed an amount to be agreed. Additionally, letters of credit issued under facilities and other credit support no longer available to the Target or its subsidiaries as of the Closing Date may be “rolled over” on the Closing Date and/or new letters of credit may be issued on the Closing Date in order to, among other things, backstop or replace any

 

B-5


   such credit support outstanding on the Closing Date under such facilities. Otherwise, letters of credit and Revolving Loans will be available at any time prior to the final maturity of the Revolving Facility, in minimum principal amounts to be agreed upon. Amounts repaid under the Revolving Facility may be reborrowed. The Revolving Facility shall permit drawings of ABR loans (as defined in Annex I) on same day notice if received by the Administrative Agent prior to 12:00 p.m. New York time.
Interest Rates and Fees:    As set forth on Annex I hereto.
Default Rate:    During the continuance of a payment or bankruptcy event of default, with respect to overdue principal, at the applicable interest rate plus 2.00% per annum, and with respect to any other overdue amount (including overdue interest), at the interest rate applicable to ABR loans plus 2.00% per annum, which, in each case, shall be payable on demand.
Letters of Credit:    An aggregate amount of an amount to be agreed of the Revolving Facility will be available to the Borrower for the purpose of issuing letters of credit on terms and conditions consistent with those set forth in the Precedent Documentation. For the avoidance of doubt, KCL, SF, Wells Fargo, Barclays and RBC shall only be required to issue standby letters of credit.
Final Maturity and Amortization:   

The Initial Term Loan Facility will mature on the date that is seven years after the Closing Date and will amortize in equal quarterly installments in aggregate annual amounts equal to 1.00% of the original principal amount of the Initial Term Loan Facility, commencing with the second full fiscal quarter after the Closing Date, with the balance payable on the maturity date thereof.

 

The Revolving Facility will mature, and the Revolving Commitments will terminate, on the date that is five years after the Closing Date.

 

The Facilities Documentation shall contain customary “amend and extend” provisions pursuant to which individual Lenders may agree to extend the maturity date of their outstanding Initial Term Loans, loans under any Incremental Facility or Revolving Commitments (which may include, among other things, an increase in the interest rate payable in respect of such extended Term Loans, loans under any Incremental Facility or Revolving Commitments, with such extensions not subject to any “default stoppers”, financial tests or “most favored nation” pricing provisions) upon the request of the Borrower and without the consent of any other Lender (it is understood that (i) no existing Lender will have any obligation to commit to any such extension and (ii) each Lender under the class being extended shall have the opportunity to participate in such extension on the same terms and conditions as each other Lender under such class).

Guarantees:    All obligations of the Borrower (the “Obligations”) under the Facilities and, at the election of the Borrower, all obligations of Holdings (as defined below) or any restricted subsidiary of Holdings under any interest rate protection, foreign exchange or other swap or hedging arrangements (other than any obligation of any Guarantor to pay or perform under any agreement, contract, or transaction that constitutes a “swap” within the meaning of section 1a(47) of the Commodity Exchange Act (a “Swap”), if, and to the extent that, all or a portion of the guarantee by such Guarantor of, or the grant by such Guarantor of a security interest to secure, such Swap (or any guarantee thereof) is or becomes illegal under the Commodity Exchange Act or any rule, regulation, or order

 

B-6


   of the Commodity Futures Trading Commission (or the application or official interpretation of any thereof) (collectively, “Excluded Swap Obligations”)) and cash management arrangements, in each case entered into with a Lender, Lead Arranger, Joint Bookrunner, the Administrative Agent, any affiliate of a Lender, Lead Arranger, Joint Bookrunner or the Administrative Agent or, upon notice to the Administrative Agent, any other person (“Hedging/Cash Management Arrangements”) will be unconditionally and irrevocably guaranteed jointly and severally on a senior basis (the “Guarantees”) by each existing and subsequently acquired or organized direct or indirect wholly-owned U.S. restricted subsidiary of the Borrower (the “Subsidiary Guarantors”) and by the direct parent company of the Borrower (“Holdings” and, together with the Subsidiary Guarantors, the “Guarantors”); provided that Subsidiary Guarantors shall not include (a) unrestricted subsidiaries, (b) immaterial or other excluded subsidiaries (to be defined in a mutually acceptable manner), (c) any subsidiary that is prohibited by applicable law, rule or regulation or by any contractual obligation existing on the Closing Date or on the date any such subsidiary is acquired (so long as in respect of any such contractual prohibition such prohibition is not incurred in contemplation of such acquisition), in each case from guaranteeing the Facilities or which would require governmental (including regulatory) consent, approval, license or authorization to provide a Guarantee, or for which the provision of a Guarantee would result in a material adverse tax consequence (including as a result of the operation of Section 956 of the Internal Revenue Code of 1986, as amended (the “IRS Code”) or any similar law or regulation in any applicable jurisdiction) to Holdings or one of its subsidiaries (as reasonably determined by the Borrower in consultation with the Administrative Agent), (d) any direct or indirect U.S. subsidiary of a non-U.S. subsidiary of the Borrower that is a “controlled foreign corporation” within the meaning of Section 957 of the IRS Code (a “CFC”) and any direct or indirect subsidiary of the Borrower that has no material assets other than equity and/or indebtedness of one or more CFCs (any such entity, a “FSHCO”), (e) any not-for-profit subsidiaries, captive insurance companies or other special purpose subsidiaries and (f) certain special purpose entities and any securitization subsidiary. Neither the Target nor any of its subsidiaries will be Guarantors prior to the consummation of the Acquisition and the initial funding of the Facilities on the Closing Date.
   Notwithstanding the foregoing, subsidiaries may be excluded from the guarantee requirements in circumstances where the Administrative Agent and the Borrower reasonably agree that the cost of providing such a guarantee is excessive in relation to the value afforded thereby.
Security:    Subject to the limitations set forth below in this section and subject to the Limited Conditionality Provisions, the Obligations, the Hedging/Cash Management Arrangements and the Guarantees in respect of the Obligations (collectively, the “Secured Obligations”) will be secured on a first priority basis by: (a) a perfected first-priority pledge of 100% of the equity interests of the Borrower and 100% of the equity interests of each direct, wholly-owned material restricted subsidiary of the Borrower and of each Subsidiary Guarantor (which pledge, in the case of capital stock of any non-U.S. subsidiary or any FSHCO, shall be limited to 65% of any voting capital stock and 100% of the non-voting capital stock of such first-tier material non-U.S. subsidiary or FSHCO) and (b) perfected first priority security interests in substantially all tangible and intangible personal property of Holdings, the Borrower and each Subsidiary Guarantor (including but not limited to accounts receivable, inventory, equipment, general intangibles (including contract rights), investment property, U.S. intellectual

 

B-7


   property, intercompany notes, instruments, chattel paper and documents, letter of credit rights, commercial tort claims and proceeds of the foregoing) (the items described in clauses (a) and (b) above, but excluding the Excluded Assets (as defined in the Precedent Documentation), collectively, the “Collateral”). The pledges of and security interests in the Collateral granted by the Borrower and each Guarantor shall secure its own respective Secured Obligations.
   All the above-described pledges and security interests shall be created on terms substantially similar to those set forth in the Precedent Documentation, after giving effect to the Documentation Considerations; and none of the Collateral shall be subject to other pledges or security interests, other than with respect to certain customary permitted encumbrances and other exceptions and baskets to be set forth in the Facilities Documentation, substantially similar to the exceptions and baskets set forth in the Precedent Documentation, after giving effect to the Documentation Considerations.
Mandatory Prepayments:    Loans under the Initial Term Loan Facility and, to the extent required thereunder, under any Incremental Term Facility shall be prepaid with:
  

(A)  commencing with the first full fiscal year of the Borrower to occur after the Closing Date, an amount equal to 50% of Excess Cash Flow (as defined in the Precedent Documentation and as further reduced on a dollar-for-dollar basis in a manner consistent with the Precedent Documentation (the “ECF Prepayment Amount”), with step-downs to 25% and 0% based upon the achievement and maintenance of First Lien Leverage Ratios equal to or less than 5.25:1.00 and 5.00:1.00, respectively (the “ECF Prepayment Step-Downs”); provided that any such dollar-for-dollar reductions that have not been applied to reduce the ECF Prepayment Amount in any fiscal year may be carried over to subsequent fiscal years and applied to reduce the ECF Prepayment Amount in respect of such subsequent fiscal years until such time as such amounts have been used to reduce any such ECF Prepayment Amount; provided, further, that prepayments shall only be required under this clause if the ECF Prepayment Amount in any fiscal year is greater than the greater of (1) $25 million and (2) 15% of Consolidated EBITDA for the last four fiscal quarters of the Borrower for which financial statements are available (and only amounts in excess of such amount shall be required to be prepaid);

  

(B)  an amount equal to 100% (with step-downs to 50% and 0% based upon the achievement and maintenance of First Lien Leverage Ratios equal to or less than 5.25:1.00 and 5.00:1.00, respectively (the “Asset Sale Step-Downs”)) of the net cash proceeds (which shall be calculated in a manner consistent with the Precedent Documentation) of non-ordinary course sales or other dispositions of assets constituting Collateral by the Borrower and its restricted subsidiaries after the Closing Date (including insurance and condemnation proceeds and sale leaseback proceeds) in excess of greater of (1) $25 million and (2) 15% of Consolidated EBITDA for the last four fiscal quarters of the Borrower for which financial statements are available (and only amounts in excess of such amount shall be required to be prepaid) made pursuant to clause (b) under the heading “Permitted Asset Sales” below and otherwise consistent with such provisions in the Precedent Documentation; in the case of asset sales or dispositions pursuant to clause (b)(x) in “Permitted Asset Sales” below, subject to the rights of the Borrower and its restricted subsidiaries to distribute (using available restricted

 

B-8


  

payment capacity) (the “Asset Sale RP Exception”) or reinvest 100% of such proceeds, if such proceeds are distributed or reinvested (or committed to be reinvested) within 540 days of the receipt of such net cash proceeds and, if so committed to reinvestment, reinvested no later than 180 days after the end of such 540-day period and other exceptions to be set forth in the Facilities Documentation; provided that the Borrower may elect to deem expenditures that otherwise would be permissible reinvestments that are made up to 180 days prior to receipt of the proceeds from an asset sale to have been reinvested in accordance with the provisions hereof; and

  

(C)  an amount equal to 100% of the net cash proceeds of issuances of debt obligations of the Borrower and its restricted subsidiaries after the Closing Date (other than debt permitted under the Facilities Documentation, except in respect of Refinancing Indebtedness).

   Mandatory prepayments shall be applied, without premium or penalty (i) amongst the Initial Term Loan Facility and any Incremental Term Facility as selected by the Borrower (except pursuant to clause (C) above with respect to Refinancing Indebtedness) and (ii) at the Borrower’s direction to the amortization payments scheduled to occur under the Term Loans Facilities and any Incremental Term Facility.
   Notwithstanding the foregoing, the Facilities Documentation will provide that, in the event that any Refinancing Indebtedness or any other indebtedness, including any Incremental Equivalent Debt, that is secured on an equal priority basis (but without regard to the control of remedies) with the liens on the Collateral securing the Facilities (collectively, “Additional First Lien Debt”), shall be issued or incurred, such Additional First Lien Debt may share no more than ratably in any prepayments required by the foregoing provisions of clauses (A) and/or (B) to the extent required by the terms of the documentation for such Additional First Lien Debt.
   Prepayments attributable to non-U.S. subsidiaries’ Excess Cash Flow and asset sale or other disposition proceeds will be limited under the Facilities Documentation to the extent the repatriation of such amounts would result in material adverse tax consequences or would be prohibited or restricted by applicable law, rule or regulation in a manner consistent with the Precedent Documentation.
  

Any Term Lender may elect not to accept its pro rata portion of any mandatory prepayment other than a prepayment described in clause (C) above (each a “Declining Lender”). Any prepayment amount declined (such amount, a “Declined Amount”) by a Declining Lender under the Term Loan Facility (including any Incremental Term Facility) may be retained by the Borrower and its restricted subsidiaries and shall increase the Available Amount Basket (as defined below).

 

The loans under the Revolving Facility shall be prepaid and the letters of credit cash collateralized to the extent such extensions of credit exceed the amount of the commitments under the Revolving Facility.

 

B-9


Voluntary Prepayments and Reductions in Commitments:   

Voluntary reductions of the unutilized portion of the Revolving Commitments and voluntary prepayments of borrowings under the Term Loan Facilities will be permitted at any time, in minimum principal amounts to be agreed, without premium or penalty (other than as set forth in the second succeeding paragraph).

 

All voluntary prepayments of the Term Loan Facilities and any Incremental Facility will be applied to the remaining amortization payments under the Term Loan Facilities or such Incremental Facility as directed by the Borrower (and absent such direction, in direct order of maturity thereof), including to any class of extending or existing Term Loans in such order as the Borrower may designate, and shall be applied to the Facilities or any Incremental Facility as determined by the Borrower.

 

Any voluntary prepayment or refinancing (other than a refinancing of the Initial Term Loan Facility in connection with any transaction that would, if consummated, constitute a change of control, an initial public offering, a Material Acquisition (as defined below), a Material Disposition (as defined below) or an increase in the aggregate principal amount of Term Loans (including by adding a new Class of Term Loans) (a “Facility Upsize”)) of the Initial Term Loan Facility with other broadly syndicated U.S. dollar-denominated term loan B financings under credit facilities with a lower Effective Yield (as defined below) than the Effective Yield of the Initial Term Loan Facility, or any amendment (other than an amendment of the Initial Term Loan Facility in connection with any transaction that would, if consummated, constitute a change of control, initial public offering, Material Acquisition, Material Disposition or Facility Upsize that reduces the Effective Yield of the Initial Term Loan Facility, in either case that occurs prior to the date that is six months following the Closing Date (the “Soft Call Date”) and the primary purpose of which is to lower the Effective Yield on the Initial Term Loan Facility, shall be subject to a prepayment premium of 1.00% of the principal amount of the Initial Term Loan Facility so prepaid, refinanced or amended (collectively, the “Soft Call Protection”). For the purposes of this paragraph, (i) “Material Acquisition” shall mean any acquisition by the Borrower or any restricted subsidiary for consideration (including any assumed indebtedness) in an aggregate amount equal to or greater than the lesser of $40 million and 25% of Consolidated EBITDA for the last four fiscal quarters of the Borrower for which financial statements are available, (ii) “Material Disposition” shall mean any disposition by the Borrower or any restricted subsidiary for consideration (including any assumed indebtedness) in an aggregate amount equal to or greater than the lesser of $40 million and 25% of Consolidated EBITDA for the last four fiscal quarters of the Borrower for which financial statements are available and (iii) “Effective Yield” shall mean, as of any date of determination, the sum of (a) the higher of (A) the Term SOFR rate on such date for a deposit in dollars with a maturity of one month and (B) the Term SOFR floor, if any, with respect thereto as of such date, (b) the interest rate margins as of such date (with such interest rate margin and interest spreads to be determined by reference to the Term SOFR rate) and (c) the amount of OID and upfront fees thereon (converted to yield assuming a four-year average life and without any present value discount).

Conditions to Initial Borrowing:    Subject to the Limited Conditionality Provisions, the availability of the initial borrowing and other extensions of credit under the Facilities on the Closing Date will be subject solely to (a) delivery of a customary borrowing/issuance notice; provided that such notice shall not include any representation or statement as to the absence (or existence) of any default or event of default, (b) the accuracy of the Specified Representations in all material respects (subject to the Limited Conditionality Provisions); provided that any representations and warranties qualified by materiality shall be, as so qualified, accurate in all respects, (c) the accuracy of the Specified Acquisition Agreement Representations in all material respects; provided that any representations and warranties qualified by materiality shall be, as so qualified, accurate in all respects, and (d) the applicable conditions expressly set forth in Exhibit C to the Commitment Letter.

 

B-10


Conditions to All Subsequent Borrowings:    After the Closing Date, the making of each extension of credit under the Revolving Facility shall be conditioned upon (a) delivery of a customary borrowing/issuance notice, (b) the accuracy of representations and warranties in all material respects; provided that any representations and warranties qualified by materiality shall be, as so qualified, accurate in all respects and (c) the absence of defaults or events of default at the time of, and after giving effect to the making of, such extension of credit.
Facilities Documentation:    The definitive financing documentation for the Facilities (the “Facilities Documentation”) shall be initially drafted by counsel for the Sponsors and contain the terms set forth in this Exhibit B (subject to the right of the Majority Lead Arrangers (as defined in the Fee Letter), as applicable, to exercise the “Market Flex Provisions” under the Fee Letter) and, to the extent any other terms are not expressly set forth in this Exhibit B, will (a) be negotiated in good faith within a reasonable time period to be determined based on the expected Closing Date in coordination with the Acquisition Agreement, and taking into account the timing of the syndication of the Initial Term Loan Facility, (b) be no less favorable to the Borrower and its subsidiaries than the Existing Credit Agreement and (c) contain only those conditions, representations, events of default and covenants set forth in this Exhibit B and such other terms (but no other conditions) as the Borrower and the Lead Arrangers shall reasonably agree; it being understood and agreed that the Facilities Documentation shall be based on, and substantially consistent with that certain Credit Agreement, dated as of June 28, 2023 (as amended, supplemented or otherwise modified through the Original Signing Date, the “Precedent Documentation”), among Quartz Intermediate, LLC, Quartz AcquireCo, LLC and JPMorgan Chase Bank, N.A., as administrative and collateral agent, and the other banks, agents, financial institutions and other parties thereto (and the related security, pledge, collateral and guarantee agreements executed and/or delivered in connection therewith and the forms of intercreditor agreements attached thereto), as modified by the terms set forth herein and subject to (i) materiality qualifications and other exceptions that give effect to and/or permit the Transactions, (ii) certain baskets, thresholds and exceptions that are to be agreed in light of the Consolidated EBITDA and leverage level of the Borrower and its subsidiaries (after giving effect to the Transactions), (iii) such other modifications to reflect the operational and strategic requirements of Holdings and its subsidiaries (after giving effect to the Transactions) in light of their size, industry (and risks and trends associated therewith), geographic locations, businesses, business practices, operations, total assets, financial accounting and the Projections, (iv) modifications to reflect changes in law or accounting standards since the date of the Precedent Documentation, (v) modifications to reflect reasonable administrative, agency and operational requirements of the Administrative Agent and (vi) modifications to reflect the financial model provided to the Original Commitment Parties on September 3, 2024 (the “Sponsor Model”) and the quality of earnings report provided to the Original Commitment Parties on September 3, 2024 (the “QofE Report”) (collectively, the “Documentation Considerations”). For the avoidance of doubt, the Facilities Documentation will include customary bail-in provisions.

 

B-11


Limited Condition Transactions:   

For purposes of (i) determining compliance with any provision of the Facilities Documentation which requires the calculation of the First Lien Leverage Ratio, the Secured Leverage Ratio (as defined in the Precedent Documentation, subject to “Financial Definitions” below), the Total Leverage Ratio (as defined in the Precedent Documentation, subject to “Financial Definitions” below) or the Interest Coverage Ratio (as defined in the Precedent Documentation, subject to “Financial Definitions” below), (ii) determining compliance with representations, warranties, defaults or events of default or (iii) testing availability under baskets set forth in the Facilities Documentation (including baskets measured as a percentage of Consolidated EBITDA), in each case, in connection with a Limited Condition Transaction, at the option of the Borrower (the Borrower’s election to exercise such option in connection with any Limited Condition Transaction, an “LCT Election”), the date of determination of whether any such action is permitted hereunder, shall be deemed to be, as applicable, the date the definitive agreements or letters of intent for such Limited Condition Transaction are entered into, or the date of delivery of irrevocable notice or a dividend declaration with respect to, such Limited Condition Transaction (such date, the “LCT Test Date”), and if, after giving pro forma effect to the Limited Condition Transaction and the other transactions to be entered into in connection therewith as if they had occurred at the beginning of the most recent test period ending prior to the LCT Test Date, the Borrower or a restricted subsidiary could have taken such action on the relevant LCT Test Date in compliance with such ratio or basket, such ratio or basket shall be deemed to have been complied with.

 

Limited Condition Transaction” shall mean (i) an acquisition or other investment by one or more of the Borrower and its restricted subsidiaries of any assets, business or person permitted by the Facilities Documentation, (ii) any repayment, repurchase or refinancing of indebtedness with respect to which an irrevocable notice of repayment (or similar irrevocable notice) is required to be delivered and (iii) any dividends or distributions on, or redemptions of, equity interests not prohibited by the Facilities Documentation declared or requiring irrevocable notice in advance thereof.

 

For the avoidance of doubt, if the Borrower has made an LCT Election and any of the ratios or baskets for which compliance was determined or tested as of the LCT Test Date (including with respect to the incurrence of any Indebtedness) are exceeded as a result of fluctuations in any such ratio or basket (including due to fluctuations in pro forma Consolidated EBITDA, including of the target of any Limited Condition Transaction) at or prior to the consummation of the relevant transaction or action, such baskets or ratios will not be deemed to have been exceeded as a result of such fluctuations; however, if any ratios improve or baskets increase as a result of such fluctuations, such improved ratios or baskets may be utilized. If the Borrower has made an LCT Election for any Limited Condition Transaction, then in connection with any subsequent calculation of any ratio or basket on or following the relevant LCT Test Date and prior to the earlier of (i) the date on which such Limited Condition Transaction is consummated or (ii) the date that the definitive agreement for such Limited Condition Transaction is terminated or expires without consummation of such Limited Condition Transaction, any such ratio or basket shall be calculated on a pro forma basis assuming such Limited Condition Transaction and other transactions in connection therewith (including any incurrence of debt and the use of proceeds thereof) have been consummated.

 

B-12


Representations and Warranties:    Subject to the Limited Conditionality Provisions, limited on the Closing Date to the Specified Representations and the Specified Acquisition Agreement Representations and thereafter to the representations and warranties set forth in Article III of the Precedent Documentation (to be applicable to Holdings, the Borrower and its restricted subsidiaries only and subject, where applicable, to qualifications and limitations for materiality consistent with those provided in the Precedent Documentation, after giving effect to the Documentation Considerations).
   Material Adverse Effect” shall (a) on the Closing Date, have the meaning ascribed to the term “Company Material Adverse Effect” in the Acquisition Agreement, and (b) thereafter, have the meaning ascribed to such term in the Precedent Documentation.
Affirmative Covenants:    Subject in all respects to the Documentation Considerations, to be applicable to the Borrower and its restricted subsidiaries only, the same (including, for the avoidance of doubt, with respect to materiality qualifiers, exceptions and limitations) as the affirmative covenants set forth in Article V of the Precedent Documentation; provided that the affirmative covenants set forth in the Facilities Documentation shall include a limitation on transactions with affiliates consistent with such limitation set forth in Section 6.09 of the Precedent Documentation.
Negative Covenants:    Limited to the following (to be applicable to the Borrower and its restricted subsidiaries):
  

a)  limitations on the incurrence of debt (which shall permit, among other things, (i) the indebtedness under the Facilities (including Incremental Facilities) and any permitted refinancing thereof, (ii) non-speculative hedging arrangements, (iii) indebtedness (including Ordinary Course Indebtedness) of the Target and its subsidiaries incurred prior to the Closing Date which remains outstanding and is permitted to remain outstanding under the Acquisition Agreement and any permitted refinancings of the foregoing, (iv) any secured or unsecured notes or loans issued by the Borrower or a Guarantor in lieu of the Incremental Facilities (such loans or notes, “Incremental Equivalent Debt”); provided that (A) the incurrence of such indebtedness shall result in a dollar-for-dollar reduction of the amount of indebtedness that the Borrower and the Guarantors may incur in respect of the Incremental Facilities and the other requirements related to the incurrence of the Incremental Facilities shall be satisfied (other than those set forth in the proviso to clause (iii) and in clauses (iv) and (v) of such requirements); provided, however, that, in the case of any Incremental Equivalent Debt consisting of junior priority secured notes or loans, in lieu of compliance with the First Lien Secured Leverage Ratio test set forth in the first paragraph under “Incremental Facilities”, the Borrower shall instead be in compliance, on a pro forma basis (and without netting any cash proceeds of such incurrence), with either (x) a Senior Secured Leverage Ratio (to be defined as provided under “Financial Definitions” below) (recomputed as of the last day of the most recently ended fiscal quarter of the Borrower for which financial statements are available) equal to or less than either (a) 6.50:1.00 or (b) the Senior Secured Leverage Ratio immediately prior to the incurrence of such Incremental Equivalent Debt or (y) an Interest Coverage Ratio of not less than either (a) 1.75:1.00 or (b) the Interest Coverage Ratio immediately prior to the incurrence of such Incremental Equivalent Debt, (B) to the extent secured, such indebtedness shall be subject to an applicable intercreditor agreement and (C)

 

B-13


  

the terms and conditions of such Incremental Equivalent Debt (excluding pricing, rate floors, discounts, fees, premiums and prepayment or redemption provisions) either (I) are not materially more favorable (when taken as a whole) to the lenders or investors providing such Incremental Equivalent Debt than the terms and conditions of the Credit Facilities Documentation (when taken as a whole) are to the Lenders (it being understood that, to the extent that any financial maintenance covenant or any other covenant is added for the benefit of any Incremental Equivalent Debt, no consent shall be required by the Administrative Agent or any of the Lenders if such financial maintenance covenant or other covenant is either (x) also added for the benefit of any corresponding Loans remaining outstanding after the issuance or incurrence of any such Incremental Equivalent Debt in connection therewith or (y) only applicable after the latest maturity date under the Credit Facilities Documentation at such time), (II) include covenants or other provisions applicable only to periods after the latest maturity date under the Credit Facilities Documentation at such time or (III) reflect market terms and conditions (taken as a whole) at the time of incurrence of such Incremental Equivalent Debt (as determined by the Borrower in good faith), (v) Refinancing Indebtedness, (vi) indebtedness assumed in connection with, or otherwise incurred to finance, Permitted Acquisitions and other investments, in each case, on terms consistent with the Precedent Documentation, after giving effect to the Documentation Considerations (including a basket in an amount equal to the greater of $55 million and 35% of Consolidated EBITDA), (vii) purchase money indebtedness and capital leases (x) in an amount equal to the greater of $55 million and 35% of Consolidated EBITDA plus (y) an unlimited amount to finance the purchase, construction and improvement of fixed or capital assets subject to compliance with a maximum Senior Secured Leverage Ratio (calculated as if such purchase money indebtedness and capital leases are secured by Collateral for these purposes) of no greater than 5.50:1.00, (viii) indebtedness arising from agreements providing for adjustments of purchase price or “earn outs” entered into in connection with acquisitions, (ix) a general debt basket in an amount equal to the greater of $75 million and 50% of Consolidated EBITDA and which may be secured to the extent permitted by exceptions to the lien covenant (the “General Debt Basket”) less amounts incurred under the General Debt Basket Incremental Component, (x) other senior, senior subordinated or subordinated indebtedness that is unsecured or that is secured solely by assets that do not constitute Collateral so long as the Borrower is in compliance, on a pro forma basis (and without netting any cash proceeds of such incurrence), with either (a) a Total Leverage Ratio (to be defined as provided under “Financial Definitions” below) (recomputed as of the last day of the most recently ended fiscal quarter of the Borrower for which financial statements are available) equal to or less than either (i) 7.00:1.00 or (ii) the Total Leverage Ratio immediately prior to the incurrence of such indebtedness or (b) an Interest Coverage Ratio of not less than either (i) 1.75:1.00 or (ii) the Interest Coverage Ratio immediately prior to the incurrence of such indebtedness (this clause (x), the “Ratio Debt”), (xi) a subsidiary debt basket for non-Guarantor subsidiaries in an amount equal to the greater of $75 million and 50% of Consolidated EBITDA, (xii) indebtedness in an amount equal to (A) 200% of any cash common equity contribution to Holdings or the Borrower following the Closing Date (other than Cure Amounts (as defined in the Precedent Documentation) and the proceeds of any such Cure Amount that is actually used pursuant to, or that increases, another basket under

 

B-14


  

the Facilities Documentation) to the extent such cash equity contribution shall not be counted for purposes of the Available Amount Basket and without any time limitation for use of proceeds of such contribution (this clause (xii)(A), the “Contribution Debt Basket”) plus (B) 200% of the unused amount of any baskets and/or exceptions permitting dividends or distributions on, or redemptions of, the equity of the Borrower (or any direct or indirect parent company thereof), prepayments or redemptions of any subordinated indebtedness owed by the Borrower or any Guarantor or restricted investments (including the Available Amount Basket and which such baskets, for the avoidance of doubt, shall be reduced by 50% of the amount of such incurrence) (this clause (xii)(B), the “RP Debt Basket”), (xiii) indebtedness in respect of any permitted securitization financings, which shall include securitization financing facilities that are approved by the board of directors of the Borrower so long as the sales and/or contributions of securitization assets to the applicable securitization subsidiary are made pursuant to “true sale” or “true contribution” transactions, (xiv) indebtedness of non-Guarantor subsidiaries in respect of any local working capital facilities to the extent such facility is non-recourse to the Borrower and the Guarantors, and (xv) other customary exceptions set forth in the Precedent Documentation, after giving effect to the Documentation Considerations);

 

b)  limitations on liens on Collateral securing indebtedness for borrowed money (which shall permit, among other things, liens securing (i) any of the Facilities and, in each case, any permitted refinancing thereof, (ii) any secured Incremental Equivalent Debt, (iii) Refinancing Indebtedness, (iv) debt assumed in connection with a Permitted Acquisition or other investment on terms consistent with the Precedent Documentation, after giving effect to the Documentation Considerations, (v) permitted purchase money indebtedness or capital leases in each case permitted to be incurred pursuant to clause (a)(vii) above, (vi) other permitted debt pursuant to a general lien basket in an amount equal to the General Debt Basket, (vii) permitted non-Guarantor subsidiary debt limited to the assets of non-Guarantors, (viii) debt incurred using the Contribution Debt Basket or the RP Debt Basket, (ix) permitted securitization financings, and (x) other exceptions and qualifications set forth in the Precedent Documentation, after giving effect to the Documentation Considerations, with incurrence ratios consistent with the secured debt incurrence ratios above);

 

c)  limitations on fundamental changes;

 

d)  limitations on asset sales (including sales of subsidiaries) and sale and lease back transactions (which, in each case, shall be permitted (i) on the terms set forth under the heading “Permitted Asset Sales” below, (ii) pursuant to an annual dollar basket in an amount equal to the greater of $40 million and 25% of Consolidated EBITDA for the last four fiscal quarters of the Borrower for which financial statements are available, with amounts not used in any fiscal year carried forward to succeeding fiscal years and (iii) subject to the other exceptions and qualifications set forth in the Precedent Documentation, after giving effect to the Documentation Considerations);

 

B-15


  

e)  limitations on investments and acquisitions (which shall be permitted on the terms set forth under “Permitted Acquisitions” below and, in addition, permit (i) unlimited investments in the Borrower and the restricted subsidiaries, (ii) investments in connection with the Transactions, (iii) [reserved], (iv) investments in amount equal to 200% of the unused amount of any baskets and/or exceptions (including, for the avoidance of doubt, unused amounts under the Available Amount Basket as set forth, and subject to, the conditions in the second succeeding paragraph) permitting dividends or distributions on, or redemptions of, the equity of the Borrower (or any direct or indirect parent company thereof) or prepayments or redemptions of any subordinated indebtedness owed by the Borrower or any Guarantor (which such baskets, for the avoidance of doubt, shall be reduced by 50% of the amount of such investment) (the “Reallocated Amount Investment Basket”), (v) additional investments subject only to pro forma compliance with either (x) a Total Leverage Ratio of no greater than either (a) 5.50:1.00 or (b) the Total Leverage Ratio immediately prior to such investment or (y) an Interest Coverage Ratio of not less than either (a) 1.75:1.00 or (b) the Interest Coverage Ratio immediately prior to such investment (the “Investment Covenant Interest Coverage Ratio”), (vi) basket for investments in similar businesses in an amount equal to the greater of $80 million and 55% of Consolidated EBITDA, (vii) a general investment basket in an amount equal to the greater of $75 million and 50% of Consolidated EBITDA, (viii) basket for investment in unrestricted subsidiaries in an amount equal to the greater of $75 million and 50% of Consolidated EBITDA, (ix) basket for loans or advances to officers, directors or employees in an amount equal to the greater of $25 million and 15% of Consolidated EBITDA, (x) basket for investments in the form of securitization assets required in connection with a permitted securitization financing, and (xi) other exceptions and qualifications set forth in the Precedent Documentation, after giving effect to the Documentation Considerations);

  

f)   limitations on dividends or distributions on, or redemptions of the Borrower’s (or any of its direct or indirect parent companies’) equity (which shall permit, among other things, (i) customary payments or distributions to pay the consolidated or similar type of income or similar tax liabilities of any direct or indirect parent, to the extent such payments cover taxes that are attributable to the activities of the Borrower or its subsidiaries or to such parent’s ownership of the Borrower or its subsidiaries, (ii) payment of legal, accounting and other ordinary course corporate overhead or other operational expenses of any direct or indirect parent entity and for the payment of franchise or similar taxes required to maintain organizational existence, (iii) subject to no continuing payment or bankruptcy event of default, customary distributions necessary to pay advisory, refinancing, subsequent transaction and exit fees, and other overhead expenses of direct and indirect parents of the Borrower attributable to the ownership of the Borrower and its subsidiaries, (iv) dividends, distributions or redemptions with the Available Amount Basket as set forth in the second succeeding paragraph, (v) a general basket in an amount equal to the greater of $45 million and 30% of Consolidated EBITDA, (vi) dividends, distributions or redemptions in connection with the Transactions (including, without limitation, as necessary to allow any parent company to make payments contemplated or otherwise required by the Acquisition Agreement whether at or after the Closing Date), (vii) the repurchase, retirement or other acquisition or retirement for value of equity interests (or any options or warrants or stock appreciation or similar rights issued with respect to any of such equity interests) held by any future, present or former employee, director, officer, consultant or other individual service provider (or any affiliates, spouses, former spouses, other immediate family members,

 

B-16


  

successors, executors, administrators, heirs, legatees or distributees of any of the foregoing) pursuant to any employee, management or director profit interests or equity plan, employee, management or director stock option plan or any other employee, management or director benefit plan or any agreement with any employee, director, officer, consultant or other individual service provider or otherwise in an amount not to exceed the greater of $40 million and 25% of Consolidated EBITDA, in any fiscal year (which, upon an IPO, shall increase to the greater of $75 million and 50% of Consolidated EBITDA); provided that any unused portion for any fiscal year may be carried forward to succeeding fiscal years, (viii) additional dividends, distributions or redemptions, subject only to pro forma compliance with a Total Leverage Ratio of 5.25:1.00 (the “Leverage Based RP Exception”) (after giving pro forma effect to such dividend, distribution or redemption and based on the Consolidated EBITDA of the Borrower and its restricted subsidiaries for the most recently ended four fiscal quarter period for which financial statements are available), (ix) after a qualified IPO, dividends, distributions or redemptions in an amount, on an annual basis, not to exceed the sum of (a) an amount not to exceed $50 million, (b) an amount equal to 7.00% of the net proceeds received by (or contributed to) the Borrower and its restricted subsidiaries from such qualified IPO and any follow on offerings and (c) an amount equal to 8.00% of the market capitalization of Holdings at the time declared and (x) other exceptions and qualifications set forth in the Precedent Documentation, after giving effect to the Documentation Considerations);

 

g)  limitations on prepayments or redemptions of any subordinated indebtedness owed by the Borrower or any Guarantor to any entity that is not Holdings, the Borrower or any restricted subsidiary (in an aggregate principal amount exceeding the cross acceleration threshold) (“Junior Debt”), in each case consummated earlier than the date that is 12 months prior to the stated maturity date of such Junior Debt, or amendments of the documents governing such Junior Debt in a manner (when taken as a whole) materially adverse to the Lenders (which shall permit, among other things (i) refinancing or exchanges of Junior Debt for like or other junior debt or, other than in the case of subordinated indebtedness, any unsecured debt, (ii) conversion of Junior Debt to common or “qualified preferred” equity, (iii) prepayments or redemptions using the Available Amount Basket as set forth in the second succeeding paragraph, (iv) the unused amount of any baskets and/or exceptions permitting dividends or distributions on, or redemptions of, the equity of the Borrower (or any direct or indirect parent company thereof) or restricted investments (which such baskets, for the avoidance of doubt, shall be reduced by the amount of such incurrence on a dollar-for-dollar basis), (v) additional prepayments or redemptions, subject only to pro forma compliance with a Total Leverage Ratio of 5.50:1.00 (the “Leverage Based RDP Exception”) (after giving pro forma effect to such prepayment or redemption) and (vi) a general prepayment or redemption basket in an amount equal to the greater of $40 million and 25% of Consolidated EBITDA of the Borrower and its restricted subsidiaries for the most recently ended four fiscal quarter period for which financial statements are available); and

 

h)  limitations on negative pledge clauses.

 

B-17


  

For the avoidance of doubt, unless expressly specified herein, no negative covenant exception shall be subject to a cap on non-Guarantor indebtedness or investments.

 

The negative covenants will be subject, in the case of each of the foregoing covenants, to exceptions, qualifications and “baskets” to be set forth in the Facilities Documentation that are substantially consistent with the exceptions, qualifications and “baskets” set forth in Precedent Documentation, but adjusted to reflect the Documentation Considerations, which shall, for the avoidance of doubt, permit classification and reclassification from time to time by the Borrower among one or more available baskets and exceptions under any such covenants and contain automatic reclassification to ratio-based incurrence exceptions; provided that (x) monetary baskets in the negative covenants will include in a manner consistent with the Precedent Documentation basket builders based on a percentage of Consolidated EBITDA of the Borrower and its restricted subsidiaries equivalent to the initial monetary amount of each such basket and (y) the amount of any basket usage (including any borrowings under any Revolving Facility or under the Incremental Facilities) or other exception not subject to a ratio test made substantially simultaneously with, or contemporaneously with, any “ratio” test under the Facilities Documentation will be disregarded when determining pro forma compliance with such “ratio.” In addition, certain negative covenants shall include an “Available Amount Basket”, which shall mean a cumulative amount equal to (a) the greater of (1) $75 million and (2) 50% of Consolidated EBITDA for the last four fiscal quarters of the Borrower for which financial statements are available (such greater amount, the “Starter Basket”) plus (b) the greater of (i) 50% of cumulative Consolidated Net Income (to be defined as provided under “Financial Definitions” below) and (ii) cumulative Consolidated EBITDA minus 1.5x cumulative Fixed Charges (as defined in the Precedent Documentation) (this clause (b), the “Builder Basket”), plus (c) the Declined Amounts, plus (d) the portion of net cash proceeds not required to be applied to prepayments pursuant to clause (B) in “Mandatory Prepayments” above as a result of the leverage-based step-downs plus (e) the cash proceeds of new public or private equity issuances of any direct or indirect parent of the Borrower or the Borrower (other than disqualified stock) actually received in the form of qualified equity, plus (f) capital contributions to the Borrower made in cash or cash equivalents (other than disqualified stock) and the fair market value of any in-kind contributions, plus (g) the net cash proceeds received by the Borrower and its restricted subsidiaries from debt and disqualified stock issuances that have been issued after the Closing Date and which have been exchanged or converted into qualified equity, plus (h) returns, profits, distributions and similar amounts received in cash or cash equivalents by the Borrower and its restricted subsidiaries on investments made using the Available Amount Basket (not to exceed the amount of such investments) or otherwise received from an unrestricted subsidiary (including the net proceeds of any sale, or issuance of stock, of an unrestricted subsidiary), plus (i) the investments of the Borrower and the restricted subsidiaries in any unrestricted subsidiary that has been re-designated as a restricted subsidiary or that has been merged or consolidated with or into the Borrower or any of its restricted subsidiaries in an amount equal to the fair market value (as determined in good faith by the Borrower) of the investments of the Borrower and its restricted subsidiaries in such unrestricted subsidiary at the time of such re-designation or merger or consolidation and otherwise defined in a manner consistent with the Precedent Documentation, after giving effect to the Documentation Considerations. The Available Amount Basket may be used for indebtedness, liens, investments, dividends and distributions and the prepayment or redemption of Junior Debt; provided that use of the Builder Basket for dividends and distributions shall be subject to the absence of any continuing payment or bankruptcy event of default.

 

B-18


Permitted Asset Sales:    The Borrower or any restricted subsidiary will be permitted to make non-ordinary course of business asset sales or dispositions without limit so long as (a) such sales or dispositions are for fair market value, (b) for any transaction or series of related transactions, with a purchase price in an amount equal to the greater of $15 million and 10% of Consolidated EBITDA, at least either (x) 75% of the consideration for asset sales and dispositions, calculated over the period since the Closing Date and through the date of such asset sale or disposition, in excess of an amount to be agreed shall consist of cash or cash equivalents or (y) 50% of the consideration for asset sales and dispositions, calculated over the period since the Closing Date and through the date of such asset sale or disposition, in excess of an amount to be agreed shall consist of cash or cash equivalents (in each case, subject to exceptions to be set forth in the Facilities Documentation to be agreed, which shall include a basket in an amount equal to the greater of $65 million and 45% of Consolidated EBITDA for non-cash consideration that may be designated as cash consideration) and (c) to the extent applicable, such asset sale or disposition is subject to the terms set forth in the section entitled “Mandatory Prepayments” hereof.
Permitted Acquisitions:    The Borrower or any restricted subsidiary will be permitted to make acquisitions of the equity interests in a person that becomes a restricted subsidiary, or all or substantially all of the assets (or all or substantially all the assets constituting a business unit, division, product line or line of business) of any person (each, a “Permitted Acquisition”) so long as (a) after giving effect thereto, no payment or bankruptcy event of default has occurred and is continuing, (b) the acquired company or assets are in the same or a generally related or ancillary line of business as the Borrower and its subsidiaries and (c) subject to the limitations set forth in “Guarantees” and “Security” above, the acquired company and its subsidiaries (other than any subsidiaries of the acquired company designated as an unrestricted subsidiary as provided in “Unrestricted Subsidiaries” below) will become Guarantors and pledge their Collateral to the Administrative Agent. Acquisitions of entities that do not become Guarantors will not be limited in any additional manner.
Financial Maintenance Covenant:   

With respect to the Term Loan Facilities: None.

 

With respect to the Revolving Facility: The Facilities Documentation will contain a maximum First Lien Leverage Ratio with regard to the Borrower and its restricted subsidiaries on a consolidated basis (the “Financial Maintenance Covenant”), at a level of 9.50:1.00 (which First Lien Leverage Ratio shall be appropriately adjusted to reflect any additional original issue discount or upfront fees required to be funded in connection with the “Market Flex Provisions” in the Fee Letter and any related increase in leverage as a result thereof to the extent necessary to maintain the same non-cumulative cushion to the Consolidated EBITDA) (and with no step-downs).

 

The foregoing Financial Maintenance Covenant will be tested with respect to the Borrower and its restricted subsidiaries on a consolidated basis, beginning with the third full fiscal quarter period ending after the Closing Date for which financial statements have been or are required to be delivered, quarterly on the last day of each fiscal quarter ending after the Closing Date for which financial statements have been or are required to be delivered, but only if, on the last day of such fiscal quarter, the aggregate

 

B-19


  

outstanding principal amount of Revolving Loans (excluding amounts drawn to fund any original issue discount or upfront fees required to be funded in connection with the “Market Flex Provisions” in the Fee Letter, Acquisition Funds and similar amounts related to other acquisitions, investments and capital expenditures and, for the avoidance of doubt, excluding letters of credit whether or not drawn), exceeds the greater of (x) $40 million and (y) 40% of the total amount of the Revolving Commitments.

 

For purposes of determining compliance with the Financial Maintenance Covenant, the Facilities Documentation shall provide for Cure Rights (as defined in the Precedent Documentation) that are the same as those set forth in the Precedent Credit Agreement (including, without limitation, as set forth in Section 7.02 of the Precedent Documentation). In addition, at the Borrower’s option, the Cure Amount (as defined in the Precedent Documentation) may instead be used to repay outstanding Revolving Loans and such repayment shall be deemed to have occurred prior to the last day of the applicable fiscal quarter for the purposes of measuring whether such Testing Condition was satisfied.

Financial Definitions:    The financial definitions in the Facilities Documentation shall be consistent with the equivalent definitions of such terms in the Precedent Documentation, after giving effect to Documentation Considerations, in each case as modified (a) as reasonably agreed to (i) more accurately reflect the business and financial accounting of the Borrower and its subsidiaries after giving effect to the Transactions and (ii) address technical clarifications adjustments, (b) to exclude any proceeds of the Revolving Facility or any Incremental Revolving Facility used for any permitted acquisition, investment in a joint venture, other similar investment or capital expenditure from the calculations of the First Lien Leverage Ratio, the Secured Leverage Ratio and the Total Leverage Ratio under the Facilities Documentation and (c) to include all adjustments and add-backs of the type included in the Sponsor Model (together with all updates and modifications thereto reasonably agreed with the Required Lead Arrangers) or the QofE Report; provided that there shall be (i) an uncapped addition to Consolidated EBITDA for pro forma “run rate” cost savings, operating expense reductions, revenue enhancements and synergies related to the Transactions that are reasonably quantifiable, factually supportable and projected by the Borrower in good faith to result from actions that have been taken or initiated or are expected to be taken (in the good faith determination of the Borrower) before or after the Closing Date, (ii) an uncapped addition to Consolidated EBITDA for pro forma “run rate” cost savings, operating expense reductions, revenue enhancements and synergies related to acquisitions, dispositions and other specified transactions, restructurings, cost savings initiatives and other initiatives that are reasonably quantifiable, factually supportable and projected by the Borrower in good faith to result from actions that have been taken or initiated or are expected to be taken (in the good faith determination of the Borrower) before or after such acquisition, disposition or other specified transaction, restructuring, cost savings initiative or other initiative, (iii) an addback for the net amount, if any, of the difference between (solely to the extent the amount in the following clause (A) exceeds the amount in the following clause (B)): (A) the deferred revenue of the Borrower and the restricted subsidiaries as of the last day of such period (the “Determination Date”) and (B) the deferred revenue of the Borrower and the restricted subsidiaries as of the date that is 12 months prior to the Determination Date, (iv) an addition to Consolidated EBITDA for the full run rate estimated benefit increase from new or amended contracts or replacement contracts entered into or coming into effect during any period or any

 

B-20


   volume or price increase that takes effect under any existing contract or amended or replacement contract during any period and (v) addbacks and adjustments at least as favorable to the Borrower as those in the Existing Credit Agreement. It being understood and agreed, for the avoidance of doubt, that all references to a First Lien Leverage Ratio, a Secured Leverage Ratio, a Total Leverage Ratio or an Interest Coverage Ratio, shall be deemed to be references to such ratios as set forth herein without regard to the amount of Consolidated EBITDA used to market and/or syndicate the Facilities.
Unrestricted Subsidiaries:    The Facilities Documentation will contain provisions pursuant to which, subject to limitations on loans, advances, guarantees and other investments in, unrestricted subsidiaries, the Borrower will be permitted to designate any existing or subsequently acquired or organized subsidiary (other than the Borrower) as an “unrestricted subsidiary” (with any subsidiary of an unrestricted subsidiary constituting an unrestricted subsidiary) and subsequently re-designate any such unrestricted subsidiary as a restricted subsidiary so long as, after giving effect to any such designation or re-designation, (a) the fair market value of such subsidiary at the time it is designated as an “unrestricted subsidiary” shall be treated as an investment by the Borrower at such time and (b) no payment or bankruptcy event of default under the Facilities Documentation has occurred or is continuing or would exist after giving effect thereto. Unrestricted subsidiaries will not be subject to the representation and warranties, affirmative or negative covenant or event of default provisions of the Facilities Documentation and the results of operations and indebtedness of unrestricted subsidiaries will not be taken into account for purposes of determining compliance with the financial maintenance covenant contained in the Facilities Documentation.
Events of Default:   

The Facilities Documentation will include event of default provisions on terms and conditions substantially consistent with the Precedent Documentation after giving effect to the Documentation Consideration with a cross default and cross acceleration to indebtedness having a principal amount in excess of the greater of $60 million and 40% of Consolidated EBITDA.

 

Notwithstanding the foregoing, (i) only lenders holding at least a majority of the Revolving Commitments and Revolving Loans shall have the ability to (and be required in order to) amend the Financial Maintenance Covenant and waive a breach of the Financial Maintenance Covenant and (ii) a breach of the Financial Maintenance Covenant shall not constitute an event of default with respect to the Term Loan Facilities or trigger a cross-default under the Term Loan Facilities until the date on which the Revolving Commitments have been terminated or the Revolving Loans (if any) have been accelerated by the Revolving Lenders in accordance with the terms of the Revolving Facility.

Voting:   

The Facilities Documentation will include voting provisions on terms and conditions substantially consistent with the Precedent Documentation after giving effect to Documentation Considerations (including with respect to the inclusion of the Revolving Facility).

 

Notwithstanding the foregoing, amendments and waivers of the Financial Maintenance Covenant will be subject to the second paragraph under “Events of Default” above.

 

B-21


Cost and Yield Protection:    The Facilities Documentation will include cost and yield protection provisions on terms and conditions substantially consistent with the Precedent Documentation after giving effect to Documentation Considerations. The Facilities Documentation will include customary provisions with respect to taxes.
Assignments and Participations:    The Facilities Documentation will include assignment and participation provisions (including with respect to affiliates of the Borrower) in accordance with the Documentation Considerations on terms and conditions substantially consistent with the Precedent Documentation after giving effect to Documentation Considerations.
Expenses and Indemnification:    The Facilities Documentation will include expense and indemnification provisions on terms and conditions substantially consistent with the Precedent Documentation after giving effect to Documentation Considerations.
Governing Law and Forum:    New York.
Counsel to the Administrative Agent, Lead Arrangers and Joint Bookrunners:    Paul Hastings LLP.

 

B-22


ANNEX I

 

Interest Rates:   

With respect to the Initial Term Loan Facility, at the option of the Borrower, Term SOFR plus a margin (the “Applicable Margin”) of 3.25% or ABR plus an Applicable Margin of 2.25%.

 

From and after the delivery by the Borrower to the Administrative Agent of the financial statements for the first full fiscal quarter of the Borrower completed after the Closing Date, interest rate spreads with respect to the Term Loan Facility shall be subject to two 25 basis point step-downs at First Lien Leverage Ratios of 5.00:1.00 and 4.50:1.00, respectively (the “First Lien Term Loan Leverage Step-downs”).

 

In addition, on and after the date of any initial public offering of the Borrower, Holdings, or any parent entity thereof (an “IPO”), the applicable margins at each leverage level in respect of the Initial Term Loan Facility shall be 25 basis points lower than the Applicable Margins set forth above (the “First Lien IPO Step-down”).

  

With respect to the Revolving Facility, at the option of the Borrower, Term SOFR plus an Applicable Margin of 3.25% or ABR plus an Applicable Margin of 2.25%.

 

From and after the delivery by the Borrower to the Administrative Agent of the financial statements for the first full fiscal quarter of the Borrower completed after the Closing Date, interest rate spreads with respect to the Revolving Facility shall be subject to two 25 basis point step-downs at First Lien Leverage Ratios of 5.00:1.00 and 4.50:1.00, respectively.

 

In addition, on and after the date of any IPO, the applicable margins at each leverage level in respect of the Revolving Facility shall be 25 basis points lower than the Applicable Margins set forth above.

   The Borrower may elect interest periods of 1, 3 or 6 months (or, if agreed by all relevant Lenders, 12 or fewer months or a period of shorter than 1 month) for Term SOFR borrowings.
   Calculation of interest shall be on the basis of the actual days elapsed in a year of 360 days (or 365 or 366 days, as the case may be, in the case of ABR loans).
   Interest shall be payable in arrears (a) for loans accruing interest at a rate based on Term SOFR, at the end of each interest period and, for interest periods of greater than 3 months, every three months, and on the applicable maturity date and (b) for loans accruing interest based on the ABR, quarterly in arrears and on the applicable maturity date.
  

“ABR” is the Alternate Base Rate, which is the highest of (i) prime commercial lending rate announced by the Administrative Agent as its “prime rate”, (ii) the Federal Funds Effective Rate plus 1/2 of 1.0% and (iii) the one-month Term SOFR plus 1.0% per annum.

 

“Term SOFR” is the secured overnight financing rate for U.S. dollars for the relevant interest period. For the avoidance of doubt, Term SOFR shall not include a credit spread adjustment.

 

B-I-1


   There shall be a minimum Term SOFR (i.e., Term SOFR prior to adding any applicable interest rate margins thereto) requirement of 0.00% per annum in respect of the Initial Term Loan Facility and the Revolving Facility.
Letter of Credit Fees:    A per annum fee equal to the Applicable Margin related to Term SOFR loans under the Revolving Facility will accrue on the aggregate face amount of outstanding letters of credit under the Revolving Facility, payable in arrears at the end of each quarter and upon the termination of the respective letter of credit, in each case for the actual number of days elapsed over a 360-day year. Such fees shall be paid to the Administrative Agent for distribution to the Revolving Lenders pro rata in accordance with the amount of each such Revolving Lender’s Revolving Commitment, with exceptions for defaulting lenders. In addition, the Borrower shall pay to each letter of credit issuer, for its own account, (a) a fronting fee equal to 0.125% per annum of the aggregate face amount of outstanding letters of credit, payable in arrears at the end of each quarter, at maturity and upon the termination of the respective letter of credit, calculated based upon the actual number of days elapsed over a 360-day year, and (b) customary issuance and administration fees.
Commitment Fees:   

The Borrower shall pay a commitment fee of 0.50% per annum on the average daily unused portion of the Revolving Facility, payable quarterly in arrears, calculated based upon the actual number of days elapsed over a 360-day year. Such fees shall be paid to the Administrative Agent for distribution to the applicable Revolving Lenders pro rata in accordance with the amount of each such Revolving Lender’s applicable Revolving Commitment, with exceptions for defaulting lenders.

 

From and after the delivery by the Borrower to the Administrative Agent of the Borrower’s financial statements for the first full fiscal quarter of the Borrower completed after the Closing Date, the commitment fee under the Revolving Facility shall be determined by reference to a leverage-based pricing grid with step-downs to 0.375% and 0.25% per annum at First Lien Leverage Ratios of 5.00:1.00 and 4.50:1.00, respectively.

 

B-I-2


Exhibit C

Project Zodiac

Facilities

Summary of Additional Conditions3

The initial borrowings under the Facilities on the Closing Date are subject solely to the satisfaction or waiver by the Commitment Parties of the applicable conditions set forth in the section entitled Conditions in the body of the Commitment Letter, the section entitled “Conditions to Initial Borrowing” in Exhibit B to the Commitment Letter and the following conditions (subject in all respects to the Limited Conditionality Provisions):

1. Since the date of the Acquisition Agreement, there shall not have occurred any Company Material Adverse Effect.

2. The Acquisition shall have been consummated, or substantially simultaneously with the initial borrowings under the Initial Term Loan Facility, shall be consummated, in all material respects in accordance with the terms of the Acquisition Agreement, after giving effect to any modifications, amendments, consents or waivers by Buyer (or any of its affiliates) thereto, other than those modifications, amendments, consents or waivers by Buyer (or its affiliate) that are materially adverse to the interests of the Lenders or the Commitment Parties in their capacities as such when taken as a whole (it being understood that any modification, amendment, consent or waiver to the definition of Company Material Adverse Effect shall be deemed to be materially adverse to the interests of the Lenders and the Commitment Parties), unless consented to in writing by the Required Lead Arrangers (such consent not to be unreasonably withheld, delayed or conditioned); provided that Required Lead Arrangers shall be deemed to have consented to such amendment, supplement, waiver or modification unless they shall object in writing thereto within three business days of being notified or otherwise becoming aware of such amendment, waiver or modification; provided, further, that that any modification, amendment or express waiver or consents by Buyer (or its affiliate) that results in (a) a reduction in the Acquisition Consideration shall not be deemed to be materially adverse to the Lenders or the Commitment Parties if such reduction is applied (i) first to reduce the Equity Contribution to 35% and (ii) thereafter to reduce the Equity Contribution and the Initial Term Loan Facility on a pro rata basis, (b) an increase in the Acquisition Consideration shall not be deemed to be materially adverse to the Lenders or the Commitment Parties if such increase is not funded with indebtedness for borrowed money or disqualified stock of the Borrower or any of its subsidiaries and (c) a modification, amendment, consent or waiver of the Acquisition Agreement to a provision requiring that the Acquisition not be consummated prior to a particular date or prior to consummation of a period of time, notwithstanding the satisfaction of conditions to the consummation of the Acquisition set forth therein, shall not be deemed to be materially adverse to the Lenders or the Commitment Parties.

3. Confirmation from you that the Equity Contribution shall have been made, or substantially simultaneously with the initial borrowings under the Facilities shall be made, in at least the amount set forth in Exhibit A to the Commitment Letter.

 

3 

All capitalized terms used but not defined herein shall have the meaning given them in the Commitment Letter to which this Exhibit C is attached, including Exhibits A and B thereto. In the case of any such capitalized term that is subject to multiple and differing definitions, the appropriate meaning thereof in this Exhibit C shall be determined by reference to the context in which it is used.


4. The Lead Arrangers shall have received (a) audited consolidated balance sheets of the Target and its consolidated subsidiaries as at the end of, and related consolidated statements of comprehensive loss, stockholders’ equity and cash flows of the Target and its consolidated subsidiaries for, the two most recently completed fiscal years ended at least 90 days prior to the Closing Date and (b) unaudited condensed consolidated balance sheets of the Target and its consolidated subsidiaries as at the end of, and related unaudited consolidated statements of comprehensive loss, stockholders’ equity and cash flows of the Target and its consolidated subsidiaries for, each subsequent fiscal quarter (other than the last fiscal quarter of the fiscal year) of the Target and its consolidated subsidiaries subsequent to the last fiscal year for which financial statements were prepared pursuant to the preceding clause (a) and ended at least 45 days before the Closing Date (in the case of this clause (b), without footnotes). The Lead Arrangers hereby acknowledge receipt of the audited financial statements referred to in clause (a) above for the fiscal years ended January 31, 2023 and January 31, 2024 and the unaudited financial statements referred to in clause (b) above for the fiscal quarters ended April 30, 2024 and July 31, 2024.

5. Subject in all respects to the Limited Conditionality Provisions, all documents and instruments required to create and perfect the Administrative Agent’s security interest in the Collateral shall have been executed (if applicable) and delivered by the Borrower and the Guarantors and, if applicable, be in proper form for filing.

6. The Administrative Agent and the Lead Arrangers shall have received all documentation at least two business days prior to the Closing Date and other information about the Borrower and the Guarantors that shall have been reasonably requested by the Administrative Agent or the Lead Arrangers in writing at least 10 business days prior to the Closing Date and that the Administrative Agent and the Lead Arrangers reasonably determine is required by United States regulatory authorities under applicable “know your customer” and anti-money laundering rules and regulations, including without limitation the PATRIOT Act. To the extent the Borrower qualifies as a “legal entity customer” under the Beneficial Ownership Regulation (as defined below), each Lender that so requests (which request is made through the Administrative Agent) shall have received a Beneficial Ownership Certification in relation to the Borrower; provided that the Administrative Agent has provided the Borrower a list of each such Lender and its electronic delivery requirements at least five Business Days prior to the Closing Date. “Beneficial Ownership Certification” means a certification regarding beneficial ownership required by the Beneficial Ownership Regulation (as defined below), which certification shall be substantially similar in substance to the form of Certification Regarding Beneficial Owners of Legal Entity Customers included as Appendix A to the Beneficial Ownership Regulation. “Beneficial Ownership Regulation” means 31 C.F.R. § 1010.230.

7. The closing of the Facilities shall occur on or before the Expiration Date.

8. With respect to any given Facility, (a) the execution and delivery by the Borrower and the Guarantors (if any) of the Facilities Documentation (including guarantees by the applicable guarantors) which shall, in each case, be in accordance with the terms of the Commitment Letter and the Term Sheet and subject to the Limited Conditionality Provisions and the Documentation Considerations and (b) delivery to the Lead Arrangers of customary legal opinions, customary officer’s closing certificates, organizational documents, customary evidence of authorization and good standing certificates in jurisdictions of formation/organization, in each case with respect to the Borrower and the Guarantors (to the extent applicable) and a solvency certificate, as of the Closing Date and after giving effect to the Transactions substantially in the form of Annex I attached to this Exhibit C, of a senior financial executive or officer of the Borrower.

9. All fees required to be paid on the Closing Date pursuant to the Fee Letter and reasonable out-of-pocket expenses required to be paid on the Closing Date pursuant to the Commitment Letter, to the extent invoiced at least three business days prior to the Closing Date (except as otherwise reasonably agreed by the Borrower), shall, upon the initial borrowings under the Initial Term Loan Facility, have been, or will be substantially simultaneously, paid (which amounts may be offset against the proceeds of the Facilities).

 

C-2


10. Substantially simultaneously with the initial borrowing under the Initial Term Loan Facility and the consummation of the Acquisition, the Existing Target Notes Repurchase/Exchange and Rollover and the Refinancing shall be consummated.

11. The Closing Date shall not occur prior to January 27, 2025.

 

C-3


EXHIBIT C

ANNEX I

Form of Solvency Certificate

[    ], 202[ ]

This Solvency Certificate (this “Certificate”) is delivered pursuant to Section [ ] of the Credit Agreement, dated as of [ ] (as amended as of the date hereof, and as it may be further amended, supplemented or otherwise modified, the “Credit Agreement”), by and among [    ] (the “Borrower”), [    ], the lending institutions from time to time parties thereto and [ ], as the Administrative Agent. Unless otherwise defined herein, capitalized terms used in this Certificate shall have the meanings set forth in the Credit Agreement.

I, [    ], the [    ] of the Borrower, in that capacity only and not in my individual capacity (and without personal liability), DO HEREBY CERTIFY on behalf of the Borrower that as of the date hereof, and based upon facts and circumstances as they exist as of the date hereof (and disclaiming any responsibility for changes in such facts and circumstances after the date hereof), that:

1. For purposes of this certificate, the terms below shall have the following definitions:

(a) “Fair Value”

The amount at which the assets (both tangible and intangible), in their entirety, of the Borrower and its subsidiaries taken as a whole would change hands between a willing buyer and a willing seller, within a commercially reasonable period of time, each having reasonable knowledge of the relevant facts, with neither being under any compulsion to act.

(b) “Present Fair Salable Value”

The amount that could be obtained by an independent willing seller from an independent willing buyer if the assets of the Borrower and its subsidiaries taken as a whole are sold with reasonable promptness in an arm’s-length transaction under present conditions for the sale of comparable business enterprises insofar as such conditions can be reasonably evaluated.

(c) “Liabilities”

The recorded liabilities (including contingent liabilities that would be recorded in accordance with GAAP) of the Borrower and its subsidiaries taken as a whole, as of the date hereof after giving effect to the consummation of the Transactions, determined in accordance with GAAP consistently applied.

(d) “Will be able to pay their Liabilities as they mature”

For the period from the date hereof through the Maturity Date, the Borrower and its subsidiaries on a consolidated basis taken as a whole will have sufficient assets and cash flow to pay their Liabilities as those liabilities mature or (in the case of contingent Liabilities) otherwise become payable, in light of business conducted or anticipated to be conducted by the Borrower and its subsidiaries as reflected in the projected financial statements and in light of the anticipated credit capacity.

 

C-I-1


(e) “Do not have Unreasonably Small Capital”

The Borrower and its subsidiaries on a consolidated basis taken as a whole after consummation of the Transactions is a going concern and has sufficient capital to reasonably ensure that it will continue to be a going concern for the period from the date hereof through the Maturity Date. I understand that “unreasonably small capital” depends upon the nature of the particular business or businesses conducted or to be conducted, and I have reached my conclusion based on the needs and anticipated needs for capital of the business conducted or anticipated to be conducted by the Borrower and its subsidiaries on a consolidated basis as reflected in the projected financial statements and in light of the anticipated credit capacity.

2. Based on and subject to the foregoing, I hereby certify on behalf of the Borrower that after giving effect to the consummation of the Transactions, it is my opinion that (i) the Fair Value of the assets of the Borrower and its subsidiaries on a consolidated basis taken as a whole exceeds their Liabilities, (ii) the Present Fair Salable Value of the assets of the Borrower and its subsidiaries on a consolidated basis taken as a whole exceeds their Liabilities; (iii) the Borrower and its subsidiaries on a consolidated basis taken as a whole do not have Unreasonably Small Capital; and (iv) the Borrower and its subsidiaries taken as a whole will be able to pay their Liabilities as they mature.

3. In reaching the conclusions set forth in this Certificate, the undersigned has made such investigations and inquiries as the undersigned has deemed appropriate, having taken into account the nature of the particular business anticipated to be conducted by the Borrower and the Subsidiaries after consummation of the transactions contemplated by the Credit Agreement.

IN WITNESS WHEREOF, I have executed this Certificate as of the date first written above.

 

By:  

 

  Name:
  Title: [Chief Financial Officer]

 

C-I-2

EXHIBIT 16(b)(iv)

CONFIDENTIAL

Execution Version

LIMITED GUARANTEE

OF

SILVER LAKE ALPINE II, L.P.

LIMITED GUARANTEE, dated as of October 17, 2024 (this “Limited Guarantee”), by Silver Lake Alpine II, L.P. (the “Guarantor”), in favor of Zuora, Inc., a Delaware corporation (the “Guaranteed Party”).

1. Limited Guarantee. To induce the Guaranteed Party to enter into the Agreement and Plan of Merger, dated as of the date hereof (as amended, supplemented or otherwise modified from time to time, the “Merger Agreement”), by and among Zodiac Purchaser, L.L.C., a Delaware limited liability company (“Parent”), Zodiac Acquisition Sub, Inc., a Delaware corporation and wholly-owned subsidiary of Parent (“Merger Sub”) and the Guaranteed Party, the Guarantor hereby absolutely, unconditionally and irrevocably guarantees to the Guaranteed Party, on the terms and conditions set forth herein, the due and punctual observance, performance and discharge of the payment obligations of Parent with respect to (a) either (i) the Parent Termination Fee when and only if such amounts become payable pursuant to Section 9.04(d) of the Merger Agreement or (ii) the Regulatory Termination Fee when and only if such amounts become payable pursuant to Section 9.04(e) of the Merger Agreement (provided that in no event shall the Guarantor’s maximum aggregate liability under this clause (ii) exceed $13,409,000) and (b) any Reimbursement Obligations or Enforcement Costs (which Reimbursement Obligations and Enforcement Costs shall not exceed the Expense Cap), in each case, subject to the limitations set forth in the Merger Agreement, including, without limitation, Section 9.04(h) thereof (clauses (a) and (b), collectively, the “Obligations”); provided, that in no event shall the Guarantor’s maximum aggregate liability under this Limited Guarantee exceed $56,233,000 (the “Cap”). The parties agree that this Limited Guarantee may not be enforced without giving effect to the Cap and that the Guaranteed Party will not seek to enforce this Limited Guarantee for an amount in excess of the Cap. Further, the Guaranteed Party hereby agrees that, to the extent Parent and Merger Sub are relieved of all or any portion of the Obligations by satisfaction thereof, pursuant to any agreement with the Guaranteed Party or otherwise (any such amount so relieved, the “Reduction Amount”), the Cap shall be reduced by an amount equal to the Reduction Amount. The Guaranteed Party may, in its sole discretion, bring and prosecute a separate Proceeding against the Guarantor for the full amount of the Obligations (subject to the Cap), regardless of whether action is brought against Parent or Merger Sub or whether Parent or Merger Sub are joined in any such action, only so long as the Guaranteed Party also exercises its rights, in substantially the same manner and at substantially the same time, against Hux Investment Pte. Ltd. (the “Other Guarantor”) pursuant to the other limited guarantee, dated as of the date hereof, of the Other Guarantor (the “Other Limited Guarantee”), if the Other Guarantor has not satisfied its obligations under, and subject to the terms and conditions of, the Other Limited Guarantee. Notwithstanding anything to the contrary contained in this Limited Guarantee or the Other Limited Guarantee, the obligations of the Guarantor under this Limited Guarantee and of the Other Guarantors under the Other Limited Guarantee shall be several and not joint or joint and several and the Guarantor shall not have any liability in respect of the amounts that may be payable pursuant to the Other Limited Guarantee.


The Guaranteed Party hereby agrees that in no event shall the Guarantor be required to pay any amount to the Guaranteed Party or any other Person under, in respect of, or in connection with this Limited Guarantee or the Merger Agreement other than as expressly set forth herein. Any obligation of the Guarantor with respect to the Obligation shall be funded no later than 14 days following such final and non-appealable determination of the Obligations, in accordance with and subject to the terms and conditions of this Limited Guarantee and the Merger Agreement, by a court of competent jurisdiction. All payments hereunder shall be made in lawful money of the United States, in immediately available funds. Each capitalized term or other term used and not defined herein but defined in the Merger Agreement shall have the meaning ascribed to it in the Merger Agreement, except as otherwise provided. The Guarantor agrees to pay on demand all reasonable and documented out-of-pocket expenses (including reasonable fees and expenses of counsel) incurred by the Guaranteed Party in connection with the enforcement of its rights hereunder if (i) the Guarantor asserts in any Proceeding that this Limited Guarantee is illegal, invalid or unenforceable in accordance with its terms and the Guaranteed Party prevails in such Proceeding as determined by a final, non-appealable judgment, or (ii) the Guarantor fails or refuses to make any payments to the Guaranteed Party hereunder if and when due and payable and it is determined by final, non-appealable judgment that the Guarantor is required to make such payment hereunder; provided that, in each case of clauses (i) and (ii), in no event shall (A) shall the maximum aggregate liability of the Guarantor under this Limited Guarantee for such expenses pursuant to the foregoing clause (i) and clause (ii) exceed 53% of the Expense Cap and (B) the maximum aggregate liability of the Guarantor under this Limited Guarantee, including any amounts payable pursuant to the foregoing clause (i) and clause (ii), exceed the Cap.

2. Nature of Limited Guarantee. The Guaranteed Party shall not be obligated to file any claim relating to the Obligations in the event that Parent becomes subject to a bankruptcy, reorganization or similar proceeding, and the failure of the Guaranteed Party to so file shall not affect the Guarantor’s obligations hereunder. In the event that any payment to the Guaranteed Party in respect of any Obligation is rescinded or must otherwise be returned for any reason whatsoever (other than in connection with the valid termination of the Guarantor’s obligations in accordance with Section 8 hereof or in other circumstances where the Guarantor is not liable to make such payment), the Guarantor shall remain liable hereunder with respect to such Obligation (subject to the terms and conditions hereof) as if such payment had not been made. This Limited Guarantee is an absolute, unconditional and irrevocable guarantee of payment and not of collection. Notwithstanding any other provision of this Limited Guarantee, the Guaranteed Party hereby agrees that the Guarantor may assert, as a defense to any payment or performance by the Guarantor under this Limited Guarantee, any defense to such payment or performance that Parent and Merger Sub may have under the terms of the Merger Agreement, other than defenses arising from bankruptcy or insolvency of Parent and Merger Sub. This Limited Guarantee is a primary and original obligation of the Guarantor and is not merely the creation of a surety relationship.

3. Changes in the Obligations; Certain Waivers. The Guarantor agrees that the Guaranteed Party may at any time and from time to time, without notice to or further consent of the Guarantor, extend the time of payment of the Obligations, and may also enter into any agreement with any of Parent and Merger Sub or any other Person interested in the transactions contemplated by the Merger Agreement for the extension, renewal, payment, compromise, discharge or release thereof, in whole or in part, or for any modification of the terms of the Merger Agreement or of any agreement between the Guaranteed Party and any of Parent and Merger Sub

 

2


or any such other Person without in any way impairing or affecting the Guarantor’s obligations under this Limited Guarantee, only so long as the Guaranteed Party also takes similar action, in substantially the same manner and at substantially the same time, with respect to the Other Limited Guarantee and, if the Guaranteed Party takes any action reference in this sentence with respect to the Other Limited Guarantee, it shall also take similar action, in substantially the same manner and at substantially the same time, with respect to this Limited Guarantee. The Guarantor agrees that the obligations of the Guarantor hereunder are absolute, unconditional and irrevocable and continuing, and shall not be released or discharged, in whole or in part, or otherwise affected by: (i) any amendment, extension, waiver, rescission or other modification of, or failure of the Guaranteed Party to enforce any right or remedy under, any of the Merger Agreement or the Obligations (with or without notice to the Guarantor) or the Equity Commitment Letter to which the Guarantor is a party (the “Guarantor Equity Commitment Letter”); (ii) the existence of any claim, set-off or other right that the Guarantor may have at any time against Parent, Merger Sub or the Guaranteed Party, whether in connection with the Obligations or otherwise; (iii) any change in the legal existence, structure or ownership of Parent, Merger Sub or the Guarantor or any other Person or any insolvency, bankruptcy, liquidation, reorganization (or similar event) of or relating to the Guarantor, Parent, Merger Sub, the Guaranteed Party or any other person; (iv) any default by Parent or Merger Sub under the Merger Agreement; (v) any incapacity, lack of authority or limitation of status or power of Parent or Merger Sub, or any defect in the formation of Parent or Merger Sub; (vii) any change in Law of any jurisdiction; (viii) the adequacy of any other means the Guaranteed Party may have of obtaining payment of the Obligations; (ix) the addition, substitution or release of any Person to or from this Limited Guarantee, the Merger Agreement, the Guarantor Equity Commitment Letter or any related agreement or document or any Person interested in the transactions contemplated by the Merger Agreement, provided that Guarantor shall be automatically released from the Obligations to the extent (A) Parent and Merger Sub are validly released from such Obligations under the Merger Agreement or (B) Guarantor is validly released from such Obligations under this Limited Guarantee; (x) the failure or delay on the part of the Guaranteed Party to assert any claim or demand or to enforce any right or remedy against Parent, Merger Sub, the Guarantor or any other Person interested in the transactions contemplated by the Merger Agreement; or (xi) any discharge of the Guarantor as a matter of Applicable Law (other than a discharge of the Guarantor as a result of payment of the Obligations in accordance with the terms of the Merger Agreement or as a result of defenses to the payment of the Obligations that would be available to Parent or Merger Sub under the Merger Agreement). To the fullest extent permitted by Applicable Law, the Guarantor hereby expressly waives (A) any and all rights or defenses arising by reason of any Applicable Law or otherwise which would otherwise require any election of remedies by the Guaranteed Party, (B) promptness, diligence, notice of the acceptance of this Limited Guarantee and of the Obligations, presentment, demand for payment, notice of non-performance, default, dishonor and protest, notice of the Obligations incurred and all other notices of any kind (except for notices to be provided to Parent or Merger Sub and their counsel in accordance with the Merger Agreement and/or any agreements entered into in connection therewith), all defenses that may be available by virtue of any valuation, stay, moratorium Applicable Law or other similar Applicable Law now or hereafter in effect, any right to require the marshalling of assets of any of Parent or Merger Sub or any other Person interested in the transactions contemplated by the Merger Agreement, and all suretyship defenses generally (other than fraud, bad faith or willful misconduct) and (C) any and all notice of the creation, renewal, extension or accrual of the Obligations and notice of or proof of reliance by the Guaranteed Party upon this Limited Guarantee or acceptance of this Limited Guarantee. The Guarantor hereby acknowledges that it will receive substantial direct and indirect benefits from the transactions contemplated by the Merger Agreement and that the waivers set forth in this Limited Guarantee are knowingly made in contemplation of such benefits.

 

3


The Guaranteed Party hereby covenants and agrees that it shall not institute, and shall cause its Subsidiaries and Affiliates not to, institute, any Proceeding arising under, or in connection with, the Guarantor Equity Commitment Letter or the Merger Agreement or the transactions contemplated hereby or thereby (whether at law or in equity, whether sounding in contract, tort, statute or otherwise), against the Guarantor or any other Parent Related Party (as defined below), except for claims that are Non-Prohibited Claims (as defined in the Guarantor Equity Commitment Letter) against such Person.

Subject to the first sentence of Section 1 hereof, the Guarantor hereby unconditionally and irrevocably agrees not to exercise any rights that it may now have or hereafter acquire against any Parent Related Party or any other Person interested in the transactions contemplated by the Merger Agreement that arise from the existence, payment, performance, or enforcement of the Guarantor’s Obligations under or in respect of this Limited Guarantee or any other agreement in connection therewith, including, without limitation, any right of subrogation, reimbursement, exoneration, contribution or indemnification and any right to participate in any claim or remedy of the Guaranteed Party or any of its Affiliates against any Parent Related Party or such other Person whether or not such claim, remedy or right arises in equity or under contract, statute or common law, including, without limitation, the right to take or receive from any Parent Related Party or such other Person, directly or indirectly, in cash or other property or by set-off or in any other manner, payment or security on account of such claim, remedy or right, unless and until the Obligations (subject to the Cap and the other limitations set forth herein) shall have been paid in full in cash. If any amount shall be paid to the Guarantor in violation of the immediately preceding sentence at any time prior to the payment in full in cash of the Obligations (subject to the Cap and the other limitations set forth herein), such amount shall be received and held in trust for the benefit of the Guaranteed Party, shall be segregated from other property and funds of the Guarantor and shall forthwith be paid or delivered to the Guaranteed Party in the same form as so received (with any necessary endorsement or assignment) to be credited and applied to the Obligations (subject to the Cap and the other limitations set forth herein), in accordance with the terms of the Merger Agreement and herewith, whether matured or unmatured, or to be held as collateral for the Obligations.

The Guarantor acknowledges and agrees that (i) the provisions of this Limited Guarantee are an integral and essential part of the transactions contemplated by the Merger Agreement and neither Parent or Merger Sub nor the Guaranteed Party would have entered into the Merger Agreement without the benefit of this Limited Guarantee and (ii) it will receive substantial direct and indirect benefits from the transactions contemplated by the Merger Agreement and that the waivers set forth in this Limited Guarantee are knowingly made in contemplation of such benefits. Nothing in this Limited Guarantee shall limit in any way the right of the Guaranteed Party to seek an injunction or injunctions or any other equitable relief under, and subject to the limitations in, Section 9.09 (Specific Performance) of the Merger Agreement.

 

4


4. No Waiver; Cumulative Rights. No failure on the part of the Guaranteed Party to exercise, and no delay in exercising, any right, remedy or power hereunder shall operate as a waiver thereof, nor shall any single or partial exercise by the Guaranteed Party of any right, remedy or power hereunder preclude any other or future exercise of any right, remedy or power hereunder. Subject to and without limiting Section 9.04(h) (Fees and Expenses) of the Merger Agreement, each and every right, remedy and power hereby granted to the Guaranteed Party or allowed it by Applicable Law or other agreement shall be cumulative and not exclusive of any other, and may be exercised by the Guaranteed Party at any time or from time to time.

When pursuing its rights and remedies hereunder against the Guarantor, the Guaranteed Party shall, subject to Section 1 hereof, be under no obligation to pursue such rights and remedies it may have against Parent or Merger Sub, their respective affiliates, or any other Person for the Guaranteed Obligations prior to pursuing such rights and remedies against the Guarantor hereunder, and any failure by the Guaranteed Party to pursue such other rights or remedies or to collect any payments from Parent or Merger Sub or any such other Person shall not relieve the Guarantor of any liability hereunder.

5. Representations and Warranties. The Guarantor hereby represents and warrants to the Guaranteed Party that:

(a) the Guarantor is duly organized, validly existing and in good standing under the laws of its jurisdiction of organization;

(b) the Guarantor has all necessary and required organizational power, approval, and authority to execute and deliver this Limited Guarantee and to perform its obligations hereunder;

(c) the execution, delivery and performance of this Limited Guarantee by the Guarantor has been duly and validly authorized by all necessary organizational action, and no other organizational proceedings on the part of the Guarantor are necessary to authorize this Limited Guarantee;

(d) all consents, approvals, authorizations, permits of, filings with and notifications to, any Governmental Authority by the Guarantor necessary for the due execution, delivery and performance of this Limited Guarantee by the Guarantor have been obtained or made and all conditions thereof have been duly complied with, and no other action by, and no notice to or filing with, any Governmental Authority by the Guarantor is required in connection with the execution, delivery or performance of this Limited Guarantee;

(e) this Limited Guarantee has been duly and validly executed and delivered by the Guarantor and, assuming due execution and delivery by the Guaranteed Party, constitutes a legal, valid and binding obligation of the Guarantor enforceable against the Guarantor in accordance with its terms, subject to applicable bankruptcy, insolvency (including all Laws relating to fraudulent transfers), reorganization, moratorium or similar Laws affecting creditors’ rights generally and subject to the effect of general principles of equity (regardless of whether considered in a proceeding at Law or in equity;

 

5


(f) the execution and delivery of this Limited Guarantee by the Guarantor does not, and the performance of this Limited Guarantee by the Guarantor will not, (i) conflict with or violate the organizational documents of the Guarantor, (ii) conflict with or violate any Law applicable to the Guarantor or by which any of its properties or assets is bound or affected, or (iii) result in any breach or violation of, or constitute a default (or an event which, with notice or lapse of time or both, would become a default) under, or give to others any right of termination, amendment, acceleration or cancellation of, any Contract or other instrument or obligation to which the Guarantor is a party or by which the Guarantor or any of its properties or assets is bound or affected, except, with respect to each of the foregoing clauses (ii) and (iii), for any such conflicts, violations, breaches, defaults or other occurrences which would not prevent or materially delay the Guarantor from performing its obligations under this Limited Guarantee; and

(g) the Guarantor has, and will continue to have for so long as this Limited Guarantee is in effect, the financial capacity to pay and perform its obligations under this Limited Guarantee, and all funds necessary for the Guarantor to fulfill the Obligations under this Limited Guarantee shall be available to the Guarantor for so long as this Limited Guarantee shall remain in effect in accordance with the terms hereof.

6. Assignment. The rights and obligations under this Limited Guarantee may not be assigned or delegated (whether by operation of law, merger, consolidation or otherwise) by any party hereto without the prior written consent of the other party. Notwithstanding the foregoing, the Guarantor may assign all or a portion of its rights, interests or the Obligations hereunder to one or more of its Affiliates; provided that no such assignment shall relieve the Guarantor of its obligations hereunder. Any assignment or delegation in breach of Section 5 (in respect of the representations and warranties deemed to be made as of the time of such assignment, delegation or transfer) or in violation of this Section 6 shall be null and void and of no force and effect.

7. Notices. All notices, requests, claims, demands and other communications under this Limited Guarantee shall be in writing and shall be given or made (and shall be deemed to have been duly given or made upon receipt) by delivery in person, by an internationally recognized overnight courier service (with proof of delivery), or by email (provided no “bounce back” or similar message indicating non-delivery is received with respect thereto) to the respective parties hereto at the following coordinates (or at such other coordinates for a party as shall be specified in a notice given in accordance with this Section 7):

 

(a)    If to the Guarantor to:
   Silver Lake Alpine II, L.P.
   c/o Silver Lake
   2775 Sand Hill Road
   Suite 100
   Menlo Park, CA 94025
   Attention:    ****
   Email:    ****

 

6


   with a copy to:
   Silver Lake
   55 Hudson Yards
   40th Floor
   New York, NY 10001
   Attention:    ****
   Email:    ****
   with a copy (which shall not constitute notice) to:
   Simpson Thacher & Bartlett LLP
   425 Lexington Avenue
   New York, NY 10017
   Attention:    Elizabeth Cooper
      Louis Argentieri
   Email:    ecooper@stblaw.com
      louis.argentieri@stblaw.com
(b)    If to the Guaranteed Party to:
   Zuora, Inc.
   101 Redwood Shores Parkway
   Redwood City, CA 94065
   Attention:    ****
   Email:    ****
   with a copy (which shall not constitute notice) to:
   Goodwin Procter LLP
   620 Eighth Avenue
   New York, New York 10018
   Attention:    Joshua M. Zachariah
      Michael R. Patrone
      James Ding
   E-Mail:    jzachariah@goodwinlaw.com
      mpatrone@goodwinlaw.com
      jding@goodwinlaw.com
   and with a copy (which shall not constitute notice) to:
   Freshfields Bruckhaus Deringer US LLP
   3 World Trade Center
   175 Greenwich Street
   New York, NY 10007
   Attention:    Ethan A. Klingsberg
      Sarah K. Solum
      Steven Y. Li
   Email:    ethan.klingsberg@freshfields.com
      sarah.solum@freshfields.com
      steven.li@freshfields.com

 

7


8. Continuing Guarantee. Unless terminated pursuant to this Section 8, this Limited Guarantee shall remain in full force and effect and shall be binding on the Guarantor, its successors and assigns until the Obligations (subject to the Cap) under this Limited Guarantee have been indefeasibly paid, observed, performed or satisfied in full, at which time this Limited Guarantee shall terminate and the Guarantor shall have no further obligations under this Limited Guarantee. Notwithstanding the foregoing, this Limited Guarantee shall terminate and the Guarantor shall have no further obligations under this Limited Guarantee automatically and immediately upon the earliest to occur of (i) the consummation of the Closing and the payment by Parent of all amounts required to be paid by it at the Closing under the Merger Agreement, (ii) payment in full of the Obligations (subject to the Cap), (iii) the valid termination of the Merger Agreement in accordance with its terms (A) by mutual consent of Parent and the Guaranteed Party or (B) under circumstances in which Parent would not be obligated to make any payment under the Merger Agreement, (iv) the valid termination of the Other Limited Guarantee other than following the satisfaction of all Obligations under the Other Limited Guarantee, (v) sixty (60) days following the valid termination of the Merger Agreement in accordance with its terms under circumstances in which Parent would be obligated to make any payment under the Merger Agreement, unless (x) by such date the Guaranteed Party shall have made a claim in writing with respect to such Obligation during such sixty (60)-day period and (y) the Guaranteed Party shall have commenced a Proceeding during such sixty (60)-day period against the Guarantor or Parent alleging that Parent is liable for such Obligation, in which case, this Limited Guarantee shall terminate no later than the earlier of the final adjudication of such claim after which no further appeal may be taken or the written agreement of the parties to such Proceeding in settlement of such claim and terminating such Proceeding) and (vi) the termination of this Limited Guarantee by mutual written agreement of the Guarantor and the Guaranteed Party. Notwithstanding anything to the contrary, (I) in the event that the Guarantor becomes obligated to pay the amount described in clause (a)(i) of the first sentence of Section 1 of this Limited Guarantee and the Guarantor pays all such amount, then the Guarantor shall have no obligation to pay any amount pursuant to clause (a)(ii) of the first sentence of Section 1 of this Limited Guarantee; and (II) in the event that the Guarantor becomes obligated to pay the amount described in clause (a)(ii) of the first sentence of Section 1 of this Limited Guarantee and the Guarantor pays all such amount, then the Guarantor shall have no obligation to pay any amount pursuant to (a)(i) of the first sentence of Section 1 of this Limited Guarantee. Notwithstanding the foregoing or anything in this Limited Guarantee that may be deemed to the contrary, in the event that the Guaranteed Party or any of its Affiliates assert in any Proceeding (a) that the provisions of Section 1 hereof limiting the Guarantor’s liability to the Cap or the provisions of this Section 8 or Section 9 hereof are illegal, invalid or unenforceable in whole or in part, or (b) any theory of liability against the Guarantor or any Parent Related Party with respect to this Limited Guarantee, the Other Limited Guarantee (including, for the avoidance of doubt, that the Guarantor is liable for any amount owed pursuant to the Other Limited Guarantee), the Guarantor Equity Commitment Letter, the Other Equity Commitment Letter (as defined in the Guarantor Equity Commitment Letter), the Merger Agreement or any of the transactions contemplated hereby or thereby (including in respect of any oral representations made or alleged to be made in connection therewith) (other than, solely with respect to this clause (b), any claim that is a Non-

 

8


Prohibited Claim), then (A) the obligations of the Guarantor under this Limited Guarantee shall terminate ab initio and be null and void and of no force or effect and (B) if the Guarantor has previously made any payments under this Limited Guarantee, it shall be entitled to recover such payments in full, and (C) neither the Guarantor nor any Parent Related Party shall have any liability to the Guaranteed Party or its Affiliates with respect to the transactions contemplated by the Merger Agreement under this Limited Guarantee or otherwise.

9. No Recourse. The Guaranteed Party acknowledges the separate corporate or entity existence of Parent and Merger Sub and that, as of the date hereof, each of Parent and Merger Sub’s sole assets (if any) are a de minimis amount of cash, and that no additional funds are expected to be contributed to Parent or Merger Sub unless and until the Closing occurs. Notwithstanding anything that may be expressed or implied in this Limited Guarantee or any document or instrument delivered in connection herewith (including, without limitation, the Guarantor Equity Commitment Letter and the Merger Agreement), (i) in no event shall the Guaranteed Party or any of its Affiliates or any of their respective former, current and future directors, officers, employees, direct or indirect holder of any equity, stockholders, controlling persons, Affiliates, attorneys, members, managers, general or limited partners, assignees, agents and representatives seek any damages or any other recovery, judgment, or remedies of any kind, including consequential, indirect or punitive damages, against Parent and Merger Sub in excess of the Cap in connection with the Merger Agreement, the failure of the Merger to be consummated for any reason or otherwise in connection with the transactions contemplated hereby and thereby or in respect of any representations made or alleged to have been made in connection therewith, whether in equity or at law, in contract, in tort or otherwise, and (ii) notwithstanding the fact that the Guarantor is a limited partnership or other type of entity, by its acceptance of the benefits of this Limited Guarantee, the Guaranteed Party acknowledges and agrees that no Person has any right of recovery against, no recourse shall be had against and no personal liability shall attach to, the Guarantor, Parent and Merger Sub, or any of their or their respective Affiliates’ respective former, current or future directors, officers, employees, direct or indirect holder of any equity, stockholders, controlling persons, Affiliates, attorneys, members, managers, general or limited partners, assignees, agents, representatives or representatives of any of the foregoing (but not including Parent, Merger Sub, the Guarantor or the Other Guarantor, a “Parent Related Party” and together, the “Parent Related Parties”), including through Parent or Merger Sub or otherwise, whether by or through attempted piercing of the corporate (or limited liability company or limited partnership) veil, by or through a claim (whether at law or equity or in tort, contract or otherwise) by or on behalf of Parent and Merger Sub against any Parent Related Parties, by the enforcement of any assessment or by any legal or equitable proceeding, by virtue of any Applicable Law, or otherwise, except for its rights to recover from the Guarantor (but not any other Person) under and to the extent provided in this Limited Guarantee and its rights to recover from the Other Guarantor under and to the extent provided in the Other Limited Guarantee, and subject to the other limitations described herein, including, for the avoidance of doubt, the Cap, and any other claims that are Non-Prohibited Claims solely against such Person; it being agreed and acknowledged that no personal liability whatsoever shall attach to, be imposed on or otherwise be incurred by any Parent Related Party for any obligation of the Guarantor or any of its successors or permitted assigns under this Limited Guarantee or any documents or instruments delivered in connection herewith or in respect of any oral or written representations made or alleged to have been made in connection herewith or for any claim (whether at law or in equity or in tort, contract or otherwise)

 

9


based on, in respect of, or by reason of such obligation or their creation. Except for any claims that are Non-Prohibited Claims against such Person, recourse against the Guarantor under this Limited Guarantee, subject to the limitations and conditions set forth herein, shall be the sole and exclusive remedy of the Guaranteed Party and all of its Affiliates against the Guarantor and any Parent Related Party in respect of any liabilities or obligations arising under, or in connection with, this Limited Guarantee and the Merger Agreement, the failure of the Merger or the other transactions contemplated by the Merger Agreement to be consummated for any reason or otherwise in connection with the transactions contemplated hereby and thereby or in respect of any representations made or alleged to have been made in connection therewith, whether in equity or at Law, in Contract, in tort or otherwise. Notwithstanding anything to the contrary contained herein, nothing herein shall limit the rights of the Guaranteed Party in respect of the Non-Prohibited Claims. Nothing set forth in this Limited Guarantee shall affect or be construed to affect any liability of Parent and Merger Sub to the Guaranteed Party or shall confer or give or shall be construed to confer or give to any Person other than the Guaranteed Party (including any Person acting in a representative capacity) any rights or remedies against any Person other than the Guarantor as expressly set forth herein.

10. Governing Law; Jurisdiction; Waiver of Jury Trial.

(a) This Limited Guarantee and all disputes or controversies arising out of or relating to this Limited Guarantee or the transactions contemplated hereby, including the applicable statute of limitations, shall be governed by and construed in accordance with the laws of the State of Delaware, without regard to the conflicts of law rules that would cause the application of law of any jurisdiction other than those of the State of Delaware.

(b) The parties hereto agree that any Proceeding seeking to enforce any provision of, or based on any matter arising out of or in connection with, this Limited Guarantee or the transactions contemplated by this Limited Guarantee shall be brought and determined exclusively in the Delaware Court of Chancery or, if that court does not have subject matter jurisdiction, the state or federal courts in the State of Delaware (the “Delaware Courts”). Each party hereto hereby irrevocably submits to the exclusive jurisdiction of the Delaware Courts in respect of any legal or equitable Proceeding arising out of or relating to this Limited Guarantee or the transactions contemplated by this Limited Guarantee, or relating to enforcement of any of the terms of this Limited Guarantee, and hereby waives, and agrees not to assert, as a defense in any such Proceeding, any claim that it is not subject personally to the jurisdiction of such court, that the Proceeding is brought in an inconvenient forum, that the venue of the Proceeding is improper or that this Limited Guarantee or the transactions contemplated by this Limited Guarantee may not be enforced in or by such courts. Each party hereto agrees that notice or the service of process in any Proceeding arising out of or relating to this Limited Guarantee or the transactions contemplated by this Limited Guarantee shall be properly served or delivered if delivered in the manner contemplated by Section 9.01 (Notices) of the Merger Agreement or in any other manner permitted by law.

 

10


(c) WAIVER OF JURY TRIAL. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATED TO THIS LIMITED GUARANTEE OR THE TRANSACTIONS CONTEMPLATED BY THIS LIMITED GUARANTEE. EACH OF THE PARTIES HERETO HEREBY (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF THE OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT HAS BEEN INDUCED TO ENTER INTO THIS LIMITED GUARANTEE AND THE TRANSACTIONS CONTEMPLATED BY THIS LIMITED GUARANTEE, AS APPLICABLE, BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 10(c).

11. Entire Agreement; Amendments. This Limited Guarantee, the Guarantor Equity Commitment Letter and the Merger Agreement constitute the entire agreement among the parties with respect to the subject matter hereof and thereof and supersedes all prior and contemporaneous agreements, undertakings, discussions, negotiations and undertakings, both written and oral, among the parties hereto, or any of them, with respect to the subject matter hereof and thereof. This Limited Guarantee may not be amended, and no provision hereof waived or modified, except by an instrument duly executed by each of the parties hereto.

12. Headings. The descriptive headings herein are inserted for convenience of reference only and are not intended to be part of or to affect the meaning or interpretation of this Limited Guarantee.

13. Counterparts. This Limited Guarantee may be executed in any number of counterparts (including by means of telecopied signature pages or electronic transmission, such as by electronic mail in “pdf” form or any electronic signature complying with the U.S. Federal ESIGN Act of 2000, e.g., www.docusign.com), with the same effect as if the signatures to each counterpart were upon a single instrument, and all such counterparts together shall be deemed an original of this Limited Guarantee. The parties irrevocably and unreservedly agree that this Limited Guarantee may be executed by way of electronic signatures and the parties agree that this Limited Guarantee, or any part hereof, shall not be challenged or denied any legal effect, validity and/or enforceability solely on the ground that it is in the form of an electronic record.

[Remainder of this page intentionally left blank.]

 

11


IN WITNESS WHEREOF, the Guarantor has caused this Limited Guarantee to be executed and delivered as of the date first written above by its officer thereunto duly authorized.

 

GUARANTOR:
SILVER LAKE ALPINE II, L.P.
By:   Silver Lake Alpine Associates II, L.P., its general partner
By:   SLAA II (GP), L.L.C., its general partner
By:   Silver Lake Group, L.L.C., its managing member
By:  

/s/ Joseph Osnoss

Name:   Joseph Osnoss
Title:   Managing Director


IN WITNESS WHEREOF, the Guaranteed Party has caused this Limited Guarantee to be executed and delivered as of the date first written above by its officer thereunto duly authorized.

 

GUARANTEED PARTY:
ZUORA, INC.
By:  

/s/ Tien Tzuo

  Name: Tien Tzuo
  Title: Chief Executive Officer

EXHIBIT 16(b)(v)

CONFIDENTIAL

Execution Version

LIMITED GUARANTEE

OF

HUX INVESTMENT PTE. LTD.

LIMITED GUARANTEE, dated as of October 17, 2024 (this “Limited Guarantee”), by Hux Investment Pte. Ltd. (the “Guarantor”), in favor of Zuora, Inc., a Delaware corporation (the “Guaranteed Party”).

1. Limited Guarantee. To induce the Guaranteed Party to enter into the Agreement and Plan of Merger, dated as of the date hereof (as amended, supplemented or otherwise modified from time to time, the “Merger Agreement”), by and among Zodiac Purchaser, L.L.C., a Delaware limited liability company (“Parent”), Zodiac Acquisition Sub, Inc., a Delaware corporation and wholly-owned subsidiary of Parent (“Merger Sub”) and the Guaranteed Party, the Guarantor hereby absolutely, unconditionally and irrevocably guarantees to the Guaranteed Party, on the terms and conditions set forth herein, the due and punctual observance, performance and discharge of the payment obligations of Parent with respect to (a) either (i) the Parent Termination Fee when and only if such amounts become payable pursuant to Section 9.04(d) of the Merger Agreement or (ii) the Regulatory Termination Fee when and only if such amounts become payable pursuant to Section 9.04(e) of the Merger Agreement (provided that in no event shall the Guarantor’s maximum aggregate liability under this clause (ii) exceed $11,891,000) and (b) any Reimbursement Obligations or Enforcement Costs (which Reimbursement Obligations and Enforcement Costs shall not exceed the Expense Cap), in each case, subject to the limitations set forth in the Merger Agreement, including, without limitation, Section 9.04(h) thereof (clauses (a) and (b), collectively, the “Obligations”); provided, that in no event shall the Guarantor’s maximum aggregate liability under this Limited Guarantee exceed $49,867,000 (as such amount may be reduced pursuant to Section 6 of this Limited Guarantee in connection with an Equity Assignment on the terms and subject to the conditions of Section 6.17(a) of the Merger Agreement (including Section 6.17(a) of the Parent Disclosure Schedule), the “Cap”). The parties agree that this Limited Guarantee may not be enforced without giving effect to the Cap and that the Guaranteed Party will not seek to enforce this Limited Guarantee for an amount in excess of the Cap. Further, the Guaranteed Party hereby agrees that, to the extent Parent and Merger Sub are relieved of all or any portion of the Obligations by satisfaction thereof, pursuant to any agreement with the Guaranteed Party or otherwise (any such amount so relieved, the “Reduction Amount”), the Cap shall be reduced by an amount equal to the Reduction Amount. The Guaranteed Party may, in its sole discretion, bring and prosecute a separate Proceeding against the Guarantor for the full amount of the Obligations (subject to the Cap), regardless of whether action is brought against Parent or Merger Sub or whether Parent or Merger Sub are joined in any such action, only so long as the Guaranteed Party also exercises its rights, in substantially the same manner and at substantially the same time, against Silver Lake Alpine II, L.P. (the “Other Guarantor”) pursuant to the other limited guarantee, dated as of the date hereof, of the Other Guarantor (the “Other Limited Guarantee”), if the Other Guarantor has not satisfied its obligations under, and subject to the terms and conditions of, the Other Limited Guarantee. Notwithstanding anything to the contrary contained in this Limited Guarantee or the Other Limited Guarantee, the obligations of the Guarantor under this Limited Guarantee and of the Other Guarantors under the Other Limited


Guarantee shall be several and not joint or joint and several and the Guarantor shall not have any liability in respect of the amounts that may be payable pursuant to the Other Limited Guarantee. The Guaranteed Party hereby agrees that in no event shall the Guarantor be required to pay any amount to the Guaranteed Party or any other Person under, in respect of, or in connection with this Limited Guarantee or the Merger Agreement other than as expressly set forth herein. Any obligation of the Guarantor with respect to the Obligation shall be funded no later than 14 days following such final and non-appealable determination of the Obligations, in accordance with and subject to the terms and conditions of this Limited Guarantee and the Merger Agreement, by a court of competent jurisdiction. All payments hereunder shall be made in lawful money of the United States, in immediately available funds. Each capitalized term or other term used and not defined herein but defined in the Merger Agreement shall have the meaning ascribed to it in the Merger Agreement, except as otherwise provided. The Guarantor agrees to pay on demand all reasonable and documented out-of-pocket expenses (including reasonable fees and expenses of counsel) incurred by the Guaranteed Party in connection with the enforcement of its rights hereunder if (i) the Guarantor asserts in any Proceeding that this Limited Guarantee is illegal, invalid or unenforceable in accordance with its terms and the Guaranteed Party prevails in such Proceeding as determined by a final, non-appealable judgment, or (ii) the Guarantor fails or refuses to make any payments to the Guaranteed Party hereunder if and when due and payable and it is determined by final, non-appealable judgment that the Guarantor is required to make such payment hereunder; provided that, in each case of clauses (i) and (ii), in no event shall (A) shall the maximum aggregate liability of the Guarantor under this Limited Guarantee for such expenses pursuant to the foregoing clause (i) and clause (ii) exceed 47% of the Expense Cap and (B) the maximum aggregate liability of the Guarantor under this Limited Guarantee, including any amounts payable pursuant to the foregoing clause (i) and clause (ii), exceed the Cap.

2. Nature of Limited Guarantee. The Guaranteed Party shall not be obligated to file any claim relating to the Obligations in the event that Parent becomes subject to a bankruptcy, reorganization or similar proceeding, and the failure of the Guaranteed Party to so file shall not affect the Guarantor’s obligations hereunder. In the event that any payment to the Guaranteed Party in respect of any Obligation is rescinded or must otherwise be returned for any reason whatsoever (other than in connection with the valid termination of the Guarantor’s obligations in accordance with Section 8 hereof or in other circumstances where the Guarantor is not liable to make such payment), the Guarantor shall remain liable hereunder with respect to such Obligation (subject to the terms and conditions hereof) as if such payment had not been made. This Limited Guarantee is an absolute, unconditional and irrevocable guarantee of payment and not of collection. Notwithstanding any other provision of this Limited Guarantee, the Guaranteed Party hereby agrees that the Guarantor may assert, as a defense to any payment or performance by the Guarantor under this Limited Guarantee, any defense to such payment or performance that Parent and Merger Sub may have under the terms of the Merger Agreement, other than defenses arising from bankruptcy or insolvency of Parent and Merger Sub. This Limited Guarantee is a primary and original obligation of the Guarantor and is not merely the creation of a surety relationship.

3. Changes in the Obligations; Certain Waivers. The Guarantor agrees that the Guaranteed Party may at any time and from time to time, without notice to or further consent of the Guarantor, extend the time of payment of the Obligations, and may also enter into any agreement with any of Parent and Merger Sub or any other Person interested in the transactions contemplated by the Merger Agreement for the extension, renewal, payment, compromise,

 

2


discharge or release thereof, in whole or in part, or for any modification of the terms of the Merger Agreement or of any agreement between the Guaranteed Party and any of Parent and Merger Sub or any such other Person without in any way impairing or affecting the Guarantor’s obligations under this Limited Guarantee, only so long as the Guaranteed Party also takes similar action, in substantially the same manner and at substantially the same time, with respect to the Other Limited Guarantee and, if the Guaranteed Party takes any action reference in this sentence with respect to the Other Limited Guarantee, it shall also take similar action, in substantially the same manner and at substantially the same time, with respect to this Limited Guarantee. The Guarantor agrees that the obligations of the Guarantor hereunder are absolute, unconditional and irrevocable and continuing, and shall not be released or discharged, in whole or in part, or otherwise affected by: (i) any amendment, extension, waiver, rescission or other modification of, or failure of the Guaranteed Party to enforce any right or remedy under, any of the Merger Agreement or the Obligations (with or without notice to the Guarantor) or the Equity Commitment Letter to which the Guarantor is a party (the “Guarantor Equity Commitment Letter”); (ii) the existence of any claim, set-off or other right that the Guarantor may have at any time against Parent, Merger Sub or the Guaranteed Party, whether in connection with the Obligations or otherwise; (iii) any change in the legal existence, structure or ownership of Parent, Merger Sub or the Guarantor or any other Person or any insolvency, bankruptcy, liquidation, reorganization (or similar event) of or relating to the Guarantor, Parent, Merger Sub, the Guaranteed Party or any other person; (iv) any default by Parent or Merger Sub under the Merger Agreement; (v) any incapacity, lack of authority or limitation of status or power of Parent or Merger Sub, or any defect in the formation of Parent or Merger Sub; (vii) any change in Law of any jurisdiction; (viii) the adequacy of any other means the Guaranteed Party may have of obtaining payment of the Obligations; (ix) the addition, substitution or release of any Person to or from this Limited Guarantee, the Merger Agreement, the Guarantor Equity Commitment Letter or any related agreement or document or any Person interested in the transactions contemplated by the Merger Agreement, provided that Guarantor shall be automatically released from the Obligations to the extent (A) Parent and Merger Sub are validly released from such Obligations under the Merger Agreement or (B) Guarantor is validly released from such Obligations under this Limited Guarantee; (x) the failure or delay on the part of the Guaranteed Party to assert any claim or demand or to enforce any right or remedy against Parent, Merger Sub, the Guarantor or any other Person interested in the transactions contemplated by the Merger Agreement; or (xi) any discharge of the Guarantor as a matter of Applicable Law (other than a discharge of the Guarantor as a result of payment of the Obligations in accordance with the terms of the Merger Agreement or as a result of defenses to the payment of the Obligations that would be available to Parent or Merger Sub under the Merger Agreement). To the fullest extent permitted by Applicable Law, the Guarantor hereby expressly waives (A) any and all rights or defenses arising by reason of any Applicable Law or otherwise which would otherwise require any election of remedies by the Guaranteed Party, (B) promptness, diligence, notice of the acceptance of this Limited Guarantee and of the Obligations, presentment, demand for payment, notice of non-performance, default, dishonor and protest, notice of the Obligations incurred and all other notices of any kind (except for notices to be provided to Parent or Merger Sub and their counsel in accordance with the Merger Agreement and/or any agreements entered into in connection therewith), all defenses that may be available by virtue of any valuation, stay, moratorium Applicable Law or other similar Applicable Law now or hereafter in effect, any right to require the marshalling of assets of any of Parent or Merger Sub or any other Person interested in the transactions contemplated by the Merger Agreement, and all suretyship defenses generally

 

3


(other than fraud, bad faith or willful misconduct) and (C) any and all notice of the creation, renewal, extension or accrual of the Obligations and notice of or proof of reliance by the Guaranteed Party upon this Limited Guarantee or acceptance of this Limited Guarantee. The Guarantor hereby acknowledges that it will receive substantial direct and indirect benefits from the transactions contemplated by the Merger Agreement and that the waivers set forth in this Limited Guarantee are knowingly made in contemplation of such benefits.

The Guaranteed Party hereby covenants and agrees that it shall not institute, and shall cause its Subsidiaries and Affiliates not to, institute, any Proceeding arising under, or in connection with, the Guarantor Equity Commitment Letter or the Merger Agreement or the transactions contemplated hereby or thereby (whether at law or in equity, whether sounding in contract, tort, statute or otherwise), against the Guarantor or any other Parent Related Party (as defined below), except for claims that are Non-Prohibited Claims (as defined in the Guarantor Equity Commitment Letter) against such Person.

Subject to the first sentence of Section 1 hereof, the Guarantor hereby unconditionally and irrevocably agrees not to exercise any rights that it may now have or hereafter acquire against any Parent Related Party or any other Person interested in the transactions contemplated by the Merger Agreement that arise from the existence, payment, performance, or enforcement of the Guarantor’s Obligations under or in respect of this Limited Guarantee or any other agreement in connection therewith, including, without limitation, any right of subrogation, reimbursement, exoneration, contribution or indemnification and any right to participate in any claim or remedy of the Guaranteed Party or any of its Affiliates against any Parent Related Party or such other Person whether or not such claim, remedy or right arises in equity or under contract, statute or common law, including, without limitation, the right to take or receive from any Parent Related Party or such other Person, directly or indirectly, in cash or other property or by set-off or in any other manner, payment or security on account of such claim, remedy or right, unless and until the Obligations (subject to the Cap and the other limitations set forth herein) shall have been paid in full in cash. If any amount shall be paid to the Guarantor in violation of the immediately preceding sentence at any time prior to the payment in full in cash of the Obligations (subject to the Cap and the other limitations set forth herein), such amount shall be received and held in trust for the benefit of the Guaranteed Party, shall be segregated from other property and funds of the Guarantor and shall forthwith be paid or delivered to the Guaranteed Party in the same form as so received (with any necessary endorsement or assignment) to be credited and applied to the Obligations (subject to the Cap and the other limitations set forth herein), in accordance with the terms of the Merger Agreement and herewith, whether matured or unmatured, or to be held as collateral for the Obligations.

The Guarantor acknowledges and agrees that (i) the provisions of this Limited Guarantee are an integral and essential part of the transactions contemplated by the Merger Agreement and neither Parent or Merger Sub nor the Guaranteed Party would have entered into the Merger Agreement without the benefit of this Limited Guarantee and (ii) it will receive substantial direct and indirect benefits from the transactions contemplated by the Merger Agreement and that the waivers set forth in this Limited Guarantee are knowingly made in contemplation of such benefits. Nothing in this Limited Guarantee shall limit in any way the right of the Guaranteed Party to seek an injunction or injunctions or any other equitable relief under, and subject to the limitations in, Section 9.09 (Specific Performance) of the Merger Agreement.

 

4


4. No Waiver; Cumulative Rights. No failure on the part of the Guaranteed Party to exercise, and no delay in exercising, any right, remedy or power hereunder shall operate as a waiver thereof, nor shall any single or partial exercise by the Guaranteed Party of any right, remedy or power hereunder preclude any other or future exercise of any right, remedy or power hereunder. Subject to and without limiting Section 9.04(h) (Fees and Expenses) of the Merger Agreement, each and every right, remedy and power hereby granted to the Guaranteed Party or allowed it by Applicable Law or other agreement shall be cumulative and not exclusive of any other, and may be exercised by the Guaranteed Party at any time or from time to time.

When pursuing its rights and remedies hereunder against the Guarantor, the Guaranteed Party shall, subject to Section 1 hereof, be under no obligation to pursue such rights and remedies it may have against Parent or Merger Sub, their respective affiliates, or any other Person for the Guaranteed Obligations prior to pursuing such rights and remedies against the Guarantor hereunder, and any failure by the Guaranteed Party to pursue such other rights or remedies or to collect any payments from Parent or Merger Sub or any such other Person shall not relieve the Guarantor of any liability hereunder.

5. Representations and Warranties. The Guarantor hereby represents and warrants to the Guaranteed Party that:

(a) the Guarantor is duly organized, validly existing and in good standing under the laws of its jurisdiction of organization;

(b) the Guarantor has all necessary and required organizational power, approval, and authority to execute and deliver this Limited Guarantee and to perform its obligations hereunder;

(c) the execution, delivery and performance of this Limited Guarantee by the Guarantor has been duly and validly authorized by all necessary organizational action, and no other organizational proceedings on the part of the Guarantor are necessary to authorize this Limited Guarantee;

(d) all consents, approvals, authorizations, permits of, filings with and notifications to, any Governmental Authority by the Guarantor necessary for the due execution, delivery and performance of this Limited Guarantee by the Guarantor have been obtained or made and all conditions thereof have been duly complied with, and no other action by, and no notice to or filing with, any Governmental Authority by the Guarantor is required in connection with the execution, delivery or performance of this Limited Guarantee;

(e) this Limited Guarantee has been duly and validly executed and delivered by the Guarantor and, assuming due execution and delivery by the Guaranteed Party, constitutes a legal, valid and binding obligation of the Guarantor enforceable against the Guarantor in accordance with its terms, subject to applicable bankruptcy, insolvency (including all Laws relating to fraudulent transfers), reorganization, moratorium or similar Laws affecting creditors’ rights generally and subject to the effect of general principles of equity (regardless of whether considered in a proceeding at Law or in equity;

 

5


(f) the execution and delivery of this Limited Guarantee by the Guarantor does not, and the performance of this Limited Guarantee by the Guarantor will not, (i) conflict with or violate the organizational documents of the Guarantor, (ii) conflict with or violate any Law applicable to the Guarantor or by which any of its properties or assets is bound or affected, or (iii) result in any breach or violation of, or constitute a default (or an event which, with notice or lapse of time or both, would become a default) under, or give to others any right of termination, amendment, acceleration or cancellation of, any Contract or other instrument or obligation to which the Guarantor is a party or by which the Guarantor or any of its properties or assets is bound or affected, except, with respect to each of the foregoing clauses (ii) and (iii), for any such conflicts, violations, breaches, defaults or other occurrences which would not prevent or materially delay the Guarantor from performing its obligations under this Limited Guarantee; and

(g) the Guarantor (i) has, and will continue to have for so long as this Limited Guarantee is in effect, the financial capacity to pay and perform its obligations under this Limited Guarantee, and (ii) will have at such time as Guarantor is obligated to pay and perform its obligations under this Limited Guarantee, all funds necessary for the Guarantor to fulfill the Obligations under this Limited Guarantee.

6. Assignment. The rights and obligations under this Limited Guarantee may not be assigned or delegated (whether by operation of law, merger, consolidation or otherwise) by any party hereto without the prior written consent of the other party. Notwithstanding the foregoing, (a) the Guarantor may assign all or a portion of its rights, interests or the Obligations hereunder to one or more of its Affiliates; provided that no such assignment shall relieve the Guarantor of its obligations hereunder, and (b) the Guarantor may assign all or a portion of its obligations hereunder (the “Assigned Guarantee”) to one or more third parties (each, an “Assigned Investor”) in connection with an Equity Assignment on the terms and subject to the conditions of Section 6.17(a) of the Merger Agreement (including Section 6.17(a) of the Parent Disclosure Schedule) and upon such assignment, notwithstanding anything to the contrary in this Limited Guarantee, the obligations of the Guarantor hereunder (and the “Obligations” and “Cap” of the Guarantor) shall be reduced dollar for dollar to the extent of the amount of such obligations assumed by such Assigned Investor; provided that such Assigned Investor shall enter into a separate limited guarantee with the Guaranteed Party on terms no less favorable to the Guaranteed Party as contained herein with respect to such assigned obligations. Any assignment or delegation in breach of Section 5 (in respect of the representations and warranties deemed to be made as of the time of such assignment, delegation or transfer) or in violation of this Section 6 shall be null and void and of no force and effect.

7. Notices. All notices, requests, claims, demands and other communications under this Limited Guarantee shall be in writing and shall be given or made (and shall be deemed to have been duly given or made upon receipt) by delivery in person, by an internationally recognized overnight courier service (with proof of delivery), or by email (provided no “bounce back” or similar message indicating non-delivery is received with respect thereto) to the respective parties hereto at the following coordinates (or at such other coordinates for a party as shall be specified in a notice given in accordance with this Section 7):

 

6


(a)   If to the Guarantor to:
  Hux Investment Pte. Ltd.
  c/o GIC Special Investments Pte. Ltd.
  280 Park Avenue, 9th Floor
  New York, NY 10017
  Attention:    ****
  Email:    ****
     ****
  with a copy (which shall not constitute notice) to:
  Dechert LLP
  1095 Avenue of the Americas
  New York, NY 10036
  Attention:    Mark E. Thierfelder, Jonathan Kim, Bernardo Piereck
  Email:    Mark.Thierfelder@dechert.com
     Jonathan.Kim@dechert.com
     Bernardo.Piereck@dechert.com
(b)   If to the Guaranteed Party to:
  Zuora, Inc.
  101 Redwood Shores Parkway
  Redwood City, CA 90465
  Attention:    ****
  Email:    ****
  with a copy (which shall not constitute notice) to:
  Goodwin Procter LLP
  620 Eighth Avenue
  New York, New York 10018
  Attention:    Joshua M. Zachariah
     Michael R. Patrone
     James Ding
  E-Mail:    jzachariah@goodwinlaw.com
     mpatrone@goodwinlaw.com
     jding@goodwinlaw.com
  and with a copy (which shall not constitute notice) to:
  Freshfields Bruckhaus Deringer US LLP
  3 World Trade Center
  175 Greenwich Street
  New York, NY 10007
  Attention: Ethan A. Klingsberg
  Sarah K. Solum
  Steven Y. Li
  Email:    ethan.klingsberg@freshfields.com
     sarah.solum@freshfields.com
     steven.li@freshfields.com

 

7


8. Continuing Guarantee. Unless terminated pursuant to this Section 8, this Limited Guarantee shall remain in full force and effect and shall be binding on the Guarantor, its successors and assigns until the Obligations (subject to the Cap) under this Limited Guarantee have been indefeasibly paid, observed, performed or satisfied in full, at which time this Limited Guarantee shall terminate and the Guarantor shall have no further obligations under this Limited Guarantee. Notwithstanding the foregoing, this Limited Guarantee shall terminate and the Guarantor shall have no further obligations under this Limited Guarantee automatically and immediately upon the earliest to occur of (i) the consummation of the Closing and the payment by Parent of all amounts required to be paid by it at the Closing under the Merger Agreement, (ii) payment in full of the Obligations (subject to the Cap), (iii) the valid termination of the Merger Agreement in accordance with its terms (A) by mutual consent of Parent and the Guaranteed Party or (B) under circumstances in which Parent would not be obligated to make any payment under the Merger Agreement, (iv) the valid termination of the Other Limited Guarantee other than following the satisfaction of all Obligations under the Other Limited Guarantee, (v) sixty (60) days following the valid termination of the Merger Agreement in accordance with its terms under circumstances in which Parent would be obligated to make any payment under the Merger Agreement, unless (x) by such date the Guaranteed Party shall have made a claim in writing with respect to such Obligation during such sixty (60)-day period and (y) the Guaranteed Party shall have commenced a Proceeding during such sixty (60)-day period against the Guarantor or Parent alleging that Parent is liable for such Obligation, in which case, this Limited Guarantee shall terminate no later than the earlier of the final adjudication of such claim after which no further appeal may be taken or the written agreement of the parties to such Proceeding in settlement of such claim and terminating such Proceeding) and (vi) the termination of this Limited Guarantee by mutual written agreement of the Guarantor and the Guaranteed Party. Notwithstanding anything to the contrary, (I) in the event that the Guarantor becomes obligated to pay the amount described in clause (a)(i) of the first sentence of Section 1 of this Limited Guarantee and the Guarantor pays all such amount, then the Guarantor shall have no obligation to pay any amount pursuant to clause (a)(ii) of the first sentence of Section 1 of this Limited Guarantee; and (II) in the event that the Guarantor becomes obligated to pay the amount described in clause (a)(ii) of the first sentence of Section 1 of this Limited Guarantee and the Guarantor pays all such amount, then the Guarantor shall have no obligation to pay any amount pursuant to (a)(i) of the first sentence of Section 1 of this Limited Guarantee. Notwithstanding the foregoing or anything in this Limited Guarantee that may be deemed to the contrary, in the event that the Guaranteed Party or any of its Affiliates assert in any Proceeding (a) that the provisions of Section 1 hereof limiting the Guarantor’s liability to the Cap or the provisions of this Section 8 or Section 9 hereof are illegal, invalid or unenforceable in whole or in part, or (b) any theory of liability against the Guarantor or any Parent Related Party with respect to this Limited Guarantee, the Other Limited Guarantee (including, for the avoidance of doubt, that the Guarantor is liable for any amount owed pursuant to the Other Limited Guarantee), the Guarantor Equity Commitment Letter, the Other Equity Commitment Letter (as defined in the Guarantor Equity Commitment Letter), the Merger Agreement or any of the transactions contemplated hereby or thereby (including in respect of any oral representations made or alleged to be made in connection therewith) (other than, solely with respect to this clause (b), any claim that is a Non-Prohibited Claim), then (A) the obligations of the Guarantor under this Limited Guarantee shall

 

8


terminate ab initio and be null and void and of no force or effect and (B) if the Guarantor has previously made any payments under this Limited Guarantee, it shall be entitled to recover such payments in full, and (C) neither the Guarantor nor any Parent Related Party shall have any liability to the Guaranteed Party or its Affiliates with respect to the transactions contemplated by the Merger Agreement under this Limited Guarantee or otherwise.

9. No Recourse. The Guaranteed Party acknowledges the separate corporate or entity existence of Parent and Merger Sub and that, as of the date hereof, each of Parent and Merger Sub’s sole assets (if any) are a de minimis amount of cash, and that no additional funds are expected to be contributed to Parent or Merger Sub unless and until the Closing occurs. Notwithstanding anything that may be expressed or implied in this Limited Guarantee or any document or instrument delivered in connection herewith (including, without limitation, the Guarantor Equity Commitment Letter and the Merger Agreement), (i) in no event shall the Guaranteed Party or any of its Affiliates or any of their respective former, current and future directors, officers, employees, direct or indirect holder of any equity, stockholders, controlling persons, Affiliates, attorneys, members, managers, general or limited partners, assignees, agents and representatives seek any damages or any other recovery, judgment, or remedies of any kind, including consequential, indirect or punitive damages, against Parent and Merger Sub in excess of the Cap in connection with the Merger Agreement, the failure of the Merger to be consummated for any reason or otherwise in connection with the transactions contemplated hereby and thereby or in respect of any representations made or alleged to have been made in connection therewith, whether in equity or at law, in contract, in tort or otherwise, and (ii) notwithstanding the fact that the Guarantor is a limited partnership or other type of entity, by its acceptance of the benefits of this Limited Guarantee, the Guaranteed Party acknowledges and agrees that no Person has any right of recovery against, no recourse shall be had against and no personal liability shall attach to, the Guarantor, Parent and Merger Sub, or any of their or their respective Affiliates’ respective former, current or future directors, officers, employees, direct or indirect holder of any equity, stockholders, controlling persons, Affiliates, attorneys, members, managers, general or limited partners, assignees, agents, representatives or representatives of any of the foregoing (but not including Parent, Merger Sub, the Guarantor or the Other Guarantor, a “Parent Related Party” and together, the “Parent Related Parties”), including through Parent or Merger Sub or otherwise, whether by or through attempted piercing of the corporate (or limited liability company or limited partnership) veil, by or through a claim (whether at law or equity or in tort, contract or otherwise) by or on behalf of Parent and Merger Sub against any Parent Related Parties, by the enforcement of any assessment or by any legal or equitable proceeding, by virtue of any Applicable Law, or otherwise, except for its rights to recover from the Guarantor (but not any other Person) under and to the extent provided in this Limited Guarantee and its rights to recover from the Other Guarantor under and to the extent provided in the Other Limited Guarantee, and subject to the other limitations described herein, including, for the avoidance of doubt, the Cap, and any other claims that are Non-Prohibited Claims solely against such Person; it being agreed and acknowledged that no personal liability whatsoever shall attach to, be imposed on or otherwise be incurred by any Parent Related Party for any obligation of the Guarantor or any of its successors or permitted assigns under this Limited Guarantee or any documents or instruments delivered in connection herewith or in respect of any oral or written representations made or alleged to have been made in connection herewith or for any claim (whether at law or in equity or in tort, contract or otherwise) based on, in respect of, or by reason of such obligation or their creation. Except for any claims

 

9


that are Non-Prohibited Claims against such Person, recourse against the Guarantor under this Limited Guarantee, subject to the limitations and conditions set forth herein, shall be the sole and exclusive remedy of the Guaranteed Party and all of its Affiliates against the Guarantor and any Parent Related Party in respect of any liabilities or obligations arising under, or in connection with, this Limited Guarantee and the Merger Agreement, the failure of the Merger or the other transactions contemplated by the Merger Agreement to be consummated for any reason or otherwise in connection with the transactions contemplated hereby and thereby or in respect of any representations made or alleged to have been made in connection therewith, whether in equity or at Law, in Contract, in tort or otherwise. Notwithstanding anything to the contrary contained herein, nothing herein shall limit the rights of the Guaranteed Party in respect of the Non-Prohibited Claims. Nothing set forth in this Limited Guarantee shall affect or be construed to affect any liability of Parent and Merger Sub to the Guaranteed Party or shall confer or give or shall be construed to confer or give to any Person other than the Guaranteed Party (including any Person acting in a representative capacity) any rights or remedies against any Person other than the Guarantor as expressly set forth herein.

10. Governing Law; Jurisdiction; Waiver of Jury Trial.

(a) This Limited Guarantee and all disputes or controversies arising out of or relating to this Limited Guarantee or the transactions contemplated hereby, including the applicable statute of limitations, shall be governed by and construed in accordance with the laws of the State of Delaware, without regard to the conflicts of law rules that would cause the application of law of any jurisdiction other than those of the State of Delaware.

(b) The parties hereto agree that any Proceeding seeking to enforce any provision of, or based on any matter arising out of or in connection with, this Limited Guarantee or the transactions contemplated by this Limited Guarantee shall be brought and determined exclusively in the Delaware Court of Chancery or, if that court does not have subject matter jurisdiction, the state or federal courts in the State of Delaware (the “Delaware Courts”). Each party hereto hereby irrevocably submits to the exclusive jurisdiction of the Delaware Courts in respect of any legal or equitable Proceeding arising out of or relating to this Limited Guarantee or the transactions contemplated by this Limited Guarantee, or relating to enforcement of any of the terms of this Limited Guarantee, and hereby waives, and agrees not to assert, as a defense in any such Proceeding, any claim that it is not subject personally to the jurisdiction of such court, that the Proceeding is brought in an inconvenient forum, that the venue of the Proceeding is improper or that this Limited Guarantee or the transactions contemplated by this Limited Guarantee may not be enforced in or by such courts. Each party hereto agrees that notice or the service of process in any Proceeding arising out of or relating to this Limited Guarantee or the transactions contemplated by this Limited Guarantee shall be properly served or delivered if delivered in the manner contemplated by Section 9.01 (Notices) of the Merger Agreement or in any other manner permitted by law.

(c) WAIVER OF JURY TRIAL. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATED TO THIS LIMITED GUARANTEE OR THE TRANSACTIONS CONTEMPLATED BY THIS LIMITED GUARANTEE. EACH OF THE PARTIES HERETO HEREBY (A) CERTIFIES THAT NO REPRESENTATIVE,

 

10


AGENT OR ATTORNEY OF THE OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT HAS BEEN INDUCED TO ENTER INTO THIS LIMITED GUARANTEE AND THE TRANSACTIONS CONTEMPLATED BY THIS LIMITED GUARANTEE, AS APPLICABLE, BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 7(c).

11. Entire Agreement; Amendments. This Limited Guarantee, the Guarantor Equity Commitment Letter and the Merger Agreement constitute the entire agreement among the parties with respect to the subject matter hereof and thereof and supersedes all prior and contemporaneous agreements, undertakings, discussions, negotiations and undertakings, both written and oral, among the parties hereto, or any of them, with respect to the subject matter hereof and thereof. This Limited Guarantee may not be amended, and no provision hereof waived or modified, except by an instrument duly executed by each of the parties hereto.

12. Headings. The descriptive headings herein are inserted for convenience of reference only and are not intended to be part of or to affect the meaning or interpretation of this Limited Guarantee.

13. Counterparts. This Limited Guarantee may be executed in any number of counterparts (including by means of telecopied signature pages or electronic transmission, such as by electronic mail in “pdf” form or any electronic signature complying with the U.S. Federal ESIGN Act of 2000, e.g., www.docusign.com), with the same effect as if the signatures to each counterpart were upon a single instrument, and all such counterparts together shall be deemed an original of this Limited Guarantee. The parties irrevocably and unreservedly agree that this Limited Guarantee may be executed by way of electronic signatures and the parties agree that this Limited Guarantee, or any part hereof, shall not be challenged or denied any legal effect, validity and/or enforceability solely on the ground that it is in the form of an electronic record.

14. Waiver of Sovereign Immunity. To the extent permitted by Applicable Law, if the Guarantor has or hereafter may acquire any immunity (sovereign or otherwise) from any Proceeding, from jurisdiction of any court of from set-off or any legal process (whether service or notice, attachment prior to judgment, attachment in aid of execution of judgment, execution of judgment or otherwise) with respect to itself or any of its property, the Guarantor hereby irrevocably waives and agrees not to plead or claim such immunity in respect of its obligations under this letter agreement or the transactions contemplated hereby.

[Remainder of this page intentionally left blank.]

 

11


IN WITNESS WHEREOF, the Guarantor has caused this Limited Guarantee to be executed and delivered as of the date first written above by its officer thereunto duly authorized.

 

GUARANTOR:
HUX INVESTMENT PTE. LTD.
By:  

/s/ Kenan Basha

  Name: Kenan Basha
  Title: Authorized Signatory


IN WITNESS WHEREOF, the Guaranteed Party has caused this Limited Guarantee to be executed and delivered as of the date first written above by its officer thereunto duly authorized.

 

GUARANTEED PARTY:
ZUORA, INC.
By:  

/s/ Tien Tzuo

  Name: Tien Tzuo
  Title: Chief Executive Officer

Slide 1

April 2024 Project Zodiac Discussion Materials Exhibit 16(c)(ii) [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 2

Agenda Zodiac Financial Overview Zodiac Preliminary Valuation Perspectives Strategic Considerations


Slide 3

Zodiac Financial Overview


Slide 4

Source: Historical financials based on company filings. Street Case projections based on FactSet mean consensus estimates as of April 12, 2024. Note: Zodiac fiscal year ends January 31. Guidance figures represent the midpoint of range. Rule of 40 = Revenue Growth + LFCF Margin. Overview of Zodiac Extrapolated Street Forecast Non-GAAP Operating Income ($MM) Levered Free Cash Flow ($MM) Non-GAAP Operating Margin (%) LFCF Margin (%) # of Brokers 7 6 Revenue ($MM) YoY Revenue Growth (%) Subscription Revenue ($MM) YoY Subscription Revenue Growth (%) Actual Consensus Estimates FY25E Guidance: $455MM 16% 7% 19% 23% 29% 29% Rule of 40(1): FY25E Guidance: 18% FY25E Guidance: 18%+ Extrapolation # of Brokers 7 6 Actual Consensus Estimates Extrapolation FY25E Guidance: $80MM # of Brokers 1 1 Actual Consensus Estimates Extrapolation Actual Consensus Estimates Extrapolation Actual Consensus Estimates Extrapolation Actual Consensus Estimates Extrapolation # of Brokers 5 4 Actual Consensus Estimates Extrapolation Actual Consensus Estimates Extrapolation 83% 85% 89% 91% 92% 93% % of Total Revenue: FY25E Guidance: $412MM FY25E Guidance: 7% FY25E Guidance: Revenue Growth: 5% ARR Growth: 9% Projected CAGR (‘24-’26): 7% FY25E Guidance: $80MM+ Projected CAGR (‘24-’26): 9% Projected CAGR (‘24-’26): 47% Projected CAGR (‘24-’26): 47%


Slide 5

(3%) (5%) 0% 1% (1%) 0% (0%) Source: FactSet mean consensus estimates as of April 12, 2024. Note: Zodiac fiscal year ends January 31. Estimates taken two days after to earnings release for the quarter. Change in estimate calculated as quarter over quarter. Zodiac Revenue Estimates Have Come Down Over Time and Focus Shifted to Profitability Evolution of Zodiac Street FY24/FY25 Estimates Over Time Revenue and % YoY Growth Non-GAAP EBIT and % Margin Estimates For FY24A ($MM) Estimates For FY25E (4%) (8%) (4%) 0% (2%) (1%) (5%) Change in Estimates (9%) (3%) 8% 1% 6% 28% 29% (10%) 98% 5% 13% 14% 23% 10% FY’23 FY’24 3% (6%) (20%) 17% 20% (11%) 9% (6%) 1-Day Price Rxn Change in Estimates Change in Estimates Change in Estimates FY’23 FY’24 FY’23 FY’24 FY’23 FY’24 FY25 Guidance Issued with Q4 Earnings: Revenue: $451MM – $459MM Non-GAAP EBIT: $79MM – $81MM Major Reset Major Reset


Slide 6

Zodiac is Primarily Valued on Revenue Today with a Median Price Target of $12 Source: Wall Street research and FactSet prices as of April 12, 2024. Note: Note: Zodiac fiscal year ends January 31. Excludes research reports, price targets, and valuation methodologies unavailable to Qatalyst. Analyst Ratings & Valuation Methodologies Summary of Price Targets Valuation Methodology and Broker Recommendation Summary Current Price: $8.60 Median represents a 40% premium to the current share price of $8.60 Broker Recommendations Over Time


Slide 7

Zodiac Preliminary Valuation Perspectives


Slide 8

Zodiac Has Traded in Line with Lower Growth Subscription Software Companies From January 2, 2013 to Current (April 12, 2024) Source: FactSet mean consensus estimates as of April 12, 2024. Note: Multiples are undiluted. Growth calculated on an NTM basis. Statistics for acquired companies included until announcement of transaction. Current dataset consists of 96 subscription software companies. <10% Growth Index: 3.5x Zuora: 2.8x 10-25% Growth Index: 7.0x EV / NTM Revenue Multiple Correction Rising Multiples Historical Trading Within a Tight Band of Multiples Return to Historical Trading Ranges COVID Highs (February 19, 2020 – November 9, 2021)


Slide 9

Zodiac Trading Performance Since IPO From April 12, 2018 to Current (April 12, 2024) NTM Revenue Multiple: Share Price: Current NTM Revenue Mult: 2.8x Current Share Price: $8.60 Source: Company Filings and FactSet as of April 12, 2024. e (11%) e +20% e +17% e (20%) e (31%) e (10%) e (19%) e (14%) e +19% Selected Earnings Releases e Legend 1-Day Price Reaction +%


Slide 10

Zodiac Trading Performance Since 2022 From January 3, 2022 to Current (April 12, 2024) NTM Revenue Multiple: Share Price: Current NTM Revenue Mult: 2.8x Current Share Price: $8.60 Source: Company Filings and FactSet as of April 12, 2024. Earnings Release e Legend 1-Day Price Reaction +% e +3% e (6%) e (11%) e +20% e +9% e +17% Announces $400MM convertible investment from Silver Lake ($250MM upfront with $150MM due up to 18 months later) March 2, 2022 – (9%) e (9%) Announces acquisition of Zephr for $44MM August 24, 2022 – (6%) Praesidium discloses 6% stake February 21, 2023 – +1% Completes remaining $150MM Convert. from Silver Lake September 25, 2023 – (4%) e (6%) e (20%) Illustrative Future Trading Multiple Range: 2.0x-4.5x


Slide 11

CY24E Operating Statistics of Selected Companies $454 $805 $475 $767 $617 $2,383 $331 $2,926 $721 $293 $4,382 $281 $1,499 $1,083 $2,544 Source: FactSet consensus estimates as of April 12, 2024. Rule of 40 = Revenue Growth + LFCF margin. Dropbox and Box LFCF adjusted for assets obtained under finance leases. Revenue Growth Non-GAAP Operating Margin Rule of 40 (1) LFCF Margin CY24 Rev. ($MM) Selected Subscription Software Legend CY24 Gross Margin (%) 74% 86% 83% 81% 80% 60% 79% 76% 82% 85% 52% 75% 85% 78% 83% (2) (2) (2) (2)


Slide 12

CY24E Trading Statistics of Selected Companies Revenue Multiple Ro40 Adjusted Rev. Multiple(1) Growth Adjusted Rev. Multiple Ent. Val. ($MM) Source: FactSet consensus estimates as of April 12, 2024. Note: “NM” = Not meaningful or not available. Multiples greater than 50.0x or negative considered not meaningful. Rule of 40 = Revenue Growth + LFCF margin. Dropbox and Box LFCF adjusted for assets obtained under finance leases. LFCF Multiple $1,262 $4,716 $2,181 $4,683 $2,667 $12,562 $2,889 $1,104 $5,330 $8,981 $2,728 $4,753 $8,632 $594 $463 Selected Subscription Software Legend (2) (2) (2) (2) Illustrative Future Trading Multiple Range: 2.0x-4.5x Illustrative Future Trading Multiple Range: 15.0x-25.0x


Slide 13

Illustrative Present Value of Future Share Price Present Value of Future Zodiac Share Price Based on a Range of Revenue Multiples Source: Company filings and FactSet consensus estimates as of April 12, 2024. Zodiac fiscal year ends January 31. FY – 1 used as a proxy for CY. Note: Assumes illustrative 13.75% cost of equity and 4% dilution per year due to employee equity issuances. Illustrative extrapolations due to lack of broker estimates for CY26E. Illustrative Revenue CAGR Driven Sensitivity 2-Year CY26E CY+0 Revenue Multiple Range 2.0x 3.75x 4.5x CY+0 Rev Mult: Revenue-Based Illustrative Future Trading Current 2.8x Implied LFCF Multiples Current Price: $8.60


Slide 14

Illustrative Present Value of Future Share Price Present Value of Future Zodiac Share Price Based on a Range of LFCF Multiples Source: Company filings and FactSet consensus estimates as of April 12, 2024. Zodiac fiscal year ends January 31. FY – 1 used as a proxy for CY. Note: Assumes illustrative 13.75% cost of equity and 4% dilution per year due to employee equity issuances. Illustrative extrapolations due to lack of broker estimates for CY26E. Illustrative Revenue CAGR and LFCF Margin Driven Sensitivity 2-Year CY26E CY+0 LFCF Multiple Range CY+0 LFCF Mult: 15.0x 20.0x 25.0x LFCF-Based Illustrative Future Trading Current Price: $8.60 Current 16.5x Implied Revenue Multiples


Slide 15

Selected Precedent Transactions Selected Public Subscription Software Transactions >$1Bn Since 2011, Positive Revenue Growth <=10% Source: Capital IQ, FactSet, company filings, company press releases and Wall Street research. Note: '–' = Not publicly available or not meaningful. Multiples greater than 50.0x or negative considered not meaningful. Unaffected premium indicates premium based on day prior to rumors of a potential transaction, or premium based on day prior to transaction announcement if no substantial rumors existed. Rule of 40 calculated as Revenue Growth + LFCF Margin.


Slide 16

Illustrative Zodiac Transaction Statistics


Slide 17

Strategic Considerations


Slide 18

Selected Potential Partners [***] [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 19

Illustrative Sources and Uses at $13.00 Per Share Assumes 7/31/24 Entry Date and 3.0x ARR for Entry Leverage Note: Zodiac fiscal year ends January 31. FY – 1 used as a proxy for CY. (1) ARR estimated by taking the midpoint of FY24A ARR of $403M and FY25E ARR derived from management ARR growth guidance. (2) Assumes 4.5% Cash Interest Rate and 12% Cost of Debt. (3) Based on Zodiac stock price of $8.60 as of April 12, 2024. (4) Based on Zodiac 8-K for the period ended January 31, 2024. Interim Free Cash Flow of $42MM for CY24Q1 – CY24Q2 based on FactSet mean consensus estimates April 12, 2024. (5) Assumes convertible debt principal is cash settled. Make-whole calculations per Zodiac indenture dated March 24, 2022.


Slide 20

Illustrative Take Private Returns Analysis Assumes 7/31/24 Entry Date, 1/31/29 Exit Date, 3.0x ARR for Entry Leverage Source: Company Filings and FactSet as of April 12, 2024. Note: Zodiac fiscal year ends January 31. FY – 1 used as a proxy for CY. Legend Denotes IRR >25.0% Denotes IRR >22.5%


Slide 21

Overview of Selected Potential Partners Legend Strategic Partners Financial Sponsors Market Cap ($Bn) | Net Cash ($Bn)| CY24E Rev Mult Source: FactSet mean consensus estimates as of April 12, 2024. [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 22

Appendix [***] Detail [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 23

[***] Company Overview Sources: Pitchbook, company filings, company website, and FactSet consensus estimates as of April 12, 2023. [***] capitalization and balance sheet statistics per 10-K for the period ended [***]. Valuation & Trading Statistics Stock Price Performance Over Time Company Overview Selected Management Team Board Members Core Strategic Priorities [***] [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 24

[***] and Zodiac Pro Forma Income Statement Source: Company filings, Company transcripts, Wall Street research, and FactSet mean consensus estimates as of April 12, 2024. (1) Pro Forma [***] does not account for transaction adjustments (interest rate on new debt, foregone interest on cash, etc.) for illustrative purposes. [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 25

Illustrative [***] Transaction Summary [***] [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 26

[***] Capitalization Summary [***] [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 27

[***] Acquisition History Source: 451 Research. [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 28

Appendix Financial Sponsor Selected Transactions


Slide 29

[***] Selected Bidding History Source: Capital IQ, FactSet, company filings, company press releases, merger proxies, and Wall Street research. (1) Unaffected premium indicates premium based on day prior to rumors of a potential transaction, or premium based on day prior to transaction announcement if no substantial rumors existed. (2) Initial interaction (e.g., email, phone call, or management meeting) that led to a transaction, not including interactions from previous processes. [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 30

Selected Bidding History Source: Capital IQ, FactSet, company filings, company press releases, merger proxies, and Wall Street research. (1) Unaffected premium indicates premium based on day prior to rumors of a potential transaction, or premium based on day prior to transaction announcement if no substantial rumors existed. (2) Initial interaction (e.g., email, phone call, or management meeting) that led to a transaction, not including interactions from previous processes. [***] [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 31

[***] Selected Bidding History Source: Capital IQ, FactSet, company filings, company press releases, merger proxies, and Wall Street research. (1) Unaffected premium indicates premium based on day prior to rumors of a potential transaction, or premium based on day prior to transaction announcement if no substantial rumors existed. (2) Initial interaction (e.g., email, phone call, or management meeting) that led to a transaction, not including interactions from previous processes. (3) NDA from first process remained in effect throughout second process. [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 32

[***] Selected Bidding History Source: Capital IQ, FactSet, company filings, company press releases, merger proxies, and Wall Street research. (1) Unaffected premium indicates premium based on day prior to rumors of a potential transaction, or premium based on day prior to transaction announcement if no substantial rumors existed. (2) Initial interaction (e.g., email, phone call, or management meeting) that led to a transaction, not including interactions from previous processes. [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission. [***]


Slide 33

[***] Selected Bidding History Source: Capital IQ, FactSet, company filings, company press releases, merger proxies, and Wall Street research. (1) Unaffected premium indicates premium based on day prior to rumors of a potential transaction, or premium based on day prior to transaction announcement if no substantial rumors existed. (2) Initial interaction (e.g., email, phone call, or management meeting) that led to a transaction, not including interactions from previous processes. [***] [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 34

[***] Selected Bidding History Source: Capital IQ, FactSet, company filings, company press releases, merger proxies, and Wall Street research. (1) Unaffected premium indicates premium based on day prior to rumors of a potential transaction, or premium based on day prior to transaction announcement if no substantial rumors existed. (2) Initial interaction (e.g., email, phone call, or management meeting) that led to a transaction, not including interactions from previous processes. [***] [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 35

Source: Capital IQ, FactSet, company filings, company press releases, merger proxies, and Wall Street research. (1) Unaffected premium indicates premium based on day prior to rumors of a potential transaction, or premium based on day prior to transaction announcement if no substantial rumors existed. (2) Initial interaction (e.g., email, phone call, or management meeting) that led to a transaction, not including interactions from previous processes. [***] [***] Selected Bidding History [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 36

[***] Selected Bidding History Source: Capital IQ, FactSet, company filings, company press releases, merger proxies, and Wall Street research. (1) Unaffected premium indicates premium based on day prior to rumors of a potential transaction, or premium based on day prior to transaction announcement if no substantial rumors existed. (2) Initial interaction (e.g., email, phone call, or management meeting) that led to a transaction, not including interactions from previous processes. [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission. [***]


Slide 37

Appendix Additional Information


Slide 38

Selected Technology Transaction Premia Premia in Selected >$1Bn Public Technology Transactions Since 2003 Source: FactSet as of April 12, 2024. Note: Based on FactSet premia and unaffected dates for technology M&A transactions greater than $1Bn enterprise value since 2003. 1- Day Premia Paid 424 Total Transactions in Data Set 25th Percentile: 17% Premium 75th Percentile: 44% Premium Median: 28% Premium Mean: 33% Premium


Slide 39

Zodiac Q4’FY24 Earnings Update Zodiac Latest Financials and Updated Guidance


Slide 40

Trading and Operating Statistics of Selected Companies


Slide 41

Trading and Operating Statistics of Potential Strategic Partners Source: FactSet mean consensus estimates and Wall Street analyst research. "In-the money" convertible debt assumed to be net share settled. Note: Based on market prices as of April 12, 2024. Multiples greater than 50x or negative noted as dashes. (1) [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission. [***] [***] [***]


Slide 42

Illustrative Zodiac Cost of Capital Calculation (1/2)


Slide 43

Illustrative Zodiac Cost of Capital Calculation (2/2)


Slide 44

Disclaimer

Slide 1

April 2024 Project Zodiac Discussion Materials Exhibit 16(c)(iii) [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 2

Zodiac Financial Overview


Slide 3

Summary of Zodiac Preliminary Management Plan Source: Historical figures per company filings. Zodiac Preliminary Management Plan provided by Zodiac Management in April 2024. Note: Zodiac fiscal year ends January 31. Rule of 40 = Revenue Growth + LFCF Margin. FY29 LFCF does not factor in a long-term effective tax rate. Non-GAAP Operating Income ($MM) Levered Free Cash Flow ($MM) Non-GAAP Operating Margin (%) LFCF Margin (%) ARR ($MM) YoY ARR Growth (%) Revenue ($MM) YoY Revenue Growth (%) 16% 7% 19% 24% 27% 31% 34% 38% Rule of 40(1): Actual Projections Projected CAGR (‘24-’29): 8% Projected CAGR (‘24-’29): 7% Projected CAGR (‘24-’29): 29% Projected CAGR (‘24-’29): 33% Actual Projections Actual Projections Actual Projections Actual Projections Actual Projections Actual Projections Actual Projections (2) (2)


Slide 4

Summary of Zodiac Preliminary Management Plan vs Street Note: Zodiac fiscal year ends January 31. Historical figures per company filings. Zodiac Street Case based on FactSet mean consensus estimates as of April 16, 2024. Zodiac Preliminary Management Plan provided by Zodiac Management in April 2024. Rule of 40 = Revenue Growth + LFCF Margin. Midpoint of guidance shown as a proxy for ARR street estimates. 7 6 # of Brokers for Consensus: 7% 19% 24% 27% 7% 19% 23% 29% Rule of 40(4): Revenue ($MM) Revenue Growth (%) FY24A – FY26E CAGR: Prelim. Mgmt. Plan (3): 6% FY24A – FY26E CAGR: Street Case (2): 7% FY25E Guidance: $451 - $459 Non-GAAP Operating Income ($MM) Non-GAAP Operating Margin (%) FY25E Guidance: $79 - $81 Levered Free Cash Flow ($MM) Levered Free Cash Flow Margin (%) FY25E Guidance: $80+ Legend Historical (1) Street Case (2) Prelim. Mgmt. Plan (3) 7 6 # of Brokers for Consensus: 1 1 # of Brokers for Consensus: ARR ($MM) ARR Growth (%) FY24A – FY26E CAGR: Prelim. Mgmt. Plan (3): 8% FY25E Guidance: $435 - $443 Mgmt: Street: FY25E Guidance: 8% - 10% FY25E Guidance: 4% - 5% FY25E Guidance: 18% FY25E Guidance: 18%+ (5) (5) FY24A – FY26E CAGR: Prelim. Mgmt. Plan (3): 47% FY24A – FY26E CAGR: Street Case (2): 47% FY24A – FY26E CAGR: Prelim. Mgmt. Plan (3): 51% FY24A – FY26E CAGR: Street Case (2): 47%


Slide 5

Zodiac is Primarily Valued on Revenue Today with a Median Price Target of $12 Source: Wall Street research and FactSet prices as of April 16, 2024. Note: Note: Zodiac fiscal year ends January 31. Excludes research reports, price targets, and valuation methodologies unavailable to Qatalyst. Analyst Ratings & Valuation Methodologies Summary of Price Targets Valuation Methodology and Broker Recommendation Summary Current Price: $8.47 Median represents a 42% premium to the current share price of $8.47 Broker Recommendations Over Time


Slide 6

Zodiac Preliminary Valuation Analysis


Slide 7

Zodiac Trading Performance Since IPO From April 12, 2018 to Current (April 16, 2024) NTM Revenue Multiple: Share Price: Current NTM Revenue Mult: 2.7x Current Share Price: $8.47 Source: Company Filings and FactSet as of April 16, 2024. e (11%) e +20% e +17% e (20%) e (31%) e (10%) e (19%) e (14%) e +19% Selected Earnings Releases e Legend 1-Day Price Reaction +%


Slide 8

Zodiac Trading Performance Since 2022 From January 3, 2022 to Current (April 16, 2024) NTM Revenue Multiple: Share Price: Current NTM Revenue Mult: 2.7x Source: Company Filings and FactSet as of April 16, 2024. Earnings Release e Legend 1-Day Price Reaction +% Announces $400MM convertible investment from Silver Lake ($250MM upfront with $150MM due up to 18 months later) March 2, 2022 – (9%) e (9%) Illustrative Future Trading Multiple Range: 2.0x-4.5x e (6%) Current Share Price: $8.47 e (11%) e +20% e +9% e +17% Praesidium discloses 6% stake February 21, 2023 – +1% Completes remaining $150MM Convert. from Silver Lake September 25, 2023 – (4%) e (6%) e (20%) Announces acquisition of Zephr for $44MM August 24, 2022 – (6%) e +3%


Slide 9

CY24E / NTM Operating Statistics of Selected Companies $454 $457 $603 $805 $475 $767 $617 $2,383 $331 $2,926 $293 $714 $281 $1,499 $1,083 $661 $1,272 $2,544 Source: FactSet consensus estimates as of April 16, 2024. Zodiac Preliminary Management Plan provided by Zodiac management in April 2024. Rule of 40 = Revenue Growth + LFCF margin. Dropbox and Box LFCF adjusted for assets obtained under finance leases. Revenue Growth Non-GAAP Operating Margin Rule of 40 (1) LFCF Margin Revenue ($MM) Selected Subscription Software Legend Gross Margin (%) 74% 74% 77% 79% 90% 86% 83% 81% 80% 60% 79% 76% 82% 85% 75% 85% 78% 77% (2) (2) (2) (2) UFCF Margin (%) 19% 18% 23% 34% 34% 30% 26% 27% 37% 23% 19% 14% 18% 14% 7% 9% 4% 3% Zodiac Zodiac Zodiac Zodiac (2) (2)


Slide 10

CY24E / NTM Trading Statistics of Selected Companies Revenue Multiple Ro40 Adjusted Rev. Multiple(1) Growth Adjusted Rev. Multiple Ent. Val. ($MM) Source: FactSet consensus estimates as of April 16, 2024. Note: “NM” = Not meaningful or not available. Multiples greater than 50.0x or negative considered not meaningful. Rule of 40 = Revenue Growth + LFCF margin. Dropbox and Box LFCF adjusted for assets obtained under finance leases. LFCF Multiple $1,225 $4,539 $6,822 $3,080 $2,678 $2,034 $4,580 $12,291 $2,782 $1,032 $8,962 $5,161 $2,664 $4,648 $568 $442 Selected Subscription Software Legend (2) (2) (2) (2) Illustrative Future Trading Multiple Range: 2.0x-4.5x Illustrative Future Trading Multiple Range: 12.0x-20.0x UFCF Multiple Ro40 Adj. Revenue Multiple(1) Growth Adj. Revenue Multiple LFCF Multiple Illustrative DCF Multiple Range: 11.0x-19.0x


Slide 11

Illustrative Present Value of Future Share Price Present Value of Future Zodiac Share Price Based on a Range of Revenue Multiples Source: FactSet consensus estimates as of April 16, 2024. Zodiac Preliminary Management Plan provided by Zodiac Management in April 2024. Zodiac fiscal year ends January 31. FY – 1 used as a proxy for CY. Note: Assumes illustrative 14.0% cost of equity and 4% dilution per year due to employee equity issuances. Illustrative Revenue CAGR Driven Sensitivity 3-Year CY27E CY+0 Revenue Multiple Range 2.0x 3.25x 4.5x CY+0 Rev Mult: Revenue-Based Illustrative Future Trading Current Price: $8.37 Current 2.7x 4.2x 2.0x 3.5x 4.3x 3.5x


Slide 12

Illustrative Present Value of Future Share Price Present Value of Future Zodiac Share Price Based on a Range of LFCF Multiples Source: FactSet consensus estimates as of April 16, 2024. Zodiac Preliminary Management Plan provided by Zodiac Management in April 2024. Zodiac fiscal year ends January 31. FY – 1 used as a proxy for CY. Note: Assumes illustrative 14.0% cost of equity and 4% dilution per year due to employee equity issuances. Illustrative Revenue CAGR and LFCF Margin Driven Sensitivity 3-Year CY27E CY+0 LFCF Multiple Range CY+0 LFCF Mult: 12.0x 20.0x LFCF-Based Illustrative Future Trading Current Price: $8.37 Current 16.3x 16.6x 14.0x 14.2x 17.4x


Slide 13

Summary of Zodiac Preliminary Management Plan UFCF Projections Highly Preliminary and Subject to Change Note: Assumes current shareholders incur 17% cumulative dilution through issuance of equity awards over the projected period. Zodiac Preliminary Management Plan provided by Zodiac management in April 2024. Based on federal NOL balance of $552MM as of January 31, 2024, per Zodiac 10-K for the period ended January 31, 2024.


Slide 14

Note: Assumes mid-period discounting convention. Unlevered Free Cash Flows and Terminal Value adjusted by the cumulative dilution to current shareholders in each respective year, and then discounted to present value as of January 31, 2024. Assumes current shareholders incur 4% annual dilution through issuance of equity awards over the projected period. Common shares outstanding, RSUs, PSUs, and options per Zodiac 10-K as of January 31, 2024. Fully-diluted shares calculated using treasury stock method. Fully diluted shares calculated using treasury stock method. Balance sheet statistics per Zodiac 10-K as of January 31, 2024. Zodiac Preliminary Management Plan provided by Zodiac management in April 2024. Zodiac Discounted Cash Flow Analysis Summary of Valuation Assumptions Unlevered free cash flow projections and terminal value discounted to January 31, 2024 using mid-period convention Excludes impact of stock-based compensation, amortization of intangibles, and other non-cash items in unlevered free cash flow Weighted average cost of capital range of 12.0% to 14.0% Terminal value based on NTM UFCF multiple range of 11.0x – 19.0x and terminal year (FY29E) UFCF of $138MM Current shareholders incur 4% annual dilution through issuance of equity awards throughout the projection period Assumed 80% utilization limit per Zodiac management for U.S. Federal NOLs Highly Preliminary and Subject to Change


Slide 15

Illustrative Preliminary Discounted Cash Flow Sensitivity Highly Preliminary and Subject to Change


Slide 16

Selected Precedent Transactions Selected Public Subscription Software Transactions >$1Bn Since 2011, Positive Revenue Growth <=10% Source: Capital IQ, FactSet, company filings, company press releases and Wall Street research. Note: '–' = Not publicly available or not meaningful. Multiples greater than 50.0x or negative considered not meaningful. Unaffected premium indicates premium based on day prior to rumors of a potential transaction, or premium based on day prior to transaction announcement if no substantial rumors existed. Rule of 40 calculated as Revenue Growth + LFCF Margin.


Slide 17

Selected Technology Transaction Premia Premia in Selected >$1Bn Public Technology Transactions Since 2003 Source: FactSet as of April 16, 2024. Note: Based on FactSet premia and unaffected dates for technology M&A transactions greater than $1Bn enterprise value since 2003. 1- Day Premia Paid 424 Total Transactions in Data Set 25th Percentile: 17% Premium 75th Percentile: 44% Premium Median: 28% Premium Mean: 33% Premium


Slide 18

Illustrative Zodiac Transaction Statistics


Slide 19

Zodiac Illustrative Valuation Framework Summary Zodiac Current: $8.47 Zodiac Preliminary Management Plan provided by Zodiac management in April 2024. Common shares outstanding, RSUs, PSUs, and options per Zodiac 10-K as of January 31, 2024. Fully-diluted shares calculated using treasury stock method. Fully diluted shares calculated using treasury stock method. Balance sheet statistics per Zodiac 10-K as of January 31, 2024. Based on Zodiac current share price of $8.47. Last twelve months for the period ending April 16, 2024. Based on available brokers with price targets as of April 16, 2024. Zodiac Street Case based on FactSet mean consensus estimates as of April 16, 2024.


Slide 20

Strategic Considerations


Slide 21

Selected Potential Partners [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission. [***]


Slide 22

Illustrative Sources and Uses at $12.00 Per Share Assumes 7/31/24 Entry Date and 3.0x ARR for Entry Leverage Note: Zodiac fiscal year ends January 31. FY – 1 used as a proxy for CY. (1) ARR estimated by taking the midpoint of FY24A ARR of $403M and FY25E ARR derived from management ARR growth guidance. (2) Assumes 4.5% Cash Interest Rate and 12% Cost of Debt. (3) Based on Zodiac stock price of $8.47 as of April 16, 2024. (4) Based on Zodiac 8-K for the period ended January 31, 2024. Interim Free Cash Flow of $42MM for CY24Q1 – CY24Q2 based on FactSet mean consensus estimates April 16, 2024. (5) Assumes convertible debt principal is cash settled. Make-whole calculations per Zodiac indenture dated March 24, 2022.


Slide 23

Illustrative Take Private Returns Analysis Assumes 7/31/24 Entry Date, 1/31/29 Exit Date, 3.0x ARR for Entry Leverage Source: Company Filings and FactSet as of April 16, 2024. Zodiac Preliminary Management Plan provided by Zodiac Management in April 2024. Note: Zodiac fiscal year ends January 31. FY – 1 used as a proxy for CY. Legend Denotes IRR >25.0% Denotes IRR >22.5% Prelim. Mgmt. Plan FY24A-FY29E CAGR: 7%


Slide 24

Overview of Selected Potential Partners Legend Market Cap ($Bn) | Net Cash ($Bn)| CY24E Rev Mult Source: FactSet mean consensus estimates as of April 16, 2024. [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission. [***]


Slide 25

Qatalyst’s Recommendation Should the Special Committee elect to engage in discussions with potential acquirors, the objective will be to create a competitive environment that will help achieve the best possible price for the Special Committee to consider In that context, Qatalyst’s proposed process recommendation is as follows: Request initial proposals from [***] (the “Initial Parties”), based on publicly available information Express strong conviction in Zodiac’s standalone path and scarcity value as the only scaled, enterprise-focused, subscription management platform The Special Committee will act as a responsible fiduciary and consider a sale if presented with a compelling offer Underscore that a typical M&A premium will not be adequate and that several parties have expressed credible interest in an acquisition Concurrently enter into NDAs with the Initial Parties Should the Initial Parties submit initial proposals that are deemed sufficiently compelling by the Special Committee, convey a willingness to engage in further discussions by providing non-public information and access to management, while making it clear such proposals are inadequate Upon receipt of the initial proposals, reach out to a targeted list of additional financial sponsors and strategics (the “Additional Parties”) Convey that the Company has received credible proposals from highly motivated parties Communicate that while the Special Committee has not decided to sell the Company, they plan to quickly assess whether a sale would be in the best interests of the shareholders at this point in time, and that we are reaching out to them to assess their level of interest Harmonize respective timelines for the Initial and Additional Parties Provide access to management and share non-public information, following the signing of an NDA Request proposals from all parties See subsequent page for an overview of a highly preliminary timeline [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 26

Preparation Phase II Phase IV Phase III Illustrative Process Timeline Illustrative Special Committee Meeting (5/28) Phase 3 Prep Populate Detailed VDR Draft Transaction Docs Complete Business & Functional DD Enable Parties Access to Financing Sources Distribute Drafts of Transaction Documentation Illustrative Final Bid Deadline (6/28) Sign & Announce (Early-Mid July) Confirmatory (Legal, Tax/Accounting) DD Negotiate & Finalize Transaction Illustrative Special Committee Meeting (6/28) Final Special Committee Meeting Special Committee / Board Meetings Outreach Process Milestones Holiday Potential Earnings Announcement / Quarter Close Date Key Dates: Initial bids (May 28th) Final bids (June 28th) Sign & announce (Early-Mid July) April May June May July June 4/15 4/22 4/29 5/6 5/13 5/20 5/27 6/3 6/10 6/17 6/24 7/1 7/8 Memorial Day (5/27) Estimated Q1’24 Earnings Announcement (5/23) HIGHLY PRELIMINARY | SUBJECT TO CHANGE Prepare Management Presentation & Key Business Diligence Items / Data Pack Negotiate & Execute NDAs with Additional Parties Management Meetings for Initial and Additional Parties (Week of 4/29 and 5/6) Access to Prelim. Data Room / Follow-up Business Diligence Meetings Juneteenth (6/19) 4th of July (7/4) Special Committee Meeting (4/17) Final Board Meeting Illustrative Bid Deadline for All Parties (5/28) Initiate Outreach to Additional Parties (4/27) Negotiate & Execute NDAs with Initial Parties Phase I Initiate Outreach to Initial Parties (4/18) Illustrative Special Committee Meeting (4/26) Deadline for Initial Parties to Submit Initial Proposals* (4/25) *Initial Proposals to be provided on the basis of public information only.


Slide 27

Appendix [***] Overview [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 28

Company Overview Sources: Pitchbook, company filings, company website, and FactSet consensus estimates as of April 16, 2023. [***} capitalization and balance sheet statistics per 10-K for the period [***] [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission. [***]


Slide 29

[***] and Zodiac Pro Forma Income Statement Source: Company filings, Company transcripts, Wall Street research, and FactSet mean consensus estimates as of April 16, 2024. (1) Pro Forma [***] does not account for transaction adjustments (interest rate on new debt, foregone interest on cash, etc.) for illustrative purposes. [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission. [***]


Slide 30

Illustrative [***] Transaction Summary Source: FactSet mean consensus estimates as of April 16, 2024. Assumes various transaction fees and expenses. [***] [***] Fully-diluted shares calculated using treasury stock method. [***] Includes [***] [***] [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 31

[***] Capitalization Summary [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 32

Appendix Financial Sponsor Selected Transactions


Slide 33

[***] Selected Bidding History Source: Capital IQ, FactSet, company filings, company press releases, merger proxies, and Wall Street research. (1) Unaffected premium indicates premium based on day prior to rumors of a potential transaction, or premium based on day prior to transaction announcement if no substantial rumors existed. (2) Initial interaction (e.g., email, phone call, or management meeting) that led to a transaction, not including interactions from previous processes. [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 34

Selected Bidding History Source: Capital IQ, FactSet, company filings, company press releases, merger proxies, and Wall Street research. (1) Unaffected premium indicates premium based on day prior to rumors of a potential transaction, or premium based on day prior to transaction announcement if no substantial rumors existed. (2) Initial interaction (e.g., email, phone call, or management meeting) that led to a transaction, not including interactions from previous processes. [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission. [***] [***]


Slide 35

Selected Bidding History Source: Capital IQ, FactSet, company filings, company press releases, merger proxies, and Wall Street research. (1) Unaffected premium indicates premium based on day prior to rumors of a potential transaction, or premium based on day prior to transaction announcement if no substantial rumors existed. (2) Initial interaction (e.g., email, phone call, or management meeting) that led to a transaction, not including interactions from previous processes. (3) NDA from first process remained in effect throughout second process. [***] [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 36

Selected Bidding History Source: Capital IQ, FactSet, company filings, company press releases, merger proxies, and Wall Street research. (1) Unaffected premium indicates premium based on day prior to rumors of a potential transaction, or premium based on day prior to transaction announcement if no substantial rumors existed. (2) Initial interaction (e.g., email, phone call, or management meeting) that led to a transaction, not including interactions from previous processes. (3)[***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission. [***] [***]


Slide 37

Selected Bidding History Source: Capital IQ, FactSet, company filings, company press releases, merger proxies, and Wall Street research. (1) Unaffected premium indicates premium based on day prior to rumors of a potential transaction, or premium based on day prior to transaction announcement if no substantial rumors existed. (2) Initial interaction (e.g., email, phone call, or management meeting) that led to a transaction, not including interactions from previous processes. [***] [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 38

Selected Bidding History Source: Capital IQ, FactSet, company filings, company press releases, merger proxies, and Wall Street research. (1) Unaffected premium indicates premium based on day prior to rumors of a potential transaction, or premium based on day prior to transaction announcement if no substantial rumors existed. (2) Initial interaction (e.g., email, phone call, or management meeting) that led to a transaction, not including interactions from previous processes. (3)[***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission. [***] [***]


Slide 39

Selected Bidding History Source: Capital IQ, FactSet, company filings, company press releases, merger proxies, and Wall Street research. (1) Unaffected premium indicates premium based on day prior to rumors of a potential transaction, or premium based on day prior to transaction announcement if no substantial rumors existed. (2) Initial interaction (e.g., email, phone call, or management meeting) that led to a transaction, not including interactions from previous processes. (3) NDA to Signing not meaningful since an NDA already existed from a prior process. (4) [***] (6) Represents proposals post-NDA. (7) [***] [***] [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 40

Source: Capital IQ, FactSet, company filings, company press releases, merger proxies, and Wall Street research. (1) Unaffected premium indicates premium based on day prior to rumors of a potential transaction, or premium based on day prior to transaction announcement if no substantial rumors existed. (2) Initial interaction (e.g., email, phone call, or management meeting) that led to a transaction, not including interactions from previous processes. [***] [***] Selected Bidding History [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 41

[***] Selected Bidding History Source: Capital IQ, FactSet, company filings, company press releases, merger proxies, and Wall Street research. (1) Unaffected premium indicates premium based on day prior to rumors of a potential transaction, or premium based on day prior to transaction announcement if no substantial rumors existed. (2) Initial interaction (e.g., email, phone call, or management meeting) that led to a transaction, not including interactions from previous processes. [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 42

Appendix Additional Information


Slide 43

(3%) (5%) 0% 1% (1%) 0% (0%) Source: FactSet mean consensus estimates as of April 16, 2024. Note: Zodiac fiscal year ends January 31. Estimates taken two days after to earnings release for the quarter. Change in estimate calculated as quarter over quarter. (1) Zodiac Preliminary Management Plan provided by Zodiac Management in April 2024. Zodiac Revenue Estimates Have Come Down Over Time and Focus Shifted to Profitability Evolution of Zodiac Street FY24/FY25 Estimates Over Time Revenue and % YoY Growth Non-GAAP Operating Income and % Margin Estimates For FY24A ($MM) Estimates For FY25E (4%) (8%) (4%) 0% (2%) (1%) (5%) Change in Estimates (9%) (3%) 8% 1% 6% 28% 29% (10%) 98% 5% 13% 14% 23% 10% FY’23 FY’24 3% (6%) (20%) 17% 20% (11%) 9% (6%) 1-Day Price Rxn Change in Estimates Change in Estimates Change in Estimates FY’23 FY’24 FY’23 FY’24 FY’23 FY’24 FY25 Guidance Issued with Q4 Earnings: Revenue: $451MM – $459MM Non-GAAP Operating Income: $79MM – $81MM Major Reset Major Reset Prelim. Mgmt. Plan: $457 (1) Prelim. Mgmt. Plan: $87 (1)


Slide 44

FY25 Zodiac Preliminary Management Plan vs Street Comparison Source: Company filings, FactSet, Zodiac Preliminary Management Plan provided by Zodiac Management in April 2024. Street estimates based upon FactSet mean consensus estimates as of April 16, 2024. FY25 Guidance Subscription Revenue: $410 - $414 Services Revenue: $41 - $45 Total Revenue: $451 - $459 Non-GAAP Op. Inc: $79 - $81 Adjusted FCF: $80+ Q1’FY25 Guidance Subscription Revenue: $98 - $99 Services Revenue: $9.8 - $10.8 Total Revenue: $107.8 - $109.8 Non-GAAP Op. Inc: $14 - $16


Slide 45

Zodiac Preliminary Management Plan Illustrative NOL Schedule Note: Effective tax rate assumed to be 21%. Federal NOL balance of $552MM as of January 31, 2024, per Zodiac 10-K for the period ended January 31, 2024. Under the US Tax Cuts and Jobs Act, carryforward NOLs are subject to an annual limitation equal to 80% of taxable income. Zodiac Preliminary Management Plan provided by Zodiac management in April 2024. Extrapolations approved by Zodiac management in April 2024.


Slide 46

Trading and Operating Statistics of Selected Companies


Slide 47

Trading and Operating Statistics of Potential Strategic Partners ($MM, except per share information) FD Capitalization Trading Multiples Operating Statistics Enterprise Value / Equity Value / Revenue Gross Operating LFCF UFCF Stock Price Equity Ent. Revenue Ro40 Adj. Rev. UFCF LFCF $ % Growth Margins Margins Margins Margins Rule of 40 (1) NTM Multiples Company (FYE) 4/16/2024 Value Value CY24E CY25E CY24E CY25E CY24E CY24E CY25E CY24E CY25E '23-24E '24-25E CY24E CY25E CY24E CY25E CY24E CY25E CY24E CY24E CY25E Zodiac (Jan.) $8.47 $1,355 $1,241 2.7x 2.5x 0.12x 0.09x 14.1x 16.3x 14.2x $454 $496 5% 9% 74% 76% 18% 21% 18% 19% 19% 23% 29% Zodiac Mgmt. (2) $457 $487 6% 6% 74% 75% 19% 21% 18% 21% 18% 24% 27% Selected Subscription Software Median 7.5x 6.6x 0.24x 0.17x 32.2x 31.4x 28.0x 9% 11% 73% 73% 29% 31% 22% 23% 25% 34% 37% Mean 7.1x 6.4x 0.23x 0.18x 31.9x 29.9x 25.6x 10% 11% 71% 71% 31% 32% 21% 23% 22% 30% 34% Source: FactSet mean consensus estimates and Wall Street analyst research. "In-the money" convertible debt assumed to be net share settled. Note: Based on market prices as of April 16, 2024. Multiples greater than 50x or negative noted as dashes. (1) Rule of 40 = Revenue Growth + LFCF Margin. (2) Zodiac Preliminary Management Plan provided by Zodiac Management in April 2024. [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 48

Illustrative Zodiac Cost of Capital Calculation (1/2)


Slide 49

Illustrative Zodiac Cost of Capital Calculation (2/2)


Slide 50

Disclaimer

Slide 1

April 2024 Project Zodiac Discussion Materials Exhibit 16(c)(iv) [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 2

Zodiac Process Summary Initial outreach to [***] parties ([***] strategics and [***] financial sponsors) Initial Proposals Received [***] Initial Outreach [***] Initial Outreach [***] Strategics Financial Sponsors Upcoming Mgmt. Meeting [***] On Hold Legend Written Proposal * On Hold [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission. [***] [***]


Slide 3

Based on unaffected price of $8.47 as of market close on April 16, 2024, the day prior to Reuter's report of Zodiac exploring a potential sale. Zodiac NTM Revenue projections based on FactSet mean consensus estimates as of April 26, 2024. Based on midpoint of proposal range. Summary of Initial Proposals 30% 35% 36% 39% 48% 48% 52% 53% 59% Premium to Unaffected Share Price (1) (3) 3.9x 4.0x 4.0x 4.1x 4.4x 4.4x 4.6x 4.6x 4.8x Implied NTM Revenue Multiple (2) (3) Legend Written Proposal * [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission. [***]


Slide 4

Summary of Written Initial Proposals [***] [***] [***] [***] [***] Purchase Price $10.75-11.25 per share 27% – 33% premium to unaffected price(1) $11.43 per share 35% premium to unaffected price(1) $11.25-12.25 per share 33% – 45% premium to unaffected price(1) $12.00-13.00 per share 42% – 53% premium to unaffected price(1) $13.00-14.00 per share 53% – 65% premium to unaffected price(1) Sources of Financing [***] Closing Conditions Definitive agreement will not be subject to any financing contingencies Definitive agreement will not be subject to any financing contingencies Definitive agreement will not be subject to any financing contingencies Definitive agreement will not be subject to any financing or other contingencies Proposal not contingent on anyone signing an employment agreement prior to closing Definitive agreement will not be subject to any financing contingencies Assumptions Share count as of most recent 10-K Assumes the convertible notes are repurchased at the Fundamental Change Repurchase Price with $118M of remaining unpaid PIK interest Assumes BS immediately prior to closing with max $400M debt; min $514M cash /eq.; FDSO no more than 160.9-161.1M Share count as of most recent 10-K Assumes the convertible notes are repurchased at the Fundamental Change Repurchase Price with $123M of remaining unpaid PIK interest - Share count as of most recent 10-K Assumes the company will have a capitalization profile and cash balance, working capital, and indebtedness materially consistent with amounts in the most recent public filings Share count as of most recent 10-K Assumes the convertible notes are repurchased at the Fundamental Change Repurchase Price with $116M of remaining unpaid PIK interest Due Diligence / Management Meetings Confirmatory business 3rd party Quality of Earnings and Quality of Revenue Tax Technology Legal and IP Standard business and confirmatory (finance, accounting, tax, legal, etc.) General business (i.e., business model, customer, financials, etc.) Sales / Engineering org discussion Product / Tech stack Partnerships Confirmatory (accounting, legal, etc.) Standard business and confirmatory (finance, accounting, tax, legal, etc.) Deep-Dives with Functional Leaders Continued Business Analysis Technology / Product Advisors [***] [***] [***] - - Timing With access to management, 30 days to sign a definitive agreement Progress to signing expeditiously With access to management, can operate on any proposed timeline Efficient and timely Efficient and timely Based on unaffected price of $8.47 as of market close on April 16, 2024, the day prior to Reuter's report of Zodiac exploring a potential sale. [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 5

Summary of Verbal Initial Proposals Party Key Contacts Additional Commentary Provided verbal initial proposal of $11.00-12.00 per share Mentioned that there were several variables in the business that warranted consideration prior to submitting an initial proposal (growth deceleration, cost structure, competitive positioning, etc.) Indicated they can speak for the full equity check but they may want to bring in an equity co-invest partner [***] [***] [***] [***] Provided verbal initial proposal of $12.50 per share [***] [***] [***] [***] Provided verbal initial proposal of $12.50-13.25 per share Indicated they will likely require LP co-investor participation Some of their base case assumptions include 200-300 bps reacceleration of growth in the next several quarters with a steady state topline growth rate of 13-14% by years 3-5 and ~25% EBITDA margins Upside case assumes M&A layered into the model for further growth reacceleration Provided verbal initial proposal of $12.00-14.00 per share Thinking of this as a growth opportunity, however there is significant opportunity to improve margins Indicated that they believe the company has suffered from too large of a vision and they are missing out on TAM in core markets While they do not require LP co-investor participation, they would like to engage with potential LP co-investors [***] [***] [***] Financial Sponsors [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 6

Selected Financial Sponsor Feedback Party Key Contacts Additional Commentary On Hold Interested in partnering and would like to be kept in mind; have a strategic asset in [***] Interested in partnering and would like to be kept in mind; have a strategic asset in [***] Potentially open to partnering Passed Passed given competing priorities Passed due to concerns around competitive landscape and future growth Passed given competing priorities Passed due to concerns around competitive landscape and future growth Have not followed the space as closely as others, do not believe they are in a position to be competitive Passed given competing priorities Financial Sponsors [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 7

Party Key Contacts Additional Commentary Scheduling Meeting May 7th 1:00 – 4:00pm PT (Confirmed) May 8th 1:00 – 4:00pm PT (Tentative) On Hold Cannot do deal standalone; indicated they would need a capital partner to help finance the combination Emphasized the significant potential synergies in a combination Indicated that Zodiac could maintain the go-forward brand Pending Initial Discussion Tien speaking with [***] on Wednesday 5/1 Passed Passing as this is not a core focus area today and the dilutive growth profile would be challenging to underwrite Indicated potential willingness to discuss commercial partnership opportunities with [***] at the appropriate time Passing as this is not a core focus area today and they believe there is too much existing product portfolio overlap between Zodiac and [***] Selected Strategic Buyer Feedback Strategic Partners [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 8

Illustrative Zodiac Transaction Statistics Note: Current market prices as of April 26, 2024. Zodiac fiscal year ends January 31. FY used as a proxy for CY. (1) Volume-weighted average prices based on trading days per FactSet as of April 16, 2024. (2) Zodiac capitalization per Zodiac 10-K for the period ended January 31, 2024. Balance sheet statistics per Zodiac 10-K for the period ended January 31, 2024. Includes Convertible Senior Notes due 2029. Current trading value assumes net share settlement treatment for the convertible senior notes. The transaction scenarios assume convertible note is cash settled at the "Fundamental Change Repurchase Price", per Zodiac indenture dated March 24, 2022. Assumes transaction close date of October 31, 2024. (3) Zodiac projections based on FactSet mean consensus estimates as of April 26, 2024. (4) Based on unaffected price as of market close on April 16, 2024, the day prior to Reuter's report of Zodiac exploring a potential sale. (5) Reflects [***] indication of interest of $12.50 - $13.25 per share received on April 26, 2024. (6) Reflects [***] initial proposal of $11.00 - $12.00 per share received on April 26, 2024. (7) Reflects [***] initial proposal of $12.00 - $14.00 per share received on April 26, 2024. (8) Reflects [***] initial proposal of $11.25 - $12.25 per share received on April 26, 2024. (9) Reflects [***] initial proposal of $12.50 per share received on April 26, 2024. (10) Reflects [***] initial proposal of $13.00 - $14.00 per share received on April 26, 2024. (11) Reflects [***] initial proposal of $11.43 per share received on April 26, 2024. (12) Reflects [***] initial proposal of $12.00 - $13.00 per share received on April 26, 2024. (13) Reflects [***] initial proposal of $10.75 - $11.25 per share received on April 27, 2024. ($MM, except per share amounts) Illustrative Zodiac Transaction Statistics Zodiac Unaffected as of (4/16/24) (4) Illustrative Share Price: $8.47 $10.75 $11.00 $11.25 $11.43 $12.00 $12.25 $12.50 $13.00 $13.25 $13.50 $14.00 $14.25 $14.50 Implied Transaction Premium Statistic Premium to Unaffected Price (4) $8.47 - 27% 30% 33% 35% 42% 45% 48% 53% 56% 59% 65% 68% 71% Premium to Unaffected Enterprise Value (4) 1,241 - 38% 41% 45% 47% 55% 58% 61% 68% 71% 75% 81% 85% 88% Premium to Current Price 9.95 (15%) 8% 11% 13% 15% 21% 23% 26% 31% 33% 36% 41% 43% 46% Premium to Current Enterprise Value 1,580 (21%) 8% 11% 14% 16% 22% 24% 27% 32% 35% 37% 43% 45% 48% Premium to 30-Day VWAP (1) (4) 8.78 (4%) 22% 25% 28% 30% 37% 40% 42% 48% 51% 54% 59% 62% 65% Premium to 90-Day VWAP (1) (4) 8.67 (2%) 24% 27% 30% 32% 38% 41% 44% 50% 53% 56% 62% 64% 67% Premium to LTM VWAP (1) (4) 9.09 (7%) 18% 21% 24% 26% 32% 35% 38% 43% 46% 49% 54% 57% 60% Premium to LTM High (6/6/23) (4) 11.81 (28%) (9%) (7%) (5%) (3%) 2% 4% 6% 10% 12% 14% 19% 21% 23% Premium to LTM Low (11/1/23) (4) 7.24 17% 48% 52% 55% 58% 66% 69% 73% 80% 83% 86% 93% 97% 100% Implied Valuation & Multiples Fully-Diluted Equity Value (2) $1,355 $1,729 $1,771 $1,812 $1,842 $1,937 $1,979 $2,020 $2,103 $2,145 $2,186 $2,269 $2,311 $2,352 Fully-Diluted Enterprise Value (2) $1,241 $1,712 $1,754 $1,795 $1,825 $1,920 $1,962 $2,003 $2,086 $2,128 $2,169 $2,252 $2,294 $2,335 Street Case (3) Revenue Multiples Statistic (3) NTM / CY24E $454 2.7x 3.8x 3.9x 4.0x 4.0x 4.2x 4.3x 4.4x 4.6x 4.7x 4.8x 5.0x 5.1x 5.1x CY25E 496 2.5 3.5 3.5 3.6 3.7 3.9 4.0 4.0 4.2 4.3 4.4 4.5 4.6 4.7 LFCF Multiples NTM / CY24E $83 16.3x 20.8x 21.3x 21.8x 22.1x 23.3x 23.8x 24.3x 25.3x 25.8x 26.3x 27.3x 27.8x 28.3x CY25E 95 14.2 18.1 18.6 19.0 19.3 20.3 20.7 21.2 22.0 22.5 22.9 23.8 24.2 24.7 [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 9

Source: FactSet as of April 26, 2024. Based on unaffected price as of market close on April 16, 2024, the day prior to Reuter's report of Zodiac exploring a potential sale. Zodiac Current: $9.95 +17% vs. Unaffected Zodiac Share Price ($) April 17 Reuters report of Zodiac exploring a potential sale released during market hours From April 26, 2022 to Current (April 26, 2024) Comparison of Range of Initial Proposals with Stock Price Performance Zodiac Unaffected: $8.47 (1) Initial Proposals Price Range $10.75 – $14.00


Slide 10

Comparison of Initial Proposals with Selected Transaction Statistics Selected Public Subscription Software Transactions >$1Bn Since 2011, Positive Revenue Growth <=10% Source: Capital IQ, FactSet, company filings, company press releases and Wall Street research. Note: '–' = Not publicly available or not meaningful. Multiples greater than 50.0x or negative considered not meaningful. NTM Revenue Multiple NTM LFCF Multiple Overall Median: 3.8x Overall 25th Percentile: 3.1x Overall 75th Percentile: 5.1x Overall Median: 22.1x Overall 25th Percentile: 17.5x Overall 75th Percentile: 27.8x NTM Rev. Growth(%): 8% 9% 4% 6% 7% 9% 6% 6% 7% 3% 8% 6% 5% 8% 3% 3% 6% 4% 4% 3% 3% 9% 10% 3% 7% 7% 7% 4% 8% 0% NTM LFCF Margin(%): 29% 23% 9% 25% 25% 8% 13% 27% 18% 23% 15% 20% 19% 21% 15% 20% 19% 17% 24% 23% 20% 4% 12% 18% 6% 21% 8% 17% 8% 15% Legend Strategic Sponsor Initial Proposal Range High [***] @ $14.00: 5.0x Initial Proposal Range High {***] @ $14.00: 27.3x Initial Proposal Range Mid [***] @ $12.25: 4.3x Initial Proposal Range Low [***] @ $10.75: 3.8x Initial Proposal Range Mid [***] @ $12.25: 23.8x Initial Proposal Range Low [***] @ $10.75: 20.8x Overall Median: 32% Overall 25th Percentile: 22% Overall 75th Percentile: 44% Initial Proposal Range High [***] @ $14.00: 65% Initial Proposal Range Mid {***] @ $12.25: 45% Initial Proposal Range Low [***] @ $10.75: 27% Premium to Unaffected Stock Price [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 11

Comparison of Initial Proposals with Selected Technology Transaction Premia Premia in Selected >$1Bn Public Technology Transactions Since 2003 Source: FactSet as of April 26, 2024. Note: Based on FactSet premia and unaffected dates for technology M&A transactions greater than $1Bn enterprise value since 2003. 1- Day Premia Paid 427 Total Transactions in Data Set 25th Percentile: 18% Premium 75th Percentile: 45% Premium Median: 28% Premium Mean: 33% Premium Initial Proposal Range High [***] [***] @ $14.00: 65% Initial Proposal Range Mid [***] [***] @ $12.25: 45% Initial Proposal Range Low [***] [***] @ $10.75: 27% [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 12

Zodiac Illustrative Valuation Framework Summary Zodiac Preliminary Management Plan provided by Zodiac management in April 2024. Common shares outstanding, RSUs, PSUs, and options per Zodiac 10-K as of January 31, 2024. Fully-diluted shares calculated using treasury stock method. Fully diluted shares calculated using treasury stock method. Balance sheet statistics per Zodiac 10-K as of January 31, 2024. Based on unaffected price as of market close on April 16, 2024, the day prior to Reuter's report of Zodiac exploring a potential sale. Last twelve months for the period ending April 26, 2024. Based on available brokers with price targets as of April 26, 2024. Zodiac Street Case based on FactSet mean consensus estimates as of April 26, 2024. Zodiac Unaffected: $8.47 (4) Initial Proposals Price Range: $10.75 - $14.00


Slide 13

Next Steps 1 Shut down the process 2. Proceed to Phase 2 – Business and Financial Diligence Admit financial sponsors from Phase 1 Continue ongoing discussions with selected strategics to assess their level of interest Broaden the circle of “in the know” Zodiac team members and finalize preparation of a management presentation and initial data package to be provided under NDA Begin meetings with management the week of May 6 (Share Management Presentation in VDR and set up follow up discussions with sponsors) Do not allow participants to involve debt or equity financing sources Provide details on Q1 results once available (Expected CY24Q1 Earnings Date: May 23rd) Request indications of value on June 4 Based on these indications determine whether to proceed to complete confirmatory diligence (including full data room) and grant access to debt and equity financing sources or shut down the process 1 2 At this juncture, the Special Committee can recommend / determine to proceed in one of two ways


Slide 14

Phase II Phase IV Phase III Illustrative Process Timeline (Assuming Go-Forward) Illustrative Special Committee Meeting (6/4) Phase 3 Prep Populate Detailed VDR Draft Transaction Docs Complete Business & Functional DD Enable Parties Access to Financing Sources Distribute Drafts of Transaction Documentation Final Bid Deadline (6/28) Sign & Announce (Early-Mid July) Confirmatory (Legal, Tax/Accounting) DD Negotiate & Finalize Transaction Illustrative Special Committee Meeting (6/28) Final Special Committee Meeting Special Committee / Board Meetings Process Milestones Holiday Potential Earnings Announcement / Quarter Close Date Key Dates: Indications of Value (May 28th) Final bids (June 28th) Sign & announce (Early-Mid July) April May June May July June 4/29 5/6 5/13 5/20 5/27 6/3 6/10 6/17 6/24 7/1 7/8 Memorial Day (5/27) Estimated Q1’24 Earnings Announcement (5/23) HIGHLY PRELIMINARY | SUBJECT TO CHANGE Finish Negotiating and Executing NDAs Access to Prelim. Data Room Initial Meeting with Management and Follow Up Sessions Juneteenth (6/19) 4th of July (7/4) Final Board Meeting Indications of Value Due (6/4) Special Committee Meeting (4/30)


Slide 15

Appendix Zodiac Preliminary Valuation Framework


Slide 16

Summary of Zodiac Preliminary Management Plan Source: Historical figures per company filings. Zodiac Preliminary Management Plan provided by Zodiac Management in April 2024. Note: Zodiac fiscal year ends January 31. Rule of 40 = Revenue Growth + LFCF Margin. FY29 LFCF does not factor in a long-term effective tax rate. Non-GAAP Operating Income ($MM) Levered Free Cash Flow ($MM) Non-GAAP Operating Margin (%) LFCF Margin (%) ARR ($MM) YoY ARR Growth (%) Revenue ($MM) YoY Revenue Growth (%) 16% 7% 19% 24% 27% 31% 34% 38% Rule of 40(1): Actual Projections Projected CAGR (‘24-’29): 8% Projected CAGR (‘24-’29): 7% Projected CAGR (‘24-’29): 29% Projected CAGR (‘24-’29): 33% Actual Projections Actual Projections Actual Projections Actual Projections Actual Projections Actual Projections Actual Projections (2) (2)


Slide 17

Summary of Zodiac Preliminary Management Plan vs Street Note: Zodiac fiscal year ends January 31. Historical figures per company filings. Zodiac Street Case based on FactSet mean consensus estimates as of April 26, 2024. Zodiac Preliminary Management Plan provided by Zodiac Management in April 2024. Rule of 40 = Revenue Growth + LFCF Margin. Midpoint of guidance shown as a proxy for ARR street estimates. 7 6 # of Brokers for Consensus: 7% 19% 24% 27% 7% 19% 23% 29% Rule of 40(4): Revenue ($MM) Revenue Growth (%) FY24A – FY26E CAGR: Prelim. Mgmt. Plan (3): 6% FY24A – FY26E CAGR: Street Case (2): 7% FY25E Guidance: $451 - $459 Non-GAAP Operating Income ($MM) Non-GAAP Operating Margin (%) FY25E Guidance: $79 - $81 Levered Free Cash Flow ($MM) Levered Free Cash Flow Margin (%) FY25E Guidance: $80+ Legend Historical (1) Street Case (2) Prelim. Mgmt. Plan (3) 7 6 # of Brokers for Consensus: 1 1 # of Brokers for Consensus: ARR ($MM) ARR Growth (%) FY24A – FY26E CAGR: Prelim. Mgmt. Plan (3): 8% FY25E Guidance: $435 - $443 Mgmt: Street: FY25E Guidance: 8% - 10% FY25E Guidance: 4% - 5% FY25E Guidance: 18% FY25E Guidance: 18%+ (5) (5) FY24A – FY26E CAGR: Prelim. Mgmt. Plan (3): 47% FY24A – FY26E CAGR: Street Case (2): 47% FY24A – FY26E CAGR: Prelim. Mgmt. Plan (3): 51% FY24A – FY26E CAGR: Street Case (2): 47%


Slide 18

Zodiac is Primarily Valued on Revenue Today with a Median Price Target of $12 Source: Wall Street research and FactSet prices as of April 2024. Note: Note: Zodiac fiscal year ends January 31. Excludes research reports, price targets, and valuation methodologies unavailable to Qatalyst. Based on unaffected price as of market close on April 16, 2024, the day prior to Reuter's report of Zodiac exploring a potential sale. Analyst Ratings & Valuation Methodologies Summary of Price Targets Valuation Methodology and Broker Recommendation Summary Median represents a 42% premium to the unaffected share price of $8.47(1) Broker Recommendations Over Time Unaff. Price: $8.47(1) Initial Proposal Price Range $10.75 – $14


Slide 19

Zodiac Trading Performance Since IPO From April 12, 2018 to Unaffected (April 26, 2024) NTM Revenue Multiple: Share Price: Source: Company Filings and FactSet as of April 26, 2024. Based on unaffected price as of market close on April 16, 2024, the day prior to Reuter's report of Zodiac exploring a potential sale. e (11%) e +20% e +17% e (20%) e (31%) e (10%) e (19%) e (14%) e +19% Selected Earnings Releases e Legend 1-Day Price Reaction +% Unaffected NTM Revenue Mult: 2.7x (1) Unaffected Share Price: $8.47 (1) Zodiac Current: $9.95 +17% vs. Unaffected Current NTM Revenue Mult: 3.5x


Slide 20

Zodiac Trading Performance Since 2022 From January 3, 2022 to Unaffected (April 26, 2024) NTM Revenue Multiple: Share Price: Unaffected NTM Revenue Mult: 2.7x (1) Source: Company Filings and FactSet as of April 26, 2024. Based on unaffected price as of market close on April 16, 2024, the day prior to Reuter's report of Zodiac exploring a potential sale. Earnings Release e Legend 1-Day Price Reaction +% Announces $400MM convertible investment from Silver Lake ($250MM upfront with $150MM due up to 18 months later) March 2, 2022 – (9%) e (9%) Illustrative Future Trading Multiple Range: 2.0x-4.5x e (6%) Unaffected Share Price: $8.47 (1) e (11%) e +20% e +9% e +17% Praesidium discloses 6% stake February 21, 2023 – +1% Completes remaining $150MM Convert. from Silver Lake September 25, 2023 – (4%) e (6%) e (20%) Announces acquisition of Zephr for $44MM August 24, 2022 – (6%) e +3% Zodiac Current: $9.95 +17% vs. Unaffected Current NTM Revenue Mult: 3.5x


Slide 21

CY24E / NTM Operating Statistics of Selected Companies $454 $457 $603 $805 $475 $767 $617 $2,383 $331 $2,926 $720 $293 $281 $1,083 $661 $1,485 $1,272 $2,544 Source: FactSet consensus estimates as of April 26, 2024. Zodiac Preliminary Management Plan provided by Zodiac management in April 2024. Rule of 40 = Revenue Growth + LFCF margin. Dropbox and Box LFCF adjusted for assets obtained under finance leases. CY24E Revenue ($MM) Selected Subscription Software Legend CY24E Gross Margin (%) 74% 74% 77% 79% 90% 86% 83% 81% 80% 60% 79% 76% 82% 85% 75% 85% 78% 77% (2) (2) (2) (2) NTM UFCF Margin (%) 19% 18% 23% 34% 34% 30% 26% 27% 37% 24% 19% 14% 18% 14% 7% 9% 4% 3% Zodiac Zodiac Zodiac Zodiac (2) (2) CY24E Revenue Growth CY24E Non-GAAP EBIT Margin CY24E Rule of 40 (1) CY24E LFCF Margin


Slide 22

CY24E / NTM Trading Statistics of Selected Companies Ent. Val. ($MM) Source: FactSet consensus estimates as of April 26, 2024. Note: “NM” = Not meaningful or not available. Multiples greater than 50.0x or negative considered not meaningful. Rule of 40 = Revenue Growth + LFCF margin. Dropbox and Box LFCF adjusted for assets obtained under finance leases. Based on unaffected price as of market close on April 16, 2024, the day prior to Reuter's report of Zodiac exploring a potential sale. $1,225 $4,550 $7,262 $3,112 $2,902 $4,669 $2,045 $12,165 $2,824 $1,093 $9,415 $5,347 $2,844 $4,675 $568 $463 Selected Subscription Software Legend (2) (2) (2) (2) Illustrative Future Trading Multiple Range: 2.0x-4.5x Illustrative Future Trading Multiple Range: 12.0x-20.0x Illustrative DCF Multiple Range: 11.0x-19.0x (3) (3) (3) (3) (3) (3) CY24E Revenue Multiple NTM UFCF Multiple CY24E Ro40 Adj. Rev. Mult.(1) CY24E Growth Adj. Rev. Mult. CY24E LFCF Multiple


Slide 23

Illustrative Present Value of Future Share Price Present Value of Future Zodiac Share Price Based on a Range of Revenue Multiples Illustrative Revenue CAGR Driven Sensitivity 3-Year CY27E CY+0 Revenue Multiple Range 2.0x 3.25x 4.5x CY+0 Rev Mult: Revenue-Based Illustrative Future Trading Unaffected (1) 2.7x 4.2x 2.0x 3.7x 4.3x 3.7x Unaffected Price: $8.47 (1) Source: FactSet consensus estimates as of April 26, 2024. Zodiac Preliminary Management Plan provided by Zodiac Management in April 2024. Zodiac fiscal year ends January 31. FY – 1 used as a proxy for CY. Note: Assumes illustrative 14.25% cost of equity and 4% dilution per year due to employee equity issuances. Based on unaffected price as of market close on April 16, 2024, the day prior to Reuter's report of Zodiac exploring a potential sale.


Slide 24

Illustrative Present Value of Future Share Price Present Value of Future Zodiac Share Price Based on a Range of LFCF Multiples Illustrative Revenue CAGR and LFCF Margin Driven Sensitivity 3-Year CY27E CY+0 LFCF Multiple Range CY+0 LFCF Mult: 12.0x 20.0x LFCF-Based Illustrative Future Trading Unaffected (1) 16.3x 16.4x 14.3x 15.3x 17.6x Unaffected Price: $8.47 (1) Source: FactSet consensus estimates as of April 26, 2024. Zodiac Preliminary Management Plan provided by Zodiac Management in April 2024. Zodiac fiscal year ends January 31. FY – 1 used as a proxy for CY. Note: Assumes illustrative 14.25% cost of equity and 4% dilution per year due to employee equity issuances. Based on unaffected price as of market close on April 16, 2024, the day prior to Reuter's report of Zodiac exploring a potential sale.


Slide 25

Summary of Zodiac Preliminary Management Plan UFCF Projections Highly Preliminary and Subject to Change Note: Assumes current shareholders incur 17% cumulative dilution through issuance of equity awards over the projected period. Zodiac Preliminary Management Plan provided by Zodiac management in April 2024. Based on federal NOL balance of $552MM as of January 31, 2024, per Zodiac 10-K for the period ended January 31, 2024.


Slide 26

Zodiac Discounted Cash Flow Analysis Summary of Valuation Assumptions Unlevered free cash flow projections and terminal value discounted to January 31, 2024 using mid-period convention Excludes impact of stock-based compensation, amortization of intangibles, and other non-cash items in unlevered free cash flow Weighted average cost of capital range of 12.0% to 14.0% Terminal value based on NTM UFCF multiple range of 11.0x – 19.0x and terminal year (FY29E) UFCF of $138MM Current shareholders incur 4% annual dilution through issuance of equity awards throughout the projection period Assumed 80% utilization limit per Zodiac management for U.S. Federal NOLs Highly Preliminary and Subject to Change Note: Assumes mid-period discounting convention. Unlevered Free Cash Flows and Terminal Value adjusted by the cumulative dilution to current shareholders in each respective year, and then discounted to present value as of January 31, 2024. Assumes current shareholders incur 4% annual dilution through issuance of equity awards over the projected period. (1) Common shares outstanding, RSUs, PSUs, and options per Zodiac 10-K as of January 31, 2024. Fully-diluted shares calculated using treasury stock method. (2) Fully diluted shares calculated using treasury stock method. Balance sheet statistics per Zodiac 10-K as of January 31, 2024. (3) Zodiac Preliminary Management Plan provided by Zodiac management in April 2024.


Slide 27

Selected Precedent Transactions Selected Public Subscription Software Transactions >$1Bn Since 2011, Positive Revenue Growth <=10% Source: Capital IQ, FactSet, company filings, company press releases and Wall Street research. Note: '–' = Not publicly available or not meaningful. Multiples greater than 50.0x or negative considered not meaningful. Unaffected premium indicates premium based on day prior to rumors of a potential transaction, or premium based on day prior to transaction announcement if no substantial rumors existed. Rule of 40 calculated as Revenue Growth + LFCF Margin. Based on unaffected price as of market close on April 16, 2024, the day prior to Reuter's report of Zodiac exploring a potential sale. [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 28

Appendix Illustrative Take-Private Analysis


Slide 29

Illustrative Sources and Uses at $13.00 Per Share Assumes 10/31/24 Entry Date and 1.9x ARR for Entry Leverage Note: Zodiac fiscal year ends January 31. FY – 1 used as a proxy for CY. (1) ARR estimated by taking the midpoint of FY24A ARR of $403M and FY25E ARR derived from management ARR growth guidance. (2) Assumes 4.5% Cash Interest Rate and 12% Cost of Debt. (3) Based on unaffected price of $8.47 as of market close on April 16, 2024, the day prior to Reuter's report of Zodiac exploring a potential sale. (4) Based on Zodiac 8-K for the period ended January 31, 2024. Interim Free Cash Flow of $42MM for CY24Q1 – CY24Q3 based on FactSet mean consensus estimates April 26, 2024. (5) Assumes convertible note is cash settled at the "Fundamental Change Repurchase Price", per Zodiac indenture dated March 24, 2022.


Slide 30

Illustrative Take Private Returns Analysis Assumes 10/31/24 Entry Date, 1/31/29 Exit Date, 1.9x ARR for Entry Leverage Source: Company Filings and FactSet as of April 26, 2024. Zodiac Preliminary Management Plan provided by Zodiac management in April 2024. Note: Zodiac fiscal year ends January 31. FY – 1 used as a proxy for CY. (1) Based on unaffected price of $8.47 as of market close on April 16, 2024, the day prior to Reuter's report of Zodiac exploring a potential sale. Legend Denotes IRR >25.0% Denotes IRR >22.5% Prelim. Mgmt. Plan FY24A-FY29E CAGR: 7%


Slide 31

Appendix Additional Information


Slide 32

Zodiac Preliminary Management Plan Illustrative NOL Schedule Note: Effective tax rate assumed to be 21%. Federal NOL balance of $552MM as of January 31, 2024, per Zodiac 10-K for the period ended January 31, 2024. Under the US Tax Cuts and Jobs Act, carryforward NOLs are subject to an annual limitation equal to 80% of taxable income. Zodiac Preliminary Management Plan provided by Zodiac management in April 2024. Extrapolations approved by Zodiac management in April 2024.


Slide 33

Trading and Operating Statistics of Selected Companies


Slide 34

Illustrative Zodiac Cost of Capital Calculation (1/2)


Slide 35

Illustrative Zodiac Cost of Capital Calculation (2/2)


Slide 36

Disclaimer

Slide 1

June 2024 Project Zodiac Discussion Materials Exhibit 16(c)(v) [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 2

Process and Proposal Summary


Slide 3

Zodiac Process Summary Contacted [***] Parties: [***] Strategics, [***] Sponsors * Denotes inbound interest. (1) Reflects [***] proposal of $11.41 per share received on June 12, 2024. (2) Reflects [***] proposal of $10.00 - $10.75 per share received on June 12, 2024. Executed NDA and Held Initial Management Meeting [***] Contacted [***] Financial Sponsors [***] Strategics [***] Requested Follow-up Meetings and Materials [***] Submitted Proposals [***] $11.41 Per Share (1) Initial Range: $11.25 - $12.25 per share $10.00 – $10.75 Per Share (2) Initial Range: $12.00 - $14.00 per share Passed After Initial Management Meeting and Business Diligence [***] [***] [***] [***] [***] [***] [***] [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 4

Source: FactSet as of June 14, 2024. Note: Indices shown as average daily change in share price of the individual companies comprising the index. iShares Expanded Tech-Software Sector ETF, composed of North American equities in the software industry. Selected Companies comprised of Amplitude, BlackLine, Box, DocuSign, Dropbox, E2open, Instructure, Pegasystems, RingCentral, Sprinklr, TeamViewer, Zoom, and ZoomInfo. Instructure share price performance included up until unaffected price as of market close on May 17, 2024, the day prior to Reuter's report of Instructure exploring a potential sale. Zodiac Current: $9.61 +13% vs. Pre-Leak (4/16) From Day Prior to Leak (April 16, 2024) to Current (June 14, 2024) Zodiac Short-Term Trading Following Reuter’s Leak April 17 Reuters reports Zodiac exploring a potential sale during market hours 1-Day Price Reaction: +12% Zodiac Trading Volume (MM’s) Share Price May 22 (after market close) Zodiac reports Q1’FY25 Earnings: Revenue of $109.8M (1% beat vs. consensus) Non-GAAP EBIT of $18.6M (25% beat vs. consensus) 1-Day Price Reaction: +4% May 1 (after market close) Announces settlement with Scalar Gauge and appointment of John Harkey to Board of Directors 1-Day Price Reaction: (1%) IGV(1): +3% vs. Pre-Leak (4/16) Selected Companies(2): (7%) vs. Pre-Leak (4/16)


Slide 5

Summary of Proposals Price $11.41 per share 35% premium to unaffected price (1) $10.00 - $10.75 per share 18% - 27% premium to unaffected price (1) Sources & Uses Financing Conditions No financing contingency Did not specify Additional Financing Details Anticipate fully committed capital in place at the time of the signing of the definitive agreement Equity financing will be provided by recently raised [***] and capital from certain limited partners of [***] Requesting access for the following potential co-invest equity LPs: [***] Requested access to the following lenders: [***] Expect to fund the transaction with new equity from [***] primarily from [***] Provided access to [***] as a potential co-invest equity LP Requested access to the following lenders: [***] Remaining Diligence Required Completion of deep dive discussions with management across the following topics: (a) Top Customer / Prospect; (b) Product Roadmap and Engineering Org; (c) Professional Services; (d) System Integrators / Channel Partners; (e) FY25 Forecast Bridge Deep Dive; (f) Go-to-Market Org. Redesign Other due diligence includes Accounting and Tax (led by [***]), Legal (led by[***]), and ESG (led by [***]) Have more work to do to conclude commercial diligence, including gaining conviction in the reacceleration of topline growth following the recent slowdown, sustainability of the Company’s competitive position, and understand the operations of the business in more detail Remaining Commercial meeting and information request topics: (a) Finance, (b) GTM, (c) Implementation, (d) Customer Deep Dive, (e) Competition, (f) Growth & M&A Other meeting and information request topics include Product / Tech, Tax / Accounting, Legal / HR Exclusivity Requested 4 weeks of exclusivity Did not request exclusivity Would like clear feedback on the number of parties included in the next round Timing 3 to 4 weeks to sign a deal assuming continued access to management and requested information for confirmatory diligence, and immediate permission to speak with lenders and selective LPs Assuming full access to management and data, expect to complete the remainder of the work in approximately 4 weeks Based on unaffected price as of market close on April 16, 2024, the day prior to Reuter's report of Zodiac exploring a potential sale. As provided by [***] on June 12, 2024. ARR estimated by taking the midpoint of FY24A ARR of $403M and FY25E ARR derived from management ARR growth guidance. Estimated debt quantum and capitalization assumptions provided by [***] on June 12, 2024. Cash and cash equivalents, short term investments, and face value of convertible debt per Zodiac management for the period ended April 30, 2024. Net cash balance reflects $21MM cash outflow for Togai acquisition on May 9, 2024. Assumes Convertible Notes are cash settled at the "Fundamental Change Repurchase Price", per Zodiac indenture dated March 24, 2022, assuming an illustrative transaction close date of October 31, 2024. [***] [***] [***] [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 6

Illustrative Zodiac Transaction Statistics Note: Current market prices as of June 14, 2024. Zodiac fiscal year ends January 31. Zodiac FY-1 used as proxy for CY. (1) Volume-weighted average prices based on trading days per FactSet as of April 16, 2024. (2) Common shares outstanding, RSUs, PSUs, options, and warrants as of May 30, 2024 per Zodiac management. Fully-diluted shares calculated using treasury stock method. Warrant shares issuable upon exercise and exercise prices adjusted in transaction scenarios as set forth under the Make-Whole Fundamental Change section in the Form of Warrant filed on March 24, 2022. Assumes an illustrative transaction close date of October 31, 2024. Transaction scenarios reflect cancellation of April 2024 CEO PSUs since share price hurdle is not met in a Change in Control, per Zodiac management. (3) Cash and cash equivalents, short term investments, and face value of convertible debt per Zodiac management for the period ended April 30, 2024. Net cash balance reflects $21MM cash outflow for Togai acquisition on May 9, 2024. Impact of Convertible Senior Notes due 2029 reflected in Enterprise Value based on Zodiac indenture dated March 24, 2022. Transaction scenarios assume Convertible Notes are cash settled at the "Fundamental Change Repurchase Price", per Zodiac indenture dated March 24, 2022. Assumes an illustrative transaction close date of October 31, 2024. (4) Based on unaffected price as of market close on April 16, 2024, the day prior to Reuter's report of Zodiac exploring a potential sale. (5) Zodiac projections based on FactSet mean consensus estimates as of June 14, 2024. Zodiac LFCF projections based on a single broker’s estimates as of June 14, 2024 per FactSet. (6) Rule of 40 = Revenue Growth + LFCF margin. (7) Reflects [***] proposal of $11.41 per share received on June 12, 2024. (8) Reflects [***] proposal of $10.00 - $10.75 per share received on June 12, 2024. [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission. ($MM, except per share amounts) Zodiac Illustrative Zodiac Transaction Statistics Unaffected as [*** ]Proposal (8) [***] of (4/16/24) (4) Low High Proposal (7) Illustrative Share Price: $8.47 $10.00 $10.75 $11.41 $11.50 $11.75 $12.00 Implied Transaction Premium Statistic Premium to Unaffected Price (4) $8.47 - 18% 27% 35% 36% 39% 42% Premium to Unaffected Enterprise Value (4) 1,288 - 27% 37% 46% 47% 50% 54% Premium to Current Price 9.61 (12%) 4% 12% 19% 20% 22% 25% Premium to Current Enterprise Value 1,481 (13%) 11% 19% 27% 28% 31% 34% Premium to 30-Day Unaffected VWAP (1) (4) 8.78 (4%) 14% 22% 30% 31% 34% 37% Premium to 90-Day Unaffected VWAP (1) (4) 8.67 (2%) 15% 24% 32% 33% 36% 38% Premium to LTM Unaffected VWAP (1) (4) 9.09 (7%) 10% 18% 26% 27% 29% 32% Premium to Unaffected LTM High (6/6/23) (4) 11.81 (28%) (15%) (9%) (3%) (3%) (1%) 2% Premium to Unaffected LTM Low (11/1/23) (4) 7.24 17% 38% 48% 58% 59% 62% 66% Implied Valuation & Multiples Fully-Diluted Equity Value (2) $1,414 $1,670 $1,796 $1,907 $1,922 $1,965 $2,007 Fully-Diluted Enterprise Value (2) (3) $1,288 $1,642 $1,769 $1,880 $1,895 $1,937 $1,980 Street Case (5) Revenue Multiples Statistic (5) CY24E $456 2.8x 3.6x 3.9x 4.1x 4.2x 4.3x 4.3x NTM (ending 4/30/25) 465 2.8 3.5 3.8 4.0 4.1 4.2 4.3 CY25E 498 2.6 3.3 3.6 3.8 3.8 3.9 4.0 EBITDA Multiples NTM (ending 4/30/25) $97 13.3x 16.9x 18.2x 19.4x 19.6x 20.0x 20.4x CY25E 113 11.4 14.5 15.6 16.6 16.7 17.1 17.5 LFCF Multiples CY24E $84 16.8x 19.9x 21.4x 22.7x 22.9x 23.4x 23.9x NTM (ending 4/30/25) 88 16.0 18.9 20.3 21.6 21.7 22.2 22.7 CY25E 96 14.8 17.4 18.7 19.9 20.1 20.5 20.9 Growth-Adjusted Revenue Multiple NTM (ending 4/30/25) 6% 0.45x 0.57x 0.62x 0.66x 0.66x 0.68x 0.69x Rule of 40-Adjusted Revenue Multiple (6) NTM (ending 4/30/25) 25% 0.11x 0.14x 0.15x 0.16x 0.16x 0.17x 0.17x


Slide 7

Comparison of Proposals with Selected Transaction Multiples Selected Public Subscription Software Transactions >$1Bn Since 2011, Revenue Growth <=10% Source: Capital IQ, FactSet, company filings, company press releases and Wall Street research. Note: ‘NM' = Not publicly available or not meaningful. Multiples greater than 50.0x or negative considered not meaningful. NTM Revenue and LFCF based on mean analyst consensus estimates for the next twelve month period as of transaction announcement. NTM revenue growth based on NTM revenue and revenue from the last completed twelve month (LTM) period with public filings as of transaction announcement. Reflects [***] proposal of $11.41 per share received on June 12, 2024. Reflects [***] proposal of $10.00 - $10.75 per share received on June 12, 2024. Rule of 40 = Revenue Growth + LFCF Margin. NTM Revenue Multiple(1) Overall Median: 3.8x Overall 25th Percentile: 3.1x Overall 75th Percentile: 5.1x NTM Rev. Growth(%): 8% 9% 4% 6% 7% 9% 6% 6% 7% 3% 8% 6% 5% 8% 3% 3% 6% 4% 4% 3% 3% 9% 10% 3% 7% 7% 4% 7% 8% 0% NTM LFCF Margin(%): 29% 23% 9% 25% 25% 8% 13% 27% 18% 23% 15% 20% 19% 21% 15% 21% 19% 17% 24% 23% 18% 4% 12% 18% 6% 21% 17% 13% 8% 14% NTM Growth Adj. Revenue Multiple(1) Overall Median: 0.81x Overall 25th Percentile: 0.57x Overall 75th Percentile: 1.00x [***] Proposal @ $11.41: 4.0x (2) [***] Proposal @ $11.41: 0.66x (2) NTM Rule of 40 Adj. Revenue Multiple(1)(4) Overall Median: 0.17x Overall 25th Percentile: 0.14x Overall 75th Percentile: 0.21x [***] Proposal @ $11.41: 0.16x (2) [***] Proposal Low @ $10.00: 3.5x (3) [***] Proposal High @ $10.75: 3.8x (3) [***] Proposal Low @ $10.00: 0.57x (3) [***] Proposal High @ $10.75: 0.62x (3) [***] Proposal Low @ $10.00: 0.14x (3) [***} Proposal High @ $10.75: 0.15x (3) Legend Strategic Sponsor [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 8

Comparison of Proposals with Selected Transaction Multiples (CONT’D) Selected Public Subscription Software Transactions >$1Bn Since 2011, Revenue Growth <=10% Source: Capital IQ, FactSet, company filings, company press releases and Wall Street research. Note: ‘NM' = Not publicly available or not meaningful. Multiples greater than 50.0x or negative considered not meaningful. NTM EBITDA and LFCF based on mean analyst consensus estimates for the next twelve month period as of transaction announcement. Reflects [***] proposal of $11.41 per share received on June 12, 2024. Reflects [***] proposal of $10.00 - $10.75 per share received on June 12, 2024. NTM EBITDA Multiple(1) Legend Strategic Sponsor Overall 75th Percentile: 19.7x Overall 25th Percentile: 12.1x Overall Median: 16.0x [***] Proposal @ $11.41: 19.4x (2) NTM LFCF Multiple(1) Overall Median: 21.5x Overall 25th Percentile: 17.4x Overall 75th Percentile: 26.7x [***] Proposal @ $11.41: 21.6x (2) [***] Proposal Low @ $10.00: 16.9x (3) [***] Proposal High @ $10.75: 18.2x (3) [***] Proposal Low @ $10.00: 18.9x (3) [***] Proposal High @ $10.75: 20.3x (3) [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 9

Comparison of Proposals with Selected Transaction Premiums Selected Public Subscription Software Transactions >$1Bn Since 2011, Revenue Growth <=10% Source: Capital IQ, FactSet, company filings, company press releases and Wall Street research. Unaffected premium indicates premium based on day prior to rumors of a potential transaction, or premium based on day prior to transaction announcement if no substantial rumors existed. Reflects [***] proposal of $11.41 per share received on June 12, 2024. Reflects [***] proposal of $10.00 - $10.75 per share received on June 12, 2024. Premium to Unaffected Stock Price(1) Premium to Unaffected Enterprise Value(1) Overall 25th Percentile: 20% Overall 75th Percentile: 44% Overall Median: 31% [***] Proposal @ $11.41: 35% (2) Overall Median: 30% Overall 25th Percentile: 22% Overall 75th Percentile: 38% [***] Proposal @ $11.41: 46% (2) Premium to Unaffected LTM-High Stock Price(1) Overall Median: (1%) Overall 25th Percentile: (14%) Overall 75th Percentile: 10% [***] Proposal @ $11.41: (3%) (2) [***] Proposal Low @ $10.00: 18% (3) [***] Proposal High @ $10.75: 27% (3) [***] Proposal Low @ $10.00: (15%) (3) [***] Proposal High @ $10.75: (9%) (3) [***] Proposal Low @ $10.00: 27% (3) [***] Proposal High @ $10.75: 37% (3) Legend Strategic Sponsor [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 10

Comparison of Proposals with Selected Technology Transaction Premia Premia in Selected >$1Bn Public Technology Transactions Since 2003 Source: FactSet as of June 14, 2024. Note: Based on FactSet premia and unaffected dates for technology M&A transactions greater than $1Bn enterprise value since 2003. Reflects [***] proposal of $11.41 per share received on June 12, 2024. Reflects [***] proposal of $10.00 - $10.75 per share received on June 12, 2024. 1- Day Premia Paid 427 Total Transactions in Data Set 75th Percentile: 45% Premium Median: 28% Premium Mean: 33% Premium [***] Proposal @ $11.41: 35% (1) 25th Percentile: 18% Premium [***] Proposal High @ $10.75: 27% (2) [***] Proposal Low @ $10.00: 18% (2) [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 11

Range of Proposals(2): $10.00 - $11.41 Source: FactSet as of June 14, 2024. Based on unaffected price as of market close on April 16, 2024, the day prior to Reuter's report of Zodiac exploring a potential sale. Reflects [***] proposal of $11.41 per share received on June 12, 2024 and [***] proposal of $10.00 - $10.75 per share received on June 12, 2024. Zodiac Current: $9.61 Zodiac Share Price ($) From June 14, 2022 to Current (June 14, 2024) Comparison of Proposals with Stock Price Performance Over The Last Two Years April 17 Reuters report of Zodiac exploring a potential sale released during market hours Zodiac Unaffected: $8.47 (1) [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 12

Zodiac Financial Overview and Preliminary Valuation Analysis


Slide 13

Summary of Zodiac Preliminary Management Plan Source: Historical figures per company filings. Zodiac Preliminary Management Plan provided by Zodiac Management in April 2024. Note: Zodiac fiscal year ends January 31. Rule of 40 = Revenue Growth + LFCF Margin. FY29 LFCF does not factor in a long-term effective tax rate. Non-GAAP Operating Income ($MM) Levered Free Cash Flow ($MM) Non-GAAP Operating Margin (%) LFCF Margin (%) ARR ($MM) YoY ARR Growth (%) Revenue ($MM) YoY Revenue Growth (%) 16% 7% 19% 24% 27% 31% 34% 38% Rule of 40(1): Actual Projections Projected CAGR (‘24-’29): 8% Projected CAGR (‘24-’29): 7% Projected CAGR (‘24-’29): 29% Projected CAGR (‘24-’29): 33% Actual Projections Actual Projections Actual Projections Actual Projections Actual Projections Actual Projections Actual Projections (2) (2)


Slide 14

Summary of Zodiac Preliminary Management Plan vs Street Note: Zodiac fiscal year ends January 31. Historical figures per company filings. Zodiac Street Case based on FactSet mean consensus estimates as of June 14, 2024. Zodiac Preliminary Management Plan provided by Zodiac Management in April 2024. Rule of 40 = Revenue Growth + LFCF Margin. Midpoint of guidance shown as a proxy for ARR street estimates. 5 5 # of Brokers for Consensus: 7% 19% 24% 27% 7% 19% 24% 28% Rule of 40(4): FY24A – FY26E CAGR: Prelim. Mgmt. Plan (3): 6% FY24A – FY26E CAGR: Street Case (2): 7% FY25E Guidance: $451 - $459 FY25E Guidance: $80 - $82 FY25E Guidance: $80+ Legend Historical (1) Street Case (2) Prelim. Mgmt. Plan (3) 6 6 # of Brokers for Consensus: 1 1 # of Brokers for Consensus: FY24A – FY26E CAGR: Prelim. Mgmt. Plan (3): 8% FY25E Guidance: $435 - $443 Mgmt: Street: FY25E Guidance: 8% - 10% FY25E Guidance: 4% - 6% FY25E Guidance: 18% FY25E Guidance: 18%+ (5) (5) FY24A – FY26E CAGR: Prelim. Mgmt. Plan (3): 47% FY24A – FY26E CAGR: Street Case (2): 47% FY24A – FY26E CAGR: Prelim. Mgmt. Plan (3): 51% FY24A – FY26E CAGR: Street Case (2): 47% Non-GAAP Operating Income ($MM) Levered Free Cash Flow ($MM) ARR ($MM) Revenue ($MM) Non-GAAP Operating Margin (%) LFCF Margin (%) YoY ARR Growth (%) YoY Revenue Growth (%)


Slide 15

Zodiac is Primarily Valued on Revenue Today with a Median Price Target of $13 Source: Wall Street research and FactSet as of June 14, 2024. Note: Zodiac fiscal year ends January 31. Based on unaffected price as of market close on April 16, 2024, the day prior to Reuter's report of Zodiac exploring a potential sale. Reflects [***] proposal of $11.41 per share received on June 12, 2024 and [***] proposal of $10.00 - $10.75 per share received on June 12, 2024. Analyst Ratings & Valuation Methodologies Summary of Price Targets Valuation Methodology and Broker Recommendation Summary Median represents a 53% premium to the unaffected share price of $8.47(1) Broker Recommendations Over Time Range of Proposals(2): $10.00 - $11.41 [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 16

Zodiac Trading Performance Since 2022 From January 3, 2022 to Current (June 14, 2024) NTM Revenue Multiple: Share Price: Unaffected NTM Revenue Mult: 2.8x (1) Source: Company Filings and FactSet as of June 14, 2024. Based on unaffected price as of market close on April 16, 2024, the day prior to Reuter's report of Zodiac exploring a potential sale. Announces $400MM convertible investment from Silver Lake ($250MM upfront with $150MM due up to 18 months later) March 2, 2022 – (9%) e (9%) e (6%) Unaffected Share Price: $8.47 (1) e (11%) e +20% e +9% e +17% Praesidium discloses 6% stake February 21, 2023 – +1% e (6%) e (20%) e +3% Reuters reports Zodiac exploring a potential sale during market hours April 17, 2024 – +12% Illustrative Future Trading CY+1 Mult. Range: 2.0x-4.5x Implied NTM Multiple Range: 2.1x-4.8x Announces acquisition of Zephr for $44MM August 24, 2022 – (6%) Selected Earnings Releases e Legend 1-Day Price Reaction +% Announces 8% RIF February 1, 2024 – (5%) Announces settlement with Scalar Gauge and appointment of John Harkey to Board of Directors May 1, 2024 – (1%) Completes remaining $150MM Convert. from Silver Lake September 25, 2023 – (4%) Zodiac Current: $9.61 +13% vs. Unaffected Current NTM Revenue Mult: 3.2x


Slide 17

Operating Statistics of Selected Companies $498 $487 $603 $728 $709 $321 $2,583 $1,363 $1,602 $770 $1,150 $832 $3,103 $662 $4,772 $2,608 Source: FactSet consensus estimates as of June 14, 2024. Zodiac Preliminary Management Plan provided by Zodiac management in April 2024. Rule of 40 = Revenue Growth + LFCF margin. Dropbox LFCF and UFCF adjusted for assets obtained under finance leases. CY25E Revenue ($MM) CY25E Gross Margin (%) 75% 75% 77% 79% 90% 79% 83% 90% 80% 82% 68% 77% 79% 80% 76% 77% (2) (2) NTM UFCF Margin (%) 19% 16% 26% 34% 34% 28% 31% 27% 28% 36% 24% 14% 20% 28% 8% 4% Zodiac (2) CY25E Revenue Growth CY25E Non-GAAP EBIT Margin CY25E Rule of 40 (1) CY25E LFCF Margin Zodiac Zodiac Zodiac Selected Companies Legend


Slide 18

Trading Statistics of Selected Companies Ent. Val. ($MM) Source: FactSet consensus estimates as of June 14, 2024. Zodiac common shares outstanding, RSUs, PSUs, options, and warrants as of May 30, 2024 per Zodiac management. Fully-diluted shares calculated using treasury stock method. Proposals reflect cancellation of April 2024 CEO PSUs as share price hurdle is not met in a Change in Control, per Zodiac management. Cash and cash equivalents, short term investments, and face value of convertible debt per Zodiac management for the period ended April 30, 2024. Net cash balance reflects $21MM cash outflow for Togai acquisition on May 9, 2024. Transaction scenarios assume Convertible Notes are cash settled at the "Fundamental Change Repurchase Price", per Zodiac indenture dated March 24, 2022. Zodiac FY-1 used as proxy for CY. Note: “NM” = Not meaningful or not available. Multiples greater than 50.0x or negative considered not meaningful. Rule of 40 = Revenue Growth + LFCF margin. Dropbox LFCF adjusted for assets obtained under finance leases. Based on unaffected price as of market close on April 16, 2024, the day prior to Reuter's report of Zodiac exploring a potential sale. Based on unaffected price as of market close on May 17, 2024, the day prior to Reuter's report of Instructure exploring a potential sale. Reflects [***] proposal range of $10.00 - $10.75 per share received on June 12, 2024. EV shown at midpoint of [***] proposal range. Reflects [***] proposal of $11.41 per share received on June 12, 2024. $1,288 $1,706 $1,880 $4,160 $3,177 $5,665 $4,599 $2,629 $10,626 $2,444 $8,137 $4,923 $875 $11,719 $1,879 $4,432 Selected Companies Legend (2) Illustrative FT CY+1 Rev. Mult. Range 2.0x-4.5x (3) (3) (3) (3) CY25E Revenue Multiple CY25E Ro40 Adj. Revenue Multiple(1) CY25E Growth Adj. Revenue Multiple (4) (4) (4) (5) (5) (5) (5) (4) Implied FT Growth Adj. Rev. Mult Range: 0.22x-0.49x Implied FT R40 Adj. Rev. Mult Range: 0.07x-0.16x (6) (6) (6) (6) As of 4/26 (Prev. SC Mtg) 4.3x – 5.3x 4.0x – 3.9x 3.6x 3.6x 3.3x 3.4x – 3.2x 1.8x As of 4/26 (Prev. SC Mtg) 1.09x – – 0.57x 0.43x 0.65x 0.60x – 0.46x 0.43x 0.29x 0.34x 0.22x As of 4/26 (Prev. SC Mtg) – 0.18x 0.11x – 0.13x 0.11x 0.12x 0.11x 0.10x 0.10x 0.09x – 0.07x [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission. [***] [***] [***] [***] [***] [***]


Slide 19

Trading Statistics of Selected Companies (CONT’D) Source: FactSet consensus estimates as of June 14, 2024. Zodiac common shares outstanding, RSUs, PSUs, options, and warrants as of May 30, 2024 per Zodiac management. Fully-diluted shares calculated using treasury stock method. Proposals reflect cancellation of April 2024 CEO PSUs as share price hurdle is not met in a Change in Control, per Zodiac management. Cash and cash equivalents, short term investments, and face value of convertible debt per Zodiac management for the period ended April 30, 2024. Net cash balance reflects $21MM cash outflow for Togai acquisition on May 9, 2024. Transaction scenarios assume Convertible Notes are cash settled at the "Fundamental Change Repurchase Price", per Zodiac indenture dated March 24, 2022. Zodiac FY-1 used as proxy for CY. Note: “NM” = Not meaningful or not available. Multiples greater than 50.0x or negative considered not meaningful. Rule of 40 = Revenue Growth + LFCF margin. Dropbox LFCF and UFCF adjusted for assets obtained under finance leases. Based on unaffected price as of market close on April 16, 2024, the day prior to Reuter's report of Zodiac exploring a potential sale. Based on unaffected price as of market close on May 17, 2024, the day prior to Reuter's report of Instructure exploring a potential sale. Reflects [***] proposal range of $10.00 - $10.75 per share received on June 12, 2024. Bar shown at midpoint of [***] proposal range. Reflects [***] proposal of $11.41 per share received on June 12, 2024. Selected Companies Legend (2) Illustrative FT LFCF Mult. Range: 9.0x-19.0x (3) CY25E LFCF Multiple (4) (5) (6) Illustrative DCF NTM Terminal Mult Range: 10.0x-17.0x (3) NTM UFCF Multiple (4) (2) (5) (6) As of 4/26 (Prev. SC Mtg) – 47.8x 12.7x 16.1x – 14.9x 16.0x 16.6x 12.1x 11.6x 10.6x – NM As of 4/26 (Prev. SC Mtg) 47.2x 28.0x – 13.7x – 12.7x 13.3x 14.6x – 13.5x 10.5x 8.9x 6.4x [***] [***] [***] [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 20

Illustrative Present Value of Future Share Price Present Value of Future Zodiac Share Price Based on a Range of Multiples Source: Zodiac Preliminary Management Plan provided by Zodiac Management in April 2024. Zodiac fiscal year ends January 31. FY – 1 used as a proxy for CY. Note: Assumes illustrative 14.0% cost of equity and 4% dilution per year due to employee equity issuances, per Zodiac management. Common shares outstanding, RSUs, PSUs, options, and warrants as of May 30, 2024 per Zodiac management. Fully-diluted shares calculated using treasury stock method. Cash and cash equivalents, short term investments, and face value of convertible debt per Zodiac management for the period ended April 30, 2024. Net cash balance reflects $21MM cash outflow for Togai acquisition on May 9, 2024. Reflects [***] proposal of $11.41 per share received on June 12, 2024 and [***] proposal of $10.00 - $10.75 per share received on June 12, 2024. Rule of 40 = Revenue Growth + LFCF Margin. Based on unaffected price as of market close on April 16, 2024, the day prior to Reuter's report of Zodiac exploring a potential sale. 2.0x 3.25x 4.5x CY+1 Rev Mult: Revenue-Based Illustrative Future Trading LFCF-Based Illustrative Future Trading CY+1 LFCF Mult: 9.0x 19.0x Range of Proposals(1): $10.00 - $11.41 Unaffected Street (3) 2.6x Unaffected Street (3) 14.8x [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 21

Summary of Zodiac Preliminary Management Plan UFCF Projections Highly Preliminary and Subject to Change Note: Assumes current shareholders incur 14% cumulative dilution through issuance of equity awards over the projected period. Zodiac Preliminary Management Plan provided by Zodiac management in April 2024. Capital Expenditures includes Capitalized Software Development Expense.


Slide 22

Zodiac Discounted Cash Flow Analysis Summary of Valuation Assumptions Unlevered free cash flow projections and terminal value discounted to April 30, 2024 using mid-period convention Excludes impact of stock-based compensation, amortization of intangibles, and other non-cash items in unlevered free cash flow Weighted average cost of capital range of 11.5% to 13.5% Terminal value based on NTM UFCF multiple range of 10.0x – 17.0x and terminal year (FY29E) UFCF of $138MM Current shareholders incur ~4% annual dilution through issuance of equity awards throughout the projection period Assumed 80% utilization limit per Zodiac management for U.S. Federal NOLs, with full NOL utilization by FY32E Highly Preliminary and Subject to Change Note: Zodiac Preliminary Management Plan provided by Zodiac management in April 2024. Assumes mid-period discounting convention. Unlevered Free Cash Flows and Terminal Value adjusted by the cumulative dilution to current shareholders in each respective year, and then discounted to present value as of April 30, 2024. Assumes current shareholders incur ~4% annual dilution through issuance of equity awards over the projected period, per Zodiac management. Common shares outstanding, RSUs, PSUs, options, and warrants as of May 30, 2024 per Zodiac management. Fully-diluted shares calculated using treasury stock method. Assumes 100% attainment of PSUs, per Zodiac management. Cash and cash equivalents, short term investments, and face value of convertible debt per Zodiac management for the period ended April 30, 2024. Net cash balance reflects $21MM cash outflow for Togai acquisition on May 9, 2024.


Slide 23

Selected Precedent Transactions Selected Public Subscription Software Transactions >$1Bn Since 2011, Revenue Growth <=10% Source: Capital IQ, FactSet, company filings, company press releases and Wall Street research. Note: '–' = Not publicly available or not meaningful. Multiples greater than 50.0x or negative considered not meaningful. Unaffected premium indicates premium based on day prior to rumors of a potential transaction, or premium based on day prior to transaction announcement if no substantial rumors existed. Rule of 40 calculated as Revenue Growth + LFCF Margin. NTM revenue and LFCF based on mean analyst consensus estimates for the next twelve month period as of transaction announcement. NTM revenue growth based on NTM revenue and revenue from the last completed twelve month (LTM) period with public filings as of transaction announcement. Reflects [***] proposal of $11.41 per share received on June 12, 2024. Zodiac consensus estimates per FactSet as of June 14, 2024. Reflects [***] proposal of $10.00 - $10.75 per share received on June 12, 2024. Zodiac consensus estimates per FactSet as of June 14, 2024. Common shares outstanding, RSUs, PSUs, options, and warrants as of May 30, 2024 per Zodiac management. Fully-diluted shares calculated using treasury stock method. Warrant shares issuable upon exercise and exercise prices adjusted in transaction scenarios as set forth under the Make-Whole Fundamental Change section in the Form of Warrant filed on March 24, 2022. Assumes an illustrative transaction close date of October 31, 2024. Transaction scenarios reflect cancellation of April 2024 CEO PSUs since share price hurdle is not met in a Change in Control, per Zodiac management. Cash and cash equivalents, short term investments, and face value of convertible debt per Zodiac management for the period ended April 30, 2024. Net cash balance reflects $21MM cash outflow for Togai acquisition on May 9, 2024. Impact of Convertible Senior Notes due 2029 reflected in Enterprise Value based on Zodiac indenture dated March 24, 2022. Transaction scenarios assume Convertible Notes are cash settled at the "Fundamental Change Repurchase Price", per Zodiac indenture dated March 24, 2022. Assumes an illustrative transaction close date of October 31, 2024. [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission. ($MM) Premium (1) NTM Operating Statistics Annc. FD Equity FD Enterprise NTM Transaction Mults (3) Unaffected Revenue EBITDA LFCF Rule of Date Target Acquiror Value Value Revenue Gr. Adj. Rev. Ro40 Adj. (2) EBITDA LFCF 1-Day Price 1-Day EV LTM High Growth Margin Margin 40 (2) 04/08/24 Model N Vista Equity Partners $1,285 $1,274 4.8x 0.89x 0.20x 24.5x 25.8x 11% 11% (16%) 5% 19% 19% 24% 03/01/24 Everbridge Thoma Bravo 1,545 1,786 3.9 1.21 0.22 17.5 22.9 47% 38% (0%) 3% 22% 15% 18% 09/21/23 Splunk Cisco 28,133 29,552 7.1 0.80 0.22 30.9 29.3 31% 38% 26% 9% 23% 23% 32% 09/06/23 NextGen Healthcare Thoma Bravo 1,638 1,750 2.4 0.31 0.16 19.2 28.8 46% 30% 15% 8% 13% 8% 15% 08/09/23 Avid STG 1,228 1,408 3.0 0.32 0.14 13.8 22.3 32% 27% (19%) 10% 22% 12% 21% 05/04/23 Software AG Silver Lake 2,667 2,945 2.6 0.39 0.20 14.4 37.5 60% 40% (2%) 7% 18% 6% 13% 03/13/23 Momentive STG 1,492 1,474 3.0 0.99 0.14 16.0 17.0 46% 47% (48%) 3% 19% 18% 21% 05/26/22 VMware Broadcom 61,083 70,200 5.1 0.85 0.16 15.1 16.6 44% 37% (17%) 6% 34% 27% 33% 05/04/22 Black Knight Intercontinental Exchange 13,259 15,873 9.7 1.22 0.26 19.7 28.2 43% 34% 2% 8% 49% 29% 37% 01/31/22 Citrix Evergreen Coast & Vista 13,633 16,519 5.1 1.84 0.19 16.0 17.9 30% 24% (28%) 3% 32% 23% 26% 12/20/21 Cerner Oracle 28,305 28,938 4.8 0.86 0.19 14.1 23.9 20% 19% 14% 6% 34% 20% 25% 08/05/21 Cornerstone OnDemand Clearlake 4,127 5,238 5.9 0.80 0.18 18.8 18.4 31% 27% 4% 7% 31% 25% 33% 06/28/21 QAD Thoma Bravo 1,961 1,824 5.3 0.57 0.30 – – 20% 22% 11% 9% 10% 8% 17% 06/01/21 Cloudera KKR & CD&R 5,285 4,884 5.2 0.81 0.26 30.4 41.9 24% 27% (16%) 6% 17% 13% 20% 12/17/19 LogMeIn Francisco Partners 4,337 4,418 3.4 0.87 0.12 10.7 14.0 25% 25% (11%) 4% 32% 24% 28% 02/12/19 Ellie Mae Thoma Bravo 3,689 3,347 6.8 1.88 0.55 31.0 – 21% 24% (15%) 4% 22% 9% 12% 12/23/18 MYOB KKR 1,423 1,708 4.9 0.59 0.21 12.1 27.5 14% 11% (10%) 8% 41% 15% 23% 10/10/18 Imperva Thoma Bravo 2,117 1,863 5.1 0.74 0.20 45.1 32.2 29% 35% (2%) 7% 11% 18% 25% 11/27/17 Barracuda Networks Thoma Bravo 1,605 1,398 3.6 0.61 0.14 18.8 21.5 16% 19% 6% 6% 19% 19% 25% 09/19/16 Infoblox Vista Equity Partners 1,607 1,349 3.6 1.15 0.15 20.0 20.7 73% 104% (5%) 3% 18% 21% 24% 08/31/16 Interactive Intelligence Genesys (Permira) 1,620 1,421 3.2 0.35 0.25 39.0 – 36% 44% 32% 9% 8% 4% 13% 07/07/16 AVG Avast 1,341 1,452 3.2 1.00 0.13 9.0 13.2 34% 31% (13%) 3% 36% 23% 26% 04/07/15 Informatica Permira & CPP 5,295 4,874 4.3 0.54 0.15 18.1 22.1 27% 30% 17% 8% 24% 21% 29% 02/02/15 Advent Software SS&C Technologies 2,501 2,683 6.4 1.14 0.21 18.0 24.1 44% 41% 26% 6% 36% 25% 30% 12/15/14 Riverbed Thoma Bravo 3,543 3,580 3.2 1.17 0.15 10.8 17.4 16% 16% (6%) 3% 30% 18% 21% 11/25/14 Advanced Computer Software Vista Equity Partners 1,138 1,196 3.5 0.95 0.17 14.9 19.2 17% 16% 10% 4% 23% 17% 21% 11/18/13 UNIT4 Advent International 1,572 1,703 2.4 0.33 0.12 11.1 17.5 33% 30% 32% 7% 22% 13% 20% 07/02/12 Quest Software Dell 2,529 2,386 2.5 0.34 0.09 10.9 12.8 44% 53% 1% 7% 23% 21% 28% 12/09/11 Blue Coat Systems Thoma Bravo 1,181 919 2.0 - 0.13 11.9 17.5 48% 61% (19%) 0% 16% 14% 15% 04/26/11 Lawson Software Infor (Golden Gate Capital) 1,966 1,928 2.4 0.68 0.12 10.8 14.3 14% 16% 8% 4% 23% 17% 21% Median: 3.8x 0.81x 0.17x 16.0x 21.5x 31% 30% (1%) 6% 22% 18% 24% Mean: 4.3 0.83 0.19 18.7 22.4 33% 33% (1%) 6% 24% 17% 23% 25th Percentile: 3.1 0.57 0.14 12.1 17.4 20% 22% (14%) 4% 18% 14% 20% 75th Percentile: 5.1 1.00 0.21 19.7 26.7 44% 38% 10% 8% 31% 22% 27% [***] Proposal @ $11.41 (4)(6)(7) 4.0x 0.66x 0.16x 19.4x 21.6x 35% 46% (3%) 6% 21% 19% 25% [***] Proposal High @ $10.75 (5)(6)(7) 3.8x 0.62x 0.15x 18.2x 20.3x 27% 37% (9%) 6% 21% 19% 25% [***] Proposal Low @ $10.00 (5)(6)(7) 3.5x 0.57x 0.14x 16.9x 18.9x 18% 27% (15%) 6% 21% 19% 25%


Slide 24

Zodiac Illustrative Valuation Framework Summary Zodiac Preliminary Management Plan provided by Zodiac management in April 2024. Zodiac fiscal year ends January 31. FY – 1 used as a proxy for CY. Common shares outstanding, RSUs, PSUs, options, and warrants as of May 30, 2024 per Zodiac management. Fully-diluted shares calculated using treasury stock method. Warrant shares issuable upon exercise and exercise prices adjusted in transaction scenarios as set forth under the Make-Whole Fundamental Change section in the Form of Warrant filed on March 24, 2022. Assumes an illustrative transaction close date of October 31, 2024. Transaction scenarios reflect cancellation of April 2024 CEO PSUs if share price hurdle is not met in a Change in Control. Cash and cash equivalents, short term investments, and face value of convertible debt per Zodiac management for the period ended April 30, 2024. Net cash balance reflects $21MM cash outflow for Togai acquisition on May 9, 2024. Impact of Convertible Senior Notes due 2029 reflected in Enterprise Value based on Zodiac indenture dated March 24, 2022. Transaction scenarios assume Convertible Notes are cash settled at the "Fundamental Change Repurchase Price", per Zodiac indenture dated March 24, 2022. Based on unaffected price as of market close on April 16, 2024, the day prior to Reuter's report of Zodiac exploring a potential sale. Last twelve months for the period ending April 16, 2024. Based on broker price targets as of June 14, 2024. Zodiac Street Case based on FactSet mean consensus estimates as of June 14, 2024. Reflects [***] proposal of $11.41 per share received on June 12, 2024 and [***] proposal of $10.00 - $10.75 per share received on June 12, 2024. Range of Proposals(8): $10.00 - $11.41 [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 25

Illustrative Take-Private Analysis


Slide 26

Illustrative Sources and Uses at $11.41 Per Share Assumes 10/31/24 Entry Date and 1.9x ARR for Entry Leverage [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission. [***]


Slide 27

Illustrative Take Private Returns Analysis Assumes 10/31/24 Entry Date, 1/31/29 Exit Date, 1.9x ARR for Entry Leverage Source: Company Filings and FactSet as of June 14, 2024. Zodiac Preliminary Management Plan provided by Zodiac management in April 2024. Note: Zodiac fiscal year ends January 31. FY – 1 used as a proxy for CY. Based on unaffected price of $8.47 as of market close on April 16, 2024, the day prior to Reuter's report of Zodiac exploring a potential sale. Zodiac projections based on FactSet mean consensus estimates as of June 14, 2024. Reflects [***] proposal of $11.41 per share received on June 12, 2024. Based on unaffected price as of market close on May 17, 2024, the day prior to Reuter's report of Instructure exploring a potential sale. Reflects [***] proposal of $10.00 - $10.75 per share received on June 12, 2024. Legend Denotes IRR >25.0% Denotes IRR >22.5% Prelim. Mgmt. Plan FY24A-FY29E CAGR: 7% [***] Proposal (2) [***] Proposal Low (4) [***] Proposal High (4) (3) Zodiac (1) [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 28

Appendix [***] and [***] Bidding History [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 29

Selected Bidding History Source: Capital IQ, FactSet, company filings, company press releases, merger proxies, and Wall Street research. (1) Unaffected premium indicates premium based on day prior to rumors of a potential transaction, or premium based on day prior to transaction announcement if no substantial rumors existed. (2) Initial interaction (e.g., email, phone call, or management meeting) that led to a transaction, not including interactions from previous processes. [***] [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 30

Selected Bidding History Source: Capital IQ, FactSet, company filings, company press releases, merger proxies, and Wall Street research. (1) Unaffected premium indicates premium based on day prior to rumors of a potential transaction, or premium based on day prior to transaction announcement if no substantial rumors existed. (2) Initial interaction (e.g., email, phone call, or management meeting) that led to a transaction, not including interactions from previous processes. [***] [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 31

Appendix Additional Information


Slide 32

Range of Proposals(2): $10.00 - $11.41 Zodiac Trading Performance Since IPO From April 12, 2018 to Current (June 14, 2024) NTM Revenue Multiple: Share Price: Source: Company Filings and FactSet as of June 14, 2024. Based on unaffected price as of market close on April 16, 2024, the day prior to Reuter's report of Zodiac exploring a potential sale. Reflects [***] proposal of $11.41 per share received on June 12, 2024 and [***] proposal of $10.00 - $10.75 per share received on June 12, 2024. e (11%) e +20% e +17% e (20%) e (31%) e (10%) e (19%) e (14%) e +19% Selected Earnings Releases e Legend 1-Day Price Reaction +% Unaffected NTM Revenue Mult: 2.8x (1) Unaffected Share Price: $8.47 (1) Zodiac Current: $9.61 +13% vs. Unaffected Current NTM Revenue Mult: 3.2x Reuters reports Zodiac exploring a potential sale during market hours April 17, 2024 – +12% [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 33

Zodiac Preliminary Management Plan Illustrative NOL Schedule Note: Effective tax rate assumed to be 21% per Zodiac management as of April 2024. Federal NOL balance of $552MM as of January 31, 2024, per Zodiac 10-K for the period ended January 31, 2024. Under the US Tax Cuts and Jobs Act, carryforward NOLs are subject to an annual limitation equal to 80% of taxable income. Zodiac Preliminary Management Plan provided by Zodiac management in April 2024. Extrapolations approved by Zodiac management in April 2024.


Slide 34

Trading and Operating Statistics of Selected Companies


Slide 35

Illustrative Zodiac Cost of Capital Calculation (1/2)


Slide 36

Illustrative Zodiac Cost of Capital Calculation (2/2)


Slide 37

Disclaimer

Slide 1

July 2024 Project Zodiac Reference Materials Exhibit 16(c)(vi) [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 2

Illustrative Zodiac Transaction Statistics Note: Current market prices as of June 28, 2024. Zodiac fiscal year ends January 31. Zodiac FY-1 used as proxy for CY. (1) Volume-weighted average prices based on trading days per FactSet as of April 16, 2024. (2) Common shares outstanding, RSUs, PSUs, options, and warrants as of May 30, 2024 per Zodiac management. Fully-diluted shares calculated using treasury stock method. Warrant shares issuable upon exercise and exercise prices adjusted in transaction scenarios as set forth under the Make-Whole Fundamental Change section in the Form of Warrant filed on March 24, 2022. Assumes an illustrative transaction close date of October 31, 2024. Transaction scenarios reflect cancellation of April 2024 CEO PSUs since share price hurdle is not met in a Change in Control, per Zodiac management. [***] capitalization per 10-Q for the period ended [***]. (3) Cash and cash equivalents, short term investments, and face value of convertible debt per Zodiac management for the period ended April 30, 2024. Net cash balance reflects $21MM cash outflow for Togai acquisition on May 9, 2024. Impact of Convertible Senior Notes due 2029 reflected in Enterprise Value based on Zodiac indenture dated March 24, 2022. Transaction scenarios assume Convertible Notes are cash settled at the "Fundamental Change Repurchase Price", per Zodiac indenture dated March 24, 2022. Assumes an illustrative transaction close date of October 31, 2024. [***] balance sheet statistics per 10-Q for the period ended [***]. (4) Based on unaffected price as of market close on April 16, 2024, the day prior to Reuter's report of Zodiac exploring a potential sale. (5) Zodiac and [***] projections based on FactSet mean consensus estimates as of June 28, 2024. Zodiac [***] projections based on a single broker’s estimates as of June 28, 2024 per FactSet. (6) Rule of 40 = Revenue Growth + [***]. (7) Reflects [***] proposal of $11.41 per share received on June 12, 2024. (8) Reflects [***] proposal of $10.00 - $10.75 per share received on June 12, 2024. ($MM, except per share amounts) Zodiac Illustrative Zodiac Transaction Statistics [***] Unaffected as [***] Proposal (8) [***] Current of (4/16/24) (4) Low High Proposal (7) as of (6/28/24) Illustrative Share Price: $8.47 $10.00 $10.75 $11.41 $11.50 $11.75 $12.00 [***] Implied Transaction Premium Statistic Statistic Premium to Unaffected Price (4) $8.47 - 18% 27% 35% 36% 39% 42% - Premium to Unaffected Enterprise Value (4) 1,288 - 27% 37% 46% 47% 50% 54% - Premium to Current Price 9.93 (15%) 1% 8% 15% 16% 18% 21% $41.17 Premium to Current Enterprise Value 1,535 (16%) 7% 15% 23% 23% 26% 29% 1,723 Premium to 30-Day Unaffected VWAP (1) (4) 8.78 (4%) 14% 22% 30% 31% 34% 37% 41.82 Premium to 90-Day Unaffected VWAP (1) (4) 8.67 (2%) 15% 24% 32% 33% 36% 38% 45.84 Premium to LTM Unaffected VWAP (1) (4) 9.09 (7%) 10% 18% 26% 27% 29% 32% 49.89 Premium to Unaffected LTM High (6/6/23) (4) 11.81 (28%) (15%) (9%) (3%) (3%) (1%) 2% 59.57 Premium to Unaffected LTM Low (11/1/23) (4) 7.24 17% 38% 48% 58% 59% 62% 66% 39.89 Implied Valuation & Multiples Fully-Diluted Equity Value (2) $1,414 $1,670 $1,796 $1,907 $1,922 $1,965 $2,007 Fully-Diluted Enterprise Value (2) (3) $1,288 $1,642 $1,769 $1,880 $1,895 $1,937 $1,980 Street Case (5) [***] Multiples Statistic (5) Statistic (5) CY24E $456 2.8x 3.6x 3.9x 4.1x 4.2x 4.3x 4.3x $1,113 NTM (ending 4/30/25) 465 2.8 3.5 3.8 4.0 4.1 4.2 4.3 1,113 CY25E 498 2.6 3.3 3.6 3.8 3.8 3.9 4.0 1,169 [***] Multiples NTM (ending 4/30/25) $97 13.3x 16.9x 18.2x 19.4x 19.6x 20.0x 20.4x $247 CY25E 113 11.4 14.5 15.6 16.6 16.7 17.1 17.5 258 [***] Multiples CY24E $84 16.8x 19.9x 21.4x 22.7x 22.9x 23.4x 23.9x $110 NTM (ending 4/30/25) 89 15.9 18.8 20.2 21.5 21.6 22.1 22.6 118 CY25E 96 14.8 17.4 18.7 19.9 20.1 20.5 20.9 124 Growth-Adjusted Revenue Multiple NTM (ending 4/30/25) 6% 0.45x 0.57x 0.62x 0.66x 0.66x 0.68x 0.69x 4% Rule of 40-Adjusted Revenue Multiple (6) NTM (ending 4/30/25) 25% 0.11x 0.14x 0.15x 0.16x 0.16x 0.16x 0.17x 14% [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 3

Company Overview Sources: Pitchbook, company filings, company website, and FactSet consensus estimates as of June 28, 2024. [***] capitalization and balance sheet statistics per 10-Q for the period ended [***]. Valuation & Trading Statistics(1) Company Overview Core Strategic Priorities [***] [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 4

[***] and Zodiac Pro Forma Income Statement Source: Company filings, Company transcripts, Wall Street research, and FactSet mean consensus estimates as of June 28, 2024. Note: Zodiac fiscal year ends January 31. Zodiac FY-1 used as proxy for CY. (1) Pro Forma [***] does not account for transaction adjustments (interest rate on new debt, foregone interest on cash, etc.) for illustrative purposes. [***] [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 5

Illustrative [***] Transaction Sources and Uses Source: FactSet mean consensus estimates as of June 28, 2024. Assumes various illustrative transaction fees and expenses. Assumes pro forma minimum cash balance of $75MM. Cash and cash equivalents, short term investments, and face value of convertible debt per Zodiac management for the period ended April 30, 2024. Net cash balance reflects $21MM cash outflow for Togai acquisition on May 9, 2024. [***] balance sheet statistics per 10-Q for the period ended [***]. Zodiac common shares outstanding, RSUs, PSUs, options, and warrants as of May 30, 2024 per Zodiac management. Fully-diluted shares calculated using treasury stock method. Proposals reflect cancellation of April 2024 CEO PSUs as share price hurdle is not met in a Change in Control, per Zodiac management. [***] capitalization per [***] 10-Q for the period ended [***]. Fully-diluted shares calculated using treasury stock method. New equity issued at [***] current share price of [***] as of June 28, 2024. Annual [***] of [***] per common share per [***] 10-K as of [***] and [***] per quarter estimated [***] per FactSet as of June 28, 2024. Assumes Convertible Notes are cash settled at the "Fundamental Change Repurchase Price", per Zodiac indenture dated March 24, 2022. [***] Based on Zodiac unaffected price as of market close on April 16, 2024, the day prior to Reuter's report of Zodiac exploring a potential sale. Based on Zodiac Street and [***] Street Estimates; Assumes Illustrative Transaction Close Date of January 31, 2025 SLP has the option to waive the retirement of its convertible note but would forego its Make-Whole & Fundamental Change Repurchase Price Assumes [***] Pro-Forma Cash Bridge (2) (5) [***] ($MM, except where otherwise noted) Illustrative Transaction Statistics Cash + Stock Cash + Stock [***] [***] Illustrative Share Price: $10.00 $11.00 $12.00 $10.00 $11.00 $12.00 $10.00 $11.00 $12.00 Implied Premium to Unaffected (8): 18% 30% 42% 18% 30% 42% 18% 30% 42% Uses of Funds Total Uses of Funds Sources of Funds Pro Forma Ownership and Leverage Statistics 100% Stock [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission. [***] [***] [***]


Slide 6

Illustrative [***] CY25E Accretion / Dilution Source: FactSet mean consensus estimates as of June 28, 2024. Assumes [***] blended CY25E [***] interest income on foregone cash. [***] [***] Based on Zodiac unaffected price as of market close on April 16, 2024, the day prior to Reuter's report of Zodiac exploring a potential sale. Based on Zodiac Street and [***] Street Estimates; Assumes Illustrative Transaction Close Date of January 31, 2025 [***] Accretion / Dilution (1) [***] Per Share Accretion / Dilution (1) ($MM, except per share data) Illustrative Transaction Statistics Cash + Stock Cash + Stock [***] [***] Illustrative Share Price: $10.00 $11.00 $12.00 $10.00 $11.00 $12.00 $10.00 $11.00 $12.00 Implied Premium to Unaffected (4): 18% 30% 42% 18% 30% 42% 18% 30% 42% 100% Stock [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 7

Appendix


Slide 8

Illustrative [***] CY25E Accretion / Dilution Source: [***] estimates per FactSet mean consensus estimates as of June 28, 2024. Zodiac Preliminary Management Plan provided by Zodiac management in April 2024. Assumes [***] blended CY25E [***] interest income on foregone cash. [***] [***] Based on Zodiac unaffected price as of market close on April 16, 2024, the day prior to Reuter's report of Zodiac exploring a potential sale. Based on Zodiac Preliminary Management Plan and [***] Street Estimates; Assumes Illustrative Transaction Close Date of January 31, 2025 [***] Accretion / Dilution (1) [***] Per Share Accretion / Dilution (1) ($MM, except per share data) Illustrative Transaction Statistics Cash + Stock Cash + Stock [***] [***] Illustrative Share Price: $10.00 $11.00 $12.00 $10.00 $11.00 $12.00 $10.00 $11.00 $12.00 Implied Premium to Unaffected (4): 18% 30% 42% 18% 30% 42% 18% 30% 42% 100% Stock [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 9

[***] Capitalization Summary Sources: Company filings, Company transcripts, Wall Street research, and FactSet mean consensus estimates as of June 28, 2024. [***] capitalization per [***] 10-Q for the period ended [***]. Balance sheet statistics per [***] 10-Q for the period ended [***]. Based on [***] 10-Q for the period ended [****]. Reflects [***] Interim free cash flow per FactSet, annual [***] of [***] per common share per [***] 10-K as of [***] estimate [***] per FactSet, and assumes [***] minimum cash. Term Loan Financial Covenants: [***] Capitalization (1) Stock Price (as of June 28, 2024) [***] Net Debt Equity Calculation of Equity and Enterprise Value [***] [***] [***] Summary of Outstanding Debt [***] [***] [***] Standalone Cash Firepower Cash Firepower LTM (CY24E) EBITDA (x) Leverage Total Debt Capacity Less: Current Debt Total Incremental Debt Capacity Plus: Available Cash at Close (1/31/2025) (2) Cash Firepower [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 10

Disclaimer

Slide 1

July 2024 Project Zodiac Reference Materials Exhibit 16(c)(vii) [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 2

[***] Overview [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 3

Company Overview Valuation & Trading Statistics(1) Company Overview Core Strategic Priorities [***] [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 4

Overview of [***] Street Forecast Source: FactSet mean consensus estimates as of July 9, 2024. Note: [***] Revenue represents [***]. [***] Non-GAAP Operating Income ($MM) Levered Free Cash Flow ($MM) Non-GAAP Operating Margin (%) LFCF Margin (%) Revenue ($MM) YoY Revenue Growth (%) Non-GAAP EBITDA ($MM) Non-GAAP EBITDA Margin (%) [***] [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 5

[***] is Primarily Valued on [***] Today, with a Median Price Target of [***] Source: Wall Street research and FactSet as of July 9, 2024. Note: [***] Analyst Ratings & Valuation Methodologies Valuation Methodology and Broker Recommendation Summary [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 6

[***] Trading Performance Since 2022 From January 3, 2022 to Current (July 9, 2024) Source: Company filings and FactSet as of July 9, 2024. Note: [***] Revenue represents [***]. Selected Earnings Releases e Legend 1-Day Price Reaction +% [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 7

Illustrative [***] + Zodiac Transaction Analysis [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 8

[***] and Zodiac Pro Forma Income Statement Source: Company filings, Company transcripts, Wall Street research, and FactSet mean consensus estimates as of July 9, 2024. Note: Zodiac fiscal year ends [***] Zodiac FY-1 used as proxy for CY. [***] Revenue represents [***]. (1) Pro Forma [***] does not account for transaction adjustments (interest rate on new debt, foregone interest on cash, etc.) for illustrative purposes. Illustrative CY25E Synergies [***] ($MM) PF Combined [***] Street Estimates Zodiac Street Estimates (Excluding Synergies) CY24E CY25E CY24E CY25E CY24E CY25E [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 9

Illustrative [***] Transaction Sources and Uses Source: FactSet mean consensus estimates as of July 9, 2024. Assumes various illustrative transaction fees and expenses. Assumes pro forma minimum cash balance of $75MM. Cash and cash equivalents, short term investments, and face value of convertible debt per Zodiac management for the period ended April 30, 2024. Net cash balance reflects $21MM cash outflow for Togai acquisition on May 9, 2024. [***] balance sheet statistics per 10-Q for the period ended [***] Zodiac common shares outstanding, RSUs, PSUs, options, and warrants as of May 30, 2024 per Zodiac management. Fully-diluted shares calculated using treasury stock method. Proposals reflect cancellation of April 2024 CEO PSUs as share price hurdle is not met in a Change in Control, per Zodiac management. [***] capitalization per [***] 10-Q for the period ended [***] Fully-diluted shares calculated using treasury stock method. New equity issued at [***] current share price of [***] as of July 9, 2024. Annual [***] of [***] per common share per [***] 10-K as of [***] and [***] estimated [***] per FactSet as of July 9, 2024. Assumes Convertible Notes are cash settled at the "Fundamental Change Repurchase Price", per Zodiac indenture dated March 24, 2022. [***] Based on Zodiac current share price of $8.75 as of July 9, 2024. Based on Zodiac Street and [***] Street Estimates; Assumes Illustrative Transaction Close Date of January 31, 2025 [***] SLP has the option to waive the retirement of its convertible note but would forego its Make-Whole & Fundamental Change Repurchase Price ($MM, except where otherwise noted) Illustrative Transaction Statistics Cash + Stock Cash + Stock [***] [***] Illustrative Share Price: $10.00 $11.00 $12.00 $10.00 $11.00 $12.00 $10.00 $11.00 $12.00 Implied Premium to Current (8): 14% 26% 37% 14% 26% 37% 14% 26% 37% Implied NTM [***] Multiple: 3.5x 3.9x 4.3x 3.5x 3.9x 4.3x 3.5x 3.9x 4.3x Implied NTM [***] Multiple: 18.7x 20.6x 22.5x 18.7x 20.6x 22.5x 18.7x 20.6x 22.5x Uses of Funds Sources of Funds [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] Pro Forma Ownership and Leverage Statistics 100% Stock [***] [***] [***] Pro-Forma Cash Bridge (2) (5) [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 10

Illustrative [***] CY25E Accretion / Dilution Source: FactSet mean consensus estimates as of July 9, 2024. Assumes [***] on new debt raised, blended CY25E [***] interest income on foregone cash. [***] [***] Based on Zodiac current share price of $8.75 as of July 9, 2024. Based on Zodiac Street and [***] Street Estimates; Assumes Illustrative Transaction Close Date of January 31, 2025 [***] Accretion / Dilution (1) [***] Per Share Accretion / Dilution (1) ($MM, except per share data) Illustrative Transaction Statistics Cash + Stock Cash + Stock [***] [***] Illustrative Share Price: $10.00 $11.00 $12.00 $10.00 $11.00 $12.00 $10.00 $11.00 $12.00 Implied Premium to Current (4): 14% 26% 37% 14% 26% 37% 14% 26% 37% Implied NTM [***] Multiple: 3.5x 3.9x 4.3x 3.5x 3.9x 4.3x 3.5x 3.9x 4.3x Implied NTM [***] Multiple: 18.7x 20.6x 22.5x 18.7x 20.6x 22.5x 18.7x 20.6x 22.5x 100% Stock [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission. [***]


Slide 11

Appendix


Slide 12

[***] Selected M&A History [***] Source: Company filings and 451 Research as of July 9, 2024. [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 13

Illustrative [***] CY25E Accretion / Dilution Source: [***] estimates per FactSet mean consensus estimates as of July 9, 2024. Zodiac Preliminary Management Plan provided by Zodiac management in April 2024. Assumes [***] blended CY25E [***] interest income on foregone cash. [***] [***] Based on Zodiac current share price of $8.75 as of July 9, 2024. Based on Zodiac Preliminary Management Plan and [***] Street Estimates; Assumes Illustrative Transaction Close Date of January 31, 2025 ($MM, except per share data) [***] Accretion / Dilution (1) [***] Per Share Accretion / Dilution (1) Illustrative Transaction Statistics Cash + Stock Cash + Stock [***] [***] Illustrative Share Price: $10.00 $11.00 $12.00 $10.00 $11.00 $12.00 $10.00 $11.00 $12.00 Implied Premium to Current (4): 14% 26% 37% 14% 26% 37% 14% 26% 37% Implied NTM R [***] Multiple: 3.5x 3.9x 4.3x 3.5x 3.9x 4.3x 3.5x 3.9x 4.3x Implied NTM [***] Multiple: 18.7x 20.6x 22.5x 18.7x 20.6x 22.5x 18.7x 20.6x 22.5x 100% Stock [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission. [***]


Slide 14

[***] Capitalization Summary Sources: Company filings, Company transcripts, Wall Street research, and FactSet mean consensus estimates as of July 9, 2024. [***] capitalization per [***] 10-Q for the period ended [***]. Balance sheet statistics per [***] 10-Q for the period ended [***]. Based on [***] 10-Q for the period ended [***]. Reflects [***] interim free cash flow per FactSet, annual [***] of [***] per common share per [***] 10-K as of [***], [***] estimated [***] [***] per FactSet, and assumes [***] minimum cash. Term Loan Financial Covenants: [***] ($MM, except per share amounts) [***] Capitalization (1) Stock Price (as of July 9, 2024) Net Debt Equity Calculation of Equity and Enterprise Value Summary of Outstanding Debt [***] Standalone Cash Firepower Cash Firepower [***] [***] [***] [***] [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission. [***]


Slide 15

Disclaimer

Slide 1

October 15, 2024 Project Zodiac Discussion Materials Exhibit 16(c)(viii) [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 2

Zodiac Process Summary Contacted [***] Parties: [***] Strategics, [***] Financial Sponsors Contacted [***] Conducted Business Diligence [***] Conducted Confirmatory Diligence [***] Submitted Final Proposal (1) Consortium Proposal (1): $9.75 Per Share Reflects Consortium Proposal of $9.75 per share received on October 15, 2024. [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission. [***] [***] [***]


Slide 3

Summary of Transaction Statistics Note: Current market prices as of October 14, 2024. Zodiac fiscal year ends January 31. Zodiac FY-1 used as proxy for CY. (1) Common shares outstanding, RSUs, PSUs, options, and warrants as of October 10, 2024 per Zodiac management. Fully-diluted shares calculated using treasury stock method. Transaction scenarios reflect cancellation of April 2024 CEO PSUs since share price hurdle is not met in a Change in Control, per Zodiac management. (2) Cash and cash equivalents, short term investments, and face value of convertible debt per Zodiac 10-Q for the period ended July 31, 2024. Impact of Convertible Senior Notes due 2029 reflected in Enterprise Value based on Zodiac indenture dated March 24, 2022. (3) Zodiac estimates based on FactSet and broker mean consensus estimates as of October 14, 2024. (4) Rule of 40 defined as Revenue Growth plus Adjusted Free Cash Flow margin. (5) Volume-weighted average prices based on trading days per FactSet. (6) Reflects Consortium Proposal of $9.75 per share received on October 15, 2024.


Slide 4

Source: FactSet as of October 14, 2024. Reflects Consortium Proposal of $9.75 per share received on October 15, 2024. Zodiac Share Price ($) From October 16, 2023 to Current (October 14, 2024) Comparison of Proposal with Stock Price Performance Over the Last Twelve Months Zodiac Current: $8.97 8/21/24: Zodiac reports Q2 FY25 earnings 8/21 – 8/22 Price Reaction: (0%) 4/16/24: 1-day prior to Reuters report of Zodiac exploring a potential sale 4/16 – 4/17 Price Reaction: +12% 5/22/24: Zodiac reports Q1 FY25 earnings 5/22 – 5/23 Price Reaction: +3% 5/1/24: Zodiac announces settlement with Scalar Gauge and appointment of John Harkey to Board of Directors 5/1 – 5/2 Price Reaction: (1%) Reuters Report of Zodiac Exploring a Potential Sale to Q2 FY25 Earnings (4/16 – 8/21) 11/29/23: Zodiac reports Q3 FY24 earnings 11/29 – 11/30 Price Reaction: +9% Consortium Proposal (1): $9.75 Per Share 2/28/24: Zodiac reports Q4 FY24 earnings 2/28 – 2/29 Price Reaction: (6%)


Slide 5

Comparison of Proposal with Selected Transaction Multiples Selected Public Software Transactions Greater Than $1 Billion with Revenue Growth Less Than or Equal to 10% Since 2011 Source: Capital IQ, FactSet, company filings, company press releases and Wall Street research. Note: ‘NM' = Not publicly available or not meaningful. Multiples greater than 50.0x considered not meaningful. Reflects Consortium Proposal of $9.75 per share received on October 15, 2024. NTM statistics based on mean analyst consensus estimates for the next twelve month period as of transaction announcement. NM deals excluded from the NTM EBITDA Multiple chart include WalkMe and QAD. NM deals excluded from the NTM LFCF Multiple chart include WalkMe, QAD, Ellie Mae and Interactive Intelligence. NTM Revenue Multiple(2) Overall Median: 3.9x Overall 25th Percentile: 3.1x Overall 75th Percentile: 5.2x NTM EBITDA Multiple(2)(3) NTM LFCF Multiple(2)(4) Overall 75th Percentile: 19.6x Overall Median: 16.5x Overall Median: 21.8x Overall 25th Percentile: 17.4x Overall 75th Percentile: 26.3x 3.2x 18.0x Legend Strategic Sponsor Consortium Proposal (1): $9.75/share Overall 25th Percentile: 12.5x 13.6x


Slide 6

Summary of Zodiac Valuation Analyses Note: Zodiac fiscal year ends January 31. FY-1 used as a proxy for CY. Present values as of July 31, 2024, assuming mid-period convention. Assumes current Zodiac shareholders incur 14% cumulative dilution through issuance of equity awards over the projected period, per Zodiac management. Common shares outstanding, RSUs, PSUs, options, and warrants as of October 10, 2024 per Zodiac management. Fully-diluted shares calculated using treasury stock method. Cash and cash equivalents, short term investments, and face value of convertible debt per Zodiac 10-Q for the period ended July 31, 2024. Reflect cancellation of April 2024 CEO PSUs if share price hurdle is not met in a Change in Control. Zodiac Management Plan provided by Zodiac management in September 2024. Zodiac street estimates based on FactSet and broker mean consensus estimates as of October 14, 2024. Reflects Consortium Proposal of $9.75 per share received on October 15, 2024. Consortium Proposal (7): $9.75 Per Share


Slide 7

Zodiac Financial Overview


Slide 8

Overview of Zodiac Management Plan Source: Historical figures per Zodiac company filings. Zodiac Management Plan provided by Zodiac Management in September 2024. Note: Zodiac fiscal year ends January 31. Rule of 40 defined as Revenue Growth plus Adjusted Free Cash Flow margin. FY29 Adjusted FCF does not factor in a long-term effective tax rate. Non-GAAP Operating Income ($MM) Adjusted FCF ($MM) Non-GAAP Operating Margin (%) Adjusted FCF Margin (%) ARR ($MM) YoY ARR Growth (%) Revenue ($MM) YoY Revenue Growth (%) 16% 7% 19% 25% 26% 31% 34% 38% Rule of 40(1): Actual Projections Projected CAGR (‘24-’29): 8% Projected CAGR (‘24-’29): 7% Projected CAGR (‘24-’29): 29% Projected CAGR (‘24-’29): 33% Actual Projections Actual Projections Actual Projections Actual Projections Actual Projections Actual Projections Actual Projections (2) (2)


Slide 9

Overview of Zodiac Management Plan vs. Street Source: Historical figures per Zodiac company filings. Zodiac Management Plan provided by Zodiac Management in September 2024. Zodiac street estimates based on FactSet and broker mean consensus estimates as of October 14, 2024. Guidance per Zodiac Q2’FY25 8-K. Note: Zodiac fiscal year ends January 31. Rule of 40 defined as Revenue Growth plus Adjusted Free Cash Flow margin. # of Brokers for Consensus: 7% 19% 25% 26% 7% 19% 24% 28% Rule of 40(1): FY24A – FY26E CAGR: Mgmt. Plan: 6% FY24A – FY26E CAGR: Street: 7% FY25E Guidance: $455.5 - $461.5 FY25E Guidance: $90 - $93 FY25E Guidance: $82+ Legend Historical Street Mgmt. Plan # of Brokers for Consensus: 2 2 # of Brokers for Consensus: Mgmt: Street: FY25E Guidance: 6% - 7% FY25E Guidance: 20% FY25E Guidance: 18%+ FY24A – FY26E CAGR: Mgmt. Plan: 47% FY24A – FY26E CAGR: Street: 51% FY24A – FY26E CAGR: Mgmt. Plan: 51% FY24A – FY26E CAGR: Street: 50% Non-GAAP Operating Income ($MM) Adjusted FCF ($MM) Revenue ($MM) Non-GAAP Operating Margin (%) Adjusted FCF Margin (%) YoY Revenue Growth (%) 6 6 6 6


Slide 10

Zodiac Analyst Price Targets and Valuation Methodologies Source: Wall Street research and FactSet as of October 14, 2024. Note: Zodiac fiscal year ends January 31. Reflects Consortium Proposal of $9.75 per share received on October 15, 2024. Analyst Ratings & Valuation Methodologies Summary of Price Targets Valuation Methodology and Broker Recommendation Summary Broker Recommendations Over Time Current share price of $8.97 and Consortium Proposal of $9.75(1) represent a 22% and 15% discount to the median, respectively Consortium Proposal (1): $9.75 Per Share


Slide 11

Zodiac Trading Overview


Slide 12

Zodiac Trading Performance Since 2022 From January 3, 2022 to Current (October 14, 2024) NTM Revenue Multiple: Share Price: NTM Revenue Mult: 2.9x Source: Zodiac company filings and FactSet as of October 14, 2024. Zodiac estimates based on FactSet and broker mean consensus estimates as of October 14, 2024. Rule of 40 defined as Revenue Growth plus Adjusted Free Cash Flow margin. Reflects Consortium Proposal of $9.75 per share received on October 15, 2024. Share Price: $8.97 Selected Earnings Releases e Legend 1-Day Price Reaction +% 3/2/22: Announces $400MM convertible investment from Silver Lake ($250MM upfront with $150MM due up to 18 months later) 3/2 – 3/3 Reaction: (9%) e (9%) e (6%) e (11%) e +9% e +17% e +3% 8/24/22: Announces acquisition of Zephr for $44MM 8/24 – 8/25 Price Reaction: (6%) e (20%) 2/21/23: Praesidium discloses 6% stake 2/21 – 2/22 Price Reaction: +1% e +20% 4/16/24: 1-day prior to Reuters reports Zodiac exploring a potential sale 4/16 – 4/17 Price Reaction: +12% 2/1/24: Announces 8% RIF 2/1 – 2/2 Price Reaction: (5%) 5/1/24: Announces settlement with Scalar Gauge and appointment of John Harkey to Board of Directors 5/1 – 5/2 Price Reaction: (1%) 9/25/23: Completes remaining $150MM convertible investment from Silver Lake 9/25 – 9/26 Price Reaction (4%) e +3% e (0%) e (6%) Consortium Proposal (2): $9.75 Per Share Reuters Report of Zodiac Exploring a Potential Sale to Q2 FY25 Earnings (4/16 – 8/21)


Slide 13

Operating Statistics of Selected Companies $493 $487 $603 $712 $320 $2,585 $785 $1,786 $1,575 $1,157 $3,114 $821 $4,774 $2,599 $621 $1,208 Source: FactSet and broker mean consensus estimates as of October 14, 2024. Zodiac Management Plan provided by Zodiac management in September 2024. Note: Zodiac fiscal year ends January 31. Zodiac FY-1 used as proxy for CY. Rule of 40 defined as revenue growth plus levered free cash flow margin. Dropbox LFCF and UFCF adjusted for assets obtained under finance leases. E2open LFCF estimates based on selected broker equity research as of October 2024. CY25E Revenue ($MM) CY25E Gross Margin (%) (2) (2) NTM UFCF Margin (%) Zodiac (2) CY25E Revenue Growth CY25E Non-GAAP EBIT Margin CY25E Rule of 40 (1) CY25E LFCF Margin Zodiac Zodiac Zodiac Selected Companies Legend 74% 75% 77% 79% 89% 84% 81% 89% 68% 82% 81% 78% 79% 80% 74% 76% 17% 16% 26% 36% 35% 28% 32% 27% 27% 28% 25% 14% 19% 30% 5% 2% (2) (3) (3) (3)


Slide 14

Trading Statistics of Selected Companies Ent. Val. ($MM) Source: FactSet and broker mean consensus estimates as of October 14, 2024. Zodiac common shares outstanding, RSUs, PSUs, options, and warrants as of October 10, 2024 per Zodiac management. Fully-diluted shares calculated using treasury stock method. Cash and cash equivalents, short term investments, and face value of convertible debt per Zodiac 10-Q for the period ended July 31, 2024. Note: Zodiac fiscal year ends January 31. Zodiac FY-1 used as proxy for CY. Multiples greater than 50.0x considered not meaningful and denoted as “NM”. E2open LFCF estimates based on selected broker equity research as of October 2024. Dropbox LFCF and UFCF adjusted for assets obtained under finance leases. Transaction scenarios reflect cancellation of April 2024 CEO PSUs since share price hurdle is not met in a Change in Control, per Zodiac management. Reflects Consortium Proposal of $9.75 per share received on October 15, 2024. $1,369 $3,874 $9,550 $5,851 $15,102 $6,530 $4,836 $10,028 $2,066 $2,509 $14,866 $922 $4,910 $1,473 Selected Companies Legend CY25E Revenue Multiple NTM UFCF Multiple Selected Companies Revenue Multiple Range: 2.0x-4.0x CY25E LFCF Multiple Consortium Proposal: $9.75 Per Share(3)(4) 3.0x Consortium Proposal: $9.75 Per Share(3)(4) 16.5x Consortium Proposal: $9.75 Per Share(3)(4) 18.6x (1) (2) (2) (1) Selected Companies LFCF Multiple Range: 11.0x-18.0x DCF Terminal Value Multiple Range: 12.0x-19.0x


Slide 15

Zodiac Valuation Overview


Slide 16

Summary of Zodiac Management Plan Projections Note: Assumes Zodiac current shareholders incur 14% cumulative dilution through issuance of equity awards over the projected period, per Zodiac Management. Zodiac Management Plan provided by Zodiac management in September 2024. One-Time Cash Expenses comprised of acquisition-related expenses and shareholder matters. Long-term effective tax rate as a percentage of GAAP pre-tax income. Based on 21% long-term effective tax rate(3)


Slide 17

Zodiac Discounted Cash Flow Analysis Summary of Valuation Assumptions Unlevered free cash flow projections and terminal value discounted to July 31, 2024 using mid-period convention Excludes impact of stock-based compensation, amortization of intangibles, and other non-cash items in unlevered free cash flow Weighted average cost of capital range of 11.5% to 13.5% Terminal value based on NTM UFCF multiple range of 12.0x – 19.0x and terminal year (FY29E) UFCF of $141MM Current shareholders incur ~4% annual dilution through issuance of equity awards throughout the projection period Assumes 80% utilization limit per Zodiac management for U.S. Federal NOLs Note: Present values as of July 31, 2024, assuming mid-period convention. Unlevered Free Cash Flows and Terminal Value adjusted by the cumulative dilution to current shareholders in each respective year, and then discounted to present value as of July 31, 2024. Assumes current shareholders incur ~4% annual dilution through issuance of equity awards over the projected period, per Zodiac management. Cash and cash equivalents, short-term investments, and face value of convertible debt per Zodiac 10-Q for the period ended July 31, 2024. Common shares outstanding, RSUs, PSUs, options, and warrants as of October 10, 2024 per Zodiac management. Fully-diluted shares calculated using treasury stock method.


Slide 18

Selected Companies Analysis Zodiac Management Plan provided by Zodiac management in September 2024. Zodiac fiscal year ends January 31. FY-1 used as a proxy for CY. Zodiac street estimates based on FactSet and broker mean consensus estimates as of October 14, 2024. Common shares outstanding, RSUs, PSUs, options, and warrants as of October 10, 2024 per Zodiac management. Fully-diluted shares calculated using treasury stock method. Cash and cash equivalents, short term investments, and face value of convertible debt per Zodiac 10-Q for the period ended July 31, 2024.


Slide 19

Selected Transactions Statistics Selected Public Software Transactions Greater Than $1 Billion with Revenue Growth Less Than or Equal to 10% Since 2011 Source: Capital IQ, FactSet, company filings, company press releases and Wall Street research. Note: ‘–' = Not publicly available or not meaningful. Multiples greater than 50.0x considered not meaningful. Unaffected premium indicates premium based on day prior to rumors of a potential transaction, or premium based on day prior to transaction announcement if no substantial rumors existed. Rule of 40 defined as revenue growth plus levered free cash flow margin. NTM statistics based on mean analyst consensus estimates for the next twelve month period as of transaction announcement. NTM revenue growth based on NTM revenue and revenue from the last completed twelve month (LTM) period with public filings as of transaction announcement. Zodiac street estimates based on FactSet and broker mean consensus estimates as of October 14, 2024. Common shares outstanding, RSUs, PSUs, options, and warrants as of October 10, 2024 per Zodiac management. Fully-diluted shares calculated using treasury stock method. Transaction scenarios reflect cancellation of April 2024 CEO PSUs since share price hurdle is not met in a Change in Control, per Zodiac management. Cash and cash equivalents, short term investments, and face value of convertible debt per Zodiac 10-Q for the period ended July 31, 2024. Impact of Convertible Senior Notes due 2029 reflected in Enterprise Value based on Zodiac indenture dated March 24, 2022. Instructure NTM revenue growth pro forma for acquisition of Parchment. Reflects Consortium Proposal of $9.75 per share received on October 15, 2024.


Slide 20

Selected Transactions Analysis Note: NTM represents the 12-month period ending July 31, 2024. Zodiac street estimates based on FactSet and broker mean consensus estimates as of October 14, 2024. Common shares outstanding, RSUs, PSUs, options, and warrants as of October 10, 2024 per Zodiac management. Fully-diluted shares calculated using treasury stock method. Transaction scenarios reflect cancellation of April 2024 CEO PSUs if share price hurdle is not met in a Change in Control. Cash and cash equivalents, short term investments, and face value of convertible debt per Zodiac 10-Q for the period ended July 31, 2024. Impact of Convertible Senior Notes due 2029 reflected in Enterprise Value based on Zodiac indenture dated March 24, 2022.


Slide 21

Appendix Additional Information


Slide 22

Zodiac Management Plan Illustrative NOL Schedule Note: Effective tax rate assumed to be 21%, as provided by Zodiac management in September 2024. Federal NOL balance of $552MM as of January 31, 2024, per Zodiac 10-K for the period ended January 31, 2024. Under the US Tax Cuts and Jobs Act, carryforward NOLs are subject to an annual limitation equal to 80% of taxable income. Zodiac Management Plan provided by Zodiac management in September 2024. Extrapolations approved by Zodiac management in September 2024. Present values as of July 31, 2024, assuming mid-period convention. Tax Savings adjusted by the cumulative dilution to current shareholders in each respective year, and then discounted to present value as of July 31, 2024.


Slide 23

Trading and Operating Statistics of Selected Companies


Slide 24

Illustrative Zodiac Cost of Capital Calculation (1/2)


Slide 25

Illustrative Zodiac Cost of Capital Calculation (2/2)


Slide 26

Disclaimer

Slide 1

October 16, 2024 Project Zodiac Discussion Materials Exhibit 16(c)(ix) [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission.


Slide 2

Zodiac Process Summary Contacted [***] Parties: [***] Strategics, [***] Financial Sponsors Contacted [***] Conducted Business Diligence [***] Conducted Confirmatory Diligence [***] Submitted Final Proposal (1) Consortium Proposals (1): 10/15: $10.00 Per Share 10/15: $9.75 per share (initial proposal) Reflects Consortium Proposals of $10.00 and $9.75 per share received on October 15, 2024. [***] [***] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission. [***] [***]


Slide 3

Summary of Transaction Statistics Note: Current market prices as of October 16, 2024. Zodiac fiscal year ends January 31. Zodiac FY-1 used as proxy for CY. (1) Common shares outstanding, RSUs, PSUs, options, and warrants as of October 11, 2024 per Zodiac management. Fully-diluted shares calculated using treasury stock method. Transaction scenarios reflect cancellation of April 2024 CEO PSUs since share price hurdle is not met in a Change in Control, per Zodiac management. (2) Cash and cash equivalents, short term investments, and face value of convertible debt per Zodiac 10-Q for the period ended July 31, 2024. Impact of Convertible Senior Notes due 2029 reflected in Enterprise Value based on Zodiac indenture dated March 24, 2022. (3) Zodiac estimates based on FactSet and broker mean consensus estimates as of October 16, 2024. (4) Volume-weighted average prices based on trading days per FactSet. (5) Reflects Consortium Proposal of $10.00 per share received on October 15, 2024. (6) Reuters reports Zodiac exploring a potential sale on April 17, 2024 during market hours.


Slide 4

Source: FactSet as of October 16, 2024. Reflects Consortium Proposal of $10.00 per share received on October 15, 2024. Bessemer Venture Partners as of October 16, 2024. Share Price ($) From April 16, 2024 (1-Day Prior to Reuters Leak) to Current (October 16, 2024); Indexed to Zodiac Share Price Comparison of Proposal with Recent Zodiac and BVP Emerging Cloud Index Price Performance Consortium Proposal (1): $10.00 Per Share BVP Emerging Cloud Index(2) Current: $8.82 +4% vs. 4/16 Zodiac Current Share Price: $9.42 +11% vs. 4/16 Ent. Val: $1,445M +13% vs. 4/16 Zodiac 4/16 Share Price: $8.47 Ent. Val: $1,284M 4/16/24: 1-day prior to Reuters report of Zodiac exploring a potential sale 4/16 – 4/17 Price Reaction: +12%


Slide 5

Source: FactSet as of October 16, 2024. Reflects Consortium Proposal of $10.00 per share received on October 15, 2024. Zodiac Share Price ($) From October 17, 2023 to Current (October 16, 2024) Comparison of Proposal with Stock Price Performance Over the Last Twelve Months Zodiac Current: $9.42 8/21/24: Zodiac reports Q2 FY25 earnings 8/21 – 8/22 Price Reaction: (0%) 4/16/24: 1-day prior to Reuters report of Zodiac exploring a potential sale 4/16 – 4/17 Price Reaction: +12% 5/22/24: Zodiac reports Q1 FY25 earnings 5/22 – 5/23 Price Reaction: +3% 5/1/24: Zodiac announces settlement with Scalar Gauge and appointment of John Harkey to Board of Directors 5/1 – 5/2 Price Reaction: (1%) Reuters Report of Zodiac Exploring a Potential Sale to Q2 FY25 Earnings (4/16 – 8/21) 11/29/23: Zodiac reports Q3 FY24 earnings 11/29 – 11/30 Price Reaction: +9% Consortium Proposal (1): $10.00 Per Share 2/28/24: Zodiac reports Q4 FY24 earnings 2/28 – 2/29 Price Reaction: (6%)


Slide 6

Comparison of Proposal with Selected Transaction Multiples Selected Public Software Transactions Greater Than $1 Billion with Revenue Growth Less Than or Equal to 10% Since 2011 Source: Capital IQ, FactSet, company filings, company press releases and Wall Street research. Note: ‘NM' = Not publicly available or not meaningful. Multiples greater than 50.0x considered not meaningful. Reflects Consortium Proposal of $10.00 per share received on October 15, 2024. NTM statistics based on mean analyst consensus estimates for the next twelve month period as of transaction announcement. NM deals excluded from the NTM EBITDA Multiple chart include WalkMe and QAD. NM deals excluded from the NTM LFCF Multiple chart include WalkMe, QAD, Ellie Mae and Interactive Intelligence. NTM Revenue Multiple(2) Overall Median: 3.9x Overall 25th Percentile: 3.1x Overall 75th Percentile: 5.2x NTM EBITDA Multiple(2)(3) NTM LFCF Multiple(2)(4) Overall 75th Percentile: 19.6x Overall Median: 16.5x Overall Median: 21.8x Overall 25th Percentile: 17.4x Overall 75th Percentile: 26.3x 3.2x 18.4x Legend Strategic Sponsor Consortium Proposal (1): $10.00/share Overall 25th Percentile: 12.5x 14.0x


Slide 7

Summary of Zodiac Valuation Analyses Note: Zodiac fiscal year ends January 31. FY-1 used as a proxy for CY. Present values as of July 31, 2024, assuming mid-period convention. Assumes current Zodiac shareholders incur 14% cumulative dilution through issuance of equity awards over the projected period, per Zodiac management. Common shares outstanding, RSUs, PSUs, options, and warrants as of October 11, 2024 per Zodiac management. Fully-diluted shares calculated using treasury stock method. Cash and cash equivalents, short term investments, and face value of convertible debt per Zodiac 10-Q for the period ended July 31, 2024. Reflect cancellation of April 2024 CEO PSUs if share price hurdle is not met in a Change in Control. Zodiac Management Plan provided by Zodiac management in September 2024. Zodiac street estimates based on FactSet and broker mean consensus estimates as of October 16, 2024. Reflects Consortium Proposal of $10.00 per share received on October 15, 2024. Consortium Proposal (7): $10.00 Per Share


Slide 8

Zodiac Financial Overview


Slide 9

Overview of Zodiac Management Plan Source: Historical figures per Zodiac company filings. Zodiac Management Plan provided by Zodiac Management in September 2024. Note: Zodiac fiscal year ends January 31. Rule of 40 defined as Revenue Growth plus Adjusted Free Cash Flow margin. FY29E Adjusted FCF does not factor in a long-term effective tax rate. Non-GAAP Operating Income ($MM) Adjusted FCF ($MM) Non-GAAP Operating Margin (%) Adjusted FCF Margin (%) ARR ($MM) YoY ARR Growth (%) Revenue ($MM) YoY Revenue Growth (%) 16% 7% 19% 25% 26% 31% 34% 38% Rule of 40(1): Actual Projections Projected CAGR (‘24-’29): 8% Projected CAGR (‘24-’29): 7% Projected CAGR (‘24-’29): 29% Projected CAGR (‘24-’29): 33% Actual Projections Actual Projections Actual Projections Actual Projections Actual Projections Actual Projections Actual Projections (2) (2)


Slide 10

Overview of Zodiac Management Plan vs. Street Source: Historical figures per Zodiac company filings. Zodiac Management Plan provided by Zodiac Management in September 2024. Zodiac street estimates based on FactSet and broker mean consensus estimates as of October 16, 2024. Guidance per Zodiac Q2’FY25 8-K. Note: Zodiac fiscal year ends January 31. Rule of 40 defined as Revenue Growth plus Adjusted Free Cash Flow margin. # of Brokers for Consensus: 7% 19% 25% 26% 7% 19% 24% 28% Rule of 40(1): FY24A – FY26E CAGR: Mgmt. Plan: 6% FY24A – FY26E CAGR: Street: 7% FY25E Guidance: $455.5 - $461.5 FY25E Guidance: $90 - $93 FY25E Guidance: $82+ Legend Historical Street Mgmt. Plan # of Brokers for Consensus: 2 2 # of Brokers for Consensus: Mgmt: Street: FY25E Guidance: 6% - 7% FY25E Guidance: 20% FY25E Guidance: 18%+ FY24A – FY26E CAGR: Mgmt. Plan: 47% FY24A – FY26E CAGR: Street: 51% FY24A – FY26E CAGR: Mgmt. Plan: 51% FY24A – FY26E CAGR: Street: 50% Non-GAAP Operating Income ($MM) Adjusted FCF ($MM) Revenue ($MM) Non-GAAP Operating Margin (%) Adjusted FCF Margin (%) YoY Revenue Growth (%) 6 6 6 6


Slide 11

Zodiac Analyst Price Targets and Valuation Methodologies Source: Wall Street research and FactSet as of October 16, 2024. Note: Zodiac fiscal year ends January 31. Reflects Consortium Proposal of $10.00 per share received on October 15, 2024. Analyst Ratings & Valuation Methodologies Summary of Price Targets Valuation Methodology and Broker Recommendation Summary Broker Recommendations Over Time Current share price of $9.42 and Consortium Proposal of $10.00(1) represent an 18% and 13% discount to the median, respectively Consortium Proposal (1): $10.00 Per Share


Slide 12

Zodiac Trading Overview


Slide 13

Zodiac Trading Performance Since 2022 From January 3, 2022 to Current (October 16, 2024) NTM Revenue Multiple: Share Price: NTM Revenue Mult: 3.0x Source: Zodiac company filings and FactSet as of October 16, 2024. Zodiac estimates based on FactSet and broker mean consensus estimates as of October 16, 2024. Rule of 40 defined as Revenue Growth plus Adjusted Free Cash Flow margin. Reflects Consortium Proposal of $10.00 per share received on October 15, 2024. Share Price: $9.42 Selected Earnings Releases e Legend 1-Day Price Reaction +% 3/2/22: Announces $400MM convertible investment from Silver Lake ($250MM upfront with $150MM due up to 18 months later) 3/2 – 3/3 Reaction: (9%) e (9%) e (6%) e (11%) e +9% e +17% e +3% 8/24/22: Announces acquisition of Zephr for $44MM 8/24 – 8/25 Price Reaction: (6%) e (20%) 2/21/23: Praesidium discloses 6% stake 2/21 – 2/22 Price Reaction: +1% e +20% 4/16/24: 1-day prior to Reuters reports Zodiac exploring a potential sale 4/16 – 4/17 Price Reaction: +12% 2/1/24: Announces 8% RIF 2/1 – 2/2 Price Reaction: (5%) 5/1/24: Announces settlement with Scalar Gauge and appointment of John Harkey to Board of Directors 5/1 – 5/2 Price Reaction: (1%) 9/25/23: Completes remaining $150MM convertible investment from Silver Lake 9/25 – 9/26 Price Reaction (4%) e +3% e (0%) e (6%) Consortium Proposal (2): $10.00 Per Share Reuters Report of Zodiac Exploring a Potential Sale to Q2 FY25 Earnings (4/16 – 8/21)


Slide 14

Operating Statistics of Selected Companies $493 $487 $603 $712 $320 $2,585 $782 $1,786 $1,575 $1,157 $3,114 $821 $4,774 $2,599 $621 $1,208 Source: FactSet and broker mean consensus estimates as of October 16, 2024. Zodiac Management Plan provided by Zodiac management in September 2024. Note: Zodiac fiscal year ends January 31. Zodiac FY-1 used as proxy for CY. Rule of 40 defined as revenue growth plus levered free cash flow margin. Dropbox LFCF and UFCF adjusted for assets obtained under finance leases. E2open LFCF estimates based on selected broker equity research as of October 2024. FY29E Adjusted FCF does not factor in a long-term effective tax rate. CY25E Revenue ($MM) CY25E Gross Margin (%) (2) (2) NTM UFCF Margin (%) Zodiac (2) CY25E Revenue Growth CY25E Non-GAAP EBIT Margin CY25E Rule of 40 (1) CY25E LFCF Margin Zodiac Zodiac Zodiac Selected Companies Legend 74% 75% 77% 79% 89% 84% 81% 89% 68% 82% 81% 78% 79% 80% 74% 76% 17% 16% 26% 36% 35% 28% 32% 27% 27% 28% 25% 14% 19% 30% 5% 2% (2) (3) (3) (3) (4) (4) (4)


Slide 15

Trading Statistics of Selected Companies Ent. Val. ($MM) Source: FactSet and broker mean consensus estimates as of October 16, 2024. Zodiac common shares outstanding, RSUs, PSUs, options, and warrants as of October 11, 2024 per Zodiac management. Fully-diluted shares calculated using treasury stock method. Cash and cash equivalents, short term investments, and face value of convertible debt per Zodiac 10-Q for the period ended July 31, 2024. Note: Zodiac fiscal year ends January 31. Zodiac FY-1 used as proxy for CY. Multiples greater than 50.0x considered not meaningful and denoted as “NM”. E2open LFCF estimates based on selected broker equity research as of October 2024. Dropbox LFCF and UFCF adjusted for assets obtained under finance leases. Transaction scenarios reflect cancellation of April 2024 CEO PSUs since share price hurdle is not met in a Change in Control, per Zodiac management. Reflects Consortium Proposal of $10.00 per share received on October 15, 2024. $1,445 $4,001 $9,592 $15,980 $5,882 $6,512 $4,779 $10,100 $2,063 $2,596 $15,216 $961 $4,929 $1,496 Selected Companies Legend CY25E Revenue Multiple NTM UFCF Multiple Selected Companies Revenue Multiple Range: 2.0x-4.0x CY25E LFCF Multiple Consortium Proposal: $10.00 Per Share(3)(4) 3.1x Consortium Proposal: $10.00 Per Share(3)(4) 16.9x Consortium Proposal: $10.00 Per Share(3)(4) 19.1x (1) (2) (2) (1) Selected Companies LFCF Multiple Range: 11.0x-18.0x DCF Terminal Value Multiple Range: 12.0x-19.0x


Slide 16

Zodiac Valuation Overview


Slide 17

Summary of Zodiac Management Plan Projections Note: Assumes Zodiac current shareholders incur 14% cumulative dilution through issuance of equity awards over the projected period, per Zodiac Management. Zodiac Management Plan provided by Zodiac management in September 2024. One-Time Cash Expenses comprised of acquisition-related expenses and shareholder matters. Long-term effective tax rate as a percentage of GAAP pre-tax income. Based on 21% long-term effective tax rate(3)


Slide 18

Zodiac Discounted Cash Flow Analysis Summary of Valuation Assumptions Unlevered free cash flow projections and terminal value discounted to July 31, 2024 using mid-period convention Excludes impact of stock-based compensation, amortization of intangibles, and other non-cash items in unlevered free cash flow Weighted average cost of capital range of 11.5% to 13.5% Terminal value based on NTM UFCF multiple range of 12.0x – 19.0x and terminal year (FY29E) UFCF of $141MM Current shareholders incur ~4% annual dilution through issuance of equity awards throughout the projection period Assumes 80% utilization limit per Zodiac management for U.S. Federal NOLs Note: Present values as of July 31, 2024, assuming mid-period convention. Unlevered Free Cash Flows and Terminal Value adjusted by the cumulative dilution to current shareholders in each respective year, and then discounted to present value as of July 31, 2024. Assumes current shareholders incur ~4% annual dilution through issuance of equity awards over the projected period, per Zodiac management. Cash and cash equivalents, short-term investments, and face value of convertible debt per Zodiac 10-Q for the period ended July 31, 2024. Common shares outstanding, RSUs, PSUs, options, and warrants as of October 11, 2024 per Zodiac management. Fully-diluted shares calculated using treasury stock method.


Slide 19

Selected Companies Analysis Zodiac Management Plan provided by Zodiac management in September 2024. Zodiac fiscal year ends January 31. FY-1 used as a proxy for CY. Zodiac street estimates based on FactSet and broker mean consensus estimates as of October 16, 2024. Common shares outstanding, RSUs, PSUs, options, and warrants as of October 11, 2024 per Zodiac management. Fully-diluted shares calculated using treasury stock method. Cash and cash equivalents, short term investments, and face value of convertible debt per Zodiac 10-Q for the period ended July 31, 2024.


Slide 20

Selected Transactions Statistics Selected Public Software Transactions Greater Than $1 Billion with Revenue Growth Less Than or Equal to 10% Since 2011 Source: Capital IQ, FactSet, company filings, company press releases and Wall Street research. Note: ‘–' = Not publicly available or not meaningful. Multiples greater than 50.0x considered not meaningful. Unaffected premium indicates premium based on day prior to rumors of a potential transaction, or premium based on day prior to transaction announcement if no substantial rumors existed. Rule of 40 defined as revenue growth plus levered free cash flow margin. NTM statistics based on mean analyst consensus estimates for the next twelve month period as of transaction announcement. NTM revenue growth based on NTM revenue and revenue from the last completed twelve month (LTM) period with public filings as of transaction announcement. Instructure NTM revenue growth pro forma for acquisition of Parchment.


Slide 21

Selected Transactions Analysis Note: NTM represents the 12-month period ending July 31, 2024. Zodiac street estimates based on FactSet and broker mean consensus estimates as of October 16, 2024. Common shares outstanding, RSUs, PSUs, options, and warrants as of October 11, 2024 per Zodiac management. Fully-diluted shares calculated using treasury stock method. Transaction scenarios reflect cancellation of April 2024 CEO PSUs if share price hurdle is not met in a Change in Control. Cash and cash equivalents, short term investments, and face value of convertible debt per Zodiac 10-Q for the period ended July 31, 2024. Impact of Convertible Senior Notes due 2029 reflected in Enterprise Value based on Zodiac indenture dated March 24, 2022.


Slide 22

Appendix Additional Information


Slide 23

Zodiac Management Plan NOL Schedule Note: Effective tax rate assumed to be 21%, as provided by Zodiac management in September 2024. Federal NOL balance of $552MM as of January 31, 2024, per Zodiac 10-K for the period ended January 31, 2024. Under the US Tax Cuts and Jobs Act, carryforward NOLs are subject to an annual limitation equal to 80% of taxable income. Zodiac Management Plan provided by Zodiac management in September 2024. Extrapolations approved by Zodiac management in September 2024. Present values as of July 31, 2024, assuming mid-period convention. Tax Savings adjusted by the cumulative dilution to current shareholders in each respective year, and then discounted to present value as of July 31, 2024.


Slide 24

Trading and Operating Statistics of Selected Companies


Slide 25

Zodiac Cost of Capital Calculation (1/2)


Slide 26

Zodiac Cost of Capital Calculation (2/2)


Slide 27

Disclaimer

Exhibit 16(f)

§ 262. Appraisal rights.

(a) Any stockholder of a corporation of this State who holds shares of stock on the date of the making of a demand pursuant to subsection (d) of this section with respect to such shares, who continuously holds such shares through the effective date of the merger, consolidation, conversion, transfer, domestication or continuance, who has otherwise complied with subsection (d) of this section and who has neither voted in favor of the merger, consolidation, conversion, transfer, domestication or continuance nor consented thereto in writing pursuant to § 228 of this title shall be entitled to an appraisal by the Court of Chancery of the fair value of the stockholder’s shares of stock under the circumstances described in subsections (b) and (c) of this section. As used in this section, the word “stockholder” means a holder of record of stock in a corporation; the words “stock” and “share” mean and include what is ordinarily meant by those words; the words “depository receipt” mean a receipt or other instrument issued by a depository representing an interest in 1 or more shares, or fractions thereof, solely of stock of a corporation, which stock is deposited with the depository; the words “beneficial owner” mean a person who is the beneficial owner of shares of stock held either in voting trust or by a nominee on behalf of such person; and the word “person” means any individual, corporation, partnership, unincorporated association or other entity.

(b) Appraisal rights shall be available for the shares of any class or series of stock of a constituent, converting, transferring, domesticating or continuing corporation in a merger, consolidation, conversion, transfer, domestication or continuance to be effected pursuant to § 251 (other than a merger effected pursuant to § 251(g) of this title), § 252, § 254, § 255, § 256, § 257, § 258, § 263, § 264, § 266 or § 390 of this title (other than, in each case and solely with respect to a converted or domesticated corporation, a merger, consolidation, conversion, transfer, domestication or continuance authorized pursuant to and in accordance with the provisions of § 265 or § 388 of this title):

(1) Provided, however, that no appraisal rights under this section shall be available for the shares of any class or series of stock, which stock, or depository receipts in respect thereof, at the record date fixed to determine the stockholders entitled to receive notice of the meeting of stockholders, or at the record date fixed to determine the stockholders entitled to consent pursuant to § 228 of this title, to act upon the agreement of merger or consolidation or the resolution providing for the conversion, transfer, domestication or continuance (or, in the case of a merger pursuant to § 251(h) of this title, as of immediately prior to the execution of the agreement of merger), were either: (i) listed on a national securities exchange or (ii) held of record by more than 2,000 holders; and further provided that no appraisal rights shall be available for any shares of stock of the constituent corporation surviving a merger if the merger did not require for its approval the vote of the stockholders of the surviving corporation as provided in § 251(f) of this title.

(2) Notwithstanding paragraph (b)(1) of this section, appraisal rights under this section shall be available for the shares of any class or series of stock of a constituent, converting, transferring, domesticating or continuing corporation if the holders thereof are required by the terms of an agreement of merger or consolidation, or by the terms of a resolution providing for conversion, transfer, domestication or continuance, pursuant to § 251, § 252, § 254, § 255, § 256, § 257, § 258, § 263, § 264, § 266 or § 390 of this title to accept for such stock anything except:

a. Shares of stock of the corporation surviving or resulting from such merger or consolidation, or of the converted entity or the entity resulting from a transfer, domestication or continuance if such entity is a corporation as a result of the conversion, transfer, domestication or continuance, or depository receipts in respect thereof;

b. Shares of stock of any other corporation, or depository receipts in respect thereof, which shares of stock (or depository receipts in respect thereof) or depository receipts at the effective date of the merger, consolidation, conversion, transfer, domestication or continuance will be either listed on a national securities exchange or held of record by more than 2,000 holders;

c. Cash in lieu of fractional shares or fractional depository receipts described in the foregoing paragraphs (b)(2)a. and b. of this section; or

d. Any combination of the shares of stock, depository receipts and cash in lieu of fractional shares or fractional depository receipts described in the foregoing paragraphs (b)(2)a., b. and c. of this section.


(3) In the event all of the stock of a subsidiary Delaware corporation party to a merger effected under § 253 or § 267 of this title is not owned by the parent immediately prior to the merger, appraisal rights shall be available for the shares of the subsidiary Delaware corporation.

(4) [Repealed.]

(c) Any corporation may provide in its certificate of incorporation that appraisal rights under this section shall be available for the shares of any class or series of its stock as a result of an amendment to its certificate of incorporation, any merger or consolidation in which the corporation is a constituent corporation, the sale of all or substantially all of the assets of the corporation or a conversion effected pursuant to § 266 of this title or a transfer, domestication or continuance effected pursuant to § 390 of this title. If the certificate of incorporation contains such a provision, the provisions of this section, including those set forth in subsections (d), (e), and (g) of this section, shall apply as nearly as is practicable.

(d) Appraisal rights shall be perfected as follows:

(1) If a proposed merger, consolidation, conversion, transfer, domestication or continuance for which appraisal rights are provided under this section is to be submitted for approval at a meeting of stockholders, the corporation, not less than 20 days prior to the meeting, shall notify each of its stockholders who was such on the record date for notice of such meeting (or such members who received notice in accordance with § 255(c) of this title) with respect to shares for which appraisal rights are available pursuant to subsection (b) or (c) of this section that appraisal rights are available for any or all of the shares of the constituent corporations or the converting, transferring, domesticating or continuing corporation, and shall include in such notice either a copy of this section (and, if 1 of the constituent corporations or the converting corporation is a nonstock corporation, a copy of § 114 of this title) or information directing the stockholders to a publicly available electronic resource at which this section (and, § 114 of this title, if applicable) may be accessed without subscription or cost. Each stockholder electing to demand the appraisal of such stockholder’s shares shall deliver to the corporation, before the taking of the vote on the merger, consolidation, conversion, transfer, domestication or continuance, a written demand for appraisal of such stockholder’s shares; provided that a demand may be delivered to the corporation by electronic transmission if directed to an information processing system (if any) expressly designated for that purpose in such notice. Such demand will be sufficient if it reasonably informs the corporation of the identity of the stockholder and that the stockholder intends thereby to demand the appraisal of such stockholder’s shares. A proxy or vote against the merger, consolidation, conversion, transfer, domestication or continuance shall not constitute such a demand. A stockholder electing to take such action must do so by a separate written demand as herein provided. Within 10 days after the effective date of such merger, consolidation, conversion, transfer, domestication or continuance, the surviving, resulting or converted entity shall notify each stockholder of each constituent or converting, transferring, domesticating or continuing corporation who has complied with this subsection and has not voted in favor of or consented to the merger, consolidation, conversion, transfer, domestication or continuance, and any beneficial owner who has demanded appraisal under paragraph (d)(3) of this section, of the date that the merger, consolidation or conversion has become effective; or

(2) If the merger, consolidation, conversion, transfer, domestication or continuance was approved pursuant to § 228, § 251(h), § 253, or § 267 of this title, then either a constituent, converting, transferring, domesticating or continuing corporation before the effective date of the merger, consolidation, conversion, transfer, domestication or continuance, or the surviving, resulting or converted entity within 10 days after such effective date, shall notify each stockholder of any class or series of stock of such constituent, converting, transferring, domesticating or continuing corporation who is entitled to appraisal rights of the approval of the merger, consolidation, conversion, transfer, domestication or continuance and that appraisal rights are available for any or all shares of such class or series of stock of such constituent, converting, transferring, domesticating or continuing corporation, and shall include in such notice either a copy of this section (and, if 1 of the constituent corporations or the converting, transferring, domesticating or continuing corporation is a nonstock corporation, a copy of § 114 of this title) or information directing the stockholders to a publicly available electronic resource at which this section (and § 114 of this title, if applicable) may be accessed without subscription or cost. Such notice may, and, if given on or after the effective date of the merger, consolidation, conversion, transfer, domestication or continuance, shall, also notify such stockholders of the effective date of the merger, consolidation, conversion, transfer, domestication or continuance. Any stockholder entitled to appraisal rights may, within 20 days after the date of giving such notice or, in the case


of a merger approved pursuant to § 251(h) of this title, within the later of the consummation of the offer contemplated by § 251(h) of this title and 20 days after the date of giving such notice, demand in writing from the surviving, resulting or converted entity the appraisal of such holder’s shares; provided that a demand may be delivered to such entity by electronic transmission if directed to an information processing system (if any) expressly designated for that purpose in such notice. Such demand will be sufficient if it reasonably informs such entity of the identity of the stockholder and that the stockholder intends thereby to demand the appraisal of such holder’s shares. If such notice did not notify stockholders of the effective date of the merger, consolidation, conversion, transfer, domestication or continuance, either (i) each such constituent corporation or the converting, transferring, domesticating or continuing corporation shall send a second notice before the effective date of the merger, consolidation, conversion, transfer, domestication or continuance notifying each of the holders of any class or series of stock of such constituent, converting, transferring, domesticating or continuing corporation that are entitled to appraisal rights of the effective date of the merger, consolidation, conversion, transfer, domestication or continuance or (ii) the surviving, resulting or converted entity shall send such a second notice to all such holders on or within 10 days after such effective date; provided, however, that if such second notice is sent more than 20 days following the sending of the first notice or, in the case of a merger approved pursuant to § 251(h) of this title, later than the later of the consummation of the offer contemplated by § 251(h) of this title and 20 days following the sending of the first notice, such second notice need only be sent to each stockholder who is entitled to appraisal rights and who has demanded appraisal of such holder’s shares in accordance with this subsection and any beneficial owner who has demanded appraisal under paragraph (d)(3) of this section. An affidavit of the secretary or assistant secretary or of the transfer agent of the corporation or entity that is required to give either notice that such notice has been given shall, in the absence of fraud, be prima facie evidence of the facts stated therein. For purposes of determining the stockholders entitled to receive either notice, each constituent corporation or the converting, transferring, domesticating or continuing corporation may fix, in advance, a record date that shall be not more than 10 days prior to the date the notice is given, provided, that if the notice is given on or after the effective date of the merger, consolidation, conversion, transfer, domestication or continuance, the record date shall be such effective date. If no record date is fixed and the notice is given prior to the effective date, the record date shall be the close of business on the day next preceding the day on which the notice is given.

(3) Notwithstanding subsection (a) of this section (but subject to this paragraph (d)(3)), a beneficial owner may, in such person’s name, demand in writing an appraisal of such beneficial owner’s shares in accordance with either paragraph (d)(1) or (2) of this section, as applicable; provided that (i) such beneficial owner continuously owns such shares through the effective date of the merger, consolidation, conversion, transfer, domestication or continuance and otherwise satisfies the requirements applicable to a stockholder under the first sentence of subsection (a) of this section and (ii) the demand made by such beneficial owner reasonably identifies the holder of record of the shares for which the demand is made, is accompanied by documentary evidence of such beneficial owner’s beneficial ownership of stock and a statement that such documentary evidence is a true and correct copy of what it purports to be, and provides an address at which such beneficial owner consents to receive notices given by the surviving, resulting or converted entity hereunder and to be set forth on the verified list required by subsection (f) of this section.

(e) Within 120 days after the effective date of the merger, consolidation, conversion, transfer, domestication or continuance, the surviving, resulting or converted entity, or any person who has complied with subsections (a) and (d) of this section and who is otherwise entitled to appraisal rights, may commence an appraisal proceeding by filing a petition in the Court of Chancery demanding a determination of the value of the stock of all such stockholders. Notwithstanding the foregoing, at any time within 60 days after the effective date of the merger, consolidation, conversion, transfer, domestication or continuance, any person entitled to appraisal rights who has not commenced an appraisal proceeding or joined that proceeding as a named party shall have the right to withdraw such person’s demand for appraisal and to accept the terms offered upon the merger, consolidation, conversion, transfer, domestication or continuance. Within 120 days after the effective date of the merger, consolidation, conversion, transfer, domestication or continuance, any person who has complied with the requirements of subsections (a) and (d) of this section, upon request given in writing (or by electronic transmission directed to an information processing system (if any) expressly designated for that purpose in the notice of appraisal), shall be entitled to receive from the surviving, resulting or converted entity a statement setting forth the aggregate number of shares not voted in favor of the merger, consolidation, conversion, transfer, domestication or continuance (or, in the case of a merger approved pursuant to § 251(h) of this title, the


aggregate number of shares (other than any excluded stock (as defined in § 251(h)(6)d. of this title)) that were the subject of, and were not tendered into, and accepted for purchase or exchange in, the offer referred to in § 251(h)(2) of this title)), and, in either case, with respect to which demands for appraisal have been received and the aggregate number of stockholders or beneficial owners holding or owning such shares (provided that, where a beneficial owner makes a demand pursuant to paragraph (d)(3) of this section, the record holder of such shares shall not be considered a separate stockholder holding such shares for purposes of such aggregate number). Such statement shall be given to the person within 10 days after such person’s request for such a statement is received by the surviving, resulting or converted entity or within 10 days after expiration of the period for delivery of demands for appraisal under subsection (d) of this section, whichever is later.

(f) Upon the filing of any such petition by any person other than the surviving, resulting or converted entity, service of a copy thereof shall be made upon such entity, which shall within 20 days after such service file in the office of the Register in Chancery in which the petition was filed a duly verified list containing the names and addresses of all persons who have demanded appraisal for their shares and with whom agreements as to the value of their shares have not been reached by such entity. If the petition shall be filed by the surviving, resulting or converted entity, the petition shall be accompanied by such a duly verified list. The Register in Chancery, if so ordered by the Court, shall give notice of the time and place fixed for the hearing of such petition by registered or certified mail to the surviving, resulting or converted entity and to the persons shown on the list at the addresses therein stated. The forms of the notices by mail and by publication shall be approved by the Court, and the costs thereof shall be borne by the surviving, resulting or converted entity.

(g) At the hearing on such petition, the Court shall determine the persons who have complied with this section and who have become entitled to appraisal rights. The Court may require the persons who have demanded an appraisal for their shares and who hold stock represented by certificates to submit their certificates of stock to the Register in Chancery for notation thereon of the pendency of the appraisal proceedings; and if any person fails to comply with such direction, the Court may dismiss the proceedings as to such person. If immediately before the merger, consolidation, conversion, transfer, domestication or continuance the shares of the class or series of stock of the constituent, converting, transferring, domesticating or continuing corporation as to which appraisal rights are available were listed on a national securities exchange, the Court shall dismiss the proceedings as to all holders of such shares who are otherwise entitled to appraisal rights unless (1) the total number of shares entitled to appraisal exceeds 1% of the outstanding shares of the class or series eligible for appraisal, (2) the value of the consideration provided in the merger, consolidation, conversion, transfer, domestication or continuance for such total number of shares exceeds $1 million, or (3) the merger was approved pursuant to § 253 or § 267 of this title.

(h) After the Court determines the persons entitled to an appraisal, the appraisal proceeding shall be conducted in accordance with the rules of the Court of Chancery, including any rules specifically governing appraisal proceedings. Through such proceeding the Court shall determine the fair value of the shares exclusive of any element of value arising from the accomplishment or expectation of the merger, consolidation, conversion, transfer, domestication or continuance, together with interest, if any, to be paid upon the amount determined to be the fair value. In determining such fair value, the Court shall take into account all relevant factors. Unless the Court in its discretion determines otherwise for good cause shown, and except as provided in this subsection, interest from the effective date of the merger, consolidation, conversion, transfer, domestication or continuance through the date of payment of the judgment shall be compounded quarterly and shall accrue at 5% over the Federal Reserve discount rate (including any surcharge) as established from time to time during the period between the effective date of the merger, consolidation or conversion and the date of payment of the judgment. At any time before the entry of judgment in the proceedings, the surviving, resulting or converted entity may pay to each person entitled to appraisal an amount in cash, in which case interest shall accrue thereafter as provided herein only upon the sum of (1) the difference, if any, between the amount so paid and the fair value of the shares as determined by the Court, and (2) interest theretofore accrued, unless paid at that time. Upon application by the surviving, resulting or converted entity or by any person entitled to participate in the appraisal proceeding, the Court may, in its discretion, proceed to trial upon the appraisal prior to the final determination of the persons entitled to an appraisal. Any person whose name appears on the list filed by the surviving, resulting or converted entity pursuant to subsection (f) of this section may participate fully in all proceedings until it is finally determined that such person is not entitled to appraisal rights under this section.


(i) The Court shall direct the payment of the fair value of the shares, together with interest, if any, by the surviving, resulting or converted entity to the persons entitled thereto. Payment shall be so made to each such person upon such terms and conditions as the Court may order. The Court’s decree may be enforced as other decrees in the Court of Chancery may be enforced, whether such surviving, resulting or converted entity be an entity of this State or of any state.

(j) The costs of the proceeding may be determined by the Court and taxed upon the parties as the Court deems equitable in the circumstances. Upon application of a person whose name appears on the list filed by the surviving, resulting or converted entity pursuant to subsection (f) of this section who participated in the proceeding and incurred expenses in connection therewith, the Court may order all or a portion of such expenses, including, without limitation, reasonable attorney’s fees and the fees and expenses of experts, to be charged pro rata against the value of all the shares entitled to an appraisal not dismissed pursuant to subsection (k) of this section or subject to such an award pursuant to a reservation of jurisdiction under subsection (k) of this section.

(k) Subject to the remainder of this subsection, from and after the effective date of the merger, consolidation, conversion, transfer, domestication or continuance, no person who has demanded appraisal rights with respect to some or all of such person’s shares as provided in subsection (d) of this section shall be entitled to vote such shares for any purpose or to receive payment of dividends or other distributions on such shares (except dividends or other distributions payable to stockholders of record at a date which is prior to the effective date of the merger, consolidation, conversion, transfer, domestication or continuance). If a person who has made a demand for an appraisal in accordance with this section shall deliver to the surviving, resulting or converted entity a written withdrawal of such person’s demand for an appraisal in respect of some or all of such person’s shares in accordance with subsection (e) of this section, either within 60 days after such effective date or thereafter with the written approval of the corporation, then the right of such person to an appraisal of the shares subject to the withdrawal shall cease. Notwithstanding the foregoing, an appraisal proceeding in the Court of Chancery shall not be dismissed as to any person without the approval of the Court, and such approval may be conditioned upon such terms as the Court deems just, including without limitation, a reservation of jurisdiction for any application to the Court made under subsection (j) of this section; provided, however that this provision shall not affect the right of any person who has not commenced an appraisal proceeding or joined that proceeding as a named party to withdraw such person’s demand for appraisal and to accept the terms offered upon the merger, consolidation, conversion, transfer, domestication or continuance within 60 days after the effective date of the merger, consolidation, conversion, transfer, domestication or continuance, as set forth in subsection (e) of this section. If a petition for an appraisal is not filed within the time provided in subsection (e) of this section, the right to appraisal with respect to all shares shall cease.

(l) The shares or other equity interests of the surviving, resulting or converted entity to which the shares of stock subject to appraisal under this section would have otherwise converted but for an appraisal demand made in accordance with this section shall have the status of authorized but not outstanding shares of stock or other equity interests of the surviving, resulting or converted entity, unless and until the person that has demanded appraisal is no longer entitled to appraisal pursuant to this section.

0001423774SC 13E-3SC 13E3EX-FILING FEESZuora, Inc.SC 14ASC 14Atruetruetruetrue 0001423774 2024-11-22 2024-11-22 0001423774 1 2024-11-22 2024-11-22 0001423774 2 2024-11-22 2024-11-22 0001423774 1 2024-11-22 2024-11-22 0001423774 2 2024-11-22 2024-11-22 iso4217:USD xbrli:pure
 
 
Exhibit 107
CALCULATION OF FILING FEE TABLES
Schedule
13E-3
(Form Type)
Zuora, Inc.
Zodiac Purchaser, L.L.C.
Zodiac Acquisition Sub, Inc.
Zodiac Guarantor, L.L.C.
Zodiac Holdco, L.L.C.
Silver Lake Alpine Associates II, L.P.
SLA Zurich Holdings, L.P.
SLA Zurich GP, L.L.C.
SLA Zurich Aggregator, L.P.
SL Alpine II Aggregator GP, L.L.C.
Silver Lake Alpine II, L.P.
SLAA II (GP), L.L.C.
Silver Lake Group, L.L.C.
Tien Tzuo
(Exact Name of Registrant and Name of Person Filing Statement)
 
 
 

Table 1: Transaction Valuation
 
       
    
Proposed
Maximum
Aggregate Value of
Transaction
   
Fee
Rate
 
Amount of
Filing Fee
 
       
Fees to be Paid
  $ 1,733,922,925.78 (1)    0.00015310    $ 265,463.60 (2) 
       
Fees Previously Paid
  $ 0       $ 0  
       
Total Transaction Valuation
  $ 1,733,922,925.78      
 
       
Total Fees Due for Filing
      $ 265,463.60  
       
Total Fees Previously Paid
      $ 0  
       
Total Fee Offsets
      $ 265,463.60 (3) 
       
Net Fee Due
 
 
 
 
 
 
  $ 0  
Capitalized terms used below but not defined herein shall have the meanings assigned to such terms in the Agreement and Plan of Merger, dated as of October 17, 2024, by and among Zodiac Purchaser, L.L.C., Zodiac Acquisition Sub, Inc. and Zuora, Inc. (the “Merger Agreement”).
 
(1)
Aggregate number of securities to which transaction applies: As of October 15, 2024, the maximum number of shares of Company Common Stock to which this transaction applies is estimated to be 174,478,932, which consists of (1) 153,710,322 shares of outstanding Company Common Stock entitled to receive the per share merger consideration of $10.00; (2) 1,879,999 shares of Company Common Stock underlying outstanding Company Stock Options with a per share exercise price less than the per share merger consideration of $10.00, which may be entitled to receive the per share merger consideration of $10.00 minus any applicable exercise price; (3) 11,651,308 shares of Company Common Stock underlying outstanding Company RSUs, which may be entitled to receive the per share merger consideration of $10.00; (4) 2,244,000 shares of Company Common Stock underlying outstanding Company PSUs (not including certain Company PSUs that vest based on the price of Company Common Stock, and are expected to be forfeited in at the Effective Time), which may be entitled to receive the per share merger consideration of $10.00; and (5) 4,993,303 shares of Company Common Stock available to grant under the Company ESPP.
(2)
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule
0-11
(set forth the amount on which the filing fee is calculated and state how it was determined): Estimated solely for the purposes of calculating the filing fee, as of October 15, 2024, the underlying value of the transaction was calculated based on the sum of (1) the product of 153,710,322 shares of Company Common Stock and the per share merger consideration of $10.00; (2) the product of 1,879,999 shares of Company Common Stock underlying Company Stock Options with a per share exercise price less than the per share merger consideration of $10.00 and $4.22 (which is the difference between the per share merger consideration of $10.00 and the weighted average exercise price of approximately $5.78); (3) the product of 11,651,308 shares of Company Common Stock underlying outstanding Company RSUs and the per share merger consideration of $10.00; (4) the product of 2,244,000 shares of Company Common Stock underlying outstanding Company PSUs (not including certain Company PSUs that vest based on the price of Company Common Stock, and are expected to be forfeited in at the Effective Time) and the per share merger consideration of $10.00; and (5) the product of 4,993,303 shares of Company Common Stock available to grant under the Company ESPP and the per share merger consideration of $10.00. In accordance with Section 14(g) of the Securities Exchange Act of 1934, as amended, the filing fee was determined by multiplying the sum calculated in the preceding sentence by .00015310.
(3)
Zuora, Inc. previously paid $265,463.60 upon the filing o
f its Prelim
inary Proxy Statement on Schedule 14A on November 2
5
, 2024 in connection with the transaction reported hereb
y.
Table 2: Fee Offset Claims and Sources
 
               
    
Registrant
or Filer
Name
   
Form or
Filing Type
   
File
Number
    Initial Filing Date   Filing Date  
Fee Offset
Claimed
   
Fee Paid with
Fee Offset
Source
               
Fee Offset
Claims
     
Schedule 14A
     
001-38451
     November 25, 2024      $ 265,463.60      
               
Fee Offset
Sources
   
Zuora, Inc.
     
Schedule 14A
     
001-38451
         November 25, 2024            $265,463.60 (3)